2519
правок
Нет описания правки |
Нет описания правки |
||
Строка 4: | Строка 4: | ||
! number of publications | ! number of publications | ||
! description from UniProt | ! description from UniProt | ||
|- | |||
|[[CSNK1G2]] | |||
|1 | |||
|Casein kinase I isoform gamma-2 (EC 2.7.11.1) (CKI-gamma 2) [CK1G2] | |||
|- | |||
|[[MYO18B]] | |||
|1 | |||
|Unconventional myosin-XVIIIb | |||
|- | |||
|[[SCN1A]] | |||
|1 | |||
|Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1) [NAC1] [SCN1] | |||
|- | |- | ||
|[[IFNAR2]] | |[[IFNAR2]] | ||
Строка 10: | Строка 22: | ||
|- | |- | ||
|[[HCRT]] | |[[HCRT]] | ||
| | |2 | ||
|Orexin precursor (Hypocretin) (Hcrt) [Contains: Orexin-A (Hypocretin-1) (Hcrt1); Orexin-B (Hypocretin-2) (Hcrt2)] [OX] [PPORX] [PPOX] | |Orexin precursor (Hypocretin) (Hcrt) [Contains: Orexin-A (Hypocretin-1) (Hcrt1); Orexin-B (Hypocretin-2) (Hcrt2)] [OX] [PPORX] [PPOX] | ||
|- | |- | ||
Строка 26: | Строка 38: | ||
|- | |- | ||
|[[PDGFRB]] | |[[PDGFRB]] | ||
| | |3 | ||
|Platelet-derived growth factor receptor beta precursor (EC 2.7.10.1) (PDGF-R-beta) (PDGFR-beta) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD140b antigen) [PDGFR] [PDGFR1] | |Platelet-derived growth factor receptor beta precursor (EC 2.7.10.1) (PDGF-R-beta) (PDGFR-beta) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD140b antigen) [PDGFR] [PDGFR1] | ||
|- | |- | ||
Строка 48: | Строка 60: | ||
|7 | |7 | ||
|Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src) [SRC1] | |Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src) [SRC1] | ||
|- | |||
|[[MBTD1]] | |||
|1 | |||
|MBT domain-containing protein 1 | |||
|- | |- | ||
|[[CIP2A]] | |[[CIP2A]] | ||
| | |2 | ||
|Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen) [KIAA1524] | |Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen) [KIAA1524] | ||
|- | |- | ||
Строка 62: | Строка 78: | ||
|- | |- | ||
|[[BRAF]] | |[[BRAF]] | ||
| | |28 | ||
|Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1) [BRAF1] [RAFB1] | |Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1) [BRAF1] [RAFB1] | ||
|- | |- | ||
|[[HDAC2]] | |[[HDAC2]] | ||
| | |9 | ||
|Histone deacetylase 2 (EC 3.5.1.98) (HD2) | |Histone deacetylase 2 (EC 3.5.1.98) (HD2) | ||
|- | |- | ||
Строка 88: | Строка 104: | ||
|3 | |3 | ||
|Gamma-interferon-inducible protein 16 (Ifi-16) (Interferon-inducible myeloid differentiation transcriptional activator) [IFNGIP1] | |Gamma-interferon-inducible protein 16 (Ifi-16) (Interferon-inducible myeloid differentiation transcriptional activator) [IFNGIP1] | ||
|- | |||
|[[CARMIL1]] | |||
|1 | |||
|F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A) [CARMIL] [LRRC16] [LRRC16A] | |||
|- | |- | ||
|[[TGFB3]] | |[[TGFB3]] | ||
| | |3 | ||
|Transforming growth factor beta-3 proprotein precursor [Contains: Latency-associated peptide (LAP); Transforming growth factor beta-3 (TGF-beta-3)] | |Transforming growth factor beta-3 proprotein precursor [Contains: Latency-associated peptide (LAP); Transforming growth factor beta-3 (TGF-beta-3)] | ||
|- | |- | ||
|[[STAT3]] | |[[STAT3]] | ||
| | |76 | ||
|Signal transducer and activator of transcription 3 (Acute-phase response factor) [APRF] | |Signal transducer and activator of transcription 3 (Acute-phase response factor) [APRF] | ||
|- | |- | ||
|[[DHFR]] | |[[DHFR]] | ||
| | |2 | ||
|Dihydrofolate reductase (EC 1.5.1.3) | |Dihydrofolate reductase (EC 1.5.1.3) | ||
|- | |- | ||
Строка 116: | Строка 136: | ||
|1 | |1 | ||
|Serine/threonine-protein kinase STK11 precursor (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) [LKB1] [PJS] | |Serine/threonine-protein kinase STK11 precursor (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) [LKB1] [PJS] | ||
|- | |||
|[[SPG11]] | |||
|1 | |||
|Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein) [KIAA1840] | |||
|- | |- | ||
|[[RAMP1]] | |[[RAMP1]] | ||
Строка 124: | Строка 148: | ||
|5 | |5 | ||
|Spermine synthase (EC 2.5.1.22) (SPMSY) (Spermidine aminopropyltransferase) | |Spermine synthase (EC 2.5.1.22) (SPMSY) (Spermidine aminopropyltransferase) | ||
|- | |||
|[[LDLRAD4]] | |||
|1 | |||
|Low-density lipoprotein receptor class A domain-containing protein 4 [C18orf1] | |||
|- | |- | ||
|[[BBS5]] | |[[BBS5]] | ||
Строка 130: | Строка 158: | ||
|- | |- | ||
|[[OPA1]] | |[[OPA1]] | ||
| | |17 | ||
|Dynamin-like 120 kDa protein, mitochondrial precursor (EC 3.6.5.5) (Optic atrophy protein 1) [Contains: Dynamin-like 120 kDa protein, form S1] [KIAA0567] | |Dynamin-like 120 kDa protein, mitochondrial precursor (EC 3.6.5.5) (Optic atrophy protein 1) [Contains: Dynamin-like 120 kDa protein, form S1] [KIAA0567] | ||
|- | |- | ||
Строка 138: | Строка 166: | ||
|- | |- | ||
|[[UCHL1]] | |[[UCHL1]] | ||
| | |8 | ||
|Ubiquitin carboxyl-terminal hydrolase isozyme L1 precursor (EC 3.4.19.12) (UCH-L1) (Neuron cytoplasmic protein 9.5) (PGP 9.5) (PGP9.5) (Ubiquitin thioesterase L1) | |Ubiquitin carboxyl-terminal hydrolase isozyme L1 precursor (EC 3.4.19.12) (UCH-L1) (Neuron cytoplasmic protein 9.5) (PGP 9.5) (PGP9.5) (Ubiquitin thioesterase L1) | ||
|- | |- | ||
Строка 146: | Строка 174: | ||
|- | |- | ||
|[[BRCA1]] | |[[BRCA1]] | ||
| | |34 | ||
|Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) [RNF53] | |Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) [RNF53] | ||
|- | |- | ||
|[[FMR1]] | |[[FMR1]] | ||
| | |10 | ||
|Synaptic functional regulator FMR1 (Fragile X mental retardation protein 1) (FMRP) (Protein FMR-1) | |Synaptic functional regulator FMR1 (Fragile X mental retardation protein 1) (FMRP) (Protein FMR-1) | ||
|- | |||
|[[WAC]] | |||
|1 | |||
|WW domain-containing adapter protein with coiled-coil [KIAA1844] | |||
|- | |- | ||
|[[MAP1A]] | |[[MAP1A]] | ||
Строка 162: | Строка 194: | ||
|- | |- | ||
|[[IL13]] | |[[IL13]] | ||
| | |3 | ||
|Interleukin-13 precursor (IL-13) [NC30] | |Interleukin-13 precursor (IL-13) [NC30] | ||
|- | |||
|[[HNMT]] | |||
|1 | |||
|Histamine N-methyltransferase (EC 2.1.1.8) (HMT) | |||
|- | |- | ||
|[[GPX4]] | |[[GPX4]] | ||
Строка 178: | Строка 214: | ||
|- | |- | ||
|[[FAR2]] | |[[FAR2]] | ||
| | |2 | ||
|Fatty acyl-CoA reductase 2 (EC 1.2.1.84) (Male sterility domain-containing protein 1) [MLSTD1] | |Fatty acyl-CoA reductase 2 (EC 1.2.1.84) (Male sterility domain-containing protein 1) [MLSTD1] | ||
|- | |- | ||
Строка 210: | Строка 246: | ||
|- | |- | ||
|[[CTH]] | |[[CTH]] | ||
| | |4 | ||
|Cystathionine gamma-lyase (EC 4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) | |Cystathionine gamma-lyase (EC 4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) | ||
|- | |- | ||
Строка 234: | Строка 270: | ||
|- | |- | ||
|[[OSM]] | |[[OSM]] | ||
| | |4 | ||
|Oncostatin-M precursor (OSM) | |Oncostatin-M precursor (OSM) | ||
|- | |- | ||
Строка 244: | Строка 280: | ||
|1 | |1 | ||
|Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD168 antigen) [IHABP] [RHAMM] | |Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD168 antigen) [IHABP] [RHAMM] | ||
|- | |||
|[[VPS4A]] | |||
|1 | |||
|Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4) [VPS4] | |||
|- | |- | ||
|[[EDN1]] | |[[EDN1]] | ||
| | |3 | ||
|Endothelin-1 precursor (Preproendothelin-1) (PPET1) [Contains: Endothelin-1 (ET-1); Big endothelin-1] | |Endothelin-1 precursor (Preproendothelin-1) (PPET1) [Contains: Endothelin-1 (ET-1); Big endothelin-1] | ||
|- | |- | ||
|[[IGFBP3]] | |[[IGFBP3]] | ||
| | |16 | ||
|Insulin-like growth factor-binding protein 3 precursor (IBP-3) (IGF-binding protein 3) (IGFBP-3) [IBP3] | |Insulin-like growth factor-binding protein 3 precursor (IBP-3) (IGF-binding protein 3) (IGFBP-3) [IBP3] | ||
|- | |- | ||
|[[MSC]] | |[[MSC]] | ||
| | |231 | ||
|Musculin (Activated B-cell factor 1) (ABF-1) (Class A basic helix-loop-helix protein 22) (bHLHa22) [ABF1] [BHLHA22] | |Musculin (Activated B-cell factor 1) (ABF-1) (Class A basic helix-loop-helix protein 22) (bHLHa22) [ABF1] [BHLHA22] | ||
|- | |- | ||
Строка 292: | Строка 332: | ||
|1 | |1 | ||
|Nucleobindin-2 precursor (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Contains: Nesfatin-1] [NEFA] | |Nucleobindin-2 precursor (DNA-binding protein NEFA) (Epididymis secretory protein Li 109) (Gastric cancer antigen Zg4) (Prepronesfatin) [Contains: Nesfatin-1] [NEFA] | ||
|- | |||
|[[P2RX7]] | |||
|2 | |||
|P2X purinoceptor 7 (P2X7) (ATP receptor) (P2Z receptor) (Purinergic receptor) | |||
|- | |- | ||
|[[ACTR3B]] | |[[ACTR3B]] | ||
Строка 300: | Строка 344: | ||
|3 | |3 | ||
|Transcription factor HES-1 (Class B basic helix-loop-helix protein 39) (bHLHb39) (Hairy and enhancer of split 1) (Hairy homolog) (Hairy-like protein) (hHL) [BHLHB39] [HL] [HRY] | |Transcription factor HES-1 (Class B basic helix-loop-helix protein 39) (bHLHb39) (Hairy and enhancer of split 1) (Hairy homolog) (Hairy-like protein) (hHL) [BHLHB39] [HL] [HRY] | ||
|- | |||
|[[SNRPE]] | |||
|1 | |||
|Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE) | |||
|- | |- | ||
|[[MOS]] | |[[MOS]] | ||
| | |11 | ||
|Proto-oncogene serine/threonine-protein kinase mos (EC 2.7.11.1) (Oocyte maturation factor mos) (Proto-oncogene c-Mos) | |Proto-oncogene serine/threonine-protein kinase mos (EC 2.7.11.1) (Oocyte maturation factor mos) (Proto-oncogene c-Mos) | ||
|- | |- | ||
|[[NES]] | |[[NES]] | ||
| | |4 | ||
|Nestin [Nbla00170] | |Nestin [Nbla00170] | ||
|- | |- | ||
Строка 314: | Строка 362: | ||
|- | |- | ||
|[[FGG]] | |[[FGG]] | ||
| | |2 | ||
|Fibrinogen gamma chain precursor [PRO2061] | |Fibrinogen gamma chain precursor [PRO2061] | ||
|- | |- | ||
Строка 322: | Строка 370: | ||
|- | |- | ||
|[[RET]] | |[[RET]] | ||
| | |18 | ||
|Proto-oncogene tyrosine-protein kinase receptor Ret precursor (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Contains: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] [CDHF12] [CDHR16] [PTC] [RET51] | |Proto-oncogene tyrosine-protein kinase receptor Ret precursor (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Contains: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] [CDHF12] [CDHR16] [PTC] [RET51] | ||
|- | |- | ||
Строка 334: | Строка 382: | ||
|- | |- | ||
|[[DRD1]] | |[[DRD1]] | ||
| | |2 | ||
|D(1A) dopamine receptor (Dopamine D1 receptor) | |D(1A) dopamine receptor (Dopamine D1 receptor) | ||
|- | |- | ||
|[[PSMB8]] | |[[PSMB8]] | ||
| | |2 | ||
|Proteasome subunit beta type-8 precursor (EC 3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 protein) [LMP7] [PSMB5i] [RING10] [Y2] | |Proteasome subunit beta type-8 precursor (EC 3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 protein) [LMP7] [PSMB5i] [RING10] [Y2] | ||
|- | |- | ||
Строка 352: | Строка 400: | ||
|1 | |1 | ||
|Dyslexia-associated protein KIAA0319 precursor | |Dyslexia-associated protein KIAA0319 precursor | ||
|- | |||
|[[CDK16]] | |||
|1 | |||
|Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1) [PCTAIRE1] [PCTK1] | |||
|- | |- | ||
|[[OAT]] | |[[OAT]] | ||
|2 | |2 | ||
|Ornithine aminotransferase, mitochondrial precursor (EC 2.6.1.13) (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Contains: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form] | |Ornithine aminotransferase, mitochondrial precursor (EC 2.6.1.13) (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Contains: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form] | ||
|- | |||
|[[CDKN2C]] | |||
|1 | |||
|Cyclin-dependent kinase 4 inhibitor C (Cyclin-dependent kinase 6 inhibitor) (p18-INK4c) (p18-INK6) [CDKN6] | |||
|- | |||
|[[GPR4]] | |||
|1 | |||
|G-protein coupled receptor 4 (G-protein coupled receptor 6C.l) (GPR6C.l) | |||
|- | |- | ||
|[[AOX1]] | |[[AOX1]] | ||
Строка 373: | Строка 433: | ||
|Protein NDNF precursor (Neuron-derived neurotrophic factor) [C4orf31] [UNQ2748/PRO6487] | |Protein NDNF precursor (Neuron-derived neurotrophic factor) [C4orf31] [UNQ2748/PRO6487] | ||
|- | |- | ||
|[[ | |[[SPO11]] | ||
|1 | |1 | ||
| | |Meiotic recombination protein SPO11 (EC 5.6.2.2) (Cancer/testis antigen 35) (CT35) | ||
|- | |- | ||
|[[HOPX]] | |[[HOPX]] | ||
Строка 382: | Строка 442: | ||
|- | |- | ||
|[[LRP1]] | |[[LRP1]] | ||
| | |7 | ||
|Prolow-density lipoprotein receptor-related protein 1 precursor (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD91 antigen) [Contains: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] [A2MR] [APR] | |Prolow-density lipoprotein receptor-related protein 1 precursor (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD91 antigen) [Contains: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)] [A2MR] [APR] | ||
|- | |- | ||
|[[MAPT]] | |[[MAPT]] | ||
| | |24 | ||
|Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) [MAPTL] [MTBT1] [TAU] | |Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) [MAPTL] [MTBT1] [TAU] | ||
|- | |- | ||
|[[RXRG]] | |[[RXRG]] | ||
| | |2 | ||
|Retinoic acid receptor RXR-gamma (Nuclear receptor subfamily 2 group B member 3) (Retinoid X receptor gamma) [NR2B3] | |Retinoic acid receptor RXR-gamma (Nuclear receptor subfamily 2 group B member 3) (Retinoid X receptor gamma) [NR2B3] | ||
|- | |- | ||
Строка 396: | Строка 456: | ||
|1 | |1 | ||
|RAB6-interacting golgin (N-terminal kinase-like-binding protein 1) (NTKL-BP1) (NTKL-binding protein 1) (hNTKL-BP1) (SCY1-like 1-binding protein 1) (SCYL1-BP1) (SCYL1-binding protein 1) [NTKLBP1] [SCYL1BP1] | |RAB6-interacting golgin (N-terminal kinase-like-binding protein 1) (NTKL-BP1) (NTKL-binding protein 1) (hNTKL-BP1) (SCY1-like 1-binding protein 1) (SCYL1-BP1) (SCYL1-binding protein 1) [NTKLBP1] [SCYL1BP1] | ||
|- | |||
|[[TMEM127]] | |||
|1 | |||
|Transmembrane protein 127 | |||
|- | |- | ||
|[[RDX]] | |[[RDX]] | ||
| | |1 | ||
|Radixin | |Radixin | ||
|- | |- | ||
Строка 406: | Строка 470: | ||
|- | |- | ||
|[[NEIL2]] | |[[NEIL2]] | ||
| | |2 | ||
|Endonuclease 8-like 2 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil2) (DNA-(apurinic or apyrimidinic site) lyase Neil2) (Endonuclease VIII-like 2) (Nei homolog 2) (NEH2) (Nei-like protein 2) | |Endonuclease 8-like 2 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil2) (DNA-(apurinic or apyrimidinic site) lyase Neil2) (Endonuclease VIII-like 2) (Nei homolog 2) (NEH2) (Nei-like protein 2) | ||
|- | |- | ||
|[[PABPN1]] | |[[PABPN1]] | ||
| | |4 | ||
|Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1) [PAB2] [PABP2] | |Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1) [PAB2] [PABP2] | ||
|- | |- | ||
Строка 438: | Строка 502: | ||
|- | |- | ||
|[[RRM2]] | |[[RRM2]] | ||
| | |3 | ||
|Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit) [RR2] | |Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit) [RR2] | ||
|- | |- | ||
|[[ARC]] | |[[ARC]] | ||
| | |55 | ||
|Activity-regulated cytoskeleton-associated protein (hArc) (Activity-regulated gene 3.1 protein homolog) (ARC/ARG3.1) (Arg3.1) [KIAA0278] | |Activity-regulated cytoskeleton-associated protein (hArc) (Activity-regulated gene 3.1 protein homolog) (ARC/ARG3.1) (Arg3.1) [KIAA0278] | ||
|- | |- | ||
Строка 450: | Строка 514: | ||
|- | |- | ||
|[[NDUFB8]] | |[[NDUFB8]] | ||
| | |6 | ||
|NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial precursor (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit) | |NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial precursor (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit) | ||
|- | |- | ||
Строка 456: | Строка 520: | ||
|3 | |3 | ||
|Heat shock factor protein 2 (HSF 2) (Heat shock transcription factor 2) (HSTF 2) [HSTF2] | |Heat shock factor protein 2 (HSF 2) (Heat shock transcription factor 2) (HSTF 2) [HSTF2] | ||
|- | |- | ||
|[[KCNAB3]] | |[[KCNAB3]] | ||
Строка 472: | Строка 532: | ||
|3 | |3 | ||
|ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4) [RECQ4] | |ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4) [RECQ4] | ||
|- | |||
|[[MMP20]] | |||
|1 | |||
|Matrix metalloproteinase-20 precursor (EC 3.4.24.-) (MMP-20) (Enamel metalloproteinase) (Enamelysin) | |||
|- | |- | ||
|[[NGFR]] | |[[NGFR]] | ||
| | |3 | ||
|Tumor necrosis factor receptor superfamily member 16 precursor (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD) (CD271 antigen) [TNFRSF16] | |Tumor necrosis factor receptor superfamily member 16 precursor (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD) (CD271 antigen) [TNFRSF16] | ||
|- | |- | ||
|[[IQGAP1]] | |[[IQGAP1]] | ||
| | |3 | ||
|Ras GTPase-activating-like protein IQGAP1 (p195) [KIAA0051] | |Ras GTPase-activating-like protein IQGAP1 (p195) [KIAA0051] | ||
|- | |- | ||
Строка 494: | Строка 558: | ||
|- | |- | ||
|[[PAK1]] | |[[PAK1]] | ||
| | |6 | ||
|Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK) | |Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK) | ||
|- | |- | ||
Строка 504: | Строка 568: | ||
|1 | |1 | ||
|Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Sb1.8) [DXS423E] [KIAA0178] [SB1.8] [SMC1] [SMC1L1] | |Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Sb1.8) [DXS423E] [KIAA0178] [SB1.8] [SMC1] [SMC1L1] | ||
|- | |||
|[[DYNLT3]] | |||
|1 | |||
|Dynein light chain Tctex-type 3 (Protein 91/23) (T-complex-associated testis-expressed 1-like) [TCTE1L] [TCTE1XL] | |||
|- | |- | ||
|[[C4B]] | |[[C4B]] | ||
Строка 526: | Строка 594: | ||
|- | |- | ||
|[[FASN]] | |[[FASN]] | ||
| | |3 | ||
|Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)] [FAS] | |Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)] [FAS] | ||
|- | |||
|[[UBE2T]] | |||
|1 | |||
|Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (Cell proliferation-inducing gene 50 protein) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T) [HSPC150] [PIG50] | |||
|- | |- | ||
|[[TLR1]] | |[[TLR1]] | ||
Строка 546: | Строка 618: | ||
|- | |- | ||
|[[CPM]] | |[[CPM]] | ||
| | |14 | ||
|Carboxypeptidase M precursor (EC 3.4.17.12) (CPM) | |Carboxypeptidase M precursor (EC 3.4.17.12) (CPM) | ||
|- | |- | ||
|[[MPI]] | |[[MPI]] | ||
| | |16 | ||
|Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI) [PMI1] | |Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI) [PMI1] | ||
|- | |||
|[[GP9]] | |||
|1 | |||
|Platelet glycoprotein IX precursor (GP-IX) (GPIX) (Glycoprotein 9) (CD42a antigen) | |||
|- | |- | ||
|[[TYRO3]] | |[[TYRO3]] | ||
Строка 560: | Строка 636: | ||
|1 | |1 | ||
|Diamine acetyltransferase 1 (EC 2.3.1.57) (Polyamine N-acetyltransferase 1) (Putrescine acetyltransferase) (Spermidine/spermine N(1)-acetyltransferase 1) (SSAT) (SSAT-1) [SAT] | |Diamine acetyltransferase 1 (EC 2.3.1.57) (Polyamine N-acetyltransferase 1) (Putrescine acetyltransferase) (Spermidine/spermine N(1)-acetyltransferase 1) (SSAT) (SSAT-1) [SAT] | ||
|- | |||
|[[DOCK7]] | |||
|1 | |||
|Dedicator of cytokinesis protein 7 [KIAA1771] | |||
|- | |- | ||
|[[GADD45B]] | |[[GADD45B]] | ||
Строка 586: | Строка 666: | ||
|- | |- | ||
|[[SORL1]] | |[[SORL1]] | ||
| | |11 | ||
|Sortilin-related receptor precursor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) [C11orf32] | |Sortilin-related receptor precursor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA) [C11orf32] | ||
|- | |- | ||
Строка 594: | Строка 674: | ||
|- | |- | ||
|[[BMP2]] | |[[BMP2]] | ||
| | |9 | ||
|Bone morphogenetic protein 2 precursor (BMP-2) (Bone morphogenetic protein 2A) (BMP-2A) [BMP2A] | |Bone morphogenetic protein 2 precursor (BMP-2) (Bone morphogenetic protein 2A) (BMP-2A) [BMP2A] | ||
|- | |- | ||
|[[FOXO1]] | |[[FOXO1]] | ||
| | |38 | ||
|Forkhead box protein O1 (Forkhead box protein O1A) (Forkhead in rhabdomyosarcoma) [FKHR] [FOXO1A] | |Forkhead box protein O1 (Forkhead box protein O1A) (Forkhead in rhabdomyosarcoma) [FKHR] [FOXO1A] | ||
|- | |- | ||
Строка 604: | Строка 684: | ||
|2 | |2 | ||
|[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial precursor (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 4) [PDHK4] | |[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial precursor (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 4) [PDHK4] | ||
|- | |||
|[[ETS2]] | |||
|2 | |||
|Protein C-ets-2 | |||
|- | |||
|[[RAB27A]] | |||
|1 | |||
|Ras-related protein Rab-27A (EC 3.6.5.2) (Rab-27) (GTP-binding protein Ram) [RAB27] | |||
|- | |- | ||
|[[TRIM28]] | |[[TRIM28]] | ||
Строка 618: | Строка 706: | ||
|- | |- | ||
|[[MET]] | |[[MET]] | ||
| | |43 | ||
|Hepatocyte growth factor receptor precursor (EC 2.7.10.1) (HGF receptor) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) | |Hepatocyte growth factor receptor precursor (EC 2.7.10.1) (HGF receptor) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) | ||
|- | |||
|[[RFWD3]] | |||
|1 | |||
|E3 ubiquitin-protein ligase RFWD3 (EC 2.3.2.27) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) [RNF201] | |||
|- | |- | ||
|[[MLKL]] | |[[MLKL]] | ||
| | |5 | ||
|Mixed lineage kinase domain-like protein (hMLKL) | |Mixed lineage kinase domain-like protein (hMLKL) | ||
|- | |- | ||
Строка 638: | Строка 730: | ||
|- | |- | ||
|[[MC4R]] | |[[MC4R]] | ||
| | |2 | ||
|Melanocortin receptor 4 (MC4-R) | |Melanocortin receptor 4 (MC4-R) | ||
|- | |- | ||
Строка 646: | Строка 738: | ||
|- | |- | ||
|[[FSTL1]] | |[[FSTL1]] | ||
| | |2 | ||
|Follistatin-related protein 1 precursor (Follistatin-like protein 1) [FRP] | |Follistatin-related protein 1 precursor (Follistatin-like protein 1) [FRP] | ||
|- | |- | ||
|[[PAH]] | |[[PAH]] | ||
| | |27 | ||
|Phenylalanine-4-hydroxylase (EC 1.14.16.1) (PAH) (Phe-4-monooxygenase) | |Phenylalanine-4-hydroxylase (EC 1.14.16.1) (PAH) (Phe-4-monooxygenase) | ||
|- | |- | ||
|[[AR]] | |[[AR]] | ||
| | |88 | ||
|Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) [DHTR] [NR3C4] | |Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) [DHTR] [NR3C4] | ||
|- | |- | ||
Строка 664: | Строка 756: | ||
|3 | |3 | ||
|NADPH oxidase 1 (EC 1.-.-.-) (NOX-1) (Mitogenic oxidase 1) (MOX-1) (NADH/NADPH mitogenic oxidase subunit P65-MOX) (NOH-1) [MOX1] [NOH1] | |NADPH oxidase 1 (EC 1.-.-.-) (NOX-1) (Mitogenic oxidase 1) (MOX-1) (NADH/NADPH mitogenic oxidase subunit P65-MOX) (NOH-1) [MOX1] [NOH1] | ||
|- | |||
|[[HAT1]] | |||
|2 | |||
|Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1) [KAT1] | |||
|- | |- | ||
|[[EYS]] | |[[EYS]] | ||
Строка 674: | Строка 770: | ||
|- | |- | ||
|[[FADD]] | |[[FADD]] | ||
| | |10 | ||
|FAS-associated death domain protein (FAS-associating death domain-containing protein) (Growth-inhibiting gene 3 protein) (Mediator of receptor induced toxicity) (Protein FADD) [MORT1] [GIG3] | |FAS-associated death domain protein (FAS-associating death domain-containing protein) (Growth-inhibiting gene 3 protein) (Mediator of receptor induced toxicity) (Protein FADD) [MORT1] [GIG3] | ||
|- | |- | ||
Строка 684: | Строка 780: | ||
|1 | |1 | ||
|Epithelial discoidin domain-containing receptor 1 precursor (EC 2.7.10.1) (Epithelial discoidin domain receptor 1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD167a antigen) [CAK] [EDDR1] [NEP] [NTRK4] [PTK3A] [RTK6] [TRKE] | |Epithelial discoidin domain-containing receptor 1 precursor (EC 2.7.10.1) (Epithelial discoidin domain receptor 1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD167a antigen) [CAK] [EDDR1] [NEP] [NTRK4] [PTK3A] [RTK6] [TRKE] | ||
|- | |||
|[[ETNK2]] | |||
|1 | |||
|Ethanolamine kinase 2 (EC 2.7.1.82) (EKI 2) (Ethanolamine kinase-like protein) [EKI2] [HMFT1716] | |||
|- | |||
|[[HAUS4]] | |||
|1 | |||
|HAUS augmin-like complex subunit 4 [C14orf94] | |||
|- | |- | ||
|[[ST18]] | |[[ST18]] | ||
Строка 690: | Строка 794: | ||
|- | |- | ||
|[[IGF1R]] | |[[IGF1R]] | ||
| | |17 | ||
|Insulin-like growth factor 1 receptor precursor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD221 antigen) [Contains: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] | |Insulin-like growth factor 1 receptor precursor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD221 antigen) [Contains: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] | ||
|- | |- | ||
Строка 706: | Строка 810: | ||
|- | |- | ||
|[[SP1]] | |[[SP1]] | ||
| | |5 | ||
|Transcription factor Sp1 [TSFP1] | |Transcription factor Sp1 [TSFP1] | ||
|- | |- | ||
Строка 716: | Строка 820: | ||
|1 | |1 | ||
|Cip1-interacting zinc finger protein (CDKN1A-interacting zinc finger protein 1) (Nuclear protein NP94) (Zinc finger protein 356) [LSFR1] [NP94] [ZNF356] | |Cip1-interacting zinc finger protein (CDKN1A-interacting zinc finger protein 1) (Nuclear protein NP94) (Zinc finger protein 356) [LSFR1] [NP94] [ZNF356] | ||
|- | |||
|[[TFG]] | |||
|1 | |||
|Protein TFG (TRK-fused gene protein) | |||
|- | |- | ||
|[[RORA]] | |[[RORA]] | ||
Строка 722: | Строка 830: | ||
|- | |- | ||
|[[DDT]] | |[[DDT]] | ||
| | |29 | ||
|D-dopachrome decarboxylase (EC 4.1.1.84) (D-dopachrome tautomerase) (Phenylpyruvate tautomerase II) | |D-dopachrome decarboxylase (EC 4.1.1.84) (D-dopachrome tautomerase) (Phenylpyruvate tautomerase II) | ||
|- | |- | ||
|[[FOXP2]] | |[[FOXP2]] | ||
| | |2 | ||
|Forkhead box protein P2 (CAG repeat protein 44) (Trinucleotide repeat-containing gene 10 protein) [CAGH44] [TNRC10] | |Forkhead box protein P2 (CAG repeat protein 44) (Trinucleotide repeat-containing gene 10 protein) [CAGH44] [TNRC10] | ||
|- | |- | ||
Строка 732: | Строка 840: | ||
|1 | |1 | ||
|Moesin (Membrane-organizing extension spike protein) | |Moesin (Membrane-organizing extension spike protein) | ||
|- | |||
|[[TDRD6]] | |||
|1 | |||
|Tudor domain-containing protein 6 (Antigen NY-CO-45) (Cancer/testis antigen 41.2) (CT41.2) | |||
|- | |||
|[[EHMT1]] | |||
|1 | |||
|Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) [EUHMTASE1] [GLP] [KIAA1876] [KMT1D] | |||
|- | |- | ||
|[[STC2]] | |[[STC2]] | ||
Строка 738: | Строка 854: | ||
|- | |- | ||
|[[CXCR5]] | |[[CXCR5]] | ||
| | |4 | ||
|C-X-C chemokine receptor type 5 (CXC-R5) (CXCR-5) (Burkitt lymphoma receptor 1) (Monocyte-derived receptor 15) (MDR-15) (CD185 antigen) [BLR1] [MDR15] | |C-X-C chemokine receptor type 5 (CXC-R5) (CXCR-5) (Burkitt lymphoma receptor 1) (Monocyte-derived receptor 15) (MDR-15) (CD185 antigen) [BLR1] [MDR15] | ||
|- | |- | ||
Строка 746: | Строка 862: | ||
|- | |- | ||
|[[EFS]] | |[[EFS]] | ||
| | |14 | ||
|Embryonal Fyn-associated substrate (hEFS) (Cas scaffolding protein family member 3) [CASS3] | |Embryonal Fyn-associated substrate (hEFS) (Cas scaffolding protein family member 3) [CASS3] | ||
|- | |- | ||
Строка 758: | Строка 874: | ||
|- | |- | ||
|[[OGG1]] | |[[OGG1]] | ||
| | |17 | ||
|N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (EC 4.2.99.18) (AP lyase)] [MMH] [MUTM] [OGH1] | |N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (EC 4.2.99.18) (AP lyase)] [MMH] [MUTM] [OGH1] | ||
|- | |- | ||
Строка 770: | Строка 886: | ||
|- | |- | ||
|[[PGAM1]] | |[[PGAM1]] | ||
| | |2 | ||
|Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B) [PGAMA] [CDABP0006] | |Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B) [PGAMA] [CDABP0006] | ||
|- | |- | ||
|[[SFN]] | |[[SFN]] | ||
| | |15 | ||
|14-3-3 protein sigma (Epithelial cell marker protein 1) (Stratifin) [HME1] | |14-3-3 protein sigma (Epithelial cell marker protein 1) (Stratifin) [HME1] | ||
|- | |- | ||
|[[BMI1]] | |[[BMI1]] | ||
| | |10 | ||
|Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4) (RING finger protein 51) [PCGF4] [RNF51] | |Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4) (RING finger protein 51) [PCGF4] [RNF51] | ||
|- | |- | ||
Строка 798: | Строка 914: | ||
|- | |- | ||
|[[PTN]] | |[[PTN]] | ||
| | |4 | ||
|Pleiotrophin precursor (PTN) (Heparin-binding brain mitogen) (HBBM) (Heparin-binding growth factor 8) (HBGF-8) (Heparin-binding growth-associated molecule) (HB-GAM) (Heparin-binding neurite outgrowth-promoting factor) (HBNF) (Heparin-binding neurite outgrowth-promoting factor 1) (HBNF-1) (Osteoblast-specific factor 1) (OSF-1) [HBNF1] [NEGF1] | |Pleiotrophin precursor (PTN) (Heparin-binding brain mitogen) (HBBM) (Heparin-binding growth factor 8) (HBGF-8) (Heparin-binding growth-associated molecule) (HB-GAM) (Heparin-binding neurite outgrowth-promoting factor) (HBNF) (Heparin-binding neurite outgrowth-promoting factor 1) (HBNF-1) (Osteoblast-specific factor 1) (OSF-1) [HBNF1] [NEGF1] | ||
|- | |- | ||
Строка 808: | Строка 924: | ||
|1 | |1 | ||
|Urocortin precursor | |Urocortin precursor | ||
|- | |||
|[[ACO2]] | |||
|1 | |||
|Aconitate hydratase, mitochondrial precursor (EC 4.2.1.3) (Aconitase) (Citrate hydro-lyase) | |||
|- | |||
|[[ASF1A]] | |||
|1 | |||
|Histone chaperone ASF1A (Anti-silencing function protein 1 homolog A) (hAsf1) (hAsf1a) (CCG1-interacting factor A) (CIA) (hCIA) [CGI-98] [HSPC146] | |||
|- | |- | ||
|[[IGFBP7]] | |[[IGFBP7]] | ||
Строка 816: | Строка 940: | ||
|1 | |1 | ||
|E3 ubiquitin-protein ligase Arkadia (EC 2.3.2.27) (RING finger protein 111) (hRNF111) (RING-type E3 ubiquitin transferase Arkadia) | |E3 ubiquitin-protein ligase Arkadia (EC 2.3.2.27) (RING finger protein 111) (hRNF111) (RING-type E3 ubiquitin transferase Arkadia) | ||
|- | |||
|[[NSD1]] | |||
|1 | |||
|Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein) [ARA267] [KMT3B] | |||
|- | |- | ||
|[[RPS6]] | |[[RPS6]] | ||
| | |4 | ||
|40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6) [OK/SW-cl.2] | |40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6) [OK/SW-cl.2] | ||
|- | |- | ||
Строка 830: | Строка 958: | ||
|- | |- | ||
|[[GDF15]] | |[[GDF15]] | ||
| | |24 | ||
|Growth/differentiation factor 15 precursor (GDF-15) (Macrophage inhibitory cytokine 1) (MIC-1) (NSAID-activated gene 1 protein) (NAG-1) (NSAID-regulated gene 1 protein) (NRG-1) (Placental TGF-beta) (Placental bone morphogenetic protein) (Prostate differentiation factor) [MIC1] [PDF] [PLAB] [PTGFB] | |Growth/differentiation factor 15 precursor (GDF-15) (Macrophage inhibitory cytokine 1) (MIC-1) (NSAID-activated gene 1 protein) (NAG-1) (NSAID-regulated gene 1 protein) (NRG-1) (Placental TGF-beta) (Placental bone morphogenetic protein) (Prostate differentiation factor) [MIC1] [PDF] [PLAB] [PTGFB] | ||
|- | |- | ||
|[[LAMP1]] | |[[LAMP1]] | ||
| | |9 | ||
|Lysosome-associated membrane glycoprotein 1 precursor (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD107a antigen) | |Lysosome-associated membrane glycoprotein 1 precursor (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD107a antigen) | ||
|- | |- | ||
Строка 842: | Строка 970: | ||
|- | |- | ||
|[[COMT]] | |[[COMT]] | ||
| | |30 | ||
|Catechol O-methyltransferase (EC 2.1.1.6) | |Catechol O-methyltransferase (EC 2.1.1.6) | ||
|- | |- | ||
|[[LIPA]] | |[[LIPA]] | ||
| | |2 | ||
|Lysosomal acid lipase/cholesteryl ester hydrolase precursor (EC 3.1.1.13) (Acid cholesteryl ester hydrolase) (LAL) (Cholesteryl esterase) (Lipase A) (Sterol esterase) | |Lysosomal acid lipase/cholesteryl ester hydrolase precursor (EC 3.1.1.13) (Acid cholesteryl ester hydrolase) (LAL) (Cholesteryl esterase) (Lipase A) (Sterol esterase) | ||
|- | |- | ||
|[[DNMT3A]] | |[[DNMT3A]] | ||
| | |22 | ||
|DNA (cytosine-5)-methyltransferase 3A (EC 2.1.1.37) (Dnmt3a) (DNA methyltransferase HsaIIIA) (DNA MTase HsaIIIA) (M.HsaIIIA) | |DNA (cytosine-5)-methyltransferase 3A (EC 2.1.1.37) (Dnmt3a) (DNA methyltransferase HsaIIIA) (DNA MTase HsaIIIA) (M.HsaIIIA) | ||
|- | |- | ||
Строка 860: | Строка 988: | ||
|1 | |1 | ||
|Inositol hexakisphosphate kinase 1 (EC 2.7.4.21) (InsP6 kinase 1) (Inositol hexaphosphate kinase 1) [IHPK1] [KIAA0263] | |Inositol hexakisphosphate kinase 1 (EC 2.7.4.21) (InsP6 kinase 1) (Inositol hexaphosphate kinase 1) [IHPK1] [KIAA0263] | ||
|- | |||
|[[GAR1]] | |||
|1 | |||
|H/ACA ribonucleoprotein complex subunit 1 (Nucleolar protein family A member 1) (snoRNP protein GAR1) [NOLA1] | |||
|- | |- | ||
|[[SPARCL1]] | |[[SPARCL1]] | ||
Строка 870: | Строка 1002: | ||
|- | |- | ||
|[[NBR1]] | |[[NBR1]] | ||
| | |5 | ||
|Next to BRCA1 gene 1 protein (Cell migration-inducing gene 19 protein) (Membrane component chromosome 17 surface marker 2) (Neighbor of BRCA1 gene 1 protein) (Protein 1A1-3B) [1A13B] [KIAA0049] [M17S2] [MIG19] | |Next to BRCA1 gene 1 protein (Cell migration-inducing gene 19 protein) (Membrane component chromosome 17 surface marker 2) (Neighbor of BRCA1 gene 1 protein) (Protein 1A1-3B) [1A13B] [KIAA0049] [M17S2] [MIG19] | ||
|- | |- | ||
Строка 882: | Строка 1014: | ||
|- | |- | ||
|[[CFH]] | |[[CFH]] | ||
| | |16 | ||
|Complement factor H precursor (H factor 1) [HF] [HF1] [HF2] | |Complement factor H precursor (H factor 1) [HF] [HF1] [HF2] | ||
|- | |- | ||
|[[RGN]] | |[[RGN]] | ||
| | |4 | ||
|Regucalcin (RC) (Gluconolactonase) (EC 3.1.1.17) (GNL) (Senescence marker protein 30) (SMP-30) [SMP30] | |Regucalcin (RC) (Gluconolactonase) (EC 3.1.1.17) (GNL) (Senescence marker protein 30) (SMP-30) [SMP30] | ||
|- | |- | ||
|[[MCM7]] | |[[MCM7]] | ||
| | |4 | ||
|DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3) [CDC47] [MCM2] | |DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3) [CDC47] [MCM2] | ||
|- | |- | ||
Строка 902: | Строка 1034: | ||
|- | |- | ||
|[[CD44]] | |[[CD44]] | ||
| | |45 | ||
|CD44 antigen precursor (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) [LHR] [MDU2] [MDU3] [MIC4] | |CD44 antigen precursor (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) [LHR] [MDU2] [MDU3] [MIC4] | ||
|- | |- | ||
|[[PRNP]] | |[[PRNP]] | ||
| | |3 | ||
|Major prion protein precursor (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD230 antigen) [ALTPRP] [PRIP] [PRP] | |Major prion protein precursor (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD230 antigen) [ALTPRP] [PRIP] [PRP] | ||
|- | |- | ||
|[[GSC]] | |[[GSC]] | ||
| | |23 | ||
|Homeobox protein goosecoid | |Homeobox protein goosecoid | ||
|- | |- | ||
Строка 920: | Строка 1052: | ||
|6 | |6 | ||
|Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule) [CHIP28] | |Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule) [CHIP28] | ||
|- | |||
|[[IMMT]] | |||
|1 | |||
|MICOS complex subunit MIC60 precursor (Cell proliferation-inducing gene 4/52 protein) (Mitochondrial inner membrane protein) (Mitofilin) (p87/89) [HMP] [MIC60] [MINOS2] [PIG4] [PIG52] | |||
|- | |- | ||
|[[PLCB1]] | |[[PLCB1]] | ||
Строка 930: | Строка 1066: | ||
|- | |- | ||
|[[CCN4]] | |[[CCN4]] | ||
| | |1 | ||
|CCN family member 4 precursor (WNT1-inducible-signaling pathway protein 1) (WISP-1) (Wnt-1-induced secreted protein) [WISP1] | |CCN family member 4 precursor (WNT1-inducible-signaling pathway protein 1) (WISP-1) (Wnt-1-induced secreted protein) [WISP1] | ||
|- | |- | ||
|[[EPO]] | |[[EPO]] | ||
| | |21 | ||
|Erythropoietin precursor (Epoetin) | |Erythropoietin precursor (Epoetin) | ||
|- | |- | ||
Строка 942: | Строка 1078: | ||
|- | |- | ||
|[[MPO]] | |[[MPO]] | ||
| | |18 | ||
|Myeloperoxidase precursor (EC 1.11.2.2) (MPO) [Contains: Myeloperoxidase; 89 kDa myeloperoxidase; 84 kDa myeloperoxidase; Myeloperoxidase light chain; Myeloperoxidase heavy chain] | |Myeloperoxidase precursor (EC 1.11.2.2) (MPO) [Contains: Myeloperoxidase; 89 kDa myeloperoxidase; 84 kDa myeloperoxidase; Myeloperoxidase light chain; Myeloperoxidase heavy chain] | ||
|- | |||
|[[ADAM22]] | |||
|1 | |||
|Disintegrin and metalloproteinase domain-containing protein 22 precursor (ADAM 22) (Metalloproteinase-disintegrin ADAM22-3) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2) [MDC2] | |||
|- | |||
|[[SLC12A8]] | |||
|1 | |||
|Solute carrier family 12 member 8 (Cation-chloride cotransporter 9) [CCC9] | |||
|- | |- | ||
|[[RXFP1]] | |[[RXFP1]] | ||
Строка 966: | Строка 1110: | ||
|- | |- | ||
|[[TRAF6]] | |[[TRAF6]] | ||
| | |3 | ||
|TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6) [RNF85] | |TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6) [RNF85] | ||
|- | |- | ||
|[[TLR4]] | |[[TLR4]] | ||
| | |82 | ||
|Toll-like receptor 4 precursor (EC 3.2.2.6) (hToll) (CD284 antigen) | |Toll-like receptor 4 precursor (EC 3.2.2.6) (hToll) (CD284 antigen) | ||
|- | |- | ||
|[[PPID]] | |[[PPID]] | ||
| | |8 | ||
|Peptidyl-prolyl cis-trans isomerase D (EC 5.2.1.8) (PPIase D) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Cyclophilin-related protein) (Rotamase D) [CYP40] [CYPD] | |Peptidyl-prolyl cis-trans isomerase D (EC 5.2.1.8) (PPIase D) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Cyclophilin-related protein) (Rotamase D) [CYP40] [CYPD] | ||
|- | |- | ||
Строка 982: | Строка 1126: | ||
|- | |- | ||
|[[GDF9]] | |[[GDF9]] | ||
| | |5 | ||
|Growth/differentiation factor 9 precursor (GDF-9) | |Growth/differentiation factor 9 precursor (GDF-9) | ||
|- | |- | ||
|[[KLF5]] | |[[KLF5]] | ||
| | |3 | ||
|Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2) [BTEB2] [CKLF] [IKLF] | |Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2) [BTEB2] [CKLF] [IKLF] | ||
|- | |- | ||
|[[ | |[[DEFB4B]] | ||
|1 | |1 | ||
| | |4A precursor (Beta-defensin 2) (BD-2) (hBD-2) (Defensin, beta 2) (Skin-antimicrobial peptide 1) (SAP1) | ||
|- | |- | ||
|[[CXCR2]] | |[[CXCR2]] | ||
| | |13 | ||
|C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (IL-8 receptor type 2) (CD182 antigen) [IL8RB] | |C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (IL-8 receptor type 2) (CD182 antigen) [IL8RB] | ||
|- | |- | ||
|[[SPN]] | |[[SPN]] | ||
| | |2 | ||
|Leukosialin precursor (GPL115) (Galactoglycoprotein) (GALGP) (Leukocyte sialoglycoprotein) (Sialophorin) (CD43 antigen) [Contains: CD43 cytoplasmic tail (CD43-ct) (CD43ct)] [CD43] | |Leukosialin precursor (GPL115) (Galactoglycoprotein) (GALGP) (Leukocyte sialoglycoprotein) (Sialophorin) (CD43 antigen) [Contains: CD43 cytoplasmic tail (CD43-ct) (CD43ct)] [CD43] | ||
|- | |- | ||
|[[WRN]] | |[[WRN]] | ||
| | |34 | ||
|Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2) [RECQ3] [RECQL2] | |Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2) [RECQ3] [RECQL2] | ||
|- | |- | ||
Строка 1012: | Строка 1156: | ||
|2 | |2 | ||
|BRCA1-associated RING domain protein 1 (EC 2.3.2.27) (BARD-1) (RING-type E3 ubiquitin transferase BARD1) | |BRCA1-associated RING domain protein 1 (EC 2.3.2.27) (BARD-1) (RING-type E3 ubiquitin transferase BARD1) | ||
|- | |||
|[[SYNC]] | |||
|2 | |||
|Syncoilin (Syncoilin intermediate filament 1) (Syncoilin-1) [SYNC1] | |||
|- | |- | ||
|[[HR]] | |[[HR]] | ||
| | |441 | ||
|Lysine-specific demethylase hairless (EC 1.14.11.65) ([histone H3]-dimethyl-L-lysine(9) demethylase hairless) | |Lysine-specific demethylase hairless (EC 1.14.11.65) ([histone H3]-dimethyl-L-lysine(9) demethylase hairless) | ||
|- | |- | ||
|[[MFI]] | |[[MFI]] | ||
| | |9 | ||
|MFI (Mitochondrial fission factor interactor) [C11orf65] | |MFI (Mitochondrial fission factor interactor) [C11orf65] | ||
|- | |- | ||
Строка 1026: | Строка 1174: | ||
|- | |- | ||
|[[FEN1]] | |[[FEN1]] | ||
| | |4 | ||
|Flap endonuclease 1 (EC 3.1.-.-) (FEN-1) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) [RAD2] | |Flap endonuclease 1 (EC 3.1.-.-) (FEN-1) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) [RAD2] | ||
|- | |||
|[[TBC1D2]] | |||
|1 | |||
|TBC1 domain family member 2A (Armus) (Prostate antigen recognized and identified by SEREX 1) (PARIS-1) [PARIS1] [PP8997] [TBC1D2A] | |||
|- | |- | ||
|[[APC]] | |[[APC]] | ||
| | |29 | ||
|Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5) [DP2.5] | |Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5) [DP2.5] | ||
|- | |- | ||
|[[CD27]] | |[[CD27]] | ||
| | |44 | ||
|CD27 antigen precursor (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) [TNFRSF7] | |CD27 antigen precursor (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) [TNFRSF7] | ||
|- | |- | ||
Строка 1046: | Строка 1198: | ||
|- | |- | ||
|[[KDM4C]] | |[[KDM4C]] | ||
| | |2 | ||
|Lysine-specific demethylase 4C (EC 1.14.11.66) (Gene amplified in squamous cell carcinoma 1 protein) (GASC-1 protein) (JmjC domain-containing histone demethylation protein 3C) (Jumonji domain-containing protein 2C) ([histone H3]-trimethyl-L-lysine(9) demethylase 4C) [GASC1] [JHDM3C] [JMJD2C] [KIAA0780] | |Lysine-specific demethylase 4C (EC 1.14.11.66) (Gene amplified in squamous cell carcinoma 1 protein) (GASC-1 protein) (JmjC domain-containing histone demethylation protein 3C) (Jumonji domain-containing protein 2C) ([histone H3]-trimethyl-L-lysine(9) demethylase 4C) [GASC1] [JHDM3C] [JMJD2C] [KIAA0780] | ||
|- | |- | ||
Строка 1062: | Строка 1214: | ||
|- | |- | ||
|[[GCLM]] | |[[GCLM]] | ||
| | |6 | ||
|Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit) [GLCLR] | |Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit) [GLCLR] | ||
|- | |- | ||
Строка 1070: | Строка 1222: | ||
|- | |- | ||
|[[KLRG1]] | |[[KLRG1]] | ||
| | |17 | ||
|Killer cell lectin-like receptor subfamily G member 1 (C-type lectin domain family 15 member A) (ITIM-containing receptor MAFA-L) (MAFA-like receptor) (Mast cell function-associated antigen) [CLEC15A] [MAFA] [MAFAL] | |Killer cell lectin-like receptor subfamily G member 1 (C-type lectin domain family 15 member A) (ITIM-containing receptor MAFA-L) (MAFA-like receptor) (Mast cell function-associated antigen) [CLEC15A] [MAFA] [MAFAL] | ||
|- | |- | ||
Строка 1092: | Строка 1244: | ||
|1 | |1 | ||
|CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (CCR4 carbon catabolite repression 4-like) (Carbon catabolite repressor protein 4 homolog) (Cytoplasmic deadenylase) [CCR4] [CCR4a] [KIAA1194] | |CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (CCR4 carbon catabolite repression 4-like) (Carbon catabolite repressor protein 4 homolog) (Cytoplasmic deadenylase) [CCR4] [CCR4a] [KIAA1194] | ||
|- | |||
|[[HTR1B]] | |||
|1 | |||
|5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B) [HTR1DB] | |||
|- | |- | ||
|[[COL17A1]] | |[[COL17A1]] | ||
Строка 1104: | Строка 1260: | ||
|1 | |1 | ||
|Cell adhesion molecule 2 precursor (Immunoglobulin superfamily member 4D) (IgSF4D) (Nectin-like protein 3) (NECL-3) (Synaptic cell adhesion molecule 2) (SynCAM 2) [IGSF4D] [NECL3] | |Cell adhesion molecule 2 precursor (Immunoglobulin superfamily member 4D) (IgSF4D) (Nectin-like protein 3) (NECL-3) (Synaptic cell adhesion molecule 2) (SynCAM 2) [IGSF4D] [NECL3] | ||
|- | |||
|[[GNPDA2]] | |||
|1 | |||
|Glucosamine-6-phosphate isomerase 2 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 2) (GNPDA 2) (GlcN6P deaminase 2) (Glucosamine-6-phosphate isomerase SB52) [GNP2] | |||
|- | |- | ||
|[[PTK7]] | |[[PTK7]] | ||
| | |2 | ||
|Inactive tyrosine-protein kinase 7 precursor (Colon carcinoma kinase 4) (CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) [CCK4] | |Inactive tyrosine-protein kinase 7 precursor (Colon carcinoma kinase 4) (CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) [CCK4] | ||
|- | |- | ||
Строка 1114: | Строка 1274: | ||
|- | |- | ||
|[[DCC]] | |[[DCC]] | ||
| | |10 | ||
|Netrin receptor DCC precursor (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC) [IGDCC1] | |Netrin receptor DCC precursor (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC) [IGDCC1] | ||
|- | |- | ||
Строка 1122: | Строка 1282: | ||
|- | |- | ||
|[[TRH]] | |[[TRH]] | ||
| | |5 | ||
|Pro-thyrotropin-releasing hormone precursor (Pro-TRH) (Prothyroliberin) [Contains: Thyrotropin-releasing hormone (TRH) (Protirelin) (TSH-releasing factor) (Thyroliberin) (Thyrotropin-releasing factor) (TRF)] | |Pro-thyrotropin-releasing hormone precursor (Pro-TRH) (Prothyroliberin) [Contains: Thyrotropin-releasing hormone (TRH) (Protirelin) (TSH-releasing factor) (Thyroliberin) (Thyrotropin-releasing factor) (TRF)] | ||
|- | |- | ||
Строка 1132: | Строка 1292: | ||
|1 | |1 | ||
|Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5) [ACS5] [FACL5] [UNQ633/PRO1250] | |Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 5) (LACS 5) [ACS5] [FACL5] [UNQ633/PRO1250] | ||
|- | |||
|[[XRCC5]] | |||
|1 | |||
|X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)) [G22P2] | |||
|- | |- | ||
|[[RPS7]] | |[[RPS7]] | ||
Строка 1166: | Строка 1330: | ||
|- | |- | ||
|[[COL1A1]] | |[[COL1A1]] | ||
| | |8 | ||
|Collagen alpha-1(I) chain precursor (Alpha-1 type I collagen) | |Collagen alpha-1(I) chain precursor (Alpha-1 type I collagen) | ||
|- | |- | ||
|[[ATF2]] | |[[ATF2]] | ||
Строка 1182: | Строка 1342: | ||
|- | |- | ||
|[[CLN3]] | |[[CLN3]] | ||
| | |5 | ||
|Battenin precursor (Batten disease protein) (Protein CLN3) [BTS] | |Battenin precursor (Batten disease protein) (Protein CLN3) [BTS] | ||
|- | |- | ||
Строка 1188: | Строка 1348: | ||
|1 | |1 | ||
|KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog) [CENP-36] [KIAA1267] [MSL1V1] [NSL1] | |KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog) [CENP-36] [KIAA1267] [MSL1V1] [NSL1] | ||
|- | |||
|[[P2RX4]] | |||
|1 | |||
|P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor) | |||
|- | |- | ||
|[[CCR2]] | |[[CCR2]] | ||
| | |22 | ||
|C-C chemokine receptor type 2 (C-C CKR-2) (CC-CKR-2) (CCR-2) (CCR2) (Monocyte chemoattractant protein 1 receptor) (MCP-1-R) (CD192 antigen) [CMKBR2] | |C-C chemokine receptor type 2 (C-C CKR-2) (CC-CKR-2) (CCR-2) (CCR2) (Monocyte chemoattractant protein 1 receptor) (MCP-1-R) (CD192 antigen) [CMKBR2] | ||
|- | |- | ||
|[[GLS]] | |[[GLS]] | ||
| | |6 | ||
|Glutaminase kidney isoform, mitochondrial precursor (EC 3.5.1.2) (GLS) (K-glutaminase) (L-glutamine amidohydrolase) [Contains: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain] [GLS1] [KIAA0838] | |Glutaminase kidney isoform, mitochondrial precursor (EC 3.5.1.2) (GLS) (K-glutaminase) (L-glutamine amidohydrolase) [Contains: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain] [GLS1] [KIAA0838] | ||
|- | |- | ||
|[[CD86]] | |[[CD86]] | ||
| | |18 | ||
|T-lymphocyte activation antigen CD86 precursor (Activation B7-2 antigen) (B70) (BU63) (CTLA-4 counter-receptor B7.2) (FUN-1) (CD86 antigen) [CD28LG2] | |T-lymphocyte activation antigen CD86 precursor (Activation B7-2 antigen) (B70) (BU63) (CTLA-4 counter-receptor B7.2) (FUN-1) (CD86 antigen) [CD28LG2] | ||
|- | |- | ||
|[[GNAQ]] | |[[GNAQ]] | ||
|2 | |||
|Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) [GAQ] | |||
|- | |||
|[[RPA1]] | |||
|1 | |1 | ||
| | |Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1) (Single-stranded DNA-binding protein) [Contains: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed] [REPA1] [RPA70] | ||
|- | |- | ||
|[[FABP3]] | |[[FABP3]] | ||
Строка 1214: | Строка 1382: | ||
|- | |- | ||
|[[IL6]] | |[[IL6]] | ||
| | |60 | ||
|Interleukin-6 precursor (IL-6) (B-cell stimulatory factor 2) (BSF-2) (CTL differentiation factor) (CDF) (Hybridoma growth factor) (Interferon beta-2) (IFN-beta-2) [IFNB2] | |Interleukin-6 precursor (IL-6) (B-cell stimulatory factor 2) (BSF-2) (CTL differentiation factor) (CDF) (Hybridoma growth factor) (Interferon beta-2) (IFN-beta-2) [IFNB2] | ||
|- | |- | ||
|[[MC1R]] | |[[MC1R]] | ||
| | |3 | ||
|Melanocyte-stimulating hormone receptor (MSH-R) (Melanocortin receptor 1) (MC1-R) [MSHR] | |Melanocyte-stimulating hormone receptor (MSH-R) (Melanocortin receptor 1) (MC1-R) [MSHR] | ||
|- | |||
|[[CCNE2]] | |||
|1 | |||
|G1/S-specific cyclin-E2 | |||
|- | |- | ||
|[[GJB2]] | |[[GJB2]] | ||
Строка 1270: | Строка 1442: | ||
|- | |- | ||
|[[DCN]] | |[[DCN]] | ||
| | |8 | ||
|Decorin precursor (Bone proteoglycan II) (PG-S2) (PG40) [SLRR1B] | |Decorin precursor (Bone proteoglycan II) (PG-S2) (PG40) [SLRR1B] | ||
|- | |- | ||
Строка 1296: | Строка 1468: | ||
|1 | |1 | ||
|Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial precursor (EC 2.3.1.12) (70 kDa mitochondrial autoantigen of primary biliary cirrhosis) (PBC) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (M2 antigen complex 70 kDa subunit) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2) [DLTA] | |Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial precursor (EC 2.3.1.12) (70 kDa mitochondrial autoantigen of primary biliary cirrhosis) (PBC) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (M2 antigen complex 70 kDa subunit) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2) [DLTA] | ||
|- | |||
|[[NDUFS4]] | |||
|1 | |||
|NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial precursor (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit) | |||
|- | |- | ||
|[[IL10]] | |[[IL10]] | ||
| | |21 | ||
|Interleukin-10 precursor (IL-10) (Cytokine synthesis inhibitory factor) (CSIF) | |Interleukin-10 precursor (IL-10) (Cytokine synthesis inhibitory factor) (CSIF) | ||
|- | |- | ||
|[[CD24]] | |[[CD24]] | ||
| | |10 | ||
|Signal transducer CD24 precursor (Small cell lung carcinoma cluster 4 antigen) (CD24 antigen) [CD24A] | |Signal transducer CD24 precursor (Small cell lung carcinoma cluster 4 antigen) (CD24 antigen) [CD24A] | ||
|- | |- | ||
Строка 1310: | Строка 1486: | ||
|- | |- | ||
|[[ACAT2]] | |[[ACAT2]] | ||
| | |2 | ||
|Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase) [ACTL] | |Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase) [ACTL] | ||
|- | |- | ||
Строка 1354: | Строка 1530: | ||
|- | |- | ||
|[[TLR2]] | |[[TLR2]] | ||
| | |30 | ||
|Toll-like receptor 2 precursor (EC 3.2.2.6) (Toll/interleukin-1 receptor-like protein 4) (CD282 antigen) [TIL4] | |Toll-like receptor 2 precursor (EC 3.2.2.6) (Toll/interleukin-1 receptor-like protein 4) (CD282 antigen) [TIL4] | ||
|- | |- | ||
Строка 1362: | Строка 1538: | ||
|- | |- | ||
|[[COL1A2]] | |[[COL1A2]] | ||
| | |4 | ||
|Collagen alpha-2(I) chain precursor (Alpha-2 type I collagen) | |Collagen alpha-2(I) chain precursor (Alpha-2 type I collagen) | ||
|- | |- | ||
|[[SDHA]] | |[[SDHA]] | ||
| | |3 | ||
|Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial precursor (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) [SDH2] [SDHF] | |Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial precursor (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) [SDH2] [SDHF] | ||
|- | |- | ||
Строка 1382: | Строка 1558: | ||
|- | |- | ||
|[[RB1]] | |[[RB1]] | ||
| | |6 | ||
|Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110) | |Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110) | ||
|- | |- | ||
|[[CCR7]] | |[[CCR7]] | ||
| | |18 | ||
|C-C chemokine receptor type 7 precursor (C-C CKR-7) (CC-CKR-7) (CCR-7) (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1) (EBI1) (EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD197 antigen) [CMKBR7] [EBI1] [EVI1] | |C-C chemokine receptor type 7 precursor (C-C CKR-7) (CC-CKR-7) (CCR-7) (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1) (EBI1) (EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD197 antigen) [CMKBR7] [EBI1] [EVI1] | ||
|- | |- | ||
|[[MR1]] | |[[MR1]] | ||
| | |1 | ||
|Major histocompatibility complex class I-related gene protein precursor (MHC class I-related gene protein) (Class I histocompatibility antigen-like protein) | |Major histocompatibility complex class I-related gene protein precursor (MHC class I-related gene protein) (Class I histocompatibility antigen-like protein) | ||
|- | |- | ||
Строка 1416: | Строка 1592: | ||
|2 | |2 | ||
|Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) [TCF13] [TEF1] | |Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13) [TCF13] [TEF1] | ||
|- | |- | ||
|[[ACAN]] | |[[ACAN]] | ||
| | |4 | ||
|Aggrecan core protein precursor (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Contains: Aggrecan core protein 2] [AGC1] [CSPG1] [MSK16] | |Aggrecan core protein precursor (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Contains: Aggrecan core protein 2] [AGC1] [CSPG1] [MSK16] | ||
|- | |- | ||
Строка 1430: | Строка 1602: | ||
|- | |- | ||
|[[HGS]] | |[[HGS]] | ||
| | |53 | ||
|Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110) [HRS] | |Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110) [HRS] | ||
|- | |- | ||
|[[CRH]] | |[[CRH]] | ||
| | |12 | ||
|Corticoliberin precursor (Corticotropin-releasing factor) (CRF) (Corticotropin-releasing hormone) | |Corticoliberin precursor (Corticotropin-releasing factor) (CRF) (Corticotropin-releasing hormone) | ||
|- | |- | ||
Строка 1444: | Строка 1616: | ||
|2 | |2 | ||
|DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I) | |DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I) | ||
|- | |||
|[[MATN4]] | |||
|1 | |||
|Matrilin-4 precursor | |||
|- | |- | ||
|[[FOS]] | |[[FOS]] | ||
Строка 1450: | Строка 1626: | ||
|- | |- | ||
|[[NHS]] | |[[NHS]] | ||
| | |53 | ||
|Nance-Horan syndrome protein (Congenital cataracts and dental anomalies protein) | |Nance-Horan syndrome protein (Congenital cataracts and dental anomalies protein) | ||
|- | |- | ||
Строка 1462: | Строка 1638: | ||
|- | |- | ||
|[[PICALM]] | |[[PICALM]] | ||
| | |13 | ||
|Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) [CALM] | |Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) [CALM] | ||
|- | |- | ||
Строка 1468: | Строка 1644: | ||
|1 | |1 | ||
|NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial precursor (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit) [NDUFS2L] | |NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial precursor (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit) [NDUFS2L] | ||
|- | |||
|[[FICD]] | |||
|1 | |||
|adenylyltransferase FICD (EC 2.7.7.n1) (AMPylator FICD) (De-AMPylase FICD) (EC 3.1.4.-) (FIC domain-containing protein) (Huntingtin yeast partner E) (Huntingtin-interacting protein 13) (HIP-13) (Huntingtin-interacting protein E) [HIP13] [HYPE] [UNQ3041/PRO9857] | |||
|- | |- | ||
|[[HSP90AA1]] | |[[HSP90AA1]] | ||
Строка 1494: | Строка 1674: | ||
|- | |- | ||
|[[HELLS]] | |[[HELLS]] | ||
| | |2 | ||
|Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) [PASG] [SMARCA6] [Nbla10143] | |Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) [PASG] [SMARCA6] [Nbla10143] | ||
|- | |- | ||
Строка 1500: | Строка 1680: | ||
|2 | |2 | ||
|Frataxin, mitochondrial precursor (EC 1.16.3.1) (Friedreich ataxia protein) (Fxn) [Contains: Frataxin intermediate form (i-FXN); Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN)] [FRDA] [X25] | |Frataxin, mitochondrial precursor (EC 1.16.3.1) (Friedreich ataxia protein) (Fxn) [Contains: Frataxin intermediate form (i-FXN); Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN)] [FRDA] [X25] | ||
|- | |||
|[[TANK]] | |||
|1 | |||
|TRAF family member-associated NF-kappa-B activator (TRAF-interacting protein) (I-TRAF) [ITRAF] [TRAF2] | |||
|- | |||
|[[OAZ1]] | |||
|1 | |||
|Ornithine decarboxylase antizyme 1 (AZ1) (ODC-Az) [OAZ] | |||
|- | |- | ||
|[[HNRNPF]] | |[[HNRNPF]] | ||
Строка 1506: | Строка 1694: | ||
|- | |- | ||
|[[PDE1C]] | |[[PDE1C]] | ||
| | |3 | ||
|Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (3',5'-cyclic-AMP phosphodiesterase) (EC 3.1.4.-) (3',5'-cyclic-GMP phosphodiesterase) (EC 3.1.4.35) (Hcam3) | |Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (3',5'-cyclic-AMP phosphodiesterase) (EC 3.1.4.-) (3',5'-cyclic-GMP phosphodiesterase) (EC 3.1.4.35) (Hcam3) | ||
|- | |||
|[[TCP1]] | |||
|1 | |||
|T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) [CCT1] [CCTA] | |||
|- | |- | ||
|[[TWIST2]] | |[[TWIST2]] | ||
Строка 1514: | Строка 1706: | ||
|- | |- | ||
|[[CLOCK]] | |[[CLOCK]] | ||
| | |16 | ||
|Circadian locomoter output cycles protein kaput (EC 2.3.1.48) (hCLOCK) (Class E basic helix-loop-helix protein 8) (bHLHe8) [BHLHE8] [KIAA0334] | |Circadian locomoter output cycles protein kaput (EC 2.3.1.48) (hCLOCK) (Class E basic helix-loop-helix protein 8) (bHLHe8) [BHLHE8] [KIAA0334] | ||
|- | |- | ||
Строка 1542: | Строка 1734: | ||
|- | |- | ||
|[[AHR]] | |[[AHR]] | ||
| | |15 | ||
|Aryl hydrocarbon receptor precursor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) [BHLHE76] | |Aryl hydrocarbon receptor precursor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) [BHLHE76] | ||
|- | |- | ||
|[[NEK2]] | |[[NEK2]] | ||
| | |2 | ||
|Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) [NEK2A] [NLK1] | |Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) [NEK2A] [NLK1] | ||
|- | |- | ||
Строка 1572: | Строка 1764: | ||
|1 | |1 | ||
|EP300-interacting inhibitor of differentiation 3 (EID-3) (E1A-like inhibitor of differentiation 3) (EID-1-like inhibitor of differentiation 3) (Non-structural maintenance of chromosomes element 4 homolog B) (NS4EB) (Non-SMC element 4 homolog B) | |EP300-interacting inhibitor of differentiation 3 (EID-3) (E1A-like inhibitor of differentiation 3) (EID-1-like inhibitor of differentiation 3) (Non-structural maintenance of chromosomes element 4 homolog B) (NS4EB) (Non-SMC element 4 homolog B) | ||
|- | |||
|[[ALPL]] | |||
|1 | |||
|Alkaline phosphatase, tissue-nonspecific isozyme precursor (EC 3.1.3.1) (AP-TNAP) (TNSALP) (Alkaline phosphatase liver/bone/kidney isozyme) | |||
|- | |- | ||
|[[NUBP2]] | |[[NUBP2]] | ||
|1 | |1 | ||
|Cytosolic Fe-S cluster assembly factor NUBP2 (Nucleotide-binding protein 2) (NBP 2) | |Cytosolic Fe-S cluster assembly factor NUBP2 (Nucleotide-binding protein 2) (NBP 2) | ||
|- | |||
|[[PCGF5]] | |||
|1 | |||
|Polycomb group RING finger protein 5 (RING finger protein 159) [RNF159] | |||
|- | |- | ||
|[[GRM3]] | |[[GRM3]] | ||
Строка 1582: | Строка 1782: | ||
|- | |- | ||
|[[C6]] | |[[C6]] | ||
| | |19 | ||
|Complement component C6 precursor | |Complement component C6 precursor | ||
|- | |||
|[[DYNC1H1]] | |||
|1 | |||
|Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) [DHC1] [DNCH1] [DNCL] [DNECL] [DYHC] [KIAA0325] | |||
|- | |- | ||
|[[USP7]] | |[[USP7]] | ||
| | |4 | ||
|Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7) [HAUSP] | |Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7) [HAUSP] | ||
|- | |||
|[[SYNE2]] | |||
|1 | |||
|Nesprin-2 (KASH domain-containing protein 2) (KASH2) (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2) [KIAA1011] [NUA] | |||
|- | |- | ||
|[[NRSN2]] | |[[NRSN2]] | ||
Строка 1600: | Строка 1808: | ||
|1 | |1 | ||
|Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform (PP2A subunit B isoform B55-beta) (PP2A subunit B isoform PR55-beta) (PP2A subunit B isoform R2-beta) (PP2A subunit B isoform beta) | |Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform (PP2A subunit B isoform B55-beta) (PP2A subunit B isoform PR55-beta) (PP2A subunit B isoform R2-beta) (PP2A subunit B isoform beta) | ||
|- | |||
|[[PPP1R1B]] | |||
|1 | |||
|Protein phosphatase 1 regulatory subunit 1B (DARPP-32) (Dopamine- and cAMP-regulated neuronal phosphoprotein) [DARPP32] | |||
|- | |||
|[[SLCO1B1]] | |||
|1 | |||
|Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) [LST1] [OATP1B1] [OATP2] [OATPC] [SLC21A6] | |||
|- | |||
|[[ABRA]] | |||
|1 | |||
|Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling) (STARS) | |||
|- | |- | ||
|[[DTX1]] | |[[DTX1]] | ||
Строка 1624: | Строка 1844: | ||
|1 | |1 | ||
|Sphingosine kinase 1 (EC 2.7.1.91) (SK 1) (SPK 1) (Acetyltransferase SPHK1) (EC 2.3.1.-) [SK1] [SPHK] [SPK] | |Sphingosine kinase 1 (EC 2.7.1.91) (SK 1) (SPK 1) (Acetyltransferase SPHK1) (EC 2.3.1.-) [SK1] [SPHK] [SPK] | ||
|- | |||
|[[SUSD2]] | |||
|1 | |||
|Sushi domain-containing protein 2 precursor | |||
|- | |- | ||
|[[TAS2R16]] | |[[TAS2R16]] | ||
Строка 1630: | Строка 1854: | ||
|- | |- | ||
|[[GNB3]] | |[[GNB3]] | ||
| | |3 | ||
|Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 (Transducin beta chain 3) | |Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 (Transducin beta chain 3) | ||
|- | |- | ||
|[[CTC1]] | |[[CTC1]] | ||
| | |4 | ||
|CST complex subunit CTC1 (Conserved telomere maintenance component 1) (HBV DNAPTP1-transactivated protein B) [C17orf68] | |CST complex subunit CTC1 (Conserved telomere maintenance component 1) (HBV DNAPTP1-transactivated protein B) [C17orf68] | ||
|- | |- | ||
Строка 1650: | Строка 1874: | ||
|- | |- | ||
|[[FGFR4]] | |[[FGFR4]] | ||
| | |3 | ||
|Fibroblast growth factor receptor 4 precursor (EC 2.7.10.1) (FGFR-4) (CD334 antigen) [JTK2] [TKF] | |Fibroblast growth factor receptor 4 precursor (EC 2.7.10.1) (FGFR-4) (CD334 antigen) [JTK2] [TKF] | ||
|- | |- | ||
Строка 1666: | Строка 1890: | ||
|- | |- | ||
|[[IL1B]] | |[[IL1B]] | ||
| | |12 | ||
|Interleukin-1 beta precursor (IL-1 beta) (Catabolin) [IL1F2] | |Interleukin-1 beta precursor (IL-1 beta) (Catabolin) [IL1F2] | ||
|- | |||
|[[OAS1]] | |||
|1 | |||
|2'-5'-oligoadenylate synthase 1 (EC 2.7.7.84) ((2-5')oligo(A) synthase 1) (2-5A synthase 1) (E18/E16) (p46/p42 OAS) [OIAS] | |||
|- | |- | ||
|[[IFNG]] | |[[IFNG]] | ||
| | |3 | ||
|Interferon gamma precursor (IFN-gamma) (Immune interferon) | |Interferon gamma precursor (IFN-gamma) (Immune interferon) | ||
|- | |- | ||
|[[PTTG1]] | |[[PTTG1]] | ||
| | |2 | ||
|Securin (Esp1-associated protein) (Pituitary tumor-transforming gene 1 protein) (Tumor-transforming protein 1) (hPTTG) [EAP1] [PTTG] [TUTR1] | |Securin (Esp1-associated protein) (Pituitary tumor-transforming gene 1 protein) (Tumor-transforming protein 1) (hPTTG) [EAP1] [PTTG] [TUTR1] | ||
|- | |- | ||
|[[CAD]] | |[[CAD]] | ||
| | |72 | ||
|CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] | |CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] | ||
|- | |- | ||
Строка 1706: | Строка 1934: | ||
|- | |- | ||
|[[CP]] | |[[CP]] | ||
| | |88 | ||
|Ceruloplasmin precursor (EC 1.16.3.1) (Ferroxidase) | |Ceruloplasmin precursor (EC 1.16.3.1) (Ferroxidase) | ||
|- | |- | ||
|[[TGFB1]] | |[[TGFB1]] | ||
| | |5 | ||
|Transforming growth factor beta-1 proprotein precursor [Contains: Latency-associated peptide (LAP); Transforming growth factor beta-1 (TGF-beta-1)] [TGFB] | |Transforming growth factor beta-1 proprotein precursor [Contains: Latency-associated peptide (LAP); Transforming growth factor beta-1 (TGF-beta-1)] [TGFB] | ||
|- | |- | ||
Строка 1750: | Строка 1978: | ||
|- | |- | ||
|[[COL3A1]] | |[[COL3A1]] | ||
| | |4 | ||
|Collagen alpha-1(III) chain precursor | |Collagen alpha-1(III) chain precursor | ||
|- | |- | ||
|[[CD47]] | |[[CD47]] | ||
| | |11 | ||
|Leukocyte surface antigen CD47 precursor (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD47 antigen) [MER6] | |Leukocyte surface antigen CD47 precursor (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD47 antigen) [MER6] | ||
|- | |- | ||
Строка 1760: | Строка 1988: | ||
|1 | |1 | ||
|Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) [PAB1] [PABP1] [PABPC2] | |Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) [PAB1] [PABP1] [PABPC2] | ||
|- | |||
|[[PPCDC]] | |||
|1 | |||
|Phosphopantothenoylcysteine decarboxylase (EC 4.1.1.36) (PPC-DC) (CoaC) [COAC] [MDS018] [UNQ9365/PRO34154] | |||
|- | |- | ||
|[[ABCC9]] | |[[ABCC9]] | ||
Строка 1766: | Строка 1998: | ||
|- | |- | ||
|[[IMPACT]] | |[[IMPACT]] | ||
| | |13 | ||
|Protein IMPACT (Imprinted and ancient gene protein homolog) | |Protein IMPACT (Imprinted and ancient gene protein homolog) | ||
|- | |- | ||
Строка 1774: | Строка 2006: | ||
|- | |- | ||
|[[ICOS]] | |[[ICOS]] | ||
| | |11 | ||
|Inducible T-cell costimulator precursor (Activation-inducible lymphocyte immunomediatory molecule) (CD278 antigen) [AILIM] | |Inducible T-cell costimulator precursor (Activation-inducible lymphocyte immunomediatory molecule) (CD278 antigen) [AILIM] | ||
|- | |- | ||
Строка 1790: | Строка 2022: | ||
|- | |- | ||
|[[RAD51]] | |[[RAD51]] | ||
| | |9 | ||
|DNA repair protein RAD51 homolog 1 (HsRAD51) (hRAD51) (RAD51 homolog A) [RAD51A] [RECA] | |DNA repair protein RAD51 homolog 1 (HsRAD51) (hRAD51) (RAD51 homolog A) [RAD51A] [RECA] | ||
|- | |- | ||
Строка 1800: | Строка 2032: | ||
|1 | |1 | ||
|Deubiquitinase MYSM1 (EC 3.4.19.-) (2A-DUB) (Myb-like, SWIRM and MPN domain-containing protein 1) [KIAA1915] | |Deubiquitinase MYSM1 (EC 3.4.19.-) (2A-DUB) (Myb-like, SWIRM and MPN domain-containing protein 1) [KIAA1915] | ||
|- | |||
|[[TERF2IP]] | |||
|1 | |||
|Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Dopamine receptor-interacting protein 5) (Repressor/activator protein 1 homolog) (RAP1 homolog) (hRap1) [DRIP5] [RAP1] [PP8000] | |||
|- | |- | ||
|[[INHBA]] | |[[INHBA]] | ||
Строка 1806: | Строка 2042: | ||
|- | |- | ||
|[[BTG1]] | |[[BTG1]] | ||
| | |2 | ||
|Protein BTG1 (B-cell translocation gene 1 protein) | |Protein BTG1 (B-cell translocation gene 1 protein) | ||
|- | |- | ||
|[[OMD]] | |[[OMD]] | ||
| | |2 | ||
|Osteomodulin precursor (Keratan sulfate proteoglycan osteomodulin) (KSPG osteomodulin) (Osteoadherin) (OSAD) [SLRR2C] [UNQ190/PRO216] | |Osteomodulin precursor (Keratan sulfate proteoglycan osteomodulin) (KSPG osteomodulin) (Osteoadherin) (OSAD) [SLRR2C] [UNQ190/PRO216] | ||
|- | |- | ||
|[[STAT1]] | |[[STAT1]] | ||
| | |14 | ||
|Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84) | |Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84) | ||
|- | |- | ||
Строка 1826: | Строка 2062: | ||
|- | |- | ||
|[[S100B]] | |[[S100B]] | ||
| | |16 | ||
|Protein S100-B (S-100 protein beta chain) (S-100 protein subunit beta) (S100 calcium-binding protein B) | |Protein S100-B (S-100 protein beta chain) (S-100 protein subunit beta) (S100 calcium-binding protein B) | ||
|- | |- | ||
Строка 1836: | Строка 2072: | ||
|1 | |1 | ||
|Tribbles homolog 2 (TRB-2) [TRB2] | |Tribbles homolog 2 (TRB-2) [TRB2] | ||
|- | |||
|[[HSPA4]] | |||
|1 | |||
|Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2) [APG2] | |||
|- | |- | ||
|[[ABLIM3]] | |[[ABLIM3]] | ||
Строка 1846: | Строка 2086: | ||
|- | |- | ||
|[[HMGA2]] | |[[HMGA2]] | ||
| | |6 | ||
|High mobility group protein HMGI-C (High mobility group AT-hook protein 2) [HMGIC] | |High mobility group protein HMGI-C (High mobility group AT-hook protein 2) [HMGIC] | ||
|- | |- | ||
Строка 1858: | Строка 2098: | ||
|- | |- | ||
|[[CTNNB1]] | |[[CTNNB1]] | ||
| | |6 | ||
|Catenin beta-1 (Beta-catenin) [CTNNB] [OK/SW-cl.35] [PRO2286] | |Catenin beta-1 (Beta-catenin) [CTNNB] [OK/SW-cl.35] [PRO2286] | ||
|- | |- | ||
Строка 1868: | Строка 2108: | ||
|1 | |1 | ||
|G0/G1 switch protein 2 (G0/G1 switch regulatory protein 2) (Putative lymphocyte G0/G1 switch gene) | |G0/G1 switch protein 2 (G0/G1 switch regulatory protein 2) (Putative lymphocyte G0/G1 switch gene) | ||
|- | |- | ||
|[[NTM]] | |[[NTM]] | ||
Строка 1894: | Строка 2130: | ||
|- | |- | ||
|[[TSC1]] | |[[TSC1]] | ||
| | |7 | ||
|Hamartin (Tuberous sclerosis 1 protein) [KIAA0243] [TSC] | |Hamartin (Tuberous sclerosis 1 protein) [KIAA0243] [TSC] | ||
|- | |- | ||
Строка 1910: | Строка 2146: | ||
|- | |- | ||
|[[INSR]] | |[[INSR]] | ||
| | |2 | ||
|Insulin receptor precursor (EC 2.7.10.1) (IR) (CD220 antigen) [Contains: Insulin receptor subunit alpha; Insulin receptor subunit beta] | |Insulin receptor precursor (EC 2.7.10.1) (IR) (CD220 antigen) [Contains: Insulin receptor subunit alpha; Insulin receptor subunit beta] | ||
|- | |- | ||
Строка 1930: | Строка 2166: | ||
|- | |- | ||
|[[ACE2]] | |[[ACE2]] | ||
| | |28 | ||
|Angiotensin-converting enzyme 2 precursor (EC 3.4.17.23) (Angiotensin-converting enzyme homolog) (ACEH) (Angiotensin-converting enzyme-related carboxypeptidase) (EC 3.4.17.-) (ACE-related carboxypeptidase) (Metalloprotease MPROT15) [Contains: Processed angiotensin-converting enzyme 2] [UNQ868/PRO1885] | |Angiotensin-converting enzyme 2 precursor (EC 3.4.17.23) (Angiotensin-converting enzyme homolog) (ACEH) (Angiotensin-converting enzyme-related carboxypeptidase) (EC 3.4.17.-) (ACE-related carboxypeptidase) (Metalloprotease MPROT15) [Contains: Processed angiotensin-converting enzyme 2] [UNQ868/PRO1885] | ||
|- | |||
|[[ASIC2]] | |||
|1 | |||
|Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog) (MDEG) [ACCN] [ACCN1] [BNAC1] [MDEG] | |||
|- | |- | ||
|[[ILK]] | |[[ILK]] | ||
| | |9 | ||
|Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (Beta-integrin-linked kinase) (ILK-1) (ILK-2) (p59ILK) [ILK1] [ILK2] | |Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (Beta-integrin-linked kinase) (ILK-1) (ILK-2) (p59ILK) [ILK1] [ILK2] | ||
|- | |- | ||
Строка 1940: | Строка 2180: | ||
|2 | |2 | ||
|Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 [KIAA1535] | |Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 [KIAA1535] | ||
|- | |||
|[[SULT2A1]] | |||
|1 | |||
|Sulfotransferase 2A1 (EC 2.8.2.2) (ST2A1) (Bile salt sulfotransferase) (EC 2.8.2.14) (Dehydroepiandrosterone sulfotransferase) (DHEA-ST) (DHEA-ST8) (Hydroxysteroid Sulfotransferase) (HST) (ST2) (SULT2A3) [HST] [STD] | |||
|- | |- | ||
|[[VDR]] | |[[VDR]] | ||
| | |29 | ||
|Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) [NR1I1] | |Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) [NR1I1] | ||
|- | |- | ||
Строка 1956: | Строка 2200: | ||
|1 | |1 | ||
|DNA oxidative demethylase ALKBH2 (EC 1.14.11.33) (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2) (Oxy DC1) [ABH2] | |DNA oxidative demethylase ALKBH2 (EC 1.14.11.33) (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2) (Oxy DC1) [ABH2] | ||
|- | |||
|[[CRB1]] | |||
|1 | |||
|Protein crumbs homolog 1 precursor | |||
|- | |- | ||
|[[BCR]] | |[[BCR]] | ||
| | |20 | ||
|Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26) [BCR1] [D22S11] | |Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26) [BCR1] [D22S11] | ||
|- | |||
|[[HTRA2]] | |||
|1 | |||
|Serine protease HTRA2, mitochondrial precursor (EC 3.4.21.108) (High temperature requirement protein A2) (HtrA2) (Omi stress-regulated endoprotease) (Serine protease 25) (Serine proteinase OMI) [OMI] [PRSS25] | |||
|- | |- | ||
|[[PSMB10]] | |[[PSMB10]] | ||
Строка 1984: | Строка 2236: | ||
|1 | |1 | ||
|Short stature homeobox protein 2 (Homeobox protein Og12X) (Paired-related homeobox protein SHOT) [OG12X] [SHOT] | |Short stature homeobox protein 2 (Homeobox protein Og12X) (Paired-related homeobox protein SHOT) [OG12X] [SHOT] | ||
|- | |||
|[[STX16]] | |||
|1 | |||
|Syntaxin-16 (Syn16) | |||
|- | |- | ||
|[[ELF3]] | |[[ELF3]] | ||
|3 | |3 | ||
|ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1) [ERT] [ESX] [JEN] | |ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1) [ERT] [ESX] [JEN] | ||
|- | |||
|[[CNKSR3]] | |||
|1 | |||
|Connector enhancer of kinase suppressor of ras 3 (Connector enhancer of KSR 3) (CNK homolog protein 3) (CNK3) (CNKSR family member 3) (Maguin-like protein) [MAGI1] | |||
|- | |- | ||
|[[FIS1]] | |[[FIS1]] | ||
| | |7 | ||
|Mitochondrial fission 1 protein (FIS1 homolog) (hFis1) (Tetratricopeptide repeat protein 11) (TPR repeat protein 11) [TTC11] [CGI-135] | |Mitochondrial fission 1 protein (FIS1 homolog) (hFis1) (Tetratricopeptide repeat protein 11) (TPR repeat protein 11) [TTC11] [CGI-135] | ||
|- | |- | ||
|[[CXCL2]] | |[[CXCL2]] | ||
| | |9 | ||
|C-X-C motif chemokine 2 precursor (Growth-regulated protein beta) (Gro-beta) (Macrophage inflammatory protein 2-alpha) (MIP2-alpha) [Contains: GRO-beta(5-73) (GRO-beta-T) (Hematopoietic synergistic factor) (HSF) (SB-251353)] [GRO2] [GROB] [MIP2A] [SCYB2] | |C-X-C motif chemokine 2 precursor (Growth-regulated protein beta) (Gro-beta) (Macrophage inflammatory protein 2-alpha) (MIP2-alpha) [Contains: GRO-beta(5-73) (GRO-beta-T) (Hematopoietic synergistic factor) (HSF) (SB-251353)] [GRO2] [GROB] [MIP2A] [SCYB2] | ||
|- | |- | ||
|[[ALB]] | |[[ALB]] | ||
| | |7 | ||
|Albumin precursor [GIG20] [GIG42] [PRO0903] [PRO1708] [PRO2044] [PRO2619] [PRO2675] [UNQ696/PRO1341] | |Albumin precursor [GIG20] [GIG42] [PRO0903] [PRO1708] [PRO2044] [PRO2619] [PRO2675] [UNQ696/PRO1341] | ||
|- | |- | ||
Строка 2010: | Строка 2270: | ||
|- | |- | ||
|[[HDAC5]] | |[[HDAC5]] | ||
| | |4 | ||
|Histone deacetylase 5 (EC 3.5.1.98) (HD5) (Antigen NY-CO-9) [KIAA0600] | |Histone deacetylase 5 (EC 3.5.1.98) (HD5) (Antigen NY-CO-9) [KIAA0600] | ||
|- | |- | ||
|[[ZBTB16]] | |[[ZBTB16]] | ||
| | |3 | ||
|Zinc finger and BTB domain-containing protein 16 (Promyelocytic leukemia zinc finger protein) (Zinc finger protein 145) (Zinc finger protein PLZF) [PLZF] [ZNF145] | |Zinc finger and BTB domain-containing protein 16 (Promyelocytic leukemia zinc finger protein) (Zinc finger protein 145) (Zinc finger protein PLZF) [PLZF] [ZNF145] | ||
|- | |- | ||
|[[NDUFV2]] | |[[NDUFV2]] | ||
| | |3 | ||
|NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial precursor (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit) | |NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial precursor (EC 7.1.1.2) (NADH-ubiquinone oxidoreductase 24 kDa subunit) | ||
|- | |- | ||
Строка 2024: | Строка 2284: | ||
|2 | |2 | ||
|Neurofilament medium polypeptide (NF-M) (160 kDa neurofilament protein) (Neurofilament 3) (Neurofilament triplet M protein) [NEF3] [NFM] | |Neurofilament medium polypeptide (NF-M) (160 kDa neurofilament protein) (Neurofilament 3) (Neurofilament triplet M protein) [NEF3] [NFM] | ||
|- | |||
|[[CXXC1]] | |||
|1 | |||
|CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1) [CFP1] [CGBP] [PCCX1] [PHF18] | |||
|- | |- | ||
|[[PIK3R3]] | |[[PIK3R3]] | ||
Строка 2038: | Строка 2302: | ||
|- | |- | ||
|[[SRY]] | |[[SRY]] | ||
| | |3 | ||
|Sex-determining region Y protein (Testis-determining factor) [TDF] | |Sex-determining region Y protein (Testis-determining factor) [TDF] | ||
|- | |- | ||
|[[APP]] | |[[APP]] | ||
| | |139 | ||
|Amyloid-beta precursor protein precursor (APP) (ABPP) (APPI) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Contains: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31] [A4] [AD1] | |Amyloid-beta precursor protein precursor (APP) (ABPP) (APPI) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Contains: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31] [A4] [AD1] | ||
|- | |- | ||
Строка 2054: | Строка 2318: | ||
|- | |- | ||
|[[MYB]] | |[[MYB]] | ||
| | |12 | ||
|Transcriptional activator Myb (Proto-oncogene c-Myb) | |Transcriptional activator Myb (Proto-oncogene c-Myb) | ||
|- | |- | ||
Строка 2078: | Строка 2342: | ||
|- | |- | ||
|[[TIMELESS]] | |[[TIMELESS]] | ||
| | |3 | ||
|Protein timeless homolog (hTIM) [TIM] [TIM1] [TIMELESS1] | |Protein timeless homolog (hTIM) [TIM] [TIM1] [TIMELESS1] | ||
|- | |||
|[[SHCBP1]] | |||
|1 | |||
|SHC SH2 domain-binding protein 1 | |||
|- | |- | ||
|[[CASP3]] | |[[CASP3]] | ||
| | |3 | ||
|Caspase-3 precursor (EC 3.4.22.56) (CASP-3) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Contains: Caspase-3 subunit p17; Caspase-3 subunit p12] [CPP32] | |Caspase-3 precursor (EC 3.4.22.56) (CASP-3) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Contains: Caspase-3 subunit p17; Caspase-3 subunit p12] [CPP32] | ||
|- | |- | ||
Строка 2088: | Строка 2356: | ||
|1 | |1 | ||
|C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (MINCLE) [CLECSF9] [MINCLE] [UNQ218/PRO244] | |C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin) (MINCLE) [CLECSF9] [MINCLE] [UNQ218/PRO244] | ||
|- | |||
|[[NR1D1]] | |||
|1 | |||
|Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) (EAR-1) [EAR1] [HREV] [THRAL] | |||
|- | |- | ||
|[[GRID1]] | |[[GRID1]] | ||
Строка 2094: | Строка 2366: | ||
|- | |- | ||
|[[SQSTM1]] | |[[SQSTM1]] | ||
| | |9 | ||
|Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62) [ORCA] [OSIL] | |Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62) [ORCA] [OSIL] | ||
|- | |||
|[[APLN]] | |||
|1 | |||
|Apelin precursor (APJ endogenous ligand) [Contains: Apelin-36; Apelin-31; Apelin-28; Apelin-13] [APEL] | |||
|- | |- | ||
|[[PROC]] | |[[PROC]] | ||
| | |6 | ||
|Vitamin K-dependent protein C precursor (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Contains: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide] | |Vitamin K-dependent protein C precursor (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Contains: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide] | ||
|- | |- | ||
Строка 2106: | Строка 2382: | ||
|- | |- | ||
|[[CACNA1C]] | |[[CACNA1C]] | ||
| | |2 | ||
|Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) [CACH2] [CACN2] [CACNL1A1] [CCHL1A1] | |Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) [CACH2] [CACN2] [CACNL1A1] [CCHL1A1] | ||
|- | |- | ||
|[[TP53]] | |[[TP53]] | ||
| | |54 | ||
|Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53) [P53] | |Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53) [P53] | ||
|- | |- | ||
|[[BACE1]] | |[[BACE1]] | ||
| | |36 | ||
|Beta-secretase 1 precursor (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2) [BACE] [KIAA1149] | |Beta-secretase 1 precursor (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2) [BACE] [KIAA1149] | ||
|- | |- | ||
Строка 2150: | Строка 2426: | ||
|- | |- | ||
|[[C7]] | |[[C7]] | ||
| | |23 | ||
|Complement component C7 precursor | |Complement component C7 precursor | ||
|- | |- | ||
Строка 2174: | Строка 2450: | ||
|- | |- | ||
|[[PON1]] | |[[PON1]] | ||
| | |11 | ||
|Serum paraoxonase/arylesterase 1 (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (PON 1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1) [PON] | |Serum paraoxonase/arylesterase 1 (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (PON 1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1) [PON] | ||
|- | |- | ||
Строка 2206: | Строка 2482: | ||
|- | |- | ||
|[[CCNA2]] | |[[CCNA2]] | ||
| | |4 | ||
|Cyclin-A2 (Cyclin-A) (Cyclin A) [CCN1] [CCNA] | |Cyclin-A2 (Cyclin-A) (Cyclin A) [CCN1] [CCNA] | ||
|- | |- | ||
Строка 2212: | Строка 2488: | ||
|2 | |2 | ||
|Ephrin type-A receptor 2 precursor (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) [ECK] | |Ephrin type-A receptor 2 precursor (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) [ECK] | ||
|- | |||
|[[TYRP1]] | |||
|1 | |||
|5,6-dihydroxyindole-2-carboxylic acid oxidase precursor (EC 1.14.18.-) (DHICA oxidase) (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1) (TRP) (TRP-1) (TRP1) [CAS2] [TYRP] [TYRRP] | |||
|- | |- | ||
|[[UGT1A6]] | |[[UGT1A6]] | ||
Строка 2221: | Строка 2501: | ||
|Vascular endothelial growth factor receptor 1 precursor (EC 2.7.10.1) (VEGFR-1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) [FLT] [FRT] [VEGFR1] | |Vascular endothelial growth factor receptor 1 precursor (EC 2.7.10.1) (VEGFR-1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) [FLT] [FRT] [VEGFR1] | ||
|- | |- | ||
|[[DLGAP2]] | |[[SLC39A5]] | ||
|1 | |||
|Zinc transporter ZIP5 precursor (Solute carrier family 39 member 5) (Zrt- and Irt-like protein 5) (ZIP-5) [ZIP5] | |||
|- | |||
|[[DLGAP2]] | |||
|1 | |1 | ||
|Disks large-associated protein 2 (DAP-2) (PSD-95/SAP90-binding protein 2) (SAP90/PSD-95-associated protein 2) (SAPAP2) [C8orf68] [DAP2] [ERICH1-AS1] | |Disks large-associated protein 2 (DAP-2) (PSD-95/SAP90-binding protein 2) (SAP90/PSD-95-associated protein 2) (SAPAP2) [C8orf68] [DAP2] [ERICH1-AS1] | ||
Строка 2230: | Строка 2514: | ||
|- | |- | ||
|[[IGFBP1]] | |[[IGFBP1]] | ||
| | |4 | ||
|Insulin-like growth factor-binding protein 1 precursor (IBP-1) (IGF-binding protein 1) (IGFBP-1) (Placental protein 12) (PP12) [IBP1] | |Insulin-like growth factor-binding protein 1 precursor (IBP-1) (IGF-binding protein 1) (IGFBP-1) (Placental protein 12) (PP12) [IBP1] | ||
|- | |- | ||
Строка 2250: | Строка 2534: | ||
|- | |- | ||
|[[ORC1]] | |[[ORC1]] | ||
| | |1 | ||
|Origin recognition complex subunit 1 (Replication control protein 1) [ORC1L] [PARC1] | |Origin recognition complex subunit 1 (Replication control protein 1) [ORC1L] [PARC1] | ||
|- | |||
|[[CDK3]] | |||
|1 | |||
|Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) [CDKN3] | |||
|- | |- | ||
|[[TFEB]] | |[[TFEB]] | ||
| | |23 | ||
|Transcription factor EB (Class E basic helix-loop-helix protein 35) (bHLHe35) [BHLHE35] | |Transcription factor EB (Class E basic helix-loop-helix protein 35) (bHLHe35) [BHLHE35] | ||
|- | |- | ||
Строка 2282: | Строка 2570: | ||
|- | |- | ||
|[[CA3]] | |[[CA3]] | ||
| | |148 | ||
|Carbonic anhydrase 3 (EC 4.2.1.1) (Carbonate dehydratase III) (Carbonic anhydrase III) (CA-III) | |Carbonic anhydrase 3 (EC 4.2.1.1) (Carbonate dehydratase III) (Carbonic anhydrase III) (CA-III) | ||
|- | |- | ||
Строка 2290: | Строка 2578: | ||
|- | |- | ||
|[[CLU]] | |[[CLU]] | ||
| | |21 | ||
|Clusterin precursor (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Sulfated glycoprotein 2) (SGP-2) (Testosterone-repressed prostate message 2) (TRPM-2) [Contains: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain); Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain)] [APOJ] [CLI] [KUB1] [AAG4] | |Clusterin precursor (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Sulfated glycoprotein 2) (SGP-2) (Testosterone-repressed prostate message 2) (TRPM-2) [Contains: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain); Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain)] [APOJ] [CLI] [KUB1] [AAG4] | ||
|- | |- | ||
|[[CDC25A]] | |[[CDC25A]] | ||
| | |3 | ||
|M-phase inducer phosphatase 1 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25A) | |M-phase inducer phosphatase 1 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25A) | ||
|- | |- | ||
Строка 2302: | Строка 2590: | ||
|- | |- | ||
|[[MMP8]] | |[[MMP8]] | ||
| | |2 | ||
|Neutrophil collagenase precursor (EC 3.4.24.34) (Matrix metalloproteinase-8) (MMP-8) (PMNL collagenase) (PMNL-CL) [CLG1] | |Neutrophil collagenase precursor (EC 3.4.24.34) (Matrix metalloproteinase-8) (MMP-8) (PMNL collagenase) (PMNL-CL) [CLG1] | ||
|- | |- | ||
Строка 2322: | Строка 2610: | ||
|- | |- | ||
|[[DMD]] | |[[DMD]] | ||
| | |35 | ||
|Dystrophin | |Dystrophin | ||
|- | |||
|[[MCM3AP]] | |||
|1 | |||
|Germinal-center associated nuclear protein (EC 2.3.1.48) (GANP) (80 kDa MCM3-associated protein) (MCM3 acetylating protein) (EC 2.3.1.-) (MCM3AP) (MCM3 acetyltransferase) [GANP] [KIAA0572] [MAP80] | |||
|- | |- | ||
|[[CUX1]] | |[[CUX1]] | ||
Строка 2330: | Строка 2622: | ||
|- | |- | ||
|[[CD4]] | |[[CD4]] | ||
| | |412 | ||
|T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (CD4 antigen) | |T-cell surface glycoprotein CD4 precursor (T-cell surface antigen T4/Leu-3) (CD4 antigen) | ||
|- | |- | ||
|[[GHR]] | |[[GHR]] | ||
| | |29 | ||
|Growth hormone receptor precursor (GH receptor) (Somatotropin receptor) [Contains: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)] | |Growth hormone receptor precursor (GH receptor) (Somatotropin receptor) [Contains: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)] | ||
|- | |- | ||
Строка 2340: | Строка 2632: | ||
|3 | |3 | ||
|Apolipoprotein C-III precursor (Apo-CIII) (ApoC-III) (Apolipoprotein C3) | |Apolipoprotein C-III precursor (Apo-CIII) (ApoC-III) (Apolipoprotein C3) | ||
|- | |||
|[[EDNRA]] | |||
|1 | |||
|Endothelin-1 receptor precursor (Endothelin receptor type A) (ET-A) (ETA-R) (hET-AR) [ETA] [ETRA] | |||
|- | |- | ||
|[[PTBP1]] | |[[PTBP1]] | ||
| | |3 | ||
|Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) [PTB] | |Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) [PTB] | ||
|- | |- | ||
Строка 2350: | Строка 2646: | ||
|- | |- | ||
|[[CBX4]] | |[[CBX4]] | ||
| | |2 | ||
|E3 SUMO-protein ligase CBX4 (EC 2.3.2.-) (Chromobox protein homolog 4) (Polycomb 2 homolog) (Pc2) (hPc2) | |E3 SUMO-protein ligase CBX4 (EC 2.3.2.-) (Chromobox protein homolog 4) (Polycomb 2 homolog) (Pc2) (hPc2) | ||
|- | |- | ||
Строка 2358: | Строка 2654: | ||
|- | |- | ||
|[[PLK1]] | |[[PLK1]] | ||
| | |2 | ||
|Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) [PLK] | |Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) [PLK] | ||
|- | |- | ||
Строка 2364: | Строка 2660: | ||
|1 | |1 | ||
|Protein bicaudal D homolog 1 (Bic-D 1) | |Protein bicaudal D homolog 1 (Bic-D 1) | ||
|- | |||
|[[RAB10]] | |||
|1 | |||
|Ras-related protein Rab-10 (EC 3.6.5.2) | |||
|- | |- | ||
|[[RUNX3]] | |[[RUNX3]] | ||
Строка 2376: | Строка 2676: | ||
|1 | |1 | ||
|ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3) [CMOAT2] [MLP2] [MRP3] | |ATP-binding cassette sub-family C member 3 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Canalicular multispecific organic anion transporter 2) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3) [CMOAT2] [MLP2] [MRP3] | ||
|- | |||
|[[TTF1]] | |||
|1 | |||
|Transcription termination factor 1 (TTF-1) (RNA polymerase I termination factor) (Transcription termination factor I) (TTF-I) | |||
|- | |- | ||
|[[ATM]] | |[[ATM]] | ||
| | |91 | ||
|Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated) | |Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated) | ||
|- | |- | ||
Строка 2390: | Строка 2694: | ||
|- | |- | ||
|[[SI]] | |[[SI]] | ||
| | |60 | ||
|Sucrase-isomaltase, intestinal [Contains: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)] | |Sucrase-isomaltase, intestinal [Contains: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)] | ||
|- | |- | ||
|[[TYR]] | |[[TYR]] | ||
| | |3 | ||
|Tyrosinase precursor (EC 1.14.18.1) (LB24-AB) (Monophenol monooxygenase) (SK29-AB) (Tumor rejection antigen AB) | |Tyrosinase precursor (EC 1.14.18.1) (LB24-AB) (Monophenol monooxygenase) (SK29-AB) (Tumor rejection antigen AB) | ||
|- | |- | ||
Строка 2404: | Строка 2708: | ||
|1 | |1 | ||
|Inorganic pyrophosphatase 2, mitochondrial precursor (EC 3.6.1.1) (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2) (PPase 2) [HSPC124] | |Inorganic pyrophosphatase 2, mitochondrial precursor (EC 3.6.1.1) (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2) (PPase 2) [HSPC124] | ||
|- | |||
|[[ARID5B]] | |||
|1 | |||
|AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (MRF1-like protein) (Modulator recognition factor 2) (MRF-2) [DESRT] [MRF2] | |||
|- | |- | ||
|[[LSR]] | |[[LSR]] | ||
| | |4 | ||
|Lipolysis-stimulated lipoprotein receptor [LISCH] | |Lipolysis-stimulated lipoprotein receptor [LISCH] | ||
|- | |- | ||
Строка 2414: | Строка 2722: | ||
|- | |- | ||
|[[NF1]] | |[[NF1]] | ||
| | |6 | ||
|Neurofibromin (Neurofibromatosis-related protein NF-1) [Contains: Neurofibromin truncated] | |Neurofibromin (Neurofibromatosis-related protein NF-1) [Contains: Neurofibromin truncated] | ||
|- | |||
|[[TFRC]] | |||
|2 | |||
|Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD71 antigen) [Contains: Transferrin receptor protein 1, serum form (sTfR)] | |||
|- | |- | ||
|[[MAP4K3]] | |[[MAP4K3]] | ||
|1 | |1 | ||
|Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) [RAB8IPL1] | |Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) [RAB8IPL1] | ||
|- | |||
|[[SNRPN]] | |||
|1 | |||
|Small nuclear ribonucleoprotein-associated protein N (snRNP-N) (Sm protein D) (Sm-D) (Sm protein N) (Sm-N) (SmN) (Tissue-specific-splicing protein) [HCERN3] [SMN] | |||
|- | |- | ||
|[[NKX2-5]] | |[[NKX2-5]] | ||
|1 | |1 | ||
|Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E) [CSX] [NKX2.5] [NKX2E] | |Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E) [CSX] [NKX2.5] [NKX2E] | ||
|- | |- | ||
|[[TJP1]] | |[[TJP1]] | ||
Строка 2440: | Строка 2752: | ||
|1 | |1 | ||
|Proto-oncogene Mas [MAS] | |Proto-oncogene Mas [MAS] | ||
|- | |||
|[[PHAX]] | |||
|1 | |||
|Phosphorylated adapter RNA export protein (RNA U small nuclear RNA export adapter protein) [RNUXA] | |||
|- | |- | ||
|[[IL4]] | |[[IL4]] | ||
Строка 2448: | Строка 2764: | ||
|1 | |1 | ||
|Zinc finger protein RFP (EC 2.3.2.27) (RING finger protein 76) (RING-type E3 ubiquitin transferase TRIM27) (Ret finger protein) (Tripartite motif-containing protein 27) [RFP] [RNF76] | |Zinc finger protein RFP (EC 2.3.2.27) (RING finger protein 76) (RING-type E3 ubiquitin transferase TRIM27) (Ret finger protein) (Tripartite motif-containing protein 27) [RFP] [RNF76] | ||
|- | |||
|[[MBOAT2]] | |||
|1 | |||
|Lysophospholipid acyltransferase 2 (EC 2.3.1.-) (LPLAT 2) (1-acylglycerophosphate O-acyltransferase MBOAT2) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase MBOAT2) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine MBOAT2 O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase) (LPAAT) (Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4) (Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2) [LPCAT4] [OACT2] | |||
|- | |- | ||
|[[FBXO46]] | |[[FBXO46]] | ||
Строка 2460: | Строка 2780: | ||
|2 | |2 | ||
|Neurexin-1-beta precursor (Neurexin I-beta) | |Neurexin-1-beta precursor (Neurexin I-beta) | ||
|- | |||
|[[SENP7]] | |||
|1 | |||
|Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7) [KIAA1707] [SSP2] [SUSP2] | |||
|- | |- | ||
|[[TTR]] | |[[TTR]] | ||
| | |16 | ||
|Transthyretin precursor (ATTR) (Prealbumin) (TBPA) [PALB] | |Transthyretin precursor (ATTR) (Prealbumin) (TBPA) [PALB] | ||
|- | |- | ||
Строка 2472: | Строка 2796: | ||
|1 | |1 | ||
|GDNF family receptor alpha-1 precursor (GDNF receptor alpha-1) (GDNFR-alpha-1) (GFR-alpha-1) (RET ligand 1) (TGF-beta-related neurotrophic factor receptor 1) [GDNFRA] [RETL1] [TRNR1] | |GDNF family receptor alpha-1 precursor (GDNF receptor alpha-1) (GDNFR-alpha-1) (GFR-alpha-1) (RET ligand 1) (TGF-beta-related neurotrophic factor receptor 1) [GDNFRA] [RETL1] [TRNR1] | ||
|- | |||
|[[RBM34]] | |||
|1 | |||
|protein 34 (RNA-binding motif protein 34) [KIAA0117] | |||
|- | |||
|[[TMEM38B]] | |||
|1 | |||
|Trimeric intracellular cation channel type B (TRIC-B) (TRICB) (Transmembrane protein 38B) [C9orf87] | |||
|- | |- | ||
|[[TRIB3]] | |[[TRIB3]] | ||
Строка 2478: | Строка 2810: | ||
|- | |- | ||
|[[NOS3]] | |[[NOS3]] | ||
| | |6 | ||
|Nitric oxide synthase, endothelial (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (Endothelial NOS) (eNOS) (NOS type III) (NOSIII) | |Nitric oxide synthase, endothelial (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (Endothelial NOS) (eNOS) (NOS type III) (NOSIII) | ||
|- | |- | ||
Строка 2484: | Строка 2816: | ||
|2 | |2 | ||
|B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (hRit1) [CTIP2] [RIT1] | |B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (hRit1) [CTIP2] [RIT1] | ||
|- | |||
|[[EGFEM1P]] | |||
|1 | |||
|EGF-like and EMI domain-containing protein 1 [C3orf50] [NCRNA00259] | |||
|- | |- | ||
|[[TRPC1]] | |[[TRPC1]] | ||
Строка 2492: | Строка 2828: | ||
|1 | |1 | ||
|Voltage-dependent calcium channel subunit alpha-2/delta-1 precursor (Voltage-gated calcium channel subunit alpha-2/delta-1) [Contains: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1] [CACNL2A] [CCHL2A] [MHS3] | |Voltage-dependent calcium channel subunit alpha-2/delta-1 precursor (Voltage-gated calcium channel subunit alpha-2/delta-1) [Contains: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1] [CACNL2A] [CCHL2A] [MHS3] | ||
|- | |||
|[[DNM1L]] | |||
|1 | |||
|Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1) [DLP1] [DRP1] | |||
|- | |- | ||
|[[PCNA]] | |[[PCNA]] | ||
| | |48 | ||
|Proliferating cell nuclear antigen (PCNA) (Cyclin) | |Proliferating cell nuclear antigen (PCNA) (Cyclin) | ||
|- | |- | ||
Строка 2517: | Строка 2857: | ||
|Polycystin-1 precursor (PC1) (Autosomal dominant polycystic kidney disease 1 protein) | |Polycystin-1 precursor (PC1) (Autosomal dominant polycystic kidney disease 1 protein) | ||
|- | |- | ||
|[[ | |[[PDE8A]] | ||
|1 | |1 | ||
| | |High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A (EC 3.1.4.53) | ||
|- | |- | ||
|[[DISC1]] | |[[DISC1]] | ||
Строка 2530: | Строка 2870: | ||
|- | |- | ||
|[[MMD]] | |[[MMD]] | ||
| | |9 | ||
|Monocyte to macrophage differentiation factor (Progestin and adipoQ receptor family member 11) (Progestin and adipoQ receptor family member XI) [PAQR11] | |Monocyte to macrophage differentiation factor (Progestin and adipoQ receptor family member 11) (Progestin and adipoQ receptor family member XI) [PAQR11] | ||
|- | |- | ||
|[[PDHB]] | |[[PDHB]] | ||
| | |2 | ||
|Pyruvate dehydrogenase E1 component subunit beta, mitochondrial precursor (EC 1.2.4.1) (PDHE1-B) [PHE1B] | |Pyruvate dehydrogenase E1 component subunit beta, mitochondrial precursor (EC 1.2.4.1) (PDHE1-B) [PHE1B] | ||
|- | |- | ||
|[[RAN]] | |[[RAN]] | ||
| | |4 | ||
|GTP-binding nuclear protein Ran (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein) [ARA24] [OK/SW-cl.81] | |GTP-binding nuclear protein Ran (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein) [ARA24] [OK/SW-cl.81] | ||
|- | |- | ||
|[[FGR]] | |[[FGR]] | ||
| | |4 | ||
|Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr) [SRC2] | |Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr) [SRC2] | ||
|- | |- | ||
Строка 2552: | Строка 2892: | ||
|2 | |2 | ||
|NACHT, LRR and PYD domains-containing protein 1 (Caspase recruitment domain-containing protein 7) (Death effector filament-forming ced-4-like apoptosis protein) (Nucleotide-binding domain and caspase recruitment domain) [CARD7] [DEFCAP] [KIAA0926] [NAC] [NALP1] | |NACHT, LRR and PYD domains-containing protein 1 (Caspase recruitment domain-containing protein 7) (Death effector filament-forming ced-4-like apoptosis protein) (Nucleotide-binding domain and caspase recruitment domain) [CARD7] [DEFCAP] [KIAA0926] [NAC] [NALP1] | ||
|- | |||
|[[MAOB]] | |||
|1 | |||
|Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) | |||
|- | |- | ||
|[[ME3]] | |[[ME3]] | ||
Строка 2562: | Строка 2906: | ||
|- | |- | ||
|[[CRP]] | |[[CRP]] | ||
| | |258 | ||
|C-reactive protein precursor [Contains: C-reactive protein(1-205)] [PTX1] | |C-reactive protein precursor [Contains: C-reactive protein(1-205)] [PTX1] | ||
|- | |- | ||
Строка 2600: | Строка 2944: | ||
|1 | |1 | ||
|Complement C1q subcomponent subunit A precursor | |Complement C1q subcomponent subunit A precursor | ||
|- | |||
|[[CASP9]] | |||
|1 | |||
|Caspase-9 precursor (EC 3.4.22.62) (CASP-9) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Contains: Caspase-9 subunit p35; Caspase-9 subunit p10] [MCH6] | |||
|- | |||
|[[OTUD7A]] | |||
|1 | |||
|OTU domain-containing protein 7A (EC 3.4.19.12) (Zinc finger protein Cezanne 2) [C15orf16] [CEZANNE2] [OTUD7] | |||
|- | |- | ||
|[[GNPAT]] | |[[GNPAT]] | ||
Строка 2614: | Строка 2966: | ||
|- | |- | ||
|[[PDE10A]] | |[[PDE10A]] | ||
| | |3 | ||
|cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) (EC 3.1.4.35) | |cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) (EC 3.1.4.35) | ||
|- | |- | ||
Строка 2634: | Строка 2986: | ||
|- | |- | ||
|[[FTO]] | |[[FTO]] | ||
| | |12 | ||
|Alpha-ketoglutarate-dependent dioxygenase FTO (Fat mass and obesity-associated protein) (U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (EC 1.14.11.-) (U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO) (EC 1.14.11.-) (mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (EC 1.14.11.-) (m6A(m)-demethylase FTO) (mRNA N(6)-methyladenosine demethylase FTO) (EC 1.14.11.53) (tRNA N1-methyl adenine demethylase FTO) (EC 1.14.11.-) [KIAA1752] | |Alpha-ketoglutarate-dependent dioxygenase FTO (Fat mass and obesity-associated protein) (U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (EC 1.14.11.-) (U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO) (EC 1.14.11.-) (mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO) (EC 1.14.11.-) (m6A(m)-demethylase FTO) (mRNA N(6)-methyladenosine demethylase FTO) (EC 1.14.11.53) (tRNA N1-methyl adenine demethylase FTO) (EC 1.14.11.-) [KIAA1752] | ||
|- | |- | ||
Строка 2658: | Строка 3010: | ||
|- | |- | ||
|[[HSF1]] | |[[HSF1]] | ||
| | |17 | ||
|Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1) [HSTF1] | |Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1) [HSTF1] | ||
|- | |- | ||
|[[MIF]] | |[[MIF]] | ||
| | |12 | ||
|Macrophage migration inhibitory factor (EC 5.3.2.1) (MIF) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase) [GLIF] [MMIF] | |Macrophage migration inhibitory factor (EC 5.3.2.1) (MIF) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase) [GLIF] [MMIF] | ||
|- | |- | ||
Строка 2676: | Строка 3028: | ||
|2 | |2 | ||
|Glutathione S-transferase A4 (EC 2.5.1.18) (GST class-alpha member 4) (Glutathione S-transferase A4-4) | |Glutathione S-transferase A4 (EC 2.5.1.18) (GST class-alpha member 4) (Glutathione S-transferase A4-4) | ||
|- | |||
|[[GALNT18]] | |||
|1 | |||
|Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase 18) (GalNAc-T18) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) [GALNTL4] | |||
|- | |- | ||
|[[ATXN3]] | |[[ATXN3]] | ||
| | |2 | ||
|Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1) (Spinocerebellar ataxia type 3 protein) [ATX3] [MJD] [MJD1] [SCA3] | |Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1) (Spinocerebellar ataxia type 3 protein) [ATX3] [MJD] [MJD1] [SCA3] | ||
|- | |- | ||
Строка 2694: | Строка 3050: | ||
|- | |- | ||
|[[TBC1D1]] | |[[TBC1D1]] | ||
| | |5 | ||
|TBC1 domain family member 1 [KIAA1108] | |TBC1 domain family member 1 [KIAA1108] | ||
|- | |- | ||
Строка 2718: | Строка 3074: | ||
|- | |- | ||
|[[CHEK2]] | |[[CHEK2]] | ||
|2 | |||
|Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) [CDS1] [CHK2] [RAD53] | |||
|- | |||
|[[MASP1]] | |||
|1 | |1 | ||
| | |Mannan-binding lectin serine protease 1 precursor (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Contains: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain] [CRARF] [CRARF1] [PRSS5] | ||
|- | |- | ||
|[[MCM2]] | |[[MCM2]] | ||
Строка 2748: | Строка 3108: | ||
|1 | |1 | ||
|Tumor protein p53-inducible nuclear protein 1 (Stress-induced protein) (p53-dependent damage-inducible nuclear protein 1) (p53DINP1) [P53DINP1] [SIP] | |Tumor protein p53-inducible nuclear protein 1 (Stress-induced protein) (p53-dependent damage-inducible nuclear protein 1) (p53DINP1) [P53DINP1] [SIP] | ||
|- | |||
|[[BBC3]] | |||
|1 | |||
|Bcl-2-binding component 3, isoforms 3/4 (JFY-1) (p53 up-regulated modulator of apoptosis) [PUMA] | |||
|- | |- | ||
|[[PER2]] | |[[PER2]] | ||
| | |11 | ||
|Period circadian protein homolog 2 (hPER2) (Circadian clock protein PERIOD 2) [KIAA0347] | |Period circadian protein homolog 2 (hPER2) (Circadian clock protein PERIOD 2) [KIAA0347] | ||
|- | |- | ||
Строка 2774: | Строка 3138: | ||
|- | |- | ||
|[[MCM4]] | |[[MCM4]] | ||
| | |2 | ||
|DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21) [CDC21] | |DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21) [CDC21] | ||
|- | |- | ||
Строка 2790: | Строка 3154: | ||
|- | |- | ||
|[[TRA]] | |[[TRA]] | ||
| | |4 | ||
|cell receptor alpha chain MC.7.G5 precursor (MC.7.G5 TRA) (TR alpha chain TRAV38-2DV8*01J31*01C*01) | |cell receptor alpha chain MC.7.G5 precursor (MC.7.G5 TRA) (TR alpha chain TRAV38-2DV8*01J31*01C*01) | ||
|- | |- | ||
Строка 2804: | Строка 3168: | ||
|28 | |28 | ||
|Apolipoprotein(a) precursor (EC 3.4.21.-) (Apo(a)) (Lp(a)) | |Apolipoprotein(a) precursor (EC 3.4.21.-) (Apo(a)) (Lp(a)) | ||
|- | |||
|[[LGALS1]] | |||
|1 | |||
|Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating protein PM12) (S-Lac lectin 1) | |||
|- | |||
|[[COG1]] | |||
|1 | |||
|Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1) [KIAA1381] [LDLB] | |||
|- | |||
|[[SCPEP1]] | |||
|1 | |||
|serine carboxypeptidase precursor (EC 3.4.16.-) (Serine carboxypeptidase 1) [RISC] [SCP1] [MSTP034] [UNQ265/PRO302] | |||
|- | |- | ||
|[[MTR]] | |[[MTR]] | ||
| | |19 | ||
|Methionine synthase (EC 2.1.1.13) (MS) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase) | |Methionine synthase (EC 2.1.1.13) (MS) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Cobalamin-dependent methionine synthase) (Vitamin-B12 dependent methionine synthase) | ||
|- | |||
|[[CTU2]] | |||
|1 | |||
|Cytoplasmic tRNA 2-thiolation protein 2 (Cytosolic thiouridylase subunit 2) [C16orf84] [NCS2] | |||
|- | |- | ||
|[[RNF8]] | |[[RNF8]] | ||
Строка 2830: | Строка 3210: | ||
|- | |- | ||
|[[REST]] | |[[REST]] | ||
| | |23 | ||
|RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor) [NRSF] [XBR] | |RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor) [NRSF] [XBR] | ||
|- | |- | ||
Строка 2850: | Строка 3230: | ||
|- | |- | ||
|[[EZR]] | |[[EZR]] | ||
| | |2 | ||
|Ezrin (Cytovillin) (Villin-2) (p81) [VIL2] | |Ezrin (Cytovillin) (Villin-2) (p81) [VIL2] | ||
|- | |- | ||
Строка 2864: | Строка 3244: | ||
|5 | |5 | ||
|DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase subunit delta p125) [POLD] | |DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase subunit delta p125) [POLD] | ||
|- | |||
|[[AOC1]] | |||
|1 | |||
|Amiloride-sensitive amine oxidase [copper-containing] precursor (EC 1.4.3.22) (DAO) (Diamine oxidase) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase) (Kidney amine oxidase) (KAO) [ABP1] [DAO1] | |||
|- | |- | ||
|[[KCNC4]] | |[[KCNC4]] | ||
Строка 2870: | Строка 3254: | ||
|- | |- | ||
|[[PARP1]] | |[[PARP1]] | ||
| | |20 | ||
|Poly [ADP-ribose] polymerase 1 (EC 2.4.2.30) (PARP-1) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD( ) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-) [ADPRT] [PPOL] | |Poly [ADP-ribose] polymerase 1 (EC 2.4.2.30) (PARP-1) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD( ) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-) [ADPRT] [PPOL] | ||
|- | |- | ||
Строка 2882: | Строка 3266: | ||
|- | |- | ||
|[[FUS]] | |[[FUS]] | ||
| | |12 | ||
|RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein) [TLS] | |RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein) [TLS] | ||
|- | |- | ||
Строка 2906: | Строка 3290: | ||
|- | |- | ||
|[[KL]] | |[[KL]] | ||
| | |33 | ||
|Klotho precursor (EC 3.2.1.31) [Contains: Klotho peptide] | |Klotho precursor (EC 3.2.1.31) [Contains: Klotho peptide] | ||
|- | |||
|[[OPLAH]] | |||
|1 | |||
|5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase) | |||
|- | |- | ||
|[[CA12]] | |[[CA12]] | ||
Строка 2928: | Строка 3316: | ||
|2 | |2 | ||
|Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2) | |Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2) | ||
|- | |||
|[[CYSLTR2]] | |||
|1 | |||
|Cysteinyl leukotriene receptor 2 (CysLTR2) (G-protein coupled receptor GPCR21) (hGPCR21) (G-protein coupled receptor HG57) (HPN321) [CYSLT2] [CYSLT2R] [PSEC0146] | |||
|- | |- | ||
|[[SDHB]] | |[[SDHB]] | ||
| | |5 | ||
|Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial precursor (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip) [SDH] [SDH1] | |Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial precursor (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip) [SDH] [SDH1] | ||
|- | |- | ||
Строка 2944: | Строка 3336: | ||
|1 | |1 | ||
|Dual specificity protein phosphatase 1 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH1) (Mitogen-activated protein kinase phosphatase 1) (MAP kinase phosphatase 1) (MKP-1) (Protein-tyrosine phosphatase CL100) [CL100] [MKP1] [PTPN10] [VH1] | |Dual specificity protein phosphatase 1 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH1) (Mitogen-activated protein kinase phosphatase 1) (MAP kinase phosphatase 1) (MKP-1) (Protein-tyrosine phosphatase CL100) [CL100] [MKP1] [PTPN10] [VH1] | ||
|- | |||
|[[UVRAG]] | |||
|1 | |||
|UV radiation resistance-associated gene protein (p63) | |||
|- | |- | ||
|[[AKAP11]] | |[[AKAP11]] | ||
Строка 2962: | Строка 3358: | ||
|- | |- | ||
|[[F8]] | |[[F8]] | ||
| | |2 | ||
|Coagulation factor VIII precursor (Antihemophilic factor) (AHF) (Procoagulant component) [Contains: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain] [F8C] | |Coagulation factor VIII precursor (Antihemophilic factor) (AHF) (Procoagulant component) [Contains: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain] [F8C] | ||
|- | |- | ||
|[[C5]] | |[[C5]] | ||
| | |15 | ||
|Complement C5 precursor (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Contains: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain] [CPAMD4] | |Complement C5 precursor (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Contains: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain] [CPAMD4] | ||
|- | |- | ||
Строка 2974: | Строка 3370: | ||
|- | |- | ||
|[[PTEN]] | |[[PTEN]] | ||
| | |83 | ||
|Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog) [MMAC1] [TEP1] | |Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog) [MMAC1] [TEP1] | ||
|- | |- | ||
|[[ATG5]] | |[[ATG5]] | ||
| | |13 | ||
|Autophagy protein 5 (APG5-like) (Apoptosis-specific protein) [APG5L] [ASP] | |Autophagy protein 5 (APG5-like) (Apoptosis-specific protein) [APG5L] [ASP] | ||
|- | |- | ||
|[[ | |[[OXT]] | ||
|1 | |1 | ||
| | |Oxytocin-neurophysin 1 precursor (OT-NPI) [Contains: Oxytocin (Ocytocin); Neurophysin 1] [OT] | ||
|- | |- | ||
|[[SMN1]] | |[[SMN1]] | ||
| | |4 | ||
|Survival motor neuron protein (Component of gems 1) (Gemin-1) [SMN] [SMNT] | |Survival motor neuron protein (Component of gems 1) (Gemin-1) [SMN] [SMNT] | ||
|- | |- | ||
|[[MME]] | |[[MME]] | ||
| | |6 | ||
|Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD10 antigen) [EPN] | |Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD10 antigen) [EPN] | ||
|- | |- | ||
|[[PDE9A]] | |[[PDE9A]] | ||
| | |2 | ||
|High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) | |High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35) | ||
|- | |- | ||
|[[SIRT2]] | |[[SIRT2]] | ||
| | |32 | ||
|NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) [SIR2L] [SIR2L2] | |NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) [SIR2L] [SIR2L2] | ||
|- | |||
|[[PLA2G4B]] | |||
|1 | |||
|Cytosolic phospholipase A2 beta (EC 3.1.1.4) (cPLA2-beta) (Lysophospholipase A1 group IVB) (EC 3.1.1.5) (Phospholipase A2 group IVB) | |||
|- | |- | ||
|[[LMNB1]] | |[[LMNB1]] | ||
| | |12 | ||
|Lamin-B1 precursor [LMN2] [LMNB] | |Lamin-B1 precursor [LMN2] [LMNB] | ||
|- | |- | ||
Строка 3014: | Строка 3414: | ||
|- | |- | ||
|[[ERF]] | |[[ERF]] | ||
| | |13 | ||
|ETS domain-containing transcription factor ERF (Ets2 repressor factor) (PE-2) | |ETS domain-containing transcription factor ERF (Ets2 repressor factor) (PE-2) | ||
|- | |- | ||
|[[HK1]] | |[[HK1]] | ||
| | |3 | ||
|Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A) | |Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A) | ||
|- | |- | ||
|[[OGA]] | |[[OGA]] | ||
| | |3 | ||
|Protein O-GlcNAcase (EC 3.2.1.169) (OGA) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT) [HEXC] [KIAA0679] [MEA5] [MGEA5] | |Protein O-GlcNAcase (EC 3.2.1.169) (OGA) (Beta-N-acetylglucosaminidase) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT) [HEXC] [KIAA0679] [MEA5] [MGEA5] | ||
|- | |- | ||
Строка 3048: | Строка 3448: | ||
|1 | |1 | ||
|KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2) (KRR-R motif-containing protein 1) (Rev-interacting protein 1) (Rip-1) [HRB2] | |KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2) (KRR-R motif-containing protein 1) (Rev-interacting protein 1) (Rip-1) [HRB2] | ||
|- | |||
|[[ADAM9]] | |||
|1 | |||
|Disintegrin and metalloproteinase domain-containing protein 9 precursor (EC 3.4.24.-) (ADAM 9) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase) [KIAA0021] [MCMP] [MDC9] [MLTNG] | |||
|- | |- | ||
|[[SUMO2]] | |[[SUMO2]] | ||
Строка 3054: | Строка 3458: | ||
|- | |- | ||
|[[PRDX1]] | |[[PRDX1]] | ||
| | |4 | ||
|Peroxiredoxin-1 (EC 1.11.1.24) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2) (Thioredoxin-dependent peroxiredoxin 1) [PAGA] [PAGB] [TDPX2] | |Peroxiredoxin-1 (EC 1.11.1.24) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2) (Thioredoxin-dependent peroxiredoxin 1) [PAGA] [PAGB] [TDPX2] | ||
|- | |- | ||
Строка 3072: | Строка 3476: | ||
|1 | |1 | ||
|NACHT, LRR and PYD domains-containing protein 5 (Mater protein homolog) [MATER] [NALP5] | |NACHT, LRR and PYD domains-containing protein 5 (Mater protein homolog) [MATER] [NALP5] | ||
|- | |||
|[[COL9A1]] | |||
|1 | |||
|Collagen alpha-1(IX) chain precursor | |||
|- | |- | ||
|[[PTPRD]] | |[[PTPRD]] | ||
Строка 3078: | Строка 3486: | ||
|- | |- | ||
|[[MGP]] | |[[MGP]] | ||
| | |5 | ||
|Matrix Gla protein precursor (MGP) (Cell growth-inhibiting gene 36 protein) [MGLAP] [GIG36] | |Matrix Gla protein precursor (MGP) (Cell growth-inhibiting gene 36 protein) [MGLAP] [GIG36] | ||
|- | |- | ||
|[[XBP1]] | |[[XBP1]] | ||
| | |13 | ||
|X-box-binding protein 1 (XBP-1) (Tax-responsive element-binding protein 5) (TREB-5) [Contains: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form] [TREB5] [XBP2] | |X-box-binding protein 1 (XBP-1) (Tax-responsive element-binding protein 5) (TREB-5) [Contains: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form] [TREB5] [XBP2] | ||
|- | |- | ||
Строка 3090: | Строка 3498: | ||
|- | |- | ||
|[[DRD2]] | |[[DRD2]] | ||
| | |14 | ||
|D(2) dopamine receptor (Dopamine D2 receptor) | |D(2) dopamine receptor (Dopamine D2 receptor) | ||
|- | |- | ||
Строка 3114: | Строка 3522: | ||
|- | |- | ||
|[[IL18]] | |[[IL18]] | ||
| | |2 | ||
|Interleukin-18 precursor (IL-18) (Iboctadekin) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma) [IGIF] [IL1F4] | |Interleukin-18 precursor (IL-18) (Iboctadekin) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma) [IGIF] [IL1F4] | ||
|- | |- | ||
Строка 3122: | Строка 3530: | ||
|- | |- | ||
|[[EGF]] | |[[EGF]] | ||
| | |46 | ||
|Pro-epidermal growth factor precursor (EGF) [Contains: Epidermal growth factor (Urogastrone)] | |Pro-epidermal growth factor precursor (EGF) [Contains: Epidermal growth factor (Urogastrone)] | ||
|- | |- | ||
|[[PDE5A]] | |[[PDE5A]] | ||
| | |2 | ||
|cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35) (cGMP-binding cGMP-specific phosphodiesterase) (CGB-PDE) [PDE5] | |cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35) (cGMP-binding cGMP-specific phosphodiesterase) (CGB-PDE) [PDE5] | ||
|- | |- | ||
Строка 3134: | Строка 3542: | ||
|- | |- | ||
|[[RAD51B]] | |[[RAD51B]] | ||
| | |2 | ||
|DNA repair protein RAD51 homolog 2 (R51H2) (RAD51 homolog B) (Rad51B) (RAD51-like protein 1) [RAD51L1] [REC2] | |DNA repair protein RAD51 homolog 2 (R51H2) (RAD51 homolog B) (Rad51B) (RAD51-like protein 1) [RAD51L1] [REC2] | ||
|- | |- | ||
Строка 3170: | Строка 3578: | ||
|- | |- | ||
|[[KCNB1]] | |[[KCNB1]] | ||
| | |5 | ||
|Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (h-DRK1) (Voltage-gated potassium channel subunit Kv2.1) | |Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (h-DRK1) (Voltage-gated potassium channel subunit Kv2.1) | ||
|- | |- | ||
Строка 3178: | Строка 3586: | ||
|- | |- | ||
|[[ELOVL2]] | |[[ELOVL2]] | ||
| | |23 | ||
|Elongation of very long chain fatty acids protein 2 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL2) (ELOVL fatty acid elongase 2) (ELOVL FA elongase 2) (Very long chain 3-ketoacyl-CoA synthase 2) (Very long chain 3-oxoacyl-CoA synthase 2) [ELG3] [SSC2] | |Elongation of very long chain fatty acids protein 2 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL2) (ELOVL fatty acid elongase 2) (ELOVL FA elongase 2) (Very long chain 3-ketoacyl-CoA synthase 2) (Very long chain 3-oxoacyl-CoA synthase 2) [ELG3] [SSC2] | ||
|- | |- | ||
Строка 3186: | Строка 3594: | ||
|- | |- | ||
|[[CCNB1]] | |[[CCNB1]] | ||
| | |5 | ||
|G2/mitotic-specific cyclin-B1 [CCNB] | |G2/mitotic-specific cyclin-B1 [CCNB] | ||
|- | |- | ||
Строка 3198: | Строка 3606: | ||
|- | |- | ||
|[[FOXO3]] | |[[FOXO3]] | ||
| | |61 | ||
|Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1) [FKHRL1] [FOXO3A] | |Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1) [FKHRL1] [FOXO3A] | ||
|- | |- | ||
Строка 3218: | Строка 3626: | ||
|- | |- | ||
|[[CSF1R]] | |[[CSF1R]] | ||
| | |7 | ||
|Macrophage colony-stimulating factor 1 receptor precursor (CSF-1 receptor) (EC 2.7.10.1) (CSF-1-R) (CSF-1R) (M-CSF-R) (Proto-oncogene c-Fms) (CD115 antigen) [FMS] | |Macrophage colony-stimulating factor 1 receptor precursor (CSF-1 receptor) (EC 2.7.10.1) (CSF-1-R) (CSF-1R) (M-CSF-R) (Proto-oncogene c-Fms) (CD115 antigen) [FMS] | ||
|- | |- | ||
|[[SDHC]] | |[[SDHC]] | ||
| | |2 | ||
|Succinate dehydrogenase cytochrome b560 subunit, mitochondrial precursor (Integral membrane protein CII-3) (QPs-1) (QPs1) (Succinate dehydrogenase complex subunit C) (Succinate-ubiquinone oxidoreductase cytochrome B large subunit) (CYBL) [CYB560] [SDH3] | |Succinate dehydrogenase cytochrome b560 subunit, mitochondrial precursor (Integral membrane protein CII-3) (QPs-1) (QPs1) (Succinate dehydrogenase complex subunit C) (Succinate-ubiquinone oxidoreductase cytochrome B large subunit) (CYBL) [CYB560] [SDH3] | ||
|- | |- | ||
Строка 3232: | Строка 3640: | ||
|9 | |9 | ||
|BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 [NIP3] | |BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 [NIP3] | ||
|- | |||
|[[NUDT12]] | |||
|1 | |||
|NAD-capped RNA hydrolase NUDT12 (EC 3.6.1.-) (DeNADding enzyme NUDT12) (NADH pyrophosphatase NUDT12) (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 12) (Nudix motif 12) | |||
|- | |- | ||
|[[MRPS5]] | |[[MRPS5]] | ||
| | |3 | ||
|28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt) (Mitochondrial small ribosomal subunit protein uS5m) | |28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt) (Mitochondrial small ribosomal subunit protein uS5m) | ||
|- | |- | ||
Строка 3242: | Строка 3654: | ||
|- | |- | ||
|[[TEF]] | |[[TEF]] | ||
| | |2 | ||
|Thyrotroph embryonic factor [KIAA1655] | |Thyrotroph embryonic factor [KIAA1655] | ||
|- | |- | ||
|[[BMX]] | |[[BMX]] | ||
| | |2 | ||
|Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) | |Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) | ||
|- | |- | ||
Строка 3276: | Строка 3688: | ||
|1 | |1 | ||
|Active regulator of SIRT1 (40S ribosomal protein S19-binding protein 1) (RPS19-binding protein 1) (S19BP) [AROS] | |Active regulator of SIRT1 (40S ribosomal protein S19-binding protein 1) (RPS19-binding protein 1) (S19BP) [AROS] | ||
|- | |||
|[[AURKB]] | |||
|1 | |||
|Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) [AIK2] [AIM1] [AIRK2] [ARK2] [STK1] [STK12] [STK5] | |||
|- | |- | ||
|[[CSRP1]] | |[[CSRP1]] | ||
Строка 3286: | Строка 3702: | ||
|- | |- | ||
|[[BCL6]] | |[[BCL6]] | ||
| | |3 | ||
|B-cell lymphoma 6 protein (BCL-6) (B-cell lymphoma 5 protein) (BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51) [BCL5] [LAZ3] [ZBTB27] [ZNF51] | |B-cell lymphoma 6 protein (BCL-6) (B-cell lymphoma 5 protein) (BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51) [BCL5] [LAZ3] [ZBTB27] [ZNF51] | ||
|- | |||
|[[PDE7A]] | |||
|1 | |||
|High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A (EC 3.1.4.53) (HCP1) (TM22) | |||
|- | |- | ||
|[[UQCRC2]] | |[[UQCRC2]] | ||
| | |4 | ||
|Cytochrome b-c1 complex subunit 2, mitochondrial precursor (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2) | |Cytochrome b-c1 complex subunit 2, mitochondrial precursor (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2) | ||
|- | |- | ||
|[[HSF4]] | |[[HSF4]] | ||
| | |2 | ||
|Heat shock factor protein 4 (HSF 4) (hHSF4) (Heat shock transcription factor 4) (HSTF 4) | |Heat shock factor protein 4 (HSF 4) (hHSF4) (Heat shock transcription factor 4) (HSTF 4) | ||
|- | |- | ||
Строка 3310: | Строка 3730: | ||
|- | |- | ||
|[[BCL2]] | |[[BCL2]] | ||
| | |21 | ||
|Apoptosis regulator Bcl-2 | |Apoptosis regulator Bcl-2 | ||
|- | |- | ||
Строка 3332: | Строка 3752: | ||
|1 | |1 | ||
|5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B) | |5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B) | ||
|- | |||
|[[KIAA1755]] | |||
|1 | |||
|protein KIAA1755 | |||
|- | |- | ||
|[[FA2H]] | |[[FA2H]] | ||
Строка 3338: | Строка 3762: | ||
|- | |- | ||
|[[PML]] | |[[PML]] | ||
| | |22 | ||
|Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19) [MYL] [PP8675] [RNF71] [TRIM19] | |Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19) [MYL] [PP8675] [RNF71] [TRIM19] | ||
|- | |||
|[[CBX1]] | |||
|1 | |||
|Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) [CBX] | |||
|- | |- | ||
|[[NFIA]] | |[[NFIA]] | ||
Строка 3362: | Строка 3790: | ||
|- | |- | ||
|[[EZH2]] | |[[EZH2]] | ||
| | |25 | ||
|Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6) [KMT6] | |Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6) [KMT6] | ||
|- | |- | ||
|[[MST1]] | |[[MST1]] | ||
| | |4 | ||
|Hepatocyte growth factor-like protein precursor (Macrophage stimulatory protein) (Macrophage-stimulating protein) (MSP) [Contains: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain] [D3F15S2] [DNF15S2] [HGFL] | |Hepatocyte growth factor-like protein precursor (Macrophage stimulatory protein) (Macrophage-stimulating protein) (MSP) [Contains: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain] [D3F15S2] [DNF15S2] [HGFL] | ||
|- | |- | ||
Строка 3374: | Строка 3802: | ||
|- | |- | ||
|[[CDC42]] | |[[CDC42]] | ||
| | |6 | ||
|Cell division control protein 42 homolog precursor (EC 3.6.5.2) (G25K GTP-binding protein) | |Cell division control protein 42 homolog precursor (EC 3.6.5.2) (G25K GTP-binding protein) | ||
|- | |- | ||
|[[CCL11]] | |[[CCL11]] | ||
| | |17 | ||
|Eotaxin precursor (C-C motif chemokine 11) (Eosinophil chemotactic protein) (Small-inducible cytokine A11) [SCYA11] | |Eotaxin precursor (C-C motif chemokine 11) (Eosinophil chemotactic protein) (Small-inducible cytokine A11) [SCYA11] | ||
|- | |||
|[[CTXND1]] | |||
|1 | |||
|domain-containing 1 | |||
|- | |- | ||
|[[KCNQ4]] | |[[KCNQ4]] | ||
|1 | |1 | ||
|Potassium voltage-gated channel subfamily KQT member 4 (KQT-like 4) (Potassium channel subunit alpha KvLQT4) (Voltage-gated potassium channel subunit Kv7.4) | |Potassium voltage-gated channel subfamily KQT member 4 (KQT-like 4) (Potassium channel subunit alpha KvLQT4) (Voltage-gated potassium channel subunit Kv7.4) | ||
|- | |||
|[[PRDX5]] | |||
|1 | |||
|Peroxiredoxin-5, mitochondrial precursor (EC 1.11.1.24) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin-dependent peroxiredoxin 5) [ACR1] [SBBI10] | |||
|- | |- | ||
|[[CXCL8]] | |[[CXCL8]] | ||
| | |13 | ||
|Interleukin-8 precursor (IL-8) (C-X-C motif chemokine 8) (Chemokine (C-X-C motif) ligand 8) (Emoctakin) (Granulocyte chemotactic protein 1) (GCP-1) (Monocyte-derived neutrophil chemotactic factor) (MDNCF) (Monocyte-derived neutrophil-activating peptide) (MONAP) (Neutrophil-activating protein 1) (NAP-1) (Protein 3-10C) (T-cell chemotactic factor) [Contains: MDNCF-a (GCP/IL-8 protein IV) (IL8/NAP1 form I); Interleukin-8 ((Ala-IL-8)77) (GCP/IL-8 protein II) (IL-8(1-77)) (IL8/NAP1 form II) (MDNCF-b); IL-8(5-77); IL-8(6-77) ((Ser-IL-8)72) (GCP/IL-8 protein I) (IL8/NAP1 form III) (Lymphocyte-derived neutrophil-activating factor) (LYNAP) (MDNCF-c) (Neutrophil-activating factor) (NAF); IL-8(7-77) (GCP/IL-8 protein V) (IL8/NAP1 form IV); IL-8(8-77) (GCP/IL-8 protein VI) (IL8/NAP1 form V); IL-8(9-77) (GCP/IL-8 protein III) (IL8/NAP1 form VI)] [IL8] | |Interleukin-8 precursor (IL-8) (C-X-C motif chemokine 8) (Chemokine (C-X-C motif) ligand 8) (Emoctakin) (Granulocyte chemotactic protein 1) (GCP-1) (Monocyte-derived neutrophil chemotactic factor) (MDNCF) (Monocyte-derived neutrophil-activating peptide) (MONAP) (Neutrophil-activating protein 1) (NAP-1) (Protein 3-10C) (T-cell chemotactic factor) [Contains: MDNCF-a (GCP/IL-8 protein IV) (IL8/NAP1 form I); Interleukin-8 ((Ala-IL-8)77) (GCP/IL-8 protein II) (IL-8(1-77)) (IL8/NAP1 form II) (MDNCF-b); IL-8(5-77); IL-8(6-77) ((Ser-IL-8)72) (GCP/IL-8 protein I) (IL8/NAP1 form III) (Lymphocyte-derived neutrophil-activating factor) (LYNAP) (MDNCF-c) (Neutrophil-activating factor) (NAF); IL-8(7-77) (GCP/IL-8 protein V) (IL8/NAP1 form IV); IL-8(8-77) (GCP/IL-8 protein VI) (IL8/NAP1 form V); IL-8(9-77) (GCP/IL-8 protein III) (IL8/NAP1 form VI)] [IL8] | ||
|- | |- | ||
Строка 3406: | Строка 3842: | ||
|- | |- | ||
|[[KLF6]] | |[[KLF6]] | ||
| | |3 | ||
|Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9) [BCD1] [COPEB] [CPBP] [ST12] | |Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9) [BCD1] [COPEB] [CPBP] [ST12] | ||
|- | |- | ||
Строка 3414: | Строка 3850: | ||
|- | |- | ||
|[[FABP1]] | |[[FABP1]] | ||
| | |2 | ||
|Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP) [FABPL] | |Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP) [FABPL] | ||
|- | |- | ||
Строка 3430: | Строка 3866: | ||
|- | |- | ||
|[[MX1]] | |[[MX1]] | ||
| | |2 | ||
|Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78) (IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Contains: Interferon-induced GTP-binding protein Mx1, N-terminally processed] | |Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78) (IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Contains: Interferon-induced GTP-binding protein Mx1, N-terminally processed] | ||
|- | |- | ||
Строка 3458: | Строка 3894: | ||
|- | |- | ||
|[[SNCA]] | |[[SNCA]] | ||
| | |8 | ||
|Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) [NACP] [PARK1] | |Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) [NACP] [PARK1] | ||
|- | |- | ||
Строка 3466: | Строка 3902: | ||
|- | |- | ||
|[[GFAP]] | |[[GFAP]] | ||
| | |127 | ||
|Glial fibrillary acidic protein (GFAP) | |Glial fibrillary acidic protein (GFAP) | ||
|- | |- | ||
Строка 3506: | Строка 3942: | ||
|- | |- | ||
|[[TET2]] | |[[TET2]] | ||
| | |20 | ||
|Methylcytosine dioxygenase TET2 (EC 1.14.11.n2) [KIAA1546] [Nbla00191] | |Methylcytosine dioxygenase TET2 (EC 1.14.11.n2) [KIAA1546] [Nbla00191] | ||
|- | |- | ||
|[[E2F1]] | |[[E2F1]] | ||
| | |22 | ||
|Transcription factor E2F1 (E2F-1) (PBR3) (Retinoblastoma-associated protein 1) (RBAP-1) (Retinoblastoma-binding protein 3) (RBBP-3) (pRB-binding protein E2F-1) [RBBP3] | |Transcription factor E2F1 (E2F-1) (PBR3) (Retinoblastoma-associated protein 1) (RBAP-1) (Retinoblastoma-binding protein 3) (RBBP-3) (pRB-binding protein E2F-1) [RBBP3] | ||
|- | |- | ||
Строка 3520: | Строка 3956: | ||
|4 | |4 | ||
|Neural cell adhesion molecule L1 precursor (N-CAM-L1) (NCAM-L1) (CD171 antigen) [CAML1] [MIC5] | |Neural cell adhesion molecule L1 precursor (N-CAM-L1) (NCAM-L1) (CD171 antigen) [CAML1] [MIC5] | ||
|- | |||
|[[STIP1]] | |||
|1 | |||
|Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521) | |||
|- | |- | ||
|[[AXL]] | |[[AXL]] | ||
Строка 3542: | Строка 3982: | ||
|- | |- | ||
|[[AVP]] | |[[AVP]] | ||
| | |12 | ||
|Vasopressin-neurophysin 2-copeptin precursor (AVP-NPII) [Contains: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin] [ARVP] [VP] | |Vasopressin-neurophysin 2-copeptin precursor (AVP-NPII) [Contains: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin] [ARVP] [VP] | ||
|- | |||
|[[PLA2G7]] | |||
|1 | |||
|Platelet-activating factor acetylhydrolase precursor (EC 3.1.1.47) (PAF acetylhydrolase) (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (Group-VIIA phospholipase A2) (gVIIA-PLA2) (LDL-associated phospholipase A2) (LDL-PLA(2)) (PAF 2-acylhydrolase) [PAFAH] | |||
|- | |- | ||
|[[NT5E]] | |[[NT5E]] | ||
Строка 3550: | Строка 3994: | ||
|- | |- | ||
|[[PDF]] | |[[PDF]] | ||
| | |5 | ||
|Peptide deformylase, mitochondrial precursor (EC 3.5.1.88) (Polypeptide deformylase) [PDF1A] | |Peptide deformylase, mitochondrial precursor (EC 3.5.1.88) (Polypeptide deformylase) [PDF1A] | ||
|- | |- | ||
Строка 3560: | Строка 4004: | ||
|3 | |3 | ||
|Oxidation resistance protein 1 [Nbla00307] | |Oxidation resistance protein 1 [Nbla00307] | ||
|- | |||
|[[MKRN1]] | |||
|1 | |||
|E3 ubiquitin-protein ligase makorin-1 (EC 2.3.2.27) (RING finger protein 61) (RING-type E3 ubiquitin transferase makorin-1) [RNF61] | |||
|- | |- | ||
|[[AQP9]] | |[[AQP9]] | ||
Строка 3566: | Строка 4014: | ||
|- | |- | ||
|[[CCR4]] | |[[CCR4]] | ||
| | |2 | ||
|C-C chemokine receptor type 4 (C-C CKR-4) (CC-CKR-4) (CCR-4) (CCR4) (K5-5) (CD194 antigen) [CMKBR4] | |C-C chemokine receptor type 4 (C-C CKR-4) (CC-CKR-4) (CCR-4) (CCR4) (K5-5) (CD194 antigen) [CMKBR4] | ||
|- | |- | ||
Строка 3584: | Строка 4032: | ||
|1 | |1 | ||
|Adenylate kinase isoenzyme 1 (EC 2.7.4.3) (EC 2.7.4.6) (AK 1) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) | |Adenylate kinase isoenzyme 1 (EC 2.7.4.3) (EC 2.7.4.6) (AK 1) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) | ||
|- | |- | ||
|[[SFRP5]] | |[[SFRP5]] | ||
Строка 3594: | Строка 4038: | ||
|- | |- | ||
|[[PPARGC1A]] | |[[PPARGC1A]] | ||
| | |4 | ||
|Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1-alpha) (PPAR-gamma coactivator 1-alpha) (PPARGC-1-alpha) (Ligand effect modulator 6) [LEM6] [PGC1] [PGC1A] [PPARGC1] | |Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1-alpha) (PPAR-gamma coactivator 1-alpha) (PPARGC-1-alpha) (Ligand effect modulator 6) [LEM6] [PGC1] [PGC1A] [PPARGC1] | ||
|- | |- | ||
Строка 3610: | Строка 4054: | ||
|- | |- | ||
|[[TCF4]] | |[[TCF4]] | ||
| | |4 | ||
|Transcription factor 4 (TCF-4) (Class B basic helix-loop-helix protein 19) (bHLHb19) (Immunoglobulin transcription factor 2) (ITF-2) (SL3-3 enhancer factor 2) (SEF-2) [BHLHB19] [ITF2] [SEF2] | |Transcription factor 4 (TCF-4) (Class B basic helix-loop-helix protein 19) (bHLHb19) (Immunoglobulin transcription factor 2) (ITF-2) (SL3-3 enhancer factor 2) (SEF-2) [BHLHB19] [ITF2] [SEF2] | ||
|- | |- | ||
Строка 3622: | Строка 4066: | ||
|- | |- | ||
|[[MMP3]] | |[[MMP3]] | ||
| | |10 | ||
|Stromelysin-1 precursor (EC 3.4.24.17) (SL-1) (Matrix metalloproteinase-3) (MMP-3) (Transin-1) [STMY1] | |Stromelysin-1 precursor (EC 3.4.24.17) (SL-1) (Matrix metalloproteinase-3) (MMP-3) (Transin-1) [STMY1] | ||
|- | |- | ||
Строка 3630: | Строка 4074: | ||
|- | |- | ||
|[[GAK]] | |[[GAK]] | ||
| | |2 | ||
|Cyclin-G-associated kinase (EC 2.7.11.1) | |Cyclin-G-associated kinase (EC 2.7.11.1) | ||
|- | |- | ||
|[[IGHD]] | |[[IGHD]] | ||
| | |2 | ||
|Immunoglobulin heavy constant delta (Ig delta chain C region) (Ig delta chain C region NIG-65) (Ig delta chain C region WAH) | |Immunoglobulin heavy constant delta (Ig delta chain C region) (Ig delta chain C region NIG-65) (Ig delta chain C region WAH) | ||
|- | |- | ||
Строка 3662: | Строка 4106: | ||
|- | |- | ||
|[[NPY5R]] | |[[NPY5R]] | ||
| | |2 | ||
|Neuropeptide Y receptor type 5 (NPY5-R) (NPY-Y5 receptor) (NPYY5-R) (Y5 receptor) [NPYR5] | |Neuropeptide Y receptor type 5 (NPY5-R) (NPY-Y5 receptor) (NPYY5-R) (Y5 receptor) [NPYR5] | ||
|- | |- | ||
Строка 3674: | Строка 4118: | ||
|- | |- | ||
|[[YY1]] | |[[YY1]] | ||
| | |2 | ||
|Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1) [INO80S] | |Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1) [INO80S] | ||
|- | |- | ||
|[[CES2]] | |[[CES2]] | ||
| | |3 | ||
|Cocaine esterase precursor (EC 3.1.1.84) (Carboxylesterase 2) (EC 3.1.1.1) (CE-2) (hCE-2) (Methylumbelliferyl-acetate deacetylase 2) (EC 3.1.1.56) [ICE] | |Cocaine esterase precursor (EC 3.1.1.84) (Carboxylesterase 2) (EC 3.1.1.1) (CE-2) (hCE-2) (Methylumbelliferyl-acetate deacetylase 2) (EC 3.1.1.56) [ICE] | ||
|- | |- | ||
Строка 3694: | Строка 4138: | ||
|- | |- | ||
|[[CCL5]] | |[[CCL5]] | ||
| | |13 | ||
|C-C motif chemokine 5 precursor (EoCP) (Eosinophil chemotactic cytokine) (SIS-delta) (Small-inducible cytokine A5) (T cell-specific protein P228) (TCP228) (T-cell-specific protein RANTES) [Contains: RANTES(3-68); RANTES(4-68)] [D17S136E] [SCYA5] | |C-C motif chemokine 5 precursor (EoCP) (Eosinophil chemotactic cytokine) (SIS-delta) (Small-inducible cytokine A5) (T cell-specific protein P228) (TCP228) (T-cell-specific protein RANTES) [Contains: RANTES(3-68); RANTES(4-68)] [D17S136E] [SCYA5] | ||
|- | |- | ||
|[[PDE3A]] | |[[PDE3A]] | ||
| | |2 | ||
|cGMP-inhibited 3',5'-cyclic phosphodiesterase A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) | |cGMP-inhibited 3',5'-cyclic phosphodiesterase A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) | ||
|- | |- | ||
Строка 3712: | Строка 4156: | ||
|1 | |1 | ||
|Sine oculis-binding protein homolog (Jackson circler protein 1) [JXC1] | |Sine oculis-binding protein homolog (Jackson circler protein 1) [JXC1] | ||
|- | |||
|[[TNR]] | |||
|2 | |||
|Tenascin-R precursor (TN-R) (Janusin) (Restrictin) | |||
|- | |- | ||
|[[CYP1A1]] | |[[CYP1A1]] | ||
| | |4 | ||
|Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) | |Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) | ||
|- | |||
|[[CEP57]] | |||
|1 | |||
|Centrosomal protein of 57 kDa (Cep57) (FGF2-interacting protein) (Testis-specific protein 57) (Translokin) [KIAA0092] [TSP57] | |||
|- | |- | ||
|[[RAC3]] | |[[RAC3]] | ||
Строка 3766: | Строка 4218: | ||
|- | |- | ||
|[[PRL]] | |[[PRL]] | ||
| | |20 | ||
|Prolactin precursor (PRL) | |Prolactin precursor (PRL) | ||
|- | |- | ||
Строка 3774: | Строка 4226: | ||
|- | |- | ||
|[[ESR2]] | |[[ESR2]] | ||
| | |8 | ||
|Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) [ESTRB] [NR3A2] | |Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) [ESTRB] [NR3A2] | ||
|- | |- | ||
Строка 3790: | Строка 4242: | ||
|- | |- | ||
|[[E2F3]] | |[[E2F3]] | ||
| | |5 | ||
|Transcription factor E2F3 (E2F-3) [KIAA0075] | |Transcription factor E2F3 (E2F-3) [KIAA0075] | ||
|- | |- | ||
Строка 3798: | Строка 4250: | ||
|- | |- | ||
|[[SPARC]] | |[[SPARC]] | ||
| | |13 | ||
|SPARC precursor (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine) [ON] | |SPARC precursor (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine) [ON] | ||
|- | |- | ||
Строка 3822: | Строка 4274: | ||
|- | |- | ||
|[[TLR3]] | |[[TLR3]] | ||
| | |6 | ||
|Toll-like receptor 3 precursor (CD283 antigen) | |Toll-like receptor 3 precursor (CD283 antigen) | ||
|- | |||
|[[KCNJ14]] | |||
|1 | |||
|ATP-sensitive inward rectifier potassium channel 14 (Inward rectifier K( ) channel Kir2.4) (IRK-4) (Potassium channel, inwardly rectifying subfamily J member 14) [IRK4] | |||
|- | |- | ||
|[[PPFIA1]] | |[[PPFIA1]] | ||
Строка 3830: | Строка 4286: | ||
|- | |- | ||
|[[POLG]] | |[[POLG]] | ||
| | |9 | ||
|DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha) [MDP1] [POLG1] [POLGA] | |DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha) [MDP1] [POLG1] [POLGA] | ||
|- | |- | ||
Строка 3842: | Строка 4298: | ||
|- | |- | ||
|[[FGFR2]] | |[[FGFR2]] | ||
| | |3 | ||
|Fibroblast growth factor receptor 2 precursor (EC 2.7.10.1) (FGFR-2) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD332 antigen) [BEK] [KGFR] [KSAM] | |Fibroblast growth factor receptor 2 precursor (EC 2.7.10.1) (FGFR-2) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD332 antigen) [BEK] [KGFR] [KSAM] | ||
|- | |- | ||
Строка 3848: | Строка 4304: | ||
|1 | |1 | ||
|Succinate receptor 1 (G-protein coupled receptor 91) (P2Y purinoceptor 1-like) [GPR91] | |Succinate receptor 1 (G-protein coupled receptor 91) (P2Y purinoceptor 1-like) [GPR91] | ||
|- | |||
|[[CCNE1]] | |||
|1 | |||
|G1/S-specific cyclin-E1 [CCNE] | |||
|- | |- | ||
|[[MMP12]] | |[[MMP12]] | ||
Строка 3854: | Строка 4314: | ||
|- | |- | ||
|[[STN1]] | |[[STN1]] | ||
| | |3 | ||
|CST complex subunit STN1 (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog) [OBFC1] | |CST complex subunit STN1 (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog) [OBFC1] | ||
|- | |- | ||
|[[HMGB2]] | |[[HMGB2]] | ||
| | |6 | ||
|High mobility group protein B2 (High mobility group protein 2) (HMG-2) [HMG2] | |High mobility group protein B2 (High mobility group protein 2) (HMG-2) [HMG2] | ||
|- | |- | ||
|[[LGR5]] | |[[LGR5]] | ||
| | |2 | ||
|Leucine-rich repeat-containing G-protein coupled receptor 5 precursor (G-protein coupled receptor 49) (G-protein coupled receptor 67) (G-protein coupled receptor HG38) [GPR49] [GPR67] | |Leucine-rich repeat-containing G-protein coupled receptor 5 precursor (G-protein coupled receptor 49) (G-protein coupled receptor 67) (G-protein coupled receptor HG38) [GPR49] [GPR67] | ||
|- | |- | ||
Строка 3878: | Строка 4338: | ||
|- | |- | ||
|[[HAS3]] | |[[HAS3]] | ||
| | |2 | ||
|Hyaluronan synthase 3 (EC 2.4.1.212) (Hyaluronate synthase 3) (Hyaluronic acid synthase 3) (HA synthase 3) | |Hyaluronan synthase 3 (EC 2.4.1.212) (Hyaluronate synthase 3) (Hyaluronic acid synthase 3) (HA synthase 3) | ||
|- | |- | ||
|[[JAK2]] | |[[JAK2]] | ||
| | |22 | ||
|Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) | |Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) | ||
|- | |- | ||
Строка 3892: | Строка 4352: | ||
|1 | |1 | ||
|Cytoplasmic dynein 2 heavy chain 1 (Cytoplasmic dynein 2 heavy chain) (Dynein cytoplasmic heavy chain 2) (Dynein heavy chain 11) (hDHC11) (Dynein heavy chain isotype 1B) [DHC1B] [DHC2] [DNCH2] [DYH1B] [KIAA1997] | |Cytoplasmic dynein 2 heavy chain 1 (Cytoplasmic dynein 2 heavy chain) (Dynein cytoplasmic heavy chain 2) (Dynein heavy chain 11) (hDHC11) (Dynein heavy chain isotype 1B) [DHC1B] [DHC2] [DNCH2] [DYH1B] [KIAA1997] | ||
|- | |||
|[[TNFAIP3]] | |||
|1 | |||
|Tumor necrosis factor alpha-induced protein 3 (EC 2.3.2.-) (EC 3.4.19.12) (TNF alpha-induced protein 3) (OTU domain-containing protein 7C) (Putative DNA-binding protein A20) (Zinc finger protein A20) [Contains: A20p50; A20p37] [OTUD7C] | |||
|- | |- | ||
|[[PHGDH]] | |[[PHGDH]] | ||
Строка 3900: | Строка 4364: | ||
|2 | |2 | ||
|Heat shock protein beta-6 (HspB6) (Heat shock 20 kDa-like protein p20) | |Heat shock protein beta-6 (HspB6) (Heat shock 20 kDa-like protein p20) | ||
|- | |||
|[[EIF2AK3]] | |||
|1 | |||
|Eukaryotic translation initiation factor 2-alpha kinase 3 precursor (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK) [PEK] [PERK] | |||
|- | |- | ||
|[[DTNBP1]] | |[[DTNBP1]] | ||
Строка 3912: | Строка 4380: | ||
|1 | |1 | ||
|Autophagy-related protein 16-1 (APG16-like 1) [APG16L] [UNQ9393/PRO34307] | |Autophagy-related protein 16-1 (APG16-like 1) [APG16L] [UNQ9393/PRO34307] | ||
|- | |||
|[[MTTP]] | |||
|1 | |||
|Microsomal triglyceride transfer protein large subunit precursor [MTP] | |||
|- | |- | ||
|[[PLD2]] | |[[PLD2]] | ||
|3 | |3 | ||
|Phospholipase D2 (EC 3.1.4.4) (PLD 2) (hPLD2) (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2) | |Phospholipase D2 (EC 3.1.4.4) (PLD 2) (hPLD2) (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2) | ||
|- | |||
|[[KCNJ12]] | |||
|1 | |||
|ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K( ) channel Kir2.2) (IRK-2) (Inward rectifier K( ) channel Kir2.2v) (Potassium channel, inwardly rectifying subfamily J member 12) [IRK2] [KCNJN1] | |||
|- | |- | ||
|[[DCAF7]] | |[[DCAF7]] | ||
Строка 3926: | Строка 4402: | ||
|- | |- | ||
|[[TNF]] | |[[TNF]] | ||
| | |596 | ||
|Tumor necrosis factor precursor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Contains: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form] [TNFA] [TNFSF2] | |Tumor necrosis factor precursor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Contains: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form] [TNFA] [TNFSF2] | ||
|- | |- | ||
|[[TRPV1]] | |[[TRPV1]] | ||
| | |16 | ||
|Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1) [VR1] | |Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1) [VR1] | ||
|- | |- | ||
|[[GLB1]] | |[[GLB1]] | ||
| | |4 | ||
|Beta-galactosidase precursor (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1) [ELNR1] | |Beta-galactosidase precursor (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1) [ELNR1] | ||
|- | |- | ||
Строка 3960: | Строка 4436: | ||
|1 | |1 | ||
|Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1) [APE] [GRDN] [KIAA1212] | |Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1) [APE] [GRDN] [KIAA1212] | ||
|- | |||
|[[TESC]] | |||
|1 | |||
|Calcineurin B homologous protein 3 (Tescalcin) (TSC) [CHP3] | |||
|- | |- | ||
|[[IDE]] | |[[IDE]] | ||
| | |11 | ||
|Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin) | |Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin) | ||
|- | |- | ||
|[[NPAS2]] | |[[NPAS2]] | ||
| | |4 | ||
|Neuronal PAS domain-containing protein 2 (Neuronal PAS2) (Basic-helix-loop-helix-PAS protein MOP4) (Class E basic helix-loop-helix protein 9) (bHLHe9) (Member of PAS protein 4) (PAS domain-containing protein 4) [BHLHE9] [MOP4] [PASD4] | |Neuronal PAS domain-containing protein 2 (Neuronal PAS2) (Basic-helix-loop-helix-PAS protein MOP4) (Class E basic helix-loop-helix protein 9) (bHLHe9) (Member of PAS protein 4) (PAS domain-containing protein 4) [BHLHE9] [MOP4] [PASD4] | ||
|- | |- | ||
Строка 3978: | Строка 4458: | ||
|- | |- | ||
|[[ERG]] | |[[ERG]] | ||
| | |26 | ||
|Transcriptional regulator ERG (Transforming protein ERG) | |Transcriptional regulator ERG (Transforming protein ERG) | ||
|- | |||
|[[ZNF483]] | |||
|1 | |||
|finger protein 483 (Zinc finger protein with KRAB and SCAN domains 16) [KIAA1962] [ZKSCAN16] | |||
|- | |- | ||
|[[MAF1]] | |[[MAF1]] | ||
|3 | |3 | ||
|Repressor of RNA polymerase III transcription MAF1 homolog | |Repressor of RNA polymerase III transcription MAF1 homolog | ||
|- | |||
|[[SLC4A7]] | |||
|1 | |||
|Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7) [BT] [NBC2] [NBC2B] [NBC3] [NBCn1] [SBC2] [SLC4A6] | |||
|- | |- | ||
|[[PDGFRA]] | |[[PDGFRA]] | ||
|1 | |1 | ||
|Platelet-derived growth factor receptor alpha precursor (EC 2.7.10.1) (PDGF-R-alpha) (PDGFR-alpha) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD140a antigen) [PDGFR2] [RHEPDGFRA] | |Platelet-derived growth factor receptor alpha precursor (EC 2.7.10.1) (PDGF-R-alpha) (PDGFR-alpha) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD140a antigen) [PDGFR2] [RHEPDGFRA] | ||
|- | |||
|[[ORMDL3]] | |||
|1 | |||
|ORM1-like protein 3 | |||
|- | |- | ||
|[[NPR1]] | |[[NPR1]] | ||
| | |6 | ||
|Atrial natriuretic peptide receptor 1 precursor (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) [ANPRA] | |Atrial natriuretic peptide receptor 1 precursor (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A) [ANPRA] | ||
|- | |- | ||
|[[CYP2D6]] | |[[CYP2D6]] | ||
| | |10 | ||
|Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) [CYP2DL1] | |Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) [CYP2DL1] | ||
|- | |- | ||
|[[SOD3]] | |[[SOD3]] | ||
| | |8 | ||
|Extracellular superoxide dismutase [Cu-Zn] precursor (EC 1.15.1.1) (EC-SOD) | |Extracellular superoxide dismutase [Cu-Zn] precursor (EC 1.15.1.1) (EC-SOD) | ||
|- | |- | ||
|[[ROCK2]] | |[[ROCK2]] | ||
| | |11 | ||
|Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) [KIAA0619] | |Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) [KIAA0619] | ||
|- | |- | ||
Строка 4010: | Строка 4502: | ||
|- | |- | ||
|[[VHL]] | |[[VHL]] | ||
| | |9 | ||
|von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL) | |von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL) | ||
|- | |- | ||
Строка 4018: | Строка 4510: | ||
|- | |- | ||
|[[APOD]] | |[[APOD]] | ||
| | |2 | ||
|Apolipoprotein D precursor (Apo-D) (ApoD) | |Apolipoprotein D precursor (Apo-D) (ApoD) | ||
|- | |- | ||
Строка 4025: | Строка 4517: | ||
|Bromodomain-containing protein 2 (O27.1.1) (Really interesting new gene 3 protein) [KIAA9001] [RING3] | |Bromodomain-containing protein 2 (O27.1.1) (Really interesting new gene 3 protein) [KIAA9001] [RING3] | ||
|- | |- | ||
|[[ | |[[SLC16A2]] | ||
|1 | |1 | ||
| | |Monocarboxylate transporter 8 (MCT 8) (Monocarboxylate transporter 7) (MCT 7) (Solute carrier family 16 member 2) (X-linked PEST-containing transporter) [MCT8] [XPCT] | ||
|- | |- | ||
|[[IL13RA1]] | |[[IL13RA1]] | ||
Строка 4038: | Строка 4530: | ||
|- | |- | ||
|[[PAPPA]] | |[[PAPPA]] | ||
| | |4 | ||
|Pappalysin-1 precursor (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A) | |Pappalysin-1 precursor (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A) | ||
|- | |- | ||
Строка 4082: | Строка 4574: | ||
|- | |- | ||
|[[TAL1]] | |[[TAL1]] | ||
| | |3 | ||
|T-cell acute lymphocytic leukemia protein 1 (TAL-1) (Class A basic helix-loop-helix protein 17) (bHLHa17) (Stem cell protein) (T-cell leukemia/lymphoma protein 5) [BHLHA17] [SCL] [TCL5] | |T-cell acute lymphocytic leukemia protein 1 (TAL-1) (Class A basic helix-loop-helix protein 17) (bHLHa17) (Stem cell protein) (T-cell leukemia/lymphoma protein 5) [BHLHA17] [SCL] [TCL5] | ||
|- | |||
|[[SLC22A12]] | |||
|1 | |||
|Solute carrier family 22 member 12 (Organic anion transporter 4-like protein) (Renal-specific transporter) (RST) (Urate anion exchanger 1) [OATL4] [URAT1] [UNQ6453/PRO34004] | |||
|- | |- | ||
|[[GLRA2]] | |[[GLRA2]] | ||
Строка 4104: | Строка 4600: | ||
|1 | |1 | ||
|Charged multivesicular body protein 1b (CHMP1.5) (Chromatin-modifying protein 1b) (CHMP1b) (Vacuolar protein sorting-associated protein 46-2) (Vps46-2) (hVps46-2) [C18orf2] | |Charged multivesicular body protein 1b (CHMP1.5) (Chromatin-modifying protein 1b) (CHMP1b) (Vacuolar protein sorting-associated protein 46-2) (Vps46-2) (hVps46-2) [C18orf2] | ||
|- | |||
|[[ZSCAN4]] | |||
|1 | |||
|Zinc finger and SCAN domain-containing protein 4 (Zinc finger protein 494) [ZNF494] | |||
|- | |- | ||
|[[LIN28B]] | |[[LIN28B]] | ||
|3 | |||
|Protein lin-28 homolog B (Lin-28B) [CSDD2] | |||
|- | |||
|[[CEBPA]] | |||
|1 | |1 | ||
| | |CCAAT/enhancer-binding protein alpha (C/EBP alpha) [CEBP] | ||
|- | |- | ||
|[[ZC3H12A]] | |[[ZC3H12A]] | ||
Строка 4118: | Строка 4622: | ||
|- | |- | ||
|[[SUZ12]] | |[[SUZ12]] | ||
| | |3 | ||
|Polycomb protein SUZ12 (Chromatin precipitated E2F target 9 protein) (ChET 9 protein) (Joined to JAZF1 protein) (Suppressor of zeste 12 protein homolog) [CHET9] [JJAZ1] [KIAA0160] | |Polycomb protein SUZ12 (Chromatin precipitated E2F target 9 protein) (ChET 9 protein) (Joined to JAZF1 protein) (Suppressor of zeste 12 protein homolog) [CHET9] [JJAZ1] [KIAA0160] | ||
|- | |- | ||
Строка 4134: | Строка 4638: | ||
|- | |- | ||
|[[RUNX2]] | |[[RUNX2]] | ||
| | |18 | ||
|Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1) (CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2) (OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit) (PEA2-alpha A) (PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit) [AML3] [CBFA1] [OSF2] [PEBP2A] | |Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1) (CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2) (OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit) (PEA2-alpha A) (PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit) [AML3] [CBFA1] [OSF2] [PEBP2A] | ||
|- | |- | ||
Строка 4140: | Строка 4644: | ||
|3 | |3 | ||
|Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (ACAT-related gene product 1) (Acyl-CoA retinol O-fatty-acyltransferase) (EC 2.3.1.76) (ARAT) (Retinol O-fatty-acyltransferase) (Diglyceride acyltransferase) [AGRP1] [DGAT] | |Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (ACAT-related gene product 1) (Acyl-CoA retinol O-fatty-acyltransferase) (EC 2.3.1.76) (ARAT) (Retinol O-fatty-acyltransferase) (Diglyceride acyltransferase) [AGRP1] [DGAT] | ||
|- | |||
|[[PARN]] | |||
|1 | |||
|Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease) [DAN] | |||
|- | |- | ||
|[[NMNAT2]] | |[[NMNAT2]] | ||
Строка 4154: | Строка 4662: | ||
|- | |- | ||
|[[GAPDH]] | |[[GAPDH]] | ||
| | |14 | ||
|Glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12) (GAPDH) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-) [GAPD] [CDABP0047] [OK/SW-cl.12] | |Glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12) (GAPDH) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-) [GAPD] [CDABP0047] [OK/SW-cl.12] | ||
|- | |- | ||
|[[WNT5A]] | |[[WNT5A]] | ||
| | |4 | ||
|Protein Wnt-5a precursor | |Protein Wnt-5a precursor | ||
|- | |||
|[[MARK4]] | |||
|1 | |||
|MAP/microtubule affinity-regulating kinase 4 (EC 2.7.11.1) (MAP/microtubule affinity-regulating kinase-like 1) [KIAA1860] [MARKL1] | |||
|- | |- | ||
|[[HLA-E]] | |[[HLA-E]] | ||
Строка 4182: | Строка 4694: | ||
|- | |- | ||
|[[PALB2]] | |[[PALB2]] | ||
| | |2 | ||
|Partner and localizer of BRCA2 [FANCN] | |Partner and localizer of BRCA2 [FANCN] | ||
|- | |- | ||
Строка 4200: | Строка 4712: | ||
|1 | |1 | ||
|Protein Wnt-7a precursor | |Protein Wnt-7a precursor | ||
|- | |||
|[[ZFX]] | |||
|2 | |||
|Zinc finger X-chromosomal protein | |||
|- | |- | ||
|[[DLC1]] | |[[DLC1]] | ||
| | |2 | ||
|Rho GTPase-activating protein 7 (Deleted in liver cancer 1 protein) (DLC-1) (HP protein) (Rho-type GTPase-activating protein 7) (START domain-containing protein 12) (StARD12) (StAR-related lipid transfer protein 12) [ARHGAP7] [KIAA1723] [STARD12] | |Rho GTPase-activating protein 7 (Deleted in liver cancer 1 protein) (DLC-1) (HP protein) (Rho-type GTPase-activating protein 7) (START domain-containing protein 12) (StARD12) (StAR-related lipid transfer protein 12) [ARHGAP7] [KIAA1723] [STARD12] | ||
|- | |- | ||
|[[CETP]] | |[[CETP]] | ||
| | |16 | ||
|Cholesteryl ester transfer protein precursor (Lipid transfer protein I) | |Cholesteryl ester transfer protein precursor (Lipid transfer protein I) | ||
|- | |- | ||
Строка 4212: | Строка 4728: | ||
|2 | |2 | ||
|ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) | |ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) | ||
|- | |||
|[[CEP55]] | |||
|1 | |||
|Centrosomal protein of 55 kDa (Cep55) (Up-regulated in colon cancer 6) [C10orf3] [URCC6] | |||
|- | |- | ||
|[[NLRP3]] | |[[NLRP3]] | ||
| | |74 | ||
|NACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1) (CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1) [C1orf7] [CIAS1] [NALP3] [PYPAF1] | |NACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1) (CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1) [C1orf7] [CIAS1] [NALP3] [PYPAF1] | ||
|- | |- | ||
|[[BMF]] | |[[BMF]] | ||
| | |6 | ||
|Bcl-2-modifying factor | |Bcl-2-modifying factor | ||
|- | |- | ||
Строка 4258: | Строка 4778: | ||
|- | |- | ||
|[[POT1]] | |[[POT1]] | ||
| | |6 | ||
|Protection of telomeres protein 1 (hPot1) (POT1-like telomere end-binding protein) | |Protection of telomeres protein 1 (hPot1) (POT1-like telomere end-binding protein) | ||
|- | |- | ||
Строка 4272: | Строка 4792: | ||
|3 | |3 | ||
|Cas scaffolding protein family member 4 (HEF-like protein) (HEF1-EFS-p130Cas-like protein) (HEPL) [C20orf32] [HEFL] | |Cas scaffolding protein family member 4 (HEF-like protein) (HEF1-EFS-p130Cas-like protein) (HEPL) [C20orf32] [HEFL] | ||
|- | |||
|[[SOX6]] | |||
|1 | |||
|Transcription factor SOX-6 | |||
|- | |- | ||
|[[ZNF396]] | |[[ZNF396]] | ||
Строка 4278: | Строка 4802: | ||
|- | |- | ||
|[[CD14]] | |[[CD14]] | ||
| | |39 | ||
|Monocyte differentiation antigen CD14 precursor (Myeloid cell-specific leucine-rich glycoprotein) (CD14 antigen) [Contains: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form] | |Monocyte differentiation antigen CD14 precursor (Myeloid cell-specific leucine-rich glycoprotein) (CD14 antigen) [Contains: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form] | ||
|- | |- | ||
Строка 4306: | Строка 4830: | ||
|- | |- | ||
|[[CCK]] | |[[CCK]] | ||
| | |38 | ||
|Cholecystokinin precursor (CCK) [Contains: Cholecystokinin-58 (CCK58); Cholecystokinin-58 desnonopeptide ((1-49)-CCK58); Cholecystokinin-39 (CCK39); Cholecystokinin-33 (CCK33); Cholecystokinin-25 (CCK25); Cholecystokinin-18 (CCK18); Cholecystokinin-12 (CCK12); Cholecystokinin-8 (CCK8); Cholecystokinin-7 (CCK7); Cholecystokinin-5 (CCK5)] | |Cholecystokinin precursor (CCK) [Contains: Cholecystokinin-58 (CCK58); Cholecystokinin-58 desnonopeptide ((1-49)-CCK58); Cholecystokinin-39 (CCK39); Cholecystokinin-33 (CCK33); Cholecystokinin-25 (CCK25); Cholecystokinin-18 (CCK18); Cholecystokinin-12 (CCK12); Cholecystokinin-8 (CCK8); Cholecystokinin-7 (CCK7); Cholecystokinin-5 (CCK5)] | ||
|- | |- | ||
Строка 4326: | Строка 4850: | ||
|- | |- | ||
|[[TGFBR2]] | |[[TGFBR2]] | ||
| | |2 | ||
|TGF-beta receptor type-2 precursor (EC 2.7.11.30) (TGFR-2) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II) | |TGF-beta receptor type-2 precursor (EC 2.7.11.30) (TGFR-2) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II) | ||
|- | |- | ||
|[[ALDOA]] | |[[ALDOA]] | ||
|2 | |||
|Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase) [ALDA] | |||
|- | |||
|[[MAK]] | |||
|1 | |1 | ||
| | |Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase) | ||
|- | |- | ||
|[[SLC24A5]] | |[[SLC24A5]] | ||
Строка 4348: | Строка 4876: | ||
|1 | |1 | ||
|Endoplasmic reticulum chaperone BiP precursor (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein) [GRP78] | |Endoplasmic reticulum chaperone BiP precursor (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein) [GRP78] | ||
|- | |||
|[[ACER2]] | |||
|1 | |||
|Alkaline ceramidase 2 (EC 3.5.1.-) (EC 3.5.1.23) (AlkCDase 2) (Alkaline CDase 2) (haCER2) (Acylsphingosine deacylase 3-like) (N-acylsphingosine amidohydrolase 3-like) [ASAH3L] [PP11646] | |||
|- | |- | ||
|[[CTSD]] | |[[CTSD]] | ||
| | |3 | ||
|Cathepsin D precursor (EC 3.4.23.5) [Contains: Cathepsin D light chain; Cathepsin D heavy chain] [CPSD] | |Cathepsin D precursor (EC 3.4.23.5) [Contains: Cathepsin D light chain; Cathepsin D heavy chain] [CPSD] | ||
|- | |- | ||
Строка 4382: | Строка 4914: | ||
|- | |- | ||
|[[RELA]] | |[[RELA]] | ||
| | |3 | ||
|Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) [NFKB3] | |Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) [NFKB3] | ||
|- | |- | ||
Строка 4390: | Строка 4922: | ||
|- | |- | ||
|[[ATOH1]] | |[[ATOH1]] | ||
|2 | |||
|Protein atonal homolog 1 (Class A basic helix-loop-helix protein 14) (bHLHa14) (Helix-loop-helix protein hATH-1) (hATH1) [ATH1] [BHLHA14] | |||
|- | |||
|[[NIPA2]] | |||
|1 | |1 | ||
| | |Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2) | ||
|- | |- | ||
|[[DBP]] | |[[DBP]] | ||
| | |75 | ||
|D site-binding protein (Albumin D box-binding protein) (Albumin D-element-binding protein) (Tax-responsive enhancer element-binding protein 302) (TaxREB302) | |D site-binding protein (Albumin D box-binding protein) (Albumin D-element-binding protein) (Tax-responsive enhancer element-binding protein 302) (TaxREB302) | ||
|- | |- | ||
|[[TTL]] | |[[TTL]] | ||
| | |3 | ||
|Tubulin--tyrosine ligase (EC 6.3.2.25) (TTL) | |Tubulin--tyrosine ligase (EC 6.3.2.25) (TTL) | ||
|- | |- | ||
|[[LBP]] | |[[LBP]] | ||
| | |36 | ||
|Lipopolysaccharide-binding protein precursor (LBP) | |Lipopolysaccharide-binding protein precursor (LBP) | ||
|- | |- | ||
|[[AKT2]] | |[[AKT2]] | ||
| | |2 | ||
|RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) | |RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) | ||
|- | |- | ||
Строка 4414: | Строка 4950: | ||
|- | |- | ||
|[[CHEK1]] | |[[CHEK1]] | ||
| | |2 | ||
|Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) [CHK1] | |Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) [CHK1] | ||
|- | |- | ||
Строка 4422: | Строка 4958: | ||
|- | |- | ||
|[[TRAF2]] | |[[TRAF2]] | ||
| | |3 | ||
|TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3) [TRAP3] | |TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3) [TRAP3] | ||
|- | |- | ||
|[[NRK]] | |[[NRK]] | ||
| | |6 | ||
|Nik-related protein kinase (EC 2.7.11.1) | |Nik-related protein kinase (EC 2.7.11.1) | ||
|- | |- | ||
Строка 4442: | Строка 4978: | ||
|- | |- | ||
|[[CCL20]] | |[[CCL20]] | ||
| | |7 | ||
|C-C motif chemokine 20 precursor (Beta-chemokine exodus-1) (CC chemokine LARC) (Liver and activation-regulated chemokine) (Macrophage inflammatory protein 3 alpha) (MIP-3-alpha) (Small-inducible cytokine A20) [Contains: CCL20(1-67); CCL20(1-64); CCL20(2-70)] [LARC] [MIP3A] [SCYA20] | |C-C motif chemokine 20 precursor (Beta-chemokine exodus-1) (CC chemokine LARC) (Liver and activation-regulated chemokine) (Macrophage inflammatory protein 3 alpha) (MIP-3-alpha) (Small-inducible cytokine A20) [Contains: CCL20(1-67); CCL20(1-64); CCL20(2-70)] [LARC] [MIP3A] [SCYA20] | ||
|- | |- | ||
Строка 4450: | Строка 4986: | ||
|- | |- | ||
|[[RAF1]] | |[[RAF1]] | ||
| | |3 | ||
|RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) [RAF] | |RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) [RAF] | ||
|- | |- | ||
Строка 4472: | Строка 5008: | ||
|1 | |1 | ||
|Translation initiation factor eIF-2B subunit beta (S20I15) (S20III15) (eIF-2B GDP-GTP exchange factor subunit beta) [EIF2BB] | |Translation initiation factor eIF-2B subunit beta (S20I15) (S20III15) (eIF-2B GDP-GTP exchange factor subunit beta) [EIF2BB] | ||
|- | |- | ||
|[[ELOVL6]] | |[[ELOVL6]] | ||
Строка 4482: | Строка 5014: | ||
|- | |- | ||
|[[RPE]] | |[[RPE]] | ||
| | |174 | ||
|Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-3-epimerase) [HUSSY-17] | |Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-3-epimerase) [HUSSY-17] | ||
|- | |- | ||
Строка 4490: | Строка 5022: | ||
|- | |- | ||
|[[YAP1]] | |[[YAP1]] | ||
| | |9 | ||
|Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) [YAP65] | |Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog) [YAP65] | ||
|- | |- | ||
Строка 4512: | Строка 5044: | ||
|1 | |1 | ||
|60S ribosomal protein L30 (Large ribosomal subunit protein eL30) | |60S ribosomal protein L30 (Large ribosomal subunit protein eL30) | ||
|- | |||
|[[TRHR]] | |||
|1 | |||
|Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor) | |||
|- | |- | ||
|[[AKAP12]] | |[[AKAP12]] | ||
Строка 4526: | Строка 5062: | ||
|- | |- | ||
|[[CYP1A2]] | |[[CYP1A2]] | ||
| | |8 | ||
|Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) | |Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) | ||
|- | |- | ||
Строка 4546: | Строка 5082: | ||
|- | |- | ||
|[[CPD]] | |[[CPD]] | ||
| | |7 | ||
|Carboxypeptidase D precursor (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) | |Carboxypeptidase D precursor (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) | ||
|- | |- | ||
Строка 4570: | Строка 5106: | ||
|- | |- | ||
|[[CD200]] | |[[CD200]] | ||
| | |4 | ||
|OX-2 membrane glycoprotein precursor (CD200 antigen) [MOX1] [MOX2] [My033] | |OX-2 membrane glycoprotein precursor (CD200 antigen) [MOX1] [MOX2] [My033] | ||
|- | |- | ||
Строка 4588: | Строка 5124: | ||
|3 | |3 | ||
|DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (DNA damage protein targeting VCP) (DVC1) (Protein with SprT-like domain at the N terminus) (Spartan) [C1orf124] [DVC1] [UNQ1880/PRO4323] | |DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (DNA damage protein targeting VCP) (DVC1) (Protein with SprT-like domain at the N terminus) (Spartan) [C1orf124] [DVC1] [UNQ1880/PRO4323] | ||
|- | |||
|[[NPSR1]] | |||
|1 | |||
|Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) [GPR154] [GPRA] [PGR14] | |||
|- | |- | ||
|[[APOB]] | |[[APOB]] | ||
| | |3 | ||
|Apolipoprotein B-100 precursor (Apo B-100) [Contains: Apolipoprotein B-48 (Apo B-48)] | |Apolipoprotein B-100 precursor (Apo B-100) [Contains: Apolipoprotein B-48 (Apo B-48)] | ||
|- | |||
|[[CCNB2]] | |||
|1 | |||
|G2/mitotic-specific cyclin-B2 | |||
|- | |- | ||
|[[TBX3]] | |[[TBX3]] | ||
Строка 4606: | Строка 5150: | ||
|- | |- | ||
|[[IL1R2]] | |[[IL1R2]] | ||
| | |1 | ||
|Interleukin-1 receptor type 2 precursor (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD121b antigen) [Contains: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)] [IL1RB] | |Interleukin-1 receptor type 2 precursor (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD121b antigen) [Contains: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)] [IL1RB] | ||
|- | |- | ||
|[[CYP27B1]] | |[[CYP27B1]] | ||
| | |4 | ||
|25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial precursor (EC 1.14.15.18) (25-OHD-1 alpha-hydroxylase) (25-hydroxyvitamin D(3) 1-alpha-hydroxylase) (VD3 1A hydroxylase) (Calcidiol 1-monooxygenase) (Cytochrome P450 subfamily XXVIIB polypeptide 1) (Cytochrome P450C1 alpha) (Cytochrome P450VD1-alpha) (Cytochrome p450 27B1) [CYP1ALPHA] [CYP27B] | |25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial precursor (EC 1.14.15.18) (25-OHD-1 alpha-hydroxylase) (25-hydroxyvitamin D(3) 1-alpha-hydroxylase) (VD3 1A hydroxylase) (Calcidiol 1-monooxygenase) (Cytochrome P450 subfamily XXVIIB polypeptide 1) (Cytochrome P450C1 alpha) (Cytochrome P450VD1-alpha) (Cytochrome p450 27B1) [CYP1ALPHA] [CYP27B] | ||
|- | |- | ||
Строка 4626: | Строка 5170: | ||
|- | |- | ||
|[[SHBG]] | |[[SHBG]] | ||
| | |63 | ||
|Sex hormone-binding globulin precursor (SHBG) (Sex steroid-binding protein) (SBP) (Testis-specific androgen-binding protein) (ABP) (Testosterone-estradiol-binding globulin) (TeBG) (Testosterone-estrogen-binding globulin) | |Sex hormone-binding globulin precursor (SHBG) (Sex steroid-binding protein) (SBP) (Testis-specific androgen-binding protein) (ABP) (Testosterone-estradiol-binding globulin) (TeBG) (Testosterone-estrogen-binding globulin) | ||
|- | |- | ||
Строка 4642: | Строка 5186: | ||
|- | |- | ||
|[[CASQ2]] | |[[CASQ2]] | ||
| | |2 | ||
|Calsequestrin-2 precursor (Calsequestrin, cardiac muscle isoform) | |Calsequestrin-2 precursor (Calsequestrin, cardiac muscle isoform) | ||
|- | |- | ||
Строка 4662: | Строка 5206: | ||
|- | |- | ||
|[[NRL]] | |[[NRL]] | ||
| | |2 | ||
|Neural retina-specific leucine zipper protein (NRL) [D14S46E] | |Neural retina-specific leucine zipper protein (NRL) [D14S46E] | ||
|- | |- | ||
Строка 4668: | Строка 5212: | ||
|1 | |1 | ||
|Protein SCO1 homolog, mitochondrial precursor [SCOD1] | |Protein SCO1 homolog, mitochondrial precursor [SCOD1] | ||
|- | |||
|[[CAMKK2]] | |||
|1 | |||
|Calcium/calmodulin-dependent protein kinase kinase 2 (EC 2.7.11.17) (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta) [CAMKKB] [KIAA0787] | |||
|- | |- | ||
|[[REL]] | |[[REL]] | ||
Строка 4674: | Строка 5222: | ||
|- | |- | ||
|[[FHL2]] | |[[FHL2]] | ||
| | |15 | ||
|Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) [DRAL] [SLIM3] | |Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3) [DRAL] [SLIM3] | ||
|- | |- | ||
Строка 4688: | Строка 5236: | ||
|2 | |2 | ||
|Homeobox protein ARX (Aristaless-related homeobox) | |Homeobox protein ARX (Aristaless-related homeobox) | ||
|- | |||
|[[LMX1B]] | |||
|1 | |||
|LIM homeobox transcription factor 1-beta (LIM/homeobox protein 1.2) (LMX-1.2) (LIM/homeobox protein LMX1B) | |||
|- | |- | ||
|[[FES]] | |[[FES]] | ||
| | |26 | ||
|Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) [FPS] | |Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) [FPS] | ||
|- | |- | ||
Строка 4696: | Строка 5248: | ||
|1 | |1 | ||
|N-myc proto-oncogene protein (Class E basic helix-loop-helix protein 37) (bHLHe37) [BHLHE37] [NMYC] | |N-myc proto-oncogene protein (Class E basic helix-loop-helix protein 37) (bHLHe37) [BHLHE37] [NMYC] | ||
|- | |||
|[[RHD]] | |||
|1 | |||
|Blood group Rh(D) polypeptide (RHXIII) (Rh polypeptide 2) (RhPII) (Rhesus D antigen) (CD240D antigen) | |||
|- | |- | ||
|[[HABP4]] | |[[HABP4]] | ||
Строка 4704: | Строка 5260: | ||
|8 | |8 | ||
|NAD(P) transhydrogenase, mitochondrial precursor (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) | |NAD(P) transhydrogenase, mitochondrial precursor (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) | ||
|- | |||
|[[STUB1]] | |||
|3 | |||
|E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1) [CHIP] [PP1131] | |||
|- | |- | ||
|[[PDE1A]] | |[[PDE1A]] | ||
| | |3 | ||
|Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (EC 3.1.4.17) (Cam-PDE 1A) (61 kDa Cam-PDE) (hCam-1) | |Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (EC 3.1.4.17) (Cam-PDE 1A) (61 kDa Cam-PDE) (hCam-1) | ||
|- | |- | ||
Строка 4722: | Строка 5282: | ||
|- | |- | ||
|[[CPNE1]] | |[[CPNE1]] | ||
| | |2 | ||
|Copine-1 (Chromobindin 17) (Copine I) [CPN1] | |Copine-1 (Chromobindin 17) (Copine I) [CPN1] | ||
|- | |- | ||
Строка 4742: | Строка 5302: | ||
|- | |- | ||
|[[CORT]] | |[[CORT]] | ||
| | |39 | ||
|Cortistatin precursor [Contains: Cortistatin-29; Cortistatin-17] [UNQ307/PRO350] | |Cortistatin precursor [Contains: Cortistatin-29; Cortistatin-17] [UNQ307/PRO350] | ||
|- | |||
|[[SLC11A1]] | |||
|1 | |||
|Natural resistance-associated macrophage protein 1 (NRAMP 1) (Solute carrier family 11 member 1) [LSH] [NRAMP] [NRAMP1] | |||
|- | |- | ||
|[[AIDA]] | |[[AIDA]] | ||
Строка 4764: | Строка 5328: | ||
|1 | |1 | ||
|Volume-regulated anion channel subunit LRRC8B (Leucine-rich repeat-containing protein 8B) (T-cell activation leucine repeat-rich protein) (TA-LRRP) [KIAA0231] [UNQ6413/PRO21207] | |Volume-regulated anion channel subunit LRRC8B (Leucine-rich repeat-containing protein 8B) (T-cell activation leucine repeat-rich protein) (TA-LRRP) [KIAA0231] [UNQ6413/PRO21207] | ||
|- | |||
|[[CA10]] | |||
|1 | |||
|Carbonic anhydrase-related protein 10 (Carbonic anhydrase-related protein X) (CA-RP X) (CARP X) (Cerebral protein 15) [hucep-15] [UNQ533/PRO1076] | |||
|- | |||
|[[XRCC2]] | |||
|1 | |||
|DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2) | |||
|- | |- | ||
|[[TPH2]] | |[[TPH2]] | ||
| | |3 | ||
|Tryptophan 5-hydroxylase 2 (EC 1.14.16.4) (Neuronal tryptophan hydroxylase) (Tryptophan 5-monooxygenase 2) [NTPH] | |Tryptophan 5-hydroxylase 2 (EC 1.14.16.4) (Neuronal tryptophan hydroxylase) (Tryptophan 5-monooxygenase 2) [NTPH] | ||
|- | |- | ||
|[[SHANK3]] | |[[SHANK3]] | ||
| | |3 | ||
|SH3 and multiple ankyrin repeat domains protein 3 (Shank3) (Proline-rich synapse-associated protein 2) (ProSAP2) [KIAA1650] [PROSAP2] [PSAP2] | |SH3 and multiple ankyrin repeat domains protein 3 (Shank3) (Proline-rich synapse-associated protein 2) (ProSAP2) [KIAA1650] [PROSAP2] [PSAP2] | ||
|- | |- | ||
Строка 4778: | Строка 5350: | ||
|- | |- | ||
|[[VDAC1]] | |[[VDAC1]] | ||
| | |8 | ||
|Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM) [VDAC] | |Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM) [VDAC] | ||
|- | |- | ||
Строка 4784: | Строка 5356: | ||
|1 | |1 | ||
|Frizzled-1 precursor (Fz-1) (hFz1) (FzE1) | |Frizzled-1 precursor (Fz-1) (hFz1) (FzE1) | ||
|- | |||
|[[ALDH4A1]] | |||
|1 | |||
|Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial precursor (EC 1.2.1.88) (P5C dehydrogenase) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase) [ALDH4] [P5CDH] | |||
|- | |- | ||
|[[TAS1R2]] | |[[TAS1R2]] | ||
Строка 4810: | Строка 5386: | ||
|- | |- | ||
|[[LRP5]] | |[[LRP5]] | ||
| | |3 | ||
|Low-density lipoprotein receptor-related protein 5 precursor (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) [LR3] [LRP7] | |Low-density lipoprotein receptor-related protein 5 precursor (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) [LR3] [LRP7] | ||
|- | |- | ||
Строка 4830: | Строка 5406: | ||
|- | |- | ||
|[[SIRT6]] | |[[SIRT6]] | ||
| | |82 | ||
|NAD-dependent protein deacetylase sirtuin-6 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 6) (SIR2-like protein 6) [SIR2L6] | |NAD-dependent protein deacetylase sirtuin-6 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 6) (SIR2-like protein 6) [SIR2L6] | ||
|- | |||
|[[TUBA1A]] | |||
|1 | |||
|Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Contains: Detyrosinated tubulin alpha-1A chain] [TUBA3] | |||
|- | |- | ||
|[[THPO]] | |[[THPO]] | ||
Строка 4842: | Строка 5422: | ||
|- | |- | ||
|[[CFD]] | |[[CFD]] | ||
| | |3 | ||
|Complement factor D precursor (EC 3.4.21.46) (Adipsin) (C3 convertase activator) (Properdin factor D) [DF] [PFD] | |Complement factor D precursor (EC 3.4.21.46) (Adipsin) (C3 convertase activator) (Properdin factor D) [DF] [PFD] | ||
|- | |- | ||
Строка 4854: | Строка 5434: | ||
|- | |- | ||
|[[EDA]] | |[[EDA]] | ||
| | |9 | ||
|Ectodysplasin-A (Ectodermal dysplasia protein) (EDA protein) [Contains: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form] [ED1] [EDA2] | |Ectodysplasin-A (Ectodermal dysplasia protein) (EDA protein) [Contains: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form] [ED1] [EDA2] | ||
|- | |- | ||
|[[ARNTL]] | |[[ARNTL]] | ||
| | |3 | ||
|Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5) (bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3) [BHLHE5] [BMAL1] [MOP3] [PASD3] | |Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5) (bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3) [BHLHE5] [BMAL1] [MOP3] [PASD3] | ||
|- | |- | ||
|[[CR2]] | |[[CR2]] | ||
| | |1 | ||
|Complement receptor type 2 precursor (Cr2) (Complement C3d receptor) (Epstein-Barr virus receptor) (EBV receptor) (CD21 antigen) [C3DR] | |Complement receptor type 2 precursor (Cr2) (Complement C3d receptor) (Epstein-Barr virus receptor) (EBV receptor) (CD21 antigen) [C3DR] | ||
|- | |- | ||
|[[CYP24A1]] | |[[CYP24A1]] | ||
| | |3 | ||
|1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial precursor (EC 1.14.15.16) (24-OHase) (Vitamin D(3) 24-hydroxylase) (Cytochrome P450 24A1) (Cytochrome P450-CC24) [CYP24] | |1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial precursor (EC 1.14.15.16) (24-OHase) (Vitamin D(3) 24-hydroxylase) (Cytochrome P450 24A1) (Cytochrome P450-CC24) [CYP24] | ||
|- | |- | ||
Строка 4878: | Строка 5458: | ||
|- | |- | ||
|[[VWF]] | |[[VWF]] | ||
| | |9 | ||
|von Willebrand factor precursor (vWF) [Contains: von Willebrand antigen 2 (von Willebrand antigen II)] [F8VWF] | |von Willebrand factor precursor (vWF) [Contains: von Willebrand antigen 2 (von Willebrand antigen II)] [F8VWF] | ||
|- | |- | ||
Строка 4886: | Строка 5466: | ||
|- | |- | ||
|[[FGF21]] | |[[FGF21]] | ||
| | |41 | ||
|Fibroblast growth factor 21 precursor (FGF-21) [UNQ3115/PRO10196] | |Fibroblast growth factor 21 precursor (FGF-21) [UNQ3115/PRO10196] | ||
|- | |||
|[[DDX25]] | |||
|1 | |||
|ATP-dependent RNA helicase DDX25 (EC 3.6.4.13) (DEAD box protein 25) (Gonadotropin-regulated testicular RNA helicase) [GRTH] | |||
|- | |- | ||
|[[FKBP5]] | |[[FKBP5]] | ||
Строка 4906: | Строка 5490: | ||
|- | |- | ||
|[[GSTA1]] | |[[GSTA1]] | ||
| | |3 | ||
|Glutathione S-transferase A1 (EC 2.5.1.18) (13-hydroperoxyoctadecadienoate peroxidase) (EC 1.11.1.-) (Androst-5-ene-3,17-dione isomerase) (EC 5.3.3.-) (GST HA subunit 1) (GST class-alpha member 1) (GST-epsilon) (GSTA1-1) (GTH1) [Contains: Glutathione S-transferase A1, N-terminally processed] | |Glutathione S-transferase A1 (EC 2.5.1.18) (13-hydroperoxyoctadecadienoate peroxidase) (EC 1.11.1.-) (Androst-5-ene-3,17-dione isomerase) (EC 5.3.3.-) (GST HA subunit 1) (GST class-alpha member 1) (GST-epsilon) (GSTA1-1) (GTH1) [Contains: Glutathione S-transferase A1, N-terminally processed] | ||
|- | |- | ||
|[[PLAU]] | |[[PLAU]] | ||
| | |5 | ||
|Urokinase-type plasminogen activator precursor (EC 3.4.21.73) (U-plasminogen activator) (uPA) [Contains: Urokinase-type plasminogen activator long chain A; Urokinase-type plasminogen activator short chain A; Urokinase-type plasminogen activator chain B] | |Urokinase-type plasminogen activator precursor (EC 3.4.21.73) (U-plasminogen activator) (uPA) [Contains: Urokinase-type plasminogen activator long chain A; Urokinase-type plasminogen activator short chain A; Urokinase-type plasminogen activator chain B] | ||
|- | |- | ||
Строка 4924: | Строка 5508: | ||
|1 | |1 | ||
|Agouti-related protein precursor [AGRT] [ART] | |Agouti-related protein precursor [AGRT] [ART] | ||
|- | |||
|[[ACSL1]] | |||
|1 | |||
|Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Acyl-CoA synthetase 1) (ACS1) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain acyl-CoA synthetase 2) (LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2) (Phytanate--CoA ligase) (EC 6.2.1.24) [FACL1] [FACL2] [LACS] [LACS1] [LACS2] | |||
|- | |||
|[[FBXO33]] | |||
|1 | |||
|F-box only protein 33 [FBX33] | |||
|- | |- | ||
|[[SATB1]] | |[[SATB1]] | ||
Строка 4950: | Строка 5542: | ||
|- | |- | ||
|[[IDH2]] | |[[IDH2]] | ||
| | |9 | ||
|Isocitrate dehydrogenase [NADP], mitochondrial precursor (EC 1.1.1.42) (IDH) (ICD-M) (IDP) (NADP( )-specific ICDH) (Oxalosuccinate decarboxylase) | |Isocitrate dehydrogenase [NADP], mitochondrial precursor (EC 1.1.1.42) (IDH) (ICD-M) (IDP) (NADP( )-specific ICDH) (Oxalosuccinate decarboxylase) | ||
|- | |||
|[[SMPD3]] | |||
|1 | |||
|Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II) | |||
|- | |- | ||
|[[HTR2A]] | |[[HTR2A]] | ||
Строка 4964: | Строка 5560: | ||
|7 | |7 | ||
|UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) | |UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) | ||
|- | |||
|[[ZIC1]] | |||
|1 | |||
|Zinc finger protein ZIC 1 (Zinc finger protein 201) (Zinc finger protein of the cerebellum 1) [ZIC] [ZNF201] | |||
|- | |- | ||
|[[GIP]] | |[[GIP]] | ||
| | |11 | ||
|Gastric inhibitory polypeptide precursor (GIP) (Glucose-dependent insulinotropic polypeptide) (Incretin hormone) | |Gastric inhibitory polypeptide precursor (GIP) (Glucose-dependent insulinotropic polypeptide) (Incretin hormone) | ||
|- | |- | ||
Строка 4976: | Строка 5576: | ||
|1 | |1 | ||
|Sperm protamine P1 (Cysteine-rich protamine) | |Sperm protamine P1 (Cysteine-rich protamine) | ||
|- | |||
|[[PPP1R15B]] | |||
|1 | |||
|Protein phosphatase 1 regulatory subunit 15B | |||
|- | |- | ||
|[[CCL17]] | |[[CCL17]] | ||
Строка 4988: | Строка 5592: | ||
|3 | |3 | ||
|Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X) [BHLHD4] | |Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X) [BHLHD4] | ||
|- | |||
|[[WBP11]] | |||
|1 | |||
|WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1) [NPWBP] [SIPP1] [SNP70] | |||
|- | |- | ||
|[[LHCGR]] | |[[LHCGR]] | ||
| | |2 | ||
|Lutropin-choriogonadotropic hormone receptor precursor (LH/CG-R) (Luteinizing hormone receptor) (LHR) (LSH-R) [LCGR] [LGR2] [LHRHR] | |Lutropin-choriogonadotropic hormone receptor precursor (LH/CG-R) (Luteinizing hormone receptor) (LHR) (LSH-R) [LCGR] [LGR2] [LHRHR] | ||
|- | |- | ||
Строка 4998: | Строка 5606: | ||
|- | |- | ||
|[[HCN2]] | |[[HCN2]] | ||
| | |5 | ||
|Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2) [BCNG2] | |Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2) [BCNG2] | ||
|- | |- | ||
Строка 5010: | Строка 5618: | ||
|- | |- | ||
|[[MTHFR]] | |[[MTHFR]] | ||
| | |15 | ||
|Methylenetetrahydrofolate reductase (EC 1.5.1.20) | |Methylenetetrahydrofolate reductase (EC 1.5.1.20) | ||
|- | |- | ||
Строка 5022: | Строка 5630: | ||
|- | |- | ||
|[[ICAM1]] | |[[ICAM1]] | ||
| | |4 | ||
|Intercellular adhesion molecule 1 precursor (ICAM-1) (Major group rhinovirus receptor) (CD54 antigen) | |Intercellular adhesion molecule 1 precursor (ICAM-1) (Major group rhinovirus receptor) (CD54 antigen) | ||
|- | |- | ||
|[[GBA]] | |[[GBA]] | ||
| | |8 | ||
|Lysosomal acid glucosylceramidase precursor (EC 3.2.1.45) (Lysosomal acid GCase) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (Cholesterol glucosyltransferase) (EC 2.4.1.-) (SGTase) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) [GC] [GLUC] | |Lysosomal acid glucosylceramidase precursor (EC 3.2.1.45) (Lysosomal acid GCase) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (Cholesterol glucosyltransferase) (EC 2.4.1.-) (SGTase) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase) [GC] [GLUC] | ||
|- | |- | ||
Строка 5032: | Строка 5640: | ||
|1 | |1 | ||
|Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI) | |Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI) | ||
|- | |||
|[[CBX2]] | |||
|1 | |||
|Chromobox protein homolog 2 | |||
|- | |- | ||
|[[PODXL]] | |[[PODXL]] | ||
|1 | |1 | ||
|Podocalyxin precursor (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1) [PCLP] [PCLP1] | |Podocalyxin precursor (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1) [PCLP] [PCLP1] | ||
|- | |||
|[[NEDD4L]] | |||
|1 | |||
|E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2) [KIAA0439] [NEDL3] | |||
|- | |- | ||
|[[PFKFB3]] | |[[PFKFB3]] | ||
Строка 5046: | Строка 5662: | ||
|- | |- | ||
|[[SSB]] | |[[SSB]] | ||
| | |5 | ||
|Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) | |Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) | ||
|- | |- | ||
Строка 5058: | Строка 5674: | ||
|- | |- | ||
|[[AQP4]] | |[[AQP4]] | ||
| | |12 | ||
|Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4) | |Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4) | ||
|- | |- | ||
Строка 5066: | Строка 5682: | ||
|- | |- | ||
|[[SLC16A7]] | |[[SLC16A7]] | ||
| | |2 | ||
|Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7) [MCT2] | |Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7) [MCT2] | ||
|- | |- | ||
Строка 5078: | Строка 5694: | ||
|- | |- | ||
|[[CD2]] | |[[CD2]] | ||
| | |4 | ||
|T-cell surface antigen CD2 precursor (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD2 antigen) [SRBC] | |T-cell surface antigen CD2 precursor (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD2 antigen) [SRBC] | ||
|- | |- | ||
Строка 5098: | Строка 5714: | ||
|- | |- | ||
|[[CDKN2A]] | |[[CDKN2A]] | ||
| | |30 | ||
|Tumor suppressor ARF (Alternative reading frame) (ARF) (Cyclin-dependent kinase inhibitor 2A) (p14ARF) [CDKN2] [MLM] | |Tumor suppressor ARF (Alternative reading frame) (ARF) (Cyclin-dependent kinase inhibitor 2A) (p14ARF) [CDKN2] [MLM] | ||
|- | |- | ||
Строка 5106: | Строка 5722: | ||
|- | |- | ||
|[[ACD]] | |[[ACD]] | ||
| | |11 | ||
|Adrenocortical dysplasia protein homolog (POT1 and TIN2-interacting protein) [PIP1] [PTOP] [TINT1] [TPP1] | |Adrenocortical dysplasia protein homolog (POT1 and TIN2-interacting protein) [PIP1] [PTOP] [TINT1] [TPP1] | ||
|- | |- | ||
|[[G6PD]] | |[[G6PD]] | ||
| | |17 | ||
|Glucose-6-phosphate 1-dehydrogenase (EC 1.1.1.49) (G6PD) | |Glucose-6-phosphate 1-dehydrogenase (EC 1.1.1.49) (G6PD) | ||
|- | |- | ||
|[[CCN2]] | |[[CCN2]] | ||
| | |4 | ||
|CCN family member 2 precursor (Cellular communication network factor 2) (Connective tissue growth factor) (Hypertrophic chondrocyte-specific protein 24) (Insulin-like growth factor-binding protein 8) (IBP-8) (IGF-binding protein 8) (IGFBP-8) [CTGF] [HCS24] [IGFBP8] | |CCN family member 2 precursor (Cellular communication network factor 2) (Connective tissue growth factor) (Hypertrophic chondrocyte-specific protein 24) (Insulin-like growth factor-binding protein 8) (IBP-8) (IGF-binding protein 8) (IGFBP-8) [CTGF] [HCS24] [IGFBP8] | ||
|- | |- | ||
Строка 5122: | Строка 5738: | ||
|- | |- | ||
|[[SMAD2]] | |[[SMAD2]] | ||
| | |9 | ||
|Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (JV18-1) (Mad-related protein 2) (hMAD-2) (SMAD family member 2) (SMAD 2) (Smad2) (hSMAD2) [MADH2] [MADR2] | |Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (JV18-1) (Mad-related protein 2) (hMAD-2) (SMAD family member 2) (SMAD 2) (Smad2) (hSMAD2) [MADH2] [MADR2] | ||
|- | |- | ||
Строка 5136: | Строка 5752: | ||
|1 | |1 | ||
|Uracil phosphoribosyltransferase homolog | |Uracil phosphoribosyltransferase homolog | ||
|- | |- | ||
|[[CTNS]] | |[[CTNS]] | ||
Строка 5146: | Строка 5758: | ||
|- | |- | ||
|[[RASGRP1]] | |[[RASGRP1]] | ||
| | |2 | ||
|RAS guanyl-releasing protein 1 (Calcium and DAG-regulated guanine nucleotide exchange factor II) (CalDAG-GEFII) (Ras guanyl-releasing protein) [RASGRP] | |RAS guanyl-releasing protein 1 (Calcium and DAG-regulated guanine nucleotide exchange factor II) (CalDAG-GEFII) (Ras guanyl-releasing protein) [RASGRP] | ||
|- | |- | ||
|[[ZP2]] | |[[ZP2]] | ||
| | |2 | ||
|Zona pellucida sperm-binding protein 2 precursor (Zona pellucida glycoprotein 2) (Zp-2) (Zona pellucida protein A) [Contains: Processed zona pellucida sperm-binding protein 2] [ZPA] | |Zona pellucida sperm-binding protein 2 precursor (Zona pellucida glycoprotein 2) (Zp-2) (Zona pellucida protein A) [Contains: Processed zona pellucida sperm-binding protein 2] [ZPA] | ||
|- | |- | ||
Строка 5170: | Строка 5782: | ||
|- | |- | ||
|[[TRPA1]] | |[[TRPA1]] | ||
| | |6 | ||
|Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (Wasabi receptor) [ANKTM1] | |Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (Wasabi receptor) [ANKTM1] | ||
|- | |- | ||
Строка 5182: | Строка 5794: | ||
|- | |- | ||
|[[CD63]] | |[[CD63]] | ||
| | |12 | ||
|CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) [MLA1] [TSPAN30] | |CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) [MLA1] [TSPAN30] | ||
|- | |- | ||
|[[GPR158]] | |[[GPR158]] | ||
| | |2 | ||
|Probable G-protein coupled receptor 158 precursor [KIAA1136] | |Probable G-protein coupled receptor 158 precursor [KIAA1136] | ||
|- | |- | ||
|[[NPC2]] | |[[NPC2]] | ||
| | |5 | ||
|NPC intracellular cholesterol transporter 2 precursor (Epididymal secretory protein E1) (Human epididymis-specific protein 1) (He1) (Niemann-Pick disease type C2 protein) [HE1] | |NPC intracellular cholesterol transporter 2 precursor (Epididymal secretory protein E1) (Human epididymis-specific protein 1) (He1) (Niemann-Pick disease type C2 protein) [HE1] | ||
|- | |- | ||
Строка 5206: | Строка 5818: | ||
|- | |- | ||
|[[CCR5]] | |[[CCR5]] | ||
| | |9 | ||
|C-C chemokine receptor type 5 (C-C CKR-5) (CC-CKR-5) (CCR-5) (CCR5) (CHEMR13) (HIV-1 fusion coreceptor) (CD195 antigen) [CMKBR5] | |C-C chemokine receptor type 5 (C-C CKR-5) (CC-CKR-5) (CCR-5) (CCR5) (CHEMR13) (HIV-1 fusion coreceptor) (CD195 antigen) [CMKBR5] | ||
|- | |- | ||
|[[ABCG5]] | |[[ABCG5]] | ||
|2 | |||
|ATP-binding cassette sub-family G member 5 (EC 7.6.2.-) (Sterolin-1) | |||
|- | |||
|[[IRAK1]] | |||
|1 | |1 | ||
| | |Interleukin-1 receptor-associated kinase 1 (EC 2.7.11.1) (IRAK-1) [IRAK] | ||
|- | |- | ||
|[[SOS1]] | |[[SOS1]] | ||
Строка 5230: | Строка 5846: | ||
|- | |- | ||
|[[CDKN1A]] | |[[CDKN1A]] | ||
| | |24 | ||
|Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6) (MDA-6) (p21) [CAP20] [CDKN1] [CIP1] [MDA6] [PIC1] [SDI1] [WAF1] | |Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6) (MDA-6) (p21) [CAP20] [CDKN1] [CIP1] [MDA6] [PIC1] [SDI1] [WAF1] | ||
|- | |- | ||
|[[TH]] | |[[TH]] | ||
| | |95 | ||
|Tyrosine 3-monooxygenase (EC 1.14.16.2) (Tyrosine 3-hydroxylase) (TH) [TYH] | |Tyrosine 3-monooxygenase (EC 1.14.16.2) (Tyrosine 3-hydroxylase) (TH) [TYH] | ||
|- | |- | ||
Строка 5254: | Строка 5870: | ||
|- | |- | ||
|[[HAS2]] | |[[HAS2]] | ||
| | |5 | ||
|Hyaluronan synthase 2 (EC 2.4.1.212) (Hyaluronate synthase 2) (Hyaluronic acid synthase 2) (HA synthase 2) | |Hyaluronan synthase 2 (EC 2.4.1.212) (Hyaluronate synthase 2) (Hyaluronic acid synthase 2) (HA synthase 2) | ||
|- | |- | ||
Строка 5262: | Строка 5878: | ||
|- | |- | ||
|[[FBL]] | |[[FBL]] | ||
| | |5 | ||
|rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen) (Histone-glutamine methyltransferase) (U6 snRNA 2'-O-methyltransferase fibrillarin) [FIB1] [FLRN] | |rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen) (Histone-glutamine methyltransferase) (U6 snRNA 2'-O-methyltransferase fibrillarin) [FIB1] [FLRN] | ||
|- | |- | ||
|[[EDNRB]] | |[[EDNRB]] | ||
| | |2 | ||
|Endothelin receptor type B precursor (ET-B) (ET-BR) (Endothelin receptor non-selective type) [ETRB] | |Endothelin receptor type B precursor (ET-B) (ET-BR) (Endothelin receptor non-selective type) [ETRB] | ||
|- | |- | ||
|[[CCL7]] | |[[CCL7]] | ||
| | |2 | ||
|C-C motif chemokine 7 precursor (Monocyte chemoattractant protein 3) (Monocyte chemotactic protein 3) (MCP-3) (NC28) (Small-inducible cytokine A7) [MCP3] [SCYA6] [SCYA7] | |C-C motif chemokine 7 precursor (Monocyte chemoattractant protein 3) (Monocyte chemotactic protein 3) (MCP-3) (NC28) (Small-inducible cytokine A7) [MCP3] [SCYA6] [SCYA7] | ||
|- | |- | ||
Строка 5278: | Строка 5894: | ||
|- | |- | ||
|[[VIP]] | |[[VIP]] | ||
| | |14 | ||
|VIP peptides precursor [Contains: Intestinal peptide PHV-42 (Peptide histidine valine 42); Intestinal peptide PHM-27 (Peptide histidine methioninamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)] | |VIP peptides precursor [Contains: Intestinal peptide PHV-42 (Peptide histidine valine 42); Intestinal peptide PHM-27 (Peptide histidine methioninamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)] | ||
|- | |- | ||
|[[TSC2]] | |[[TSC2]] | ||
| | |8 | ||
|Tuberin (Tuberous sclerosis 2 protein) [TSC4] | |Tuberin (Tuberous sclerosis 2 protein) [TSC4] | ||
|- | |- | ||
Строка 5306: | Строка 5922: | ||
|- | |- | ||
|[[BID]] | |[[BID]] | ||
| | |6 | ||
|BH3-interacting domain death agonist (p22 BID) (BID) [Contains: BH3-interacting domain death agonist p15 (p15 BID); BH3-interacting domain death agonist p13 (p13 BID); BH3-interacting domain death agonist p11 (p11 BID)] | |BH3-interacting domain death agonist (p22 BID) (BID) [Contains: BH3-interacting domain death agonist p15 (p15 BID); BH3-interacting domain death agonist p13 (p13 BID); BH3-interacting domain death agonist p11 (p11 BID)] | ||
|- | |- | ||
|[[NDRG1]] | |[[NDRG1]] | ||
| | |4 | ||
|Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42) [CAP43] [DRG1] [RTP] | |Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42) [CAP43] [DRG1] [RTP] | ||
|- | |- | ||
Строка 5322: | Строка 5938: | ||
|- | |- | ||
|[[PTGS2]] | |[[PTGS2]] | ||
| | |6 | ||
|Prostaglandin G/H synthase 2 precursor (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) [COX2] | |Prostaglandin G/H synthase 2 precursor (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) [COX2] | ||
|- | |- | ||
Строка 5348: | Строка 5964: | ||
|3 | |3 | ||
|Antiviral innate immune response receptor RIG-I (DEAD box protein 58) (Probable ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) | |Antiviral innate immune response receptor RIG-I (DEAD box protein 58) (Probable ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) | ||
|- | |||
|[[CEACAM1]] | |||
|1 | |||
|Carcinoembryonic antigen-related cell adhesion molecule 1 precursor (Biliary glycoprotein 1) (BGP-1) (CD66a antigen) [BGP] [BGP1] | |||
|- | |- | ||
|[[VASP]] | |[[VASP]] | ||
Строка 5358: | Строка 5978: | ||
|- | |- | ||
|[[MECP2]] | |[[MECP2]] | ||
| | |12 | ||
|Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2) | |Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2) | ||
|- | |- | ||
Строка 5364: | Строка 5984: | ||
|1 | |1 | ||
|Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA) [PPPM1A] | |Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA) [PPPM1A] | ||
|- | |||
|[[IL12B]] | |||
|1 | |||
|Interleukin-12 subunit beta precursor (IL-12B) (Cytotoxic lymphocyte maturation factor 40 kDa subunit) (CLMF p40) (IL-12 subunit p40) (NK cell stimulatory factor chain 2) (NKSF2) [NKSF2] | |||
|- | |- | ||
|[[CX3CR1]] | |[[CX3CR1]] | ||
| | |20 | ||
|CX3C chemokine receptor 1 (C-X3-C CKR-1) (CX3CR1) (Beta chemokine receptor-like 1) (CMK-BRL-1) (CMK-BRL1) (Fractalkine receptor) (G-protein coupled receptor 13) (V28) [CMKBRL1] [GPR13] | |CX3C chemokine receptor 1 (C-X3-C CKR-1) (CX3CR1) (Beta chemokine receptor-like 1) (CMK-BRL-1) (CMK-BRL1) (Fractalkine receptor) (G-protein coupled receptor 13) (V28) [CMKBRL1] [GPR13] | ||
|- | |- | ||
|[[ | |[[KCNJ10]] | ||
|1 | |1 | ||
| | |ATP-sensitive inward rectifier potassium channel 10 (ATP-dependent inwardly rectifying potassium channel Kir4.1) (Inward rectifier K( ) channel Kir1.2) (Potassium channel, inwardly rectifying subfamily J member 10) | ||
|- | |- | ||
|[[ | |[[CERK]] | ||
|1 | |1 | ||
|E3 ubiquitin-protein ligase RNF13 precursor (EC 2.3.2.27) (RING finger protein 13) (RING-type E3 ubiquitin transferase RNF13) [RZF] | |Ceramide kinase (EC 2.7.1.138) (hCERK) (Acylsphingosine kinase) (Lipid kinase 4) (LK4) [KIAA1646] | ||
|- | |||
|[[GTF3C4]] | |||
|1 | |||
|General transcription factor 3C polypeptide 4 (EC 2.3.1.48) (TF3C-delta) (Transcription factor IIIC 90 kDa subunit) (TFIIIC 90 kDa subunit) (TFIIIC90) (Transcription factor IIIC subunit delta) | |||
|- | |||
|[[RNF13]] | |||
|1 | |||
|E3 ubiquitin-protein ligase RNF13 precursor (EC 2.3.2.27) (RING finger protein 13) (RING-type E3 ubiquitin transferase RNF13) [RZF] | |||
|- | |- | ||
|[[TIGIT]] | |[[TIGIT]] | ||
| | |8 | ||
|T-cell immunoreceptor with Ig and ITIM domains precursor (V-set and immunoglobulin domain-containing protein 9) (V-set and transmembrane domain-containing protein 3) [VSIG9] [VSTM3] | |T-cell immunoreceptor with Ig and ITIM domains precursor (V-set and immunoglobulin domain-containing protein 9) (V-set and transmembrane domain-containing protein 3) [VSIG9] [VSTM3] | ||
|- | |- | ||
Строка 5386: | Строка 6018: | ||
|- | |- | ||
|[[AMHR2]] | |[[AMHR2]] | ||
| | |3 | ||
|Anti-Muellerian hormone type-2 receptor precursor (EC 2.7.11.30) (Anti-Muellerian hormone type II receptor) (AMH type II receptor) (MIS type II receptor) (MISRII) (MRII) [AMHR] [MISR2] | |Anti-Muellerian hormone type-2 receptor precursor (EC 2.7.11.30) (Anti-Muellerian hormone type II receptor) (AMH type II receptor) (MIS type II receptor) (MISRII) (MRII) [AMHR] [MISR2] | ||
|- | |- | ||
Строка 5392: | Строка 6024: | ||
|2 | |2 | ||
|V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (p31) (Vacuolar proton pump subunit E 1) [ATP6E] [ATP6E2] | |V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (p31) (Vacuolar proton pump subunit E 1) [ATP6E] [ATP6E2] | ||
|- | |||
|[[VPS4B]] | |||
|1 | |||
|Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K( ) transport growth defect 1) (Protein SKD1) [SKD1] [VPS42] [MIG1] | |||
|- | |- | ||
|[[TGDS]] | |[[TGDS]] | ||
Строка 5398: | Строка 6034: | ||
|- | |- | ||
|[[EOMES]] | |[[EOMES]] | ||
| | |2 | ||
|Eomesodermin homolog (T-box brain protein 2) (T-brain-2) (TBR-2) [TBR2] | |Eomesodermin homolog (T-box brain protein 2) (T-brain-2) (TBR-2) [TBR2] | ||
|- | |- | ||
Строка 5406: | Строка 6042: | ||
|- | |- | ||
|[[HAL]] | |[[HAL]] | ||
| | |6 | ||
|Histidine ammonia-lyase (EC 4.3.1.3) (Histidase) [HIS] | |Histidine ammonia-lyase (EC 4.3.1.3) (Histidase) [HIS] | ||
|- | |- | ||
Строка 5422: | Строка 6058: | ||
|- | |- | ||
|[[MYOCD]] | |[[MYOCD]] | ||
| | |2 | ||
|Myocardin [MYCD] | |Myocardin [MYCD] | ||
|- | |- | ||
Строка 5430: | Строка 6066: | ||
|- | |- | ||
|[[FAAH]] | |[[FAAH]] | ||
| | |8 | ||
|Fatty-acid amide hydrolase 1 (EC 3.5.1.99) (Anandamide amidohydrolase 1) (Fatty acid ester hydrolase) (EC 3.1.1.-) (Oleamide hydrolase 1) [FAAH1] | |Fatty-acid amide hydrolase 1 (EC 3.5.1.99) (Anandamide amidohydrolase 1) (Fatty acid ester hydrolase) (EC 3.1.1.-) (Oleamide hydrolase 1) [FAAH1] | ||
|- | |- | ||
Строка 5445: | Строка 6081: | ||
|Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1) [CATX11] [CSIG] [PBK1] [L12] | |Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1) [CATX11] [CSIG] [PBK1] [L12] | ||
|- | |- | ||
|[[ | |[[CRX]] | ||
|1 | |1 | ||
| | |Cone-rod homeobox protein [CORD2] | ||
|- | |- | ||
|[[ERCC2]] | |[[ERCC2]] | ||
| | |1 | ||
|General transcription and DNA repair factor IIH helicase subunit XPD (EC 3.6.4.12) (TFIIH subunit XPD) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein) [XPD] [XPDC] | |General transcription and DNA repair factor IIH helicase subunit XPD (EC 3.6.4.12) (TFIIH subunit XPD) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein) [XPD] [XPDC] | ||
|- | |- | ||
|[[TBX21]] | |[[TBX21]] | ||
| | |2 | ||
|T-box transcription factor TBX21 (T-box protein 21) (T-cell-specific T-box transcription factor T-bet) (Transcription factor TBLYM) [TBET] [TBLYM] | |T-box transcription factor TBX21 (T-box protein 21) (T-cell-specific T-box transcription factor T-bet) (Transcription factor TBLYM) [TBET] [TBLYM] | ||
|- | |- | ||
Строка 5460: | Строка 6096: | ||
|3 | |3 | ||
|Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Syld709613) [KIAA1248] [SYLD] | |Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Syld709613) [KIAA1248] [SYLD] | ||
|- | |||
|[[PKNOX1]] | |||
|1 | |||
|Homeobox protein PKNOX1 (Homeobox protein PREP-1) (PBX/knotted homeobox 1) [PREP1] | |||
|- | |- | ||
|[[FABP4]] | |[[FABP4]] | ||
Строка 5474: | Строка 6114: | ||
|- | |- | ||
|[[DES]] | |[[DES]] | ||
| | |9 | ||
|Desmin | |Desmin | ||
|- | |||
|[[FGF8]] | |||
|1 | |||
|Fibroblast growth factor 8 precursor (FGF-8) (Androgen-induced growth factor) (AIGF) (Heparin-binding growth factor 8) (HBGF-8) [AIGF] | |||
|- | |- | ||
|[[UBB]] | |[[UBB]] | ||
Строка 5484: | Строка 6128: | ||
|2 | |2 | ||
|Microtubule-associated proteins 1A/1B light chain 3B precursor (Autophagy-related protein LC3 B) (Autophagy-related ubiquitin-like modifier LC3 B) (MAP1 light chain 3-like protein 2) (MAP1A/MAP1B light chain 3 B) (MAP1A/MAP1B LC3 B) (Microtubule-associated protein 1 light chain 3 beta) [MAP1ALC3] | |Microtubule-associated proteins 1A/1B light chain 3B precursor (Autophagy-related protein LC3 B) (Autophagy-related ubiquitin-like modifier LC3 B) (MAP1 light chain 3-like protein 2) (MAP1A/MAP1B light chain 3 B) (MAP1A/MAP1B LC3 B) (Microtubule-associated protein 1 light chain 3 beta) [MAP1ALC3] | ||
|- | |||
|[[PIAS1]] | |||
|1 | |||
|E3 SUMO-protein ligase PIAS1 (EC 2.3.2.-) (DEAD/H box-binding protein 1) (E3 SUMO-protein transferase PIAS1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) [DDXBP1] | |||
|- | |- | ||
|[[PYY]] | |[[PYY]] | ||
| | |7 | ||
|Peptide YY precursor (PYY) (PYY-I) (Peptide tyrosine tyrosine) [Contains: Peptide YY(3-36) (PYY-II)] | |Peptide YY precursor (PYY) (PYY-I) (Peptide tyrosine tyrosine) [Contains: Peptide YY(3-36) (PYY-II)] | ||
|- | |- | ||
Строка 5494: | Строка 6142: | ||
|- | |- | ||
|[[SIRT4]] | |[[SIRT4]] | ||
| | |15 | ||
|NAD-dependent protein lipoamidase sirtuin-4, mitochondrial precursor (EC 2.3.1.-) (NAD-dependent ADP-ribosyltransferase sirtuin-4) (EC 2.4.2.-) (NAD-dependent protein deacetylase sirtuin-4) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4) [SIR2L4] | |NAD-dependent protein lipoamidase sirtuin-4, mitochondrial precursor (EC 2.3.1.-) (NAD-dependent ADP-ribosyltransferase sirtuin-4) (EC 2.4.2.-) (NAD-dependent protein deacetylase sirtuin-4) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4) [SIR2L4] | ||
|- | |- | ||
Строка 5502: | Строка 6150: | ||
|- | |- | ||
|[[DCD]] | |[[DCD]] | ||
| | |3 | ||
|Dermcidin precursor (EC 3.4.-.-) (Preproteolysin) [Contains: Survival-promoting peptide; DCD-1] [AIDD] [DSEP] | |Dermcidin precursor (EC 3.4.-.-) (Preproteolysin) [Contains: Survival-promoting peptide; DCD-1] [AIDD] [DSEP] | ||
|- | |- | ||
Строка 5514: | Строка 6162: | ||
|- | |- | ||
|[[ANG]] | |[[ANG]] | ||
| | |14 | ||
|Angiogenin precursor (EC 3.1.27.-) (Ribonuclease 5) (RNase 5) [RNASE5] | |Angiogenin precursor (EC 3.1.27.-) (Ribonuclease 5) (RNase 5) [RNASE5] | ||
|- | |- | ||
|[[PTPN1]] | |[[PTPN1]] | ||
| | |2 | ||
|Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B) [PTP1B] | |Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B) [PTP1B] | ||
|- | |- | ||
Строка 5528: | Строка 6176: | ||
|2 | |2 | ||
|Growth factor receptor-bound protein 10 (GRB10 adapter protein) (Insulin receptor-binding protein Grb-IR) [GRBIR] [KIAA0207] | |Growth factor receptor-bound protein 10 (GRB10 adapter protein) (Insulin receptor-binding protein Grb-IR) [GRBIR] [KIAA0207] | ||
|- | |||
|[[RC3H2]] | |||
|1 | |||
|Roquin-2 (EC 2.3.2.27) (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING finger protein 164) (RING-type E3 ubiquitin transferase Roquin-2) [MNAB] [RNF164] | |||
|- | |- | ||
|[[MAPK14]] | |[[MAPK14]] | ||
| | |5 | ||
|Mitogen-activated protein kinase 14 (EC 2.7.11.24) (MAP kinase 14) (MAPK 14) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) [CSBP] [CSBP1] [CSBP2] [CSPB1] [MXI2] [SAPK2A] | |Mitogen-activated protein kinase 14 (EC 2.7.11.24) (MAP kinase 14) (MAPK 14) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) [CSBP] [CSBP1] [CSBP2] [CSPB1] [MXI2] [SAPK2A] | ||
|- | |- | ||
Строка 5542: | Строка 6194: | ||
|- | |- | ||
|[[LRP6]] | |[[LRP6]] | ||
| | |4 | ||
|Low-density lipoprotein receptor-related protein 6 precursor (LRP-6) | |Low-density lipoprotein receptor-related protein 6 precursor (LRP-6) | ||
|- | |- | ||
Строка 5550: | Строка 6202: | ||
|- | |- | ||
|[[C9]] | |[[C9]] | ||
| | |8 | ||
|Complement component C9 precursor [Contains: Complement component C9a; Complement component C9b] | |Complement component C9 precursor [Contains: Complement component C9a; Complement component C9b] | ||
|- | |- | ||
|[[CD81]] | |[[CD81]] | ||
| | |5 | ||
|CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD81 antigen) [TAPA1] [TSPAN28] | |CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD81 antigen) [TAPA1] [TSPAN28] | ||
|- | |- | ||
|[[EP300]] | |[[EP300]] | ||
| | |4 | ||
|Histone acetyltransferase p300 (EC 2.3.1.48) (p300 HAT) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) [P300] | |Histone acetyltransferase p300 (EC 2.3.1.48) (p300 HAT) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) [P300] | ||
|- | |- | ||
Строка 5578: | Строка 6230: | ||
|- | |- | ||
|[[TST]] | |[[TST]] | ||
| | |23 | ||
|Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese) | |Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese) | ||
|- | |- | ||
Строка 5590: | Строка 6242: | ||
|- | |- | ||
|[[POU5F1]] | |[[POU5F1]] | ||
| | |5 | ||
|POU domain, class 5, transcription factor 1 (Octamer-binding protein 3) (Oct-3) (Octamer-binding protein 4) (Oct-4) (Octamer-binding transcription factor 3) (OTF-3) [OCT3] [OCT4] [OTF3] | |POU domain, class 5, transcription factor 1 (Octamer-binding protein 3) (Oct-3) (Octamer-binding protein 4) (Oct-4) (Octamer-binding transcription factor 3) (OTF-3) [OCT3] [OCT4] [OTF3] | ||
|- | |- | ||
Строка 5600: | Строка 6252: | ||
|1 | |1 | ||
|Polyamine deacetylase HDAC10 (EC 3.5.1.48) (EC 3.5.1.62) (Histone deacetylase 10) (HD10) | |Polyamine deacetylase HDAC10 (EC 3.5.1.48) (EC 3.5.1.62) (Histone deacetylase 10) (HD10) | ||
|- | |||
|[[TEAD4]] | |||
|1 | |||
|Transcriptional enhancer factor TEF-3 (TEA domain family member 4) (TEAD-4) (Transcription factor 13-like 1) (Transcription factor RTEF-1) [RTEF1] [TCF13L1] [TEF3] | |||
|- | |||
|[[JHY]] | |||
|1 | |||
|Jhy protein homolog [C11orf63] | |||
|- | |- | ||
|[[FDPS]] | |[[FDPS]] | ||
Строка 5606: | Строка 6266: | ||
|- | |- | ||
|[[ATRX]] | |[[ATRX]] | ||
| | |7 | ||
|Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX) [RAD54L] [XH2] | |Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX) [RAD54L] [XH2] | ||
|- | |- | ||
|[[CASP7]] | |[[CASP7]] | ||
| | |2 | ||
|Caspase-7 precursor (EC 3.4.22.60) (CASP-7) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Contains: Caspase-7 subunit p20; Caspase-7 subunit p11] [MCH3] | |Caspase-7 precursor (EC 3.4.22.60) (CASP-7) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Contains: Caspase-7 subunit p20; Caspase-7 subunit p11] [MCH3] | ||
|- | |- | ||
Строка 5634: | Строка 6294: | ||
|- | |- | ||
|[[CDA]] | |[[CDA]] | ||
| | |9 | ||
|Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase) [CDD] | |Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase) [CDD] | ||
|- | |- | ||
|[[GC]] | |[[GC]] | ||
| | |143 | ||
|Vitamin D-binding protein precursor (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf) | |Vitamin D-binding protein precursor (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf) | ||
|- | |- | ||
Строка 5648: | Строка 6308: | ||
|1 | |1 | ||
|Rho-related GTP-binding protein RhoB precursor (Rho cDNA clone 6) (h6) [ARH6] [ARHB] | |Rho-related GTP-binding protein RhoB precursor (Rho cDNA clone 6) (h6) [ARH6] [ARHB] | ||
|- | |||
|[[ADRB2]] | |||
|2 | |||
|Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) [ADRB2R] [B2AR] | |||
|- | |- | ||
|[[NANOG]] | |[[NANOG]] | ||
| | |17 | ||
|Homeobox protein NANOG (Homeobox transcription factor Nanog) (hNanog) | |Homeobox protein NANOG (Homeobox transcription factor Nanog) (hNanog) | ||
|- | |- | ||
Строка 5674: | Строка 6338: | ||
|- | |- | ||
|[[UCP3]] | |[[UCP3]] | ||
| | |7 | ||
|Mitochondrial uncoupling protein 3 (UCP 3) (Solute carrier family 25 member 9) [SLC25A9] | |Mitochondrial uncoupling protein 3 (UCP 3) (Solute carrier family 25 member 9) [SLC25A9] | ||
|- | |- | ||
Строка 5686: | Строка 6350: | ||
|- | |- | ||
|[[DGCR8]] | |[[DGCR8]] | ||
| | |4 | ||
|Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8) [C22orf12] [DGCRK6] [LP4941] | |Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8) [C22orf12] [DGCRK6] [LP4941] | ||
|- | |- | ||
|[[HDAC1]] | |[[HDAC1]] | ||
| | |17 | ||
|Histone deacetylase 1 (EC 3.5.1.98) (HD1) [RPD3L1] | |Histone deacetylase 1 (EC 3.5.1.98) (HD1) [RPD3L1] | ||
|- | |- | ||
Строка 5696: | Строка 6360: | ||
|1 | |1 | ||
|Vinculin (Metavinculin) (MV) | |Vinculin (Metavinculin) (MV) | ||
|- | |||
|[[CSGALNACT1]] | |||
|1 | |||
|Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (EC 2.4.1.174) (CsGalNAcT-1) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1) (Beta4GalNAcT-1) [CHGN] [GALNACT1] [UNQ656/PRO1287] | |||
|- | |- | ||
|[[ACACA]] | |[[ACACA]] | ||
Строка 5736: | Строка 6404: | ||
|1 | |1 | ||
|Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII) [PCANAP7] | |Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII) [PCANAP7] | ||
|- | |||
|[[VRK2]] | |||
|1 | |||
|Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) | |||
|- | |- | ||
|[[ATG4D]] | |[[ATG4D]] | ||
Строка 5742: | Строка 6414: | ||
|- | |- | ||
|[[DNMT3B]] | |[[DNMT3B]] | ||
| | |8 | ||
|DNA (cytosine-5)-methyltransferase 3B (EC 2.1.1.37) (Dnmt3b) (DNA methyltransferase HsaIIIB) (DNA MTase HsaIIIB) (M.HsaIIIB) | |DNA (cytosine-5)-methyltransferase 3B (EC 2.1.1.37) (Dnmt3b) (DNA methyltransferase HsaIIIB) (DNA MTase HsaIIIB) (M.HsaIIIB) | ||
|- | |- | ||
Строка 5766: | Строка 6438: | ||
|- | |- | ||
|[[DCX]] | |[[DCX]] | ||
| | |24 | ||
|Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X) [DBCN] [LISX] | |Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X) [DBCN] [LISX] | ||
|- | |- | ||
Строка 5782: | Строка 6454: | ||
|- | |- | ||
|[[KY]] | |[[KY]] | ||
| | |1 | ||
|Kyphoscoliosis peptidase (EC 3.4.-.-) | |Kyphoscoliosis peptidase (EC 3.4.-.-) | ||
|- | |- | ||
|[[MIP]] | |[[MIP]] | ||
| | |44 | ||
|Lens fiber major intrinsic protein (Aquaporin-0) (MIP26) (MP26) [AQP0] | |Lens fiber major intrinsic protein (Aquaporin-0) (MIP26) (MP26) [AQP0] | ||
|- | |- | ||
Строка 5810: | Строка 6482: | ||
|- | |- | ||
|[[FGF2]] | |[[FGF2]] | ||
| | |16 | ||
|Fibroblast growth factor 2 precursor (FGF-2) (Basic fibroblast growth factor) (bFGF) (Heparin-binding growth factor 2) (HBGF-2) [FGFB] | |Fibroblast growth factor 2 precursor (FGF-2) (Basic fibroblast growth factor) (bFGF) (Heparin-binding growth factor 2) (HBGF-2) [FGFB] | ||
|- | |- | ||
Строка 5818: | Строка 6490: | ||
|- | |- | ||
|[[NOG]] | |[[NOG]] | ||
| | |4 | ||
|Noggin precursor | |Noggin precursor | ||
|- | |- | ||
Строка 5826: | Строка 6498: | ||
|- | |- | ||
|[[CTRL]] | |[[CTRL]] | ||
| | |13 | ||
|Chymotrypsin-like protease CTRL-1 precursor (EC 3.4.21.-) [CTRL1] | |Chymotrypsin-like protease CTRL-1 precursor (EC 3.4.21.-) [CTRL1] | ||
|- | |- | ||
Строка 5834: | Строка 6506: | ||
|- | |- | ||
|[[PTPN11]] | |[[PTPN11]] | ||
| | |4 | ||
|Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3) [PTP2C] [SHPTP2] | |Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3) [PTP2C] [SHPTP2] | ||
|- | |||
|[[SERPINB3]] | |||
|1 | |||
|Serpin B3 (Protein T4-A) (Squamous cell carcinoma antigen 1) (SCCA-1) [SCCA] [SCCA1] | |||
|- | |||
|[[NMUR2]] | |||
|1 | |||
|Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1) [NMU2R] [TGR1] | |||
|- | |- | ||
|[[NPM1]] | |[[NPM1]] | ||
| | |4 | ||
|Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin) [NPM] | |Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin) [NPM] | ||
|- | |- | ||
Строка 5854: | Строка 6534: | ||
|- | |- | ||
|[[FADS1]] | |[[FADS1]] | ||
|2 | |||
|Acyl-CoA (8-3)-desaturase (EC 1.14.19.44) (Delta(5) fatty acid desaturase) (D5D) (Delta(5) desaturase) (Delta-5 desaturase) (Fatty acid desaturase 1) [FADSD5] | |||
|- | |||
|[[SDHAF2]] | |||
|1 | |1 | ||
| | |Succinate dehydrogenase assembly factor 2, mitochondrial precursor (SDH assembly factor 2) (SDHAF2) [C11orf79] [PGL2] [SDH5] | ||
|- | |- | ||
|[[MUC1]] | |[[MUC1]] | ||
|2 | |||
|Mucin-1 precursor (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD227 antigen) [Contains: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)] [PUM] | |||
|- | |||
|[[HNF1A]] | |||
|1 | |1 | ||
| | |Hepatocyte nuclear factor 1-alpha (HNF-1-alpha) (HNF-1A) (Liver-specific transcription factor LF-B1) (LFB1) (Transcription factor 1) (TCF-1) [TCF1] | ||
|- | |- | ||
|[[ATG4B]] | |[[ATG4B]] | ||
Строка 5874: | Строка 6562: | ||
|- | |- | ||
|[[GPR55]] | |[[GPR55]] | ||
| | |3 | ||
|G-protein coupled receptor 55 | |G-protein coupled receptor 55 | ||
|- | |||
|[[PDE3B]] | |||
|1 | |||
|cGMP-inhibited 3',5'-cyclic phosphodiesterase B (EC 3.1.4.17) (CGIPDE1) (CGIP1) (Cyclic GMP-inhibited phosphodiesterase B) (CGI-PDE B) | |||
|- | |- | ||
|[[PBX1]] | |[[PBX1]] | ||
Строка 5882: | Строка 6574: | ||
|- | |- | ||
|[[USP10]] | |[[USP10]] | ||
| | |2 | ||
|Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10) [KIAA0190] | |Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10) [KIAA0190] | ||
|- | |- | ||
Строка 5930: | Строка 6622: | ||
|- | |- | ||
|[[TREM2]] | |[[TREM2]] | ||
| | |23 | ||
|Triggering receptor expressed on myeloid cells 2 precursor (TREM-2) (Triggering receptor expressed on monocytes 2) | |Triggering receptor expressed on myeloid cells 2 precursor (TREM-2) (Triggering receptor expressed on monocytes 2) | ||
|- | |- | ||
Строка 5938: | Строка 6630: | ||
|- | |- | ||
|[[IDS]] | |[[IDS]] | ||
| | |9 | ||
|Iduronate 2-sulfatase precursor (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Contains: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain] [SIDS] | |Iduronate 2-sulfatase precursor (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Contains: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain] [SIDS] | ||
|- | |- | ||
|[[HTT]] | |[[HTT]] | ||
| | |15 | ||
|Huntingtin (Huntington disease protein) (HD protein) [Contains: Huntingtin, myristoylated N-terminal fragment] [HD] [IT15] | |Huntingtin (Huntington disease protein) (HD protein) [Contains: Huntingtin, myristoylated N-terminal fragment] [HD] [IT15] | ||
|- | |||
|[[EZH1]] | |||
|1 | |||
|Histone-lysine N-methyltransferase EZH1 (EC 2.1.1.356) (ENX-2) (Enhancer of zeste homolog 1) [KIAA0388] | |||
|- | |- | ||
|[[SCD]] | |[[SCD]] | ||
| | |80 | ||
|Stearoyl-CoA desaturase (EC 1.14.19.1) (hSCD1) (Acyl-CoA desaturase) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) [FADS5] [SCD1] [SCDOS] | |Stearoyl-CoA desaturase (EC 1.14.19.1) (hSCD1) (Acyl-CoA desaturase) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) [FADS5] [SCD1] [SCDOS] | ||
|- | |- | ||
Строка 5960: | Строка 6656: | ||
|1 | |1 | ||
|Osteoclast-associated immunoglobulin-like receptor precursor (Osteoclast-associated receptor) (hOSCAR) (Polymeric immunoglobulin receptor 3) (PIgR-3) (PIgR3) (Poly-Ig receptor 3) | |Osteoclast-associated immunoglobulin-like receptor precursor (Osteoclast-associated receptor) (hOSCAR) (Polymeric immunoglobulin receptor 3) (PIgR-3) (PIgR3) (Poly-Ig receptor 3) | ||
|- | |||
|[[CFL2]] | |||
|1 | |||
|Cofilin-2 (Cofilin, muscle isoform) | |||
|- | |- | ||
|[[GPD1]] | |[[GPD1]] | ||
|1 | |1 | ||
|Glycerol-3-phosphate dehydrogenase [NAD( )], cytoplasmic (EC 1.1.1.8) (GPD-C) (GPDH-C) | |Glycerol-3-phosphate dehydrogenase [NAD( )], cytoplasmic (EC 1.1.1.8) (GPD-C) (GPDH-C) | ||
|- | |||
|[[DEPDC1]] | |||
|1 | |||
|DEP domain-containing protein 1A [DEPDC1A] | |||
|- | |- | ||
|[[SEMA3A]] | |[[SEMA3A]] | ||
Строка 5978: | Строка 6682: | ||
|- | |- | ||
|[[TPR]] | |[[TPR]] | ||
| | |14 | ||
|Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) | |Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) | ||
|- | |- | ||
|[[HOXA5]] | |[[HOXA5]] | ||
| | |3 | ||
|Homeobox protein Hox-A5 (Homeobox protein Hox-1C) [HOX1C] | |Homeobox protein Hox-A5 (Homeobox protein Hox-1C) [HOX1C] | ||
|- | |- | ||
Строка 5996: | Строка 6700: | ||
|1 | |1 | ||
|Delta-aminolevulinic acid dehydratase (EC 4.2.1.24) (ALADH) (Porphobilinogen synthase) | |Delta-aminolevulinic acid dehydratase (EC 4.2.1.24) (ALADH) (Porphobilinogen synthase) | ||
|- | |||
|[[NPB]] | |||
|1 | |||
|Neuropeptide B precursor (Preproprotein L7) (hPPL7) [Contains: Neuropeptide B-23 (NPB23) (hL7); Neuropeptide B-29 (NPB29) (hL7C)] [PPL7] [PPNPB] | |||
|- | |||
|[[ATP7B]] | |||
|1 | |||
|Copper-transporting ATPase 2 (EC 7.2.2.8) (Copper pump 2) (Wilson disease-associated protein) [Contains: WND/140 kDa] [PWD] [WC1] [WND] | |||
|- | |- | ||
|[[CYP19A1]] | |[[CYP19A1]] | ||
Строка 6010: | Строка 6722: | ||
|- | |- | ||
|[[BAX]] | |[[BAX]] | ||
| | |25 | ||
|Apoptosis regulator BAX (Bcl-2-like protein 4) (Bcl2-L-4) [BCL2L4] | |Apoptosis regulator BAX (Bcl-2-like protein 4) (Bcl2-L-4) [BCL2L4] | ||
|- | |- | ||
Строка 6024: | Строка 6736: | ||
|3 | |3 | ||
|Thioredoxin-dependent peroxide reductase, mitochondrial precursor (EC 1.11.1.24) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog) (Thioredoxin-dependent peroxiredoxin 3) [AOP1] | |Thioredoxin-dependent peroxide reductase, mitochondrial precursor (EC 1.11.1.24) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog) (Thioredoxin-dependent peroxiredoxin 3) [AOP1] | ||
|- | |||
|[[HMGN2]] | |||
|1 | |||
|Non-histone chromosomal protein HMG-17 (High mobility group nucleosome-binding domain-containing protein 2) [HMG17] | |||
|- | |||
|[[BIRC5]] | |||
|1 | |||
|Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin) [API4] [IAP4] | |||
|- | |- | ||
|[[SV2A]] | |[[SV2A]] | ||
|2 | |2 | ||
|Synaptic vesicle glycoprotein 2A [KIAA0736] [PSEC0174] | |Synaptic vesicle glycoprotein 2A [KIAA0736] [PSEC0174] | ||
|- | |||
|[[GNA11]] | |||
|1 | |||
|Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (G-protein subunit alpha-11) (Guanine nucleotide-binding protein G(y) subunit alpha) [GA11] | |||
|- | |||
|[[CD8B]] | |||
|1 | |||
|T-cell surface glycoprotein CD8 beta chain precursor (CD8b antigen) [CD8B1] | |||
|- | |- | ||
|[[PAM]] | |[[PAM]] | ||
| | |12 | ||
|Peptidyl-glycine alpha-amidating monooxygenase precursor (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (EC 1.14.17.3) (PHM); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)] | |Peptidyl-glycine alpha-amidating monooxygenase precursor (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (EC 1.14.17.3) (PHM); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)] | ||
|- | |- | ||
Строка 6042: | Строка 6770: | ||
|- | |- | ||
|[[NLRC5]] | |[[NLRC5]] | ||
| | |3 | ||
|Protein NLRC5 (Caterpiller protein 16.1) (CLR16.1) (Nucleotide-binding oligomerization domain protein 27) (Nucleotide-binding oligomerization domain protein 4) [NOD27] [NOD4] | |Protein NLRC5 (Caterpiller protein 16.1) (CLR16.1) (Nucleotide-binding oligomerization domain protein 27) (Nucleotide-binding oligomerization domain protein 4) [NOD27] [NOD4] | ||
|- | |- | ||
|[[FOXO4]] | |[[FOXO4]] | ||
| | |16 | ||
|Forkhead box protein O4 (Fork head domain transcription factor AFX1) [AFX] [AFX1] [MLLT7] | |Forkhead box protein O4 (Fork head domain transcription factor AFX1) [AFX] [AFX1] [MLLT7] | ||
|- | |- | ||
Строка 6060: | Строка 6788: | ||
|4 | |4 | ||
|3-hydroxy-3-methylglutaryl-coenzyme A reductase (EC 1.1.1.34) (HMG-CoA reductase) | |3-hydroxy-3-methylglutaryl-coenzyme A reductase (EC 1.1.1.34) (HMG-CoA reductase) | ||
|- | |- | ||
|[[KLF10]] | |[[KLF10]] | ||
Строка 6070: | Строка 6794: | ||
|- | |- | ||
|[[KIF1B]] | |[[KIF1B]] | ||
| | |3 | ||
|Kinesin-like protein KIF1B (Klp) [KIAA0591] [KIAA1448] | |Kinesin-like protein KIF1B (Klp) [KIAA0591] [KIAA1448] | ||
|- | |- | ||
|[[CFB]] | |[[CFB]] | ||
| | |5 | ||
|Complement factor B precursor (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Contains: Complement factor B Ba fragment; Complement factor B Bb fragment] [BF] [BFD] | |Complement factor B precursor (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Contains: Complement factor B Ba fragment; Complement factor B Bb fragment] [BF] [BFD] | ||
|- | |||
|[[KCNS3]] | |||
|1 | |||
|Potassium voltage-gated channel subfamily S member 3 (Delayed-rectifier K( ) channel alpha subunit 3) (Voltage-gated potassium channel subunit Kv9.3) | |||
|- | |- | ||
|[[NMNAT1]] | |[[NMNAT1]] | ||
Строка 6084: | Строка 6812: | ||
|3 | |3 | ||
|Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3) [MAPKKK3] [MEKK3] | |Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3) [MAPKKK3] [MEKK3] | ||
|- | |||
|[[FLCN]] | |||
|1 | |||
|Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein) [BHD] | |||
|- | |- | ||
|[[CYCS]] | |[[CYCS]] | ||
Строка 6094: | Строка 6826: | ||
|- | |- | ||
|[[ID2]] | |[[ID2]] | ||
| | |2 | ||
|DNA-binding protein inhibitor ID-2 (Class B basic helix-loop-helix protein 26) (bHLHb26) (Inhibitor of DNA binding 2) (Inhibitor of differentiation 2) [BHLHB26] | |DNA-binding protein inhibitor ID-2 (Class B basic helix-loop-helix protein 26) (bHLHb26) (Inhibitor of DNA binding 2) (Inhibitor of differentiation 2) [BHLHB26] | ||
|- | |- | ||
Строка 6104: | Строка 6836: | ||
|1 | |1 | ||
|Little elongation complex subunit 1 (Interactor of little elongator complex ELL subunit 1) [KIAA0947] | |Little elongation complex subunit 1 (Interactor of little elongator complex ELL subunit 1) [KIAA0947] | ||
|- | |||
|[[VCPIP1]] | |||
|1 | |||
|Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein) [KIAA1850] [VCIP135] | |||
|- | |- | ||
|[[SOCS3]] | |[[SOCS3]] | ||
| | |12 | ||
|Suppressor of cytokine signaling 3 (SOCS-3) (Cytokine-inducible SH2 protein 3) (CIS-3) (STAT-induced STAT inhibitor 3) (SSI-3) [CIS3] [SSI3] | |Suppressor of cytokine signaling 3 (SOCS-3) (Cytokine-inducible SH2 protein 3) (CIS-3) (STAT-induced STAT inhibitor 3) (SSI-3) [CIS3] [SSI3] | ||
|- | |- | ||
|[[CCS]] | |[[CCS]] | ||
| | |15 | ||
|Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone) | |Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone) | ||
|- | |- | ||
Строка 6122: | Строка 6858: | ||
|- | |- | ||
|[[CTCF]] | |[[CTCF]] | ||
| | |9 | ||
|Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog) | |Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog) | ||
|- | |- | ||
Строка 6146: | Строка 6882: | ||
|- | |- | ||
|[[CD36]] | |[[CD36]] | ||
| | |27 | ||
|Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD36 antigen) [GP3B] [GP4] | |Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD36 antigen) [GP3B] [GP4] | ||
|- | |||
|[[MEPE]] | |||
|1 | |||
|Matrix extracellular phosphoglycoprotein precursor (Osteoblast/osteocyte factor 45) (OF45) (Osteoregulin) | |||
|- | |- | ||
|[[SKI]] | |[[SKI]] | ||
Строка 6158: | Строка 6898: | ||
|- | |- | ||
|[[TG]] | |[[TG]] | ||
| | |142 | ||
|Thyroglobulin precursor (Tg) | |Thyroglobulin precursor (Tg) | ||
|- | |- | ||
Строка 6180: | Строка 6920: | ||
|2 | |2 | ||
|Transcription factor 7 (TCF-7) (T-cell-specific transcription factor 1) (T-cell factor 1) (TCF-1) [TCF1] | |Transcription factor 7 (TCF-7) (T-cell-specific transcription factor 1) (T-cell factor 1) (TCF-1) [TCF1] | ||
|- | |||
|[[UBE2C]] | |||
|1 | |||
|Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UbcH10) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C) [UBCH10] | |||
|- | |- | ||
|[[CA1]] | |[[CA1]] | ||
| | |331 | ||
|Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) | |Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) | ||
|- | |- | ||
Строка 6190: | Строка 6934: | ||
|- | |- | ||
|[[NOS2]] | |[[NOS2]] | ||
| | |8 | ||
|Nitric oxide synthase, inducible (EC 1.14.13.39) (Hepatocyte NOS) (HEP-NOS) (Inducible NO synthase) (Inducible NOS) (iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2) [NOS2A] | |Nitric oxide synthase, inducible (EC 1.14.13.39) (Hepatocyte NOS) (HEP-NOS) (Inducible NO synthase) (Inducible NOS) (iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2) [NOS2A] | ||
|- | |- | ||
Строка 6198: | Строка 6942: | ||
|- | |- | ||
|[[MMP9]] | |[[MMP9]] | ||
| | |26 | ||
|Matrix metalloproteinase-9 precursor (EC 3.4.24.35) (MMP-9) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Contains: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9] [CLG4B] | |Matrix metalloproteinase-9 precursor (EC 3.4.24.35) (MMP-9) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Contains: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9] [CLG4B] | ||
|- | |- | ||
Строка 6214: | Строка 6958: | ||
|- | |- | ||
|[[XRCC3]] | |[[XRCC3]] | ||
| | |4 | ||
|DNA repair protein XRCC3 (X-ray repair cross-complementing protein 3) | |DNA repair protein XRCC3 (X-ray repair cross-complementing protein 3) | ||
|- | |- | ||
|[[CBS]] | |[[CBS]] | ||
| | |11 | ||
|Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase) | |Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase) | ||
|- | |- | ||
Строка 6226: | Строка 6970: | ||
|- | |- | ||
|[[AGER]] | |[[AGER]] | ||
| | |4 | ||
|Advanced glycosylation end product-specific receptor precursor (Receptor for advanced glycosylation end products) [RAGE] | |Advanced glycosylation end product-specific receptor precursor (Receptor for advanced glycosylation end products) [RAGE] | ||
|- | |- | ||
Строка 6238: | Строка 6982: | ||
|- | |- | ||
|[[FGF23]] | |[[FGF23]] | ||
| | |35 | ||
|Fibroblast growth factor 23 precursor (FGF-23) (Phosphatonin) (Tumor-derived hypophosphatemia-inducing factor) [Contains: Fibroblast growth factor 23 N-terminal peptide; Fibroblast growth factor 23 C-terminal peptide] [HYPF] [UNQ3027/PRO9828] | |Fibroblast growth factor 23 precursor (FGF-23) (Phosphatonin) (Tumor-derived hypophosphatemia-inducing factor) [Contains: Fibroblast growth factor 23 N-terminal peptide; Fibroblast growth factor 23 C-terminal peptide] [HYPF] [UNQ3027/PRO9828] | ||
|- | |||
|[[GAGE10]] | |||
|1 | |||
|G antigen 10 (GAGE-10) | |||
|- | |- | ||
|[[NIN]] | |[[NIN]] | ||
Строка 6250: | Строка 6998: | ||
|- | |- | ||
|[[BDNF]] | |[[BDNF]] | ||
| | |273 | ||
|Brain-derived neurotrophic factor precursor (BDNF) (Abrineurin) [Contains: BDNF precursor form (ProBDNF)] | |Brain-derived neurotrophic factor precursor (BDNF) (Abrineurin) [Contains: BDNF precursor form (ProBDNF)] | ||
|- | |- | ||
Строка 6260: | Строка 7008: | ||
|2 | |2 | ||
|Calcium-binding mitochondrial carrier protein SCaMC-1 (Mitochondrial ATP-Mg/Pi carrier protein 1) (Mitochondrial Ca(2 )-dependent solute carrier protein 1) (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) [APC1] [MCSC1] [SCAMC1] | |Calcium-binding mitochondrial carrier protein SCaMC-1 (Mitochondrial ATP-Mg/Pi carrier protein 1) (Mitochondrial Ca(2 )-dependent solute carrier protein 1) (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) [APC1] [MCSC1] [SCAMC1] | ||
|- | |||
|[[KIF4A]] | |||
|1 | |||
|Chromosome-associated kinesin KIF4A (Chromokinesin-A) [KIF4] | |||
|- | |- | ||
|[[GPR19]] | |[[GPR19]] | ||
Строка 6270: | Строка 7022: | ||
|- | |- | ||
|[[CDK4]] | |[[CDK4]] | ||
| | |37 | ||
|Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3) | |Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3) | ||
|- | |- | ||
Строка 6282: | Строка 7034: | ||
|- | |- | ||
|[[BPI]] | |[[BPI]] | ||
| | |5 | ||
|Bactericidal permeability-increasing protein precursor (BPI) (CAP 57) | |Bactericidal permeability-increasing protein precursor (BPI) (CAP 57) | ||
|- | |- | ||
Строка 6290: | Строка 7042: | ||
|- | |- | ||
|[[SCO2]] | |[[SCO2]] | ||
| | |2 | ||
|Protein SCO2 homolog, mitochondrial precursor | |Protein SCO2 homolog, mitochondrial precursor | ||
|- | |- | ||
Строка 6310: | Строка 7062: | ||
|- | |- | ||
|[[CFI]] | |[[CFI]] | ||
| | |22 | ||
|Complement factor I precursor (EC 3.4.21.45) (C3B/C4B inactivator) [Contains: Complement factor I heavy chain; Complement factor I light chain] [IF] | |Complement factor I precursor (EC 3.4.21.45) (C3B/C4B inactivator) [Contains: Complement factor I heavy chain; Complement factor I light chain] [IF] | ||
|- | |- | ||
Строка 6316: | Строка 7068: | ||
|3 | |3 | ||
|Aromatic-L-amino-acid decarboxylase (EC 4.1.1.28) (AADC) (DOPA decarboxylase) (DDC) [AADC] | |Aromatic-L-amino-acid decarboxylase (EC 4.1.1.28) (AADC) (DOPA decarboxylase) (DDC) [AADC] | ||
|- | |||
|[[CDH23]] | |||
|1 | |||
|Cadherin-23 precursor (Otocadherin) [KIAA1774] [KIAA1812] [UNQ1894/PRO4340] | |||
|- | |- | ||
|[[COQ5]] | |[[COQ5]] | ||
Строка 6324: | Строка 7080: | ||
|1 | |1 | ||
|Calcium uptake protein 1, mitochondrial precursor (Atopy-related autoantigen CALC) (ara CALC) (Calcium-binding atopy-related autoantigen 1) (Allergen Hom s 4) [CALC] [CBARA1] | |Calcium uptake protein 1, mitochondrial precursor (Atopy-related autoantigen CALC) (ara CALC) (Calcium-binding atopy-related autoantigen 1) (Allergen Hom s 4) [CALC] [CBARA1] | ||
|- | |- | ||
|[[SRPK1]] | |[[SRPK1]] | ||
Строка 6340: | Строка 7092: | ||
|1 | |1 | ||
|Protocadherin gamma-A3 precursor (PCDH-gamma-A3) | |Protocadherin gamma-A3 precursor (PCDH-gamma-A3) | ||
|- | |||
|[[LIPC]] | |||
|1 | |||
|Hepatic triacylglycerol lipase precursor (EC 3.1.1.3) (HL) (Hepatic lipase) (Lipase member C) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A1) (EC 3.1.1.32) [HTGL] | |||
|- | |- | ||
|[[PAPSS2]] | |[[PAPSS2]] | ||
| | |3 | ||
|Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPS synthase 2) (PAPSS 2) (Sulfurylase kinase 2) (SK 2) (SK2) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)] [ATPSK2] | |Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPS synthase 2) (PAPSS 2) (Sulfurylase kinase 2) (SK 2) (SK2) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)] [ATPSK2] | ||
|- | |- | ||
|[[RPTOR]] | |[[RPTOR]] | ||
| | |4 | ||
|Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein) [KIAA1303] [RAPTOR] | |Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein) [KIAA1303] [RAPTOR] | ||
|- | |||
|[[IL5]] | |||
|1 | |||
|Interleukin-5 precursor (IL-5) (B-cell differentiation factor I) (Eosinophil differentiation factor) (T-cell replacing factor) (TRF) | |||
|- | |- | ||
|[[MYH10]] | |[[MYH10]] | ||
Строка 6358: | Строка 7118: | ||
|- | |- | ||
|[[PDK1]] | |[[PDK1]] | ||
| | |8 | ||
|[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial precursor (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) [PDHK1] | |[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial precursor (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) [PDHK1] | ||
|- | |- | ||
Строка 6366: | Строка 7126: | ||
|- | |- | ||
|[[VIT]] | |[[VIT]] | ||
| | |1 | ||
|Vitrin precursor [UNQ647/PRO1277] | |Vitrin precursor [UNQ647/PRO1277] | ||
|- | |- | ||
Строка 6374: | Строка 7134: | ||
|- | |- | ||
|[[IFITM3]] | |[[IFITM3]] | ||
| | |2 | ||
|Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b) (DSPA2b) (Interferon-inducible protein 1-8U) | |Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b) (DSPA2b) (Interferon-inducible protein 1-8U) | ||
|- | |- | ||
Строка 6382: | Строка 7142: | ||
|- | |- | ||
|[[TDG]] | |[[TDG]] | ||
| | |3 | ||
|G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG) | |G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG) | ||
|- | |- | ||
|[[PMS2]] | |[[PMS2]] | ||
| | |3 | ||
|Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2) [PMSL2] | |Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2) [PMSL2] | ||
|- | |- | ||
Строка 6418: | Строка 7178: | ||
|- | |- | ||
|[[CR1]] | |[[CR1]] | ||
| | |12 | ||
|Complement receptor type 1 precursor (C3b/C4b receptor) (CD35 antigen) [C3BR] | |Complement receptor type 1 precursor (C3b/C4b receptor) (CD35 antigen) [C3BR] | ||
|- | |- | ||
Строка 6426: | Строка 7186: | ||
|- | |- | ||
|[[TEN1]] | |[[TEN1]] | ||
| | |2 | ||
|CST complex subunit TEN1 (Protein telomeric pathways with STN1 homolog) (Telomere length regulation protein TEN1 homolog) [C17orf106] | |CST complex subunit TEN1 (Protein telomeric pathways with STN1 homolog) (Telomere length regulation protein TEN1 homolog) [C17orf106] | ||
|- | |- | ||
Строка 6442: | Строка 7202: | ||
|- | |- | ||
|[[CAT]] | |[[CAT]] | ||
| | |161 | ||
|Catalase (EC 1.11.1.6) | |Catalase (EC 1.11.1.6) | ||
|- | |- | ||
Строка 6454: | Строка 7214: | ||
|- | |- | ||
|[[MDM4]] | |[[MDM4]] | ||
| | |2 | ||
|Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4) [MDMX] | |Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4) [MDMX] | ||
|- | |- | ||
|[[SIRT5]] | |[[SIRT5]] | ||
| | |12 | ||
|NAD-dependent protein deacylase sirtuin-5, mitochondrial precursor (EC 2.3.1.-) (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5) [SIR2L5] | |NAD-dependent protein deacylase sirtuin-5, mitochondrial precursor (EC 2.3.1.-) (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5) [SIR2L5] | ||
|- | |- | ||
Строка 6464: | Строка 7224: | ||
|3 | |3 | ||
|C-C chemokine receptor type 3 (C C CKR3) (C-C CKR-3) (CC-CKR-3) (CCR-3) (CCR3) (CKR 3) (CKR3) (Eosinophil eotaxin receptor) (CD193 antigen) [CMKBR3] | |C-C chemokine receptor type 3 (C C CKR3) (C-C CKR-3) (CC-CKR-3) (CCR-3) (CCR3) (CKR 3) (CKR3) (Eosinophil eotaxin receptor) (CD193 antigen) [CMKBR3] | ||
|- | |||
|[[TNKS2]] | |||
|1 | |||
|Poly [ADP-ribose] polymerase tankyrase-2 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (Protein poly-ADP-ribosyltransferase tankyrase-2) (EC 2.4.2.-) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-2) (TANK2) (Tankyrase-like protein) (Tankyrase-related protein) [PARP5B] [TANK2] [TNKL] | |||
|- | |- | ||
|[[TOMM40]] | |[[TOMM40]] | ||
| | |12 | ||
|Mitochondrial import receptor subunit TOM40 homolog (Protein Haymaker) (Translocase of outer membrane 40 kDa subunit homolog) (p38.5) [C19orf1] [PEREC1] [TOM40] | |Mitochondrial import receptor subunit TOM40 homolog (Protein Haymaker) (Translocase of outer membrane 40 kDa subunit homolog) (p38.5) [C19orf1] [PEREC1] [TOM40] | ||
|- | |- | ||
|[[CD209]] | |[[CD209]] | ||
| | |2 | ||
|CD209 antigen (C-type lectin domain family 4 member L) (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN) (DC-SIGN1) [CLEC4L] | |CD209 antigen (C-type lectin domain family 4 member L) (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN) (DC-SIGN1) [CLEC4L] | ||
|- | |- | ||
Строка 6492: | Строка 7256: | ||
|2 | |2 | ||
|Aquaporin-3 (AQP-3) (Aquaglyceroporin-3) | |Aquaporin-3 (AQP-3) (Aquaglyceroporin-3) | ||
|- | |||
|[[PRDX2]] | |||
|1 | |||
|Peroxiredoxin-2 (EC 1.11.1.24) (Natural killer cell-enhancing factor B) (NKEF-B) (PRP) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1) (Thioredoxin-dependent peroxiredoxin 2) [NKEFB] [TDPX1] | |||
|- | |- | ||
|[[TEC]] | |[[TEC]] | ||
| | |23 | ||
|Tyrosine-protein kinase Tec (EC 2.7.10.2) [PSCTK4] | |Tyrosine-protein kinase Tec (EC 2.7.10.2) [PSCTK4] | ||
|- | |||
|[[NCAPG2]] | |||
|1 | |||
|Condensin-2 complex subunit G2 (Chromosome-associated protein G2) (CAP-G2) (hCAP-G2) (Leucine zipper protein 5) (Non-SMC condensin II complex subunit G2) [LUZP5] | |||
|- | |- | ||
|[[CDR1]] | |[[CDR1]] | ||
Строка 6504: | Строка 7276: | ||
|2 | |2 | ||
|Pescadillo homolog | |Pescadillo homolog | ||
|- | |||
|[[CCDC85A]] | |||
|1 | |||
|domain-containing protein 85A [KIAA1912] | |||
|- | |- | ||
|[[NPY]] | |[[NPY]] | ||
| | |34 | ||
|Pro-neuropeptide Y precursor [Contains: Neuropeptide Y (Neuropeptide tyrosine) (NPY); C-flanking peptide of NPY (CPON)] | |Pro-neuropeptide Y precursor [Contains: Neuropeptide Y (Neuropeptide tyrosine) (NPY); C-flanking peptide of NPY (CPON)] | ||
|- | |- | ||
Строка 6522: | Строка 7298: | ||
|- | |- | ||
|[[AQP5]] | |[[AQP5]] | ||
| | |4 | ||
|Aquaporin-5 (AQP-5) | |Aquaporin-5 (AQP-5) | ||
|- | |- | ||
|[[ASXL1]] | |[[ASXL1]] | ||
| | |8 | ||
|Polycomb group protein ASXL1 (Additional sex combs-like protein 1) [KIAA0978] | |Polycomb group protein ASXL1 (Additional sex combs-like protein 1) [KIAA0978] | ||
|- | |- | ||
|[[HRAS]] | |[[HRAS]] | ||
| | |7 | ||
|GTPase HRas precursor (EC 3.6.5.2) (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) [Contains: GTPase HRas, N-terminally processed] [HRAS1] | |GTPase HRas precursor (EC 3.6.5.2) (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) [Contains: GTPase HRas, N-terminally processed] [HRAS1] | ||
|- | |- | ||
Строка 6538: | Строка 7314: | ||
|- | |- | ||
|[[SUV39H1]] | |[[SUV39H1]] | ||
| | |10 | ||
|Histone-lysine N-methyltransferase SUV39H1 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 1) (H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1) (Su(var)3-9 homolog 1) [KMT1A] [SUV39H] | |Histone-lysine N-methyltransferase SUV39H1 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 1) (H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1) (Su(var)3-9 homolog 1) [KMT1A] [SUV39H] | ||
|- | |- | ||
Строка 6544: | Строка 7320: | ||
|1 | |1 | ||
|Period circadian protein homolog 3 (hPER3) (Cell growth-inhibiting gene 13 protein) (Circadian clock protein PERIOD 3) [GIG13] | |Period circadian protein homolog 3 (hPER3) (Cell growth-inhibiting gene 13 protein) (Circadian clock protein PERIOD 3) [GIG13] | ||
|- | |||
|[[ALOX15B]] | |||
|1 | |||
|Polyunsaturated fatty acid lipoxygenase ALOX15B (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase B) (EC 1.13.11.33) (15-LOX-B) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) | |||
|- | |- | ||
|[[PTGDS]] | |[[PTGDS]] | ||
Строка 6558: | Строка 7338: | ||
|- | |- | ||
|[[SOD1]] | |[[SOD1]] | ||
| | |104 | ||
|Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1) | |Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1) | ||
|- | |- | ||
Строка 6564: | Строка 7344: | ||
|1 | |1 | ||
|Cerebellar degeneration-related protein 2 (Major Yo paraneoplastic antigen) (Paraneoplastic cerebellar degeneration-associated antigen) [PCD17] | |Cerebellar degeneration-related protein 2 (Major Yo paraneoplastic antigen) (Paraneoplastic cerebellar degeneration-associated antigen) [PCD17] | ||
|- | |||
|[[TUBAL3]] | |||
|1 | |||
|alpha chain-like 3 | |||
|- | |- | ||
|[[NONO]] | |[[NONO]] | ||
Строка 6592: | Строка 7376: | ||
|1 | |1 | ||
|Testis-specific Y-encoded-like protein 5 (TSPY-like protein 5) [KIAA1750] | |Testis-specific Y-encoded-like protein 5 (TSPY-like protein 5) [KIAA1750] | ||
|- | |||
|[[CBR1]] | |||
|1 | |||
|Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP( )]) (EC 1.1.1.196) (EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1) [CBR] [CRN] [SDR21C1] | |||
|- | |- | ||
|[[CDC20]] | |[[CDC20]] | ||
Строка 6604: | Строка 7392: | ||
|2 | |2 | ||
|Transcription factor E2F2 (E2F-2) | |Transcription factor E2F2 (E2F-2) | ||
|- | |||
|[[FGF7]] | |||
|1 | |||
|Fibroblast growth factor 7 precursor (FGF-7) (Heparin-binding growth factor 7) (HBGF-7) (Keratinocyte growth factor) [KGF] | |||
|- | |- | ||
|[[ME1]] | |[[ME1]] | ||
Строка 6634: | Строка 7426: | ||
|- | |- | ||
|[[PNN]] | |[[PNN]] | ||
| | |9 | ||
|Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein) [DRS] [MEMA] | |Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein) [DRS] [MEMA] | ||
|- | |- | ||
|[[MDM2]] | |[[MDM2]] | ||
| | |29 | ||
|E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Hdm2) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2) | |E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Hdm2) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2) | ||
|- | |- | ||
Строка 6650: | Строка 7442: | ||
|- | |- | ||
|[[ATF6]] | |[[ATF6]] | ||
| | |12 | ||
|Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Contains: Processed cyclic AMP-dependent transcription factor ATF-6 alpha] | |Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Contains: Processed cyclic AMP-dependent transcription factor ATF-6 alpha] | ||
|- | |- | ||
Строка 6668: | Строка 7460: | ||
|4 | |4 | ||
|DNA repair protein XRCC4 (X-ray repair cross-complementing protein 4) | |DNA repair protein XRCC4 (X-ray repair cross-complementing protein 4) | ||
|- | |||
|[[NCAPD2]] | |||
|1 | |||
|Condensin complex subunit 1 (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (hCAP-D2) (Non-SMC condensin I complex subunit D2) (XCAP-D2 homolog) [CAPD2] [CNAP1] [KIAA0159] | |||
|- | |- | ||
|[[GRN]] | |[[GRN]] | ||
| | |16 | ||
|Progranulin precursor (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Contains: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] | |Progranulin precursor (PGRN) (Acrogranin) (Epithelin precursor) (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Granulin precursor) (PC cell-derived growth factor) (PCDGF) (Proepithelin) (PEPI) [Contains: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)] | ||
|- | |- | ||
|[[CD80]] | |[[CD80]] | ||
| | |15 | ||
|T-lymphocyte activation antigen CD80 precursor (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD80 antigen) [CD28LG] [CD28LG1] [LAB7] | |T-lymphocyte activation antigen CD80 precursor (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD80 antigen) [CD28LG] [CD28LG1] [LAB7] | ||
|- | |||
|[[SREBF1]] | |||
|1 | |||
|Sterol regulatory element-binding protein 1 (SREBP-1) (Class D basic helix-loop-helix protein 1) (bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Contains: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1)] [BHLHD1] [SREBP1] | |||
|- | |||
|[[PDE8B]] | |||
|1 | |||
|High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (EC 3.1.4.53) (HsPDE8B) (Cell proliferation-inducing gene 22 protein) [PIG22] | |||
|- | |- | ||
|[[DGAT2]] | |[[DGAT2]] | ||
Строка 6694: | Строка 7498: | ||
|- | |- | ||
|[[MAP1S]] | |[[MAP1S]] | ||
| | |3 | ||
|Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Contains: MAP1S heavy chain; MAP1S light chain] [BPY2IP1] [C19orf5] [MAP8] [VCY2IP1] | |Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Contains: MAP1S heavy chain; MAP1S light chain] [BPY2IP1] [C19orf5] [MAP8] [VCY2IP1] | ||
|- | |- | ||
Строка 6700: | Строка 7504: | ||
|2 | |2 | ||
|DNA helicase MCM9 (EC 3.6.4.12) (hMCM9) (Mini-chromosome maintenance deficient domain-containing protein 1) (Minichromosome maintenance 9) [C6orf61] [MCMDC1] | |DNA helicase MCM9 (EC 3.6.4.12) (hMCM9) (Mini-chromosome maintenance deficient domain-containing protein 1) (Minichromosome maintenance 9) [C6orf61] [MCMDC1] | ||
|- | |||
|[[GABRR3]] | |||
|1 | |||
|Gamma-aminobutyric acid receptor subunit rho-3 precursor (GABA(A) receptor subunit rho-3) (GABA(C) receptor) | |||
|- | |- | ||
|[[IGFBP6]] | |[[IGFBP6]] | ||
|1 | |1 | ||
|Insulin-like growth factor-binding protein 6 precursor (IBP-6) (IGF-binding protein 6) (IGFBP-6) [IBP6] | |Insulin-like growth factor-binding protein 6 precursor (IBP-6) (IGF-binding protein 6) (IGFBP-6) [IBP6] | ||
|- | |||
|[[CHRFAM7A]] | |||
|1 | |||
|CHRNA7-FAM7A fusion protein (CHRNA7-DR1) (D-10) | |||
|- | |- | ||
|[[AQP2]] | |[[AQP2]] | ||
| | |2 | ||
|Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct) | |Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct) | ||
|- | |- | ||
Строка 6734: | Строка 7546: | ||
|- | |- | ||
|[[PTH]] | |[[PTH]] | ||
| | |65 | ||
|Parathyroid hormone precursor (PTH) (Parathormone) (Parathyrin) | |Parathyroid hormone precursor (PTH) (Parathormone) (Parathyrin) | ||
|- | |- | ||
|[[XDH]] | |[[XDH]] | ||
| | |4 | ||
|Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (EC 1.17.1.4) (XD); Xanthine oxidase (EC 1.17.3.2) (XO) (Xanthine oxidoreductase) (XOR)] [XDHA] | |Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (EC 1.17.1.4) (XD); Xanthine oxidase (EC 1.17.3.2) (XO) (Xanthine oxidoreductase) (XOR)] [XDHA] | ||
|- | |- | ||
|[[DNMT1]] | |[[DNMT1]] | ||
| | |23 | ||
|DNA (cytosine-5)-methyltransferase 1 (EC 2.1.1.37) (Dnmt1) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT) [AIM] [CXXC9] [DNMT] | |DNA (cytosine-5)-methyltransferase 1 (EC 2.1.1.37) (Dnmt1) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT) [AIM] [CXXC9] [DNMT] | ||
|- | |- | ||
Строка 6790: | Строка 7602: | ||
|- | |- | ||
|[[STAT4]] | |[[STAT4]] | ||
| | |2 | ||
|Signal transducer and activator of transcription 4 | |Signal transducer and activator of transcription 4 | ||
|- | |- | ||
|[[PDE2A]] | |[[PDE2A]] | ||
| | |2 | ||
|cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) | |cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) | ||
|- | |- | ||
Строка 6834: | Строка 7646: | ||
|- | |- | ||
|[[CES1]] | |[[CES1]] | ||
| | |5 | ||
|Liver carboxylesterase 1 precursor (Acyl-coenzyme A:cholesterol acyltransferase) (ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1) (EC 3.1.1.1) (CE-1) (hCE-1) (Cholesteryl ester hydrolase) (EC 3.1.1.13) (CEH) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1) (EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase) (REH) (Serine esterase 1) (Triacylglycerol hydrolase) (TGH) [CES2] [SES1] | |Liver carboxylesterase 1 precursor (Acyl-coenzyme A:cholesterol acyltransferase) (ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1) (EC 3.1.1.1) (CE-1) (hCE-1) (Cholesteryl ester hydrolase) (EC 3.1.1.13) (CEH) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1) (EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase) (REH) (Serine esterase 1) (Triacylglycerol hydrolase) (TGH) [CES2] [SES1] | ||
|- | |||
|[[F11]] | |||
|1 | |||
|Coagulation factor XI precursor (EC 3.4.21.27) (FXI) (Plasma thromboplastin antecedent) (PTA) [Contains: Coagulation factor XIa heavy chain; Coagulation factor XIa light chain] | |||
|- | |- | ||
|[[EDARADD]] | |[[EDARADD]] | ||
| | |3 | ||
|Ectodysplasin-A receptor-associated adapter protein (EDAR-associated death domain protein) (Protein crinkled homolog) | |Ectodysplasin-A receptor-associated adapter protein (EDAR-associated death domain protein) (Protein crinkled homolog) | ||
|- | |- | ||
Строка 6858: | Строка 7674: | ||
|- | |- | ||
|[[KRAS]] | |[[KRAS]] | ||
| | |14 | ||
|GTPase KRas precursor (EC 3.6.5.2) (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Contains: GTPase KRas, N-terminally processed] [KRAS2] [RASK2] | |GTPase KRas precursor (EC 3.6.5.2) (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Contains: GTPase KRas, N-terminally processed] [KRAS2] [RASK2] | ||
|- | |- | ||
|[[OTC]] | |[[OTC]] | ||
| | |12 | ||
|Ornithine transcarbamylase, mitochondrial precursor (EC 2.1.3.3) (OTCase) (Ornithine carbamoyltransferase, mitochondrial) | |Ornithine transcarbamylase, mitochondrial precursor (EC 2.1.3.3) (OTCase) (Ornithine carbamoyltransferase, mitochondrial) | ||
|- | |- | ||
|[[ETV5]] | |[[ETV5]] | ||
Строка 6874: | Строка 7686: | ||
|- | |- | ||
|[[CCN1]] | |[[CCN1]] | ||
| | |9 | ||
|CCN family member 1 precursor (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61) (Protein GIG1) [CYR61] [GIG1] [IGFBP10] | |CCN family member 1 precursor (Cellular communication network factor 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein CYR61) (Protein GIG1) [CYR61] [GIG1] [IGFBP10] | ||
|- | |- | ||
|[[TAT]] | |[[TAT]] | ||
| | |7 | ||
|Tyrosine aminotransferase (EC 2.6.1.5) (TAT) (L-tyrosine:2-oxoglutarate aminotransferase) | |Tyrosine aminotransferase (EC 2.6.1.5) (TAT) (L-tyrosine:2-oxoglutarate aminotransferase) | ||
|- | |- | ||
Строка 6886: | Строка 7698: | ||
|- | |- | ||
|[[TCF7L2]] | |[[TCF7L2]] | ||
| | |6 | ||
|Transcription factor 7-like 2 (HMG box transcription factor 4) (T-cell-specific transcription factor 4) (T-cell factor 4) (TCF-4) (hTCF-4) [TCF4] | |Transcription factor 7-like 2 (HMG box transcription factor 4) (T-cell-specific transcription factor 4) (T-cell factor 4) (TCF-4) (hTCF-4) [TCF4] | ||
|- | |- | ||
|[[GDNF]] | |[[GDNF]] | ||
| | |24 | ||
|Glial cell line-derived neurotrophic factor precursor (hGDNF) (Astrocyte-derived trophic factor) (ATF) | |Glial cell line-derived neurotrophic factor precursor (hGDNF) (Astrocyte-derived trophic factor) (ATF) | ||
|- | |- | ||
|[[SLC2A9]] | |[[SLC2A9]] | ||
| | |2 | ||
|Solute carrier family 2, facilitated glucose transporter member 9 (Glucose transporter type 9) (GLUT-9) (Urate transporter) [GLUT9] | |Solute carrier family 2, facilitated glucose transporter member 9 (Glucose transporter type 9) (GLUT-9) (Urate transporter) [GLUT9] | ||
|- | |- | ||
|[[XPC]] | |[[XPC]] | ||
| | |7 | ||
|DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125) [XPCC] | |DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125) [XPCC] | ||
|- | |- | ||
Строка 6906: | Строка 7718: | ||
|- | |- | ||
|[[IFITM1]] | |[[IFITM1]] | ||
| | |2 | ||
|Interferon-induced transmembrane protein 1 (Dispanin subfamily A member 2a) (DSPA2a) (Interferon-induced protein 17) (Interferon-inducible protein 9-27) (Leu-13 antigen) (CD225 antigen) [CD225] [IFI17] | |Interferon-induced transmembrane protein 1 (Dispanin subfamily A member 2a) (DSPA2a) (Interferon-induced protein 17) (Interferon-inducible protein 9-27) (Leu-13 antigen) (CD225 antigen) [CD225] [IFI17] | ||
|- | |- | ||
Строка 6914: | Строка 7726: | ||
|- | |- | ||
|[[RIPK3]] | |[[RIPK3]] | ||
| | |7 | ||
|Receptor-interacting serine/threonine-protein kinase 3 (EC 2.7.11.1) (RIP-like protein kinase 3) (Receptor-interacting protein 3) (RIP-3) [RIP3] | |Receptor-interacting serine/threonine-protein kinase 3 (EC 2.7.11.1) (RIP-like protein kinase 3) (Receptor-interacting protein 3) (RIP-3) [RIP3] | ||
|- | |- | ||
|[[PDE4C]] | |[[PDE4C]] | ||
| | |8 | ||
|cAMP-specific 3',5'-cyclic phosphodiesterase 4C (EC 3.1.4.53) (DPDE1) (PDE21) [DPDE1] | |cAMP-specific 3',5'-cyclic phosphodiesterase 4C (EC 3.1.4.53) (DPDE1) (PDE21) [DPDE1] | ||
|- | |- | ||
Строка 6950: | Строка 7762: | ||
|- | |- | ||
|[[CD19]] | |[[CD19]] | ||
| | |19 | ||
|B-lymphocyte antigen CD19 precursor (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD19 antigen) | |B-lymphocyte antigen CD19 precursor (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD19 antigen) | ||
|- | |- | ||
Строка 6970: | Строка 7782: | ||
|- | |- | ||
|[[LAG3]] | |[[LAG3]] | ||
| | |3 | ||
|Lymphocyte activation gene 3 protein precursor (LAG-3) (CD223 antigen) [Contains: Secreted lymphocyte activation gene 3 protein (sLAG-3)] [FDC] | |Lymphocyte activation gene 3 protein precursor (LAG-3) (CD223 antigen) [Contains: Secreted lymphocyte activation gene 3 protein (sLAG-3)] [FDC] | ||
|- | |- | ||
|[[PGC]] | |[[PGC]] | ||
| | |156 | ||
|Gastricsin precursor (EC 3.4.23.3) (Pepsinogen C) | |Gastricsin precursor (EC 3.4.23.3) (Pepsinogen C) | ||
|- | |- | ||
Строка 6980: | Строка 7792: | ||
|14 | |14 | ||
|Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9) [CAGB] [CFAG] [MRP14] | |Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9) [CAGB] [CFAG] [MRP14] | ||
|- | |||
|[[CHRM2]] | |||
|1 | |||
|Muscarinic acetylcholine receptor M2 | |||
|- | |- | ||
|[[HAPLN1]] | |[[HAPLN1]] | ||
Строка 6993: | Строка 7809: | ||
|Secreted frizzled-related protein 2 precursor (FRP-2) (sFRP-2) (Secreted apoptosis-related protein 1) (SARP-1) [FRP2] [SARP1] [FKSG12] [UNQ361/PRO697] | |Secreted frizzled-related protein 2 precursor (FRP-2) (sFRP-2) (Secreted apoptosis-related protein 1) (SARP-1) [FRP2] [SARP1] [FKSG12] [UNQ361/PRO697] | ||
|- | |- | ||
|[[ | |[[EPHA3]] | ||
|1 | |1 | ||
|Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1) [C6orf98] [KIAA0796] [KIAA1262] [KIAA1756] [MYNE1] | |Ephrin type-A receptor 3 precursor (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1) [ETK] [ETK1] [HEK] [TYRO4] | ||
|- | |||
|[[RBFOX1]] | |||
|1 | |||
|RNA binding protein fox-1 homolog 1 (Ataxin-2-binding protein 1) (Fox-1 homolog A) (Hexaribonucleotide-binding protein 1) [A2BP] [A2BP1] [FOX1] [HRNBP1] | |||
|- | |||
|[[EIF4EBP1]] | |||
|1 | |||
|Eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) (eIF4E-binding protein 1) (Phosphorylated heat- and acid-stable protein regulated by insulin 1) (PHAS-I) | |||
|- | |||
|[[SYNE1]] | |||
|1 | |||
|Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1) [C6orf98] [KIAA0796] [KIAA1262] [KIAA1756] [MYNE1] | |||
|- | |- | ||
|[[BACH2]] | |[[BACH2]] | ||
| | |2 | ||
|Transcription regulator protein BACH2 (BTB and CNC homolog 2) | |Transcription regulator protein BACH2 (BTB and CNC homolog 2) | ||
|- | |- | ||
|[[SOX2]] | |[[SOX2]] | ||
| | |29 | ||
|Transcription factor SOX-2 | |Transcription factor SOX-2 | ||
|- | |- | ||
Строка 7010: | Строка 7838: | ||
|- | |- | ||
|[[MMP2]] | |[[MMP2]] | ||
| | |20 | ||
|72 kDa type IV collagenase precursor (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Contains: PEX] [CLG4A] | |72 kDa type IV collagenase precursor (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Contains: PEX] [CLG4A] | ||
|- | |- | ||
|[[TERT]] | |[[TERT]] | ||
| | |79 | ||
|Telomerase reverse transcriptase (EC 2.7.7.49) (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2) (TP2) [EST2] [TCS1] [TRT] | |Telomerase reverse transcriptase (EC 2.7.7.49) (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2) (TP2) [EST2] [TCS1] [TRT] | ||
|- | |- | ||
|[[KIT]] | |[[KIT]] | ||
| | |6 | ||
|Mast/stem cell growth factor receptor Kit precursor (EC 2.7.10.1) (SCFR) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD117 antigen) [SCFR] | |Mast/stem cell growth factor receptor Kit precursor (EC 2.7.10.1) (SCFR) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD117 antigen) [SCFR] | ||
|- | |- | ||
|[[CXCR1]] | |[[CXCR1]] | ||
| | |5 | ||
|C-X-C chemokine receptor type 1 (CXC-R1) (CXCR-1) (CDw128a) (High affinity interleukin-8 receptor A) (IL-8R A) (IL-8 receptor type 1) (CD181 antigen) [CMKAR1] [IL8RA] | |C-X-C chemokine receptor type 1 (CXC-R1) (CXCR-1) (CDw128a) (High affinity interleukin-8 receptor A) (IL-8R A) (IL-8 receptor type 1) (CD181 antigen) [CMKAR1] [IL8RA] | ||
|- | |- | ||
|[[CIT]] | |[[CIT]] | ||
| | |26 | ||
|Citron Rho-interacting kinase (EC 2.7.11.1) (CRIK) (Serine/threonine-protein kinase 21) [CRIK] [KIAA0949] [STK21] | |Citron Rho-interacting kinase (EC 2.7.11.1) (CRIK) (Serine/threonine-protein kinase 21) [CRIK] [KIAA0949] [STK21] | ||
|- | |- | ||
Строка 7050: | Строка 7878: | ||
|- | |- | ||
|[[SRI]] | |[[SRI]] | ||
| | |1 | ||
|Sorcin (22 kDa protein) (CP-22) (CP22) (V19) | |Sorcin (22 kDa protein) (CP-22) (CP22) (V19) | ||
|- | |- | ||
Строка 7066: | Строка 7894: | ||
|- | |- | ||
|[[CD69]] | |[[CD69]] | ||
| | |15 | ||
|Early activation antigen CD69 (Activation inducer molecule) (AIM) (BL-AC/P26) (C-type lectin domain family 2 member C) (EA1) (Early T-cell activation antigen p60) (GP32/28) (Leukocyte surface antigen Leu-23) (MLR-3) (CD69 antigen) [CLEC2C] | |Early activation antigen CD69 (Activation inducer molecule) (AIM) (BL-AC/P26) (C-type lectin domain family 2 member C) (EA1) (Early T-cell activation antigen p60) (GP32/28) (Leukocyte surface antigen Leu-23) (MLR-3) (CD69 antigen) [CLEC2C] | ||
|- | |- | ||
|[[RIG]] | |[[RIG]] | ||
| | |6 | ||
|protein RIG (Protein regulated in glioma) | |protein RIG (Protein regulated in glioma) | ||
|- | |- | ||
Строка 7086: | Строка 7914: | ||
|- | |- | ||
|[[CXCL5]] | |[[CXCL5]] | ||
| | |4 | ||
|C-X-C motif chemokine 5 precursor (ENA-78(1-78)) (Epithelial-derived neutrophil-activating protein 78) (Neutrophil-activating peptide ENA-78) (Small-inducible cytokine B5) [Contains: ENA-78(8-78); ENA-78(9-78)] [ENA78] [SCYB5] | |C-X-C motif chemokine 5 precursor (ENA-78(1-78)) (Epithelial-derived neutrophil-activating protein 78) (Neutrophil-activating peptide ENA-78) (Small-inducible cytokine B5) [Contains: ENA-78(8-78); ENA-78(9-78)] [ENA78] [SCYB5] | ||
|- | |||
|[[DLG1]] | |||
|1 | |||
|Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) (hDlg) | |||
|- | |- | ||
|[[MEIS1]] | |[[MEIS1]] | ||
|2 | |2 | ||
|Homeobox protein Meis1 | |Homeobox protein Meis1 | ||
|- | |||
|[[BAG5]] | |||
|1 | |||
|BAG family molecular chaperone regulator 5 (BAG-5) (Bcl-2-associated athanogene 5) [KIAA0873] | |||
|- | |- | ||
|[[CCNG2]] | |[[CCNG2]] | ||
Строка 7102: | Строка 7938: | ||
|- | |- | ||
|[[SIRT1]] | |[[SIRT1]] | ||
| | |456 | ||
|NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (hSIRT1) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Contains: SirtT1 75 kDa fragment (75SirT1)] [SIR2L1] | |NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (hSIRT1) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Contains: SirtT1 75 kDa fragment (75SirT1)] [SIR2L1] | ||
|- | |- | ||
Строка 7146: | Строка 7982: | ||
|- | |- | ||
|[[HLA-A]] | |[[HLA-A]] | ||
| | |2 | ||
|HLA class I histocompatibility antigen, A alpha chain precursor (Human leukocyte antigen A) (HLA-A) [HLAA] | |HLA class I histocompatibility antigen, A alpha chain precursor (Human leukocyte antigen A) (HLA-A) [HLAA] | ||
|- | |||
|[[SOX1]] | |||
|1 | |||
|Transcription factor SOX-1 | |||
|- | |- | ||
|[[CCND1]] | |[[CCND1]] | ||
| | |5 | ||
|G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene) [BCL1] [PRAD1] | |G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene) [BCL1] [PRAD1] | ||
|- | |- | ||
Строка 7164: | Строка 8004: | ||
|1 | |1 | ||
|Integrin alpha-2 precursor (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD49b antigen) [CD49B] | |Integrin alpha-2 precursor (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD49b antigen) [CD49B] | ||
|- | |||
|[[IL17RB]] | |||
|1 | |||
|Interleukin-17 receptor B precursor (IL-17 receptor B) (IL-17RB) (Cytokine receptor-like 4) (IL-17 receptor homolog 1) (IL-17Rh1) (IL17Rh1) (Interleukin-17B receptor) (IL-17B receptor) [CRL4] [EVI27] [IL17BR] [UNQ2501/PRO19612] | |||
|- | |- | ||
|[[CD59]] | |[[CD59]] | ||
Строка 7172: | Строка 8016: | ||
|1 | |1 | ||
|Tissue-type plasminogen activator precursor (EC 3.4.21.68) (t-PA) (t-plasminogen activator) (tPA) (Alteplase) (Reteplase) [Contains: Tissue-type plasminogen activator chain A; Tissue-type plasminogen activator chain B] | |Tissue-type plasminogen activator precursor (EC 3.4.21.68) (t-PA) (t-plasminogen activator) (tPA) (Alteplase) (Reteplase) [Contains: Tissue-type plasminogen activator chain A; Tissue-type plasminogen activator chain B] | ||
|- | |||
|[[CBX6]] | |||
|1 | |||
|Chromobox protein homolog 6 | |||
|- | |- | ||
|[[PCSK9]] | |[[PCSK9]] | ||
Строка 7178: | Строка 8026: | ||
|- | |- | ||
|[[PRMT5]] | |[[PRMT5]] | ||
| | |3 | ||
|Protein arginine N-methyltransferase 5 (EC 2.1.1.320) (PRMT5) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Contains: Protein arginine N-methyltransferase 5, N-terminally processed] [HRMT1L5] [IBP72] [JBP1] [SKB1] | |Protein arginine N-methyltransferase 5 (EC 2.1.1.320) (PRMT5) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Contains: Protein arginine N-methyltransferase 5, N-terminally processed] [HRMT1L5] [IBP72] [JBP1] [SKB1] | ||
|- | |- | ||
Строка 7216: | Строка 8064: | ||
|2 | |2 | ||
|Pancreatic prohormone precursor (Pancreatic polypeptide) (PP) (Obinepitide) [Contains: Pancreatic hormone (PH); Pancreatic icosapeptide (PI)] [PNP] | |Pancreatic prohormone precursor (Pancreatic polypeptide) (PP) (Obinepitide) [Contains: Pancreatic hormone (PH); Pancreatic icosapeptide (PI)] [PNP] | ||
|- | |- | ||
|[[LAMC1]] | |[[LAMC1]] | ||
Строка 7228: | Строка 8072: | ||
|1 | |1 | ||
|Probable G-protein coupled receptor 173 (Super conserved receptor expressed in brain 3) [SREB3] | |Probable G-protein coupled receptor 173 (Super conserved receptor expressed in brain 3) [SREB3] | ||
|- | |||
|[[GNAS]] | |||
|2 | |||
|Protein ALEX (Alternative gene product encoded by XL-exon) [GNAS1] | |||
|- | |- | ||
|[[SPRY1]] | |[[SPRY1]] | ||
Строка 7238: | Строка 8086: | ||
|- | |- | ||
|[[TES]] | |[[TES]] | ||
| | |2 | ||
|Testin (TESS) | |Testin (TESS) | ||
|- | |- | ||
|[[NBN]] | |[[NBN]] | ||
| | |3 | ||
|Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1) [NBS] [NBS1] [P95] | |Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1) [NBS] [NBS1] [P95] | ||
|- | |- | ||
|[[TSPO]] | |[[TSPO]] | ||
| | |21 | ||
|Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR) [BZRP] [MBR] | |Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR) [BZRP] [MBR] | ||
|- | |- | ||
Строка 7254: | Строка 8102: | ||
|- | |- | ||
|[[CS]] | |[[CS]] | ||
| | |142 | ||
|Citrate synthase, mitochondrial precursor (EC 2.3.3.1) (Citrate (Si)-synthase) | |Citrate synthase, mitochondrial precursor (EC 2.3.3.1) (Citrate (Si)-synthase) | ||
|- | |- | ||
Строка 7260: | Строка 8108: | ||
|1 | |1 | ||
|Neurogenic locus notch homolog protein 4 precursor (Notch 4) (hNotch4) [Contains: Notch 4 extracellular truncation; Notch 4 intracellular domain] [INT3] | |Neurogenic locus notch homolog protein 4 precursor (Notch 4) (hNotch4) [Contains: Notch 4 extracellular truncation; Notch 4 intracellular domain] [INT3] | ||
|- | |||
|[[KIR3DL2]] | |||
|1 | |||
|Killer cell immunoglobulin-like receptor 3DL2 precursor (CD158 antigen-like family member K) (MHC class I NK cell receptor) (Natural killer-associated transcript 4) (NKAT-4) (p70 natural killer cell receptor clone CL-5) (p70 NK receptor CL-5) (CD158k antigen) [CD158K] [NKAT4] | |||
|- | |- | ||
|[[CST3]] | |[[CST3]] | ||
Строка 7266: | Строка 8118: | ||
|- | |- | ||
|[[RUNX1]] | |[[RUNX1]] | ||
| | |7 | ||
|Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) [AML1] [CBFA2] | |Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) [AML1] [CBFA2] | ||
|- | |- | ||
|[[AURKA]] | |[[AURKA]] | ||
| | |4 | ||
|Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) [AIK] [AIRK1] [ARK1] [AURA] [AYK1] [BTAK] [IAK1] [STK15] [STK6] | |Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) [AIK] [AIRK1] [ARK1] [AURA] [AYK1] [BTAK] [IAK1] [STK15] [STK6] | ||
|- | |- | ||
|[[EGFR]] | |[[EGFR]] | ||
| | |37 | ||
|Epidermal growth factor receptor precursor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) [ERBB] [ERBB1] [HER1] | |Epidermal growth factor receptor precursor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) [ERBB] [ERBB1] [HER1] | ||
|- | |- | ||
Строка 7282: | Строка 8134: | ||
|- | |- | ||
|[[IL9]] | |[[IL9]] | ||
| | |2 | ||
|Interleukin-9 precursor (IL-9) (Cytokine P40) (T-cell growth factor P40) | |Interleukin-9 precursor (IL-9) (Cytokine P40) (T-cell growth factor P40) | ||
|- | |- | ||
|[[NRP1]] | |[[NRP1]] | ||
| | |2 | ||
|Neuropilin-1 precursor (Vascular endothelial cell growth factor 165 receptor) (CD304 antigen) [NRP] [VEGF165R] | |Neuropilin-1 precursor (Vascular endothelial cell growth factor 165 receptor) (CD304 antigen) [NRP] [VEGF165R] | ||
|- | |- | ||
Строка 7302: | Строка 8154: | ||
|- | |- | ||
|[[JUN]] | |[[JUN]] | ||
| | |13 | ||
|Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39) | |Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39) | ||
|- | |- | ||
Строка 7334: | Строка 8186: | ||
|- | |- | ||
|[[AMH]] | |[[AMH]] | ||
| | |101 | ||
|Muellerian-inhibiting factor precursor (Anti-Muellerian hormone) (AMH) (Muellerian-inhibiting substance) (MIS) [MIF] | |Muellerian-inhibiting factor precursor (Anti-Muellerian hormone) (AMH) (Muellerian-inhibiting substance) (MIS) [MIF] | ||
|- | |- | ||
Строка 7350: | Строка 8202: | ||
|- | |- | ||
|[[TRADD]] | |[[TRADD]] | ||
| | |3 | ||
|Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain) | |Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain) | ||
|- | |- | ||
|[[PROX1]] | |[[PROX1]] | ||
| | |2 | ||
|Prospero homeobox protein 1 (Homeobox prospero-like protein PROX1) (PROX-1) | |Prospero homeobox protein 1 (Homeobox prospero-like protein PROX1) (PROX-1) | ||
|- | |- | ||
|[[MCC]] | |[[MCC]] | ||
| | |23 | ||
|Colorectal mutant cancer protein (Protein MCC) | |Colorectal mutant cancer protein (Protein MCC) | ||
|- | |- | ||
Строка 7370: | Строка 8222: | ||
|- | |- | ||
|[[SMPD1]] | |[[SMPD1]] | ||
| | |2 | ||
|Sphingomyelin phosphodiesterase precursor (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase) [ASM] | |Sphingomyelin phosphodiesterase precursor (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase) [ASM] | ||
|- | |- | ||
Строка 7388: | Строка 8240: | ||
|1 | |1 | ||
|Necdin | |Necdin | ||
|- | |- | ||
|[[IRS2]] | |[[IRS2]] | ||
Строка 7402: | Строка 8250: | ||
|- | |- | ||
|[[TET1]] | |[[TET1]] | ||
| | |6 | ||
|Methylcytosine dioxygenase TET1 (EC 1.14.11.n2) (CXXC-type zinc finger protein 6) (Leukemia-associated protein with a CXXC domain) (Ten-eleven translocation 1 gene protein) [CXXC6] [KIAA1676] [LCX] | |Methylcytosine dioxygenase TET1 (EC 1.14.11.n2) (CXXC-type zinc finger protein 6) (Leukemia-associated protein with a CXXC domain) (Ten-eleven translocation 1 gene protein) [CXXC6] [KIAA1676] [LCX] | ||
|- | |- | ||
Строка 7418: | Строка 8266: | ||
|- | |- | ||
|[[SERPINE1]] | |[[SERPINE1]] | ||
| | |6 | ||
|Plasminogen activator inhibitor 1 precursor (PAI) (PAI-1) (Endothelial plasminogen activator inhibitor) (Serpin E1) [PAI1] [PLANH1] | |Plasminogen activator inhibitor 1 precursor (PAI) (PAI-1) (Endothelial plasminogen activator inhibitor) (Serpin E1) [PAI1] [PLANH1] | ||
|- | |- | ||
|[[PRG4]] | |[[PRG4]] | ||
| | |2 | ||
|Proteoglycan 4 precursor (Lubricin) (Megakaryocyte-stimulating factor) (Superficial zone proteoglycan) [Contains: Proteoglycan 4 C-terminal part] [MSF] [SZP] | |Proteoglycan 4 precursor (Lubricin) (Megakaryocyte-stimulating factor) (Superficial zone proteoglycan) [Contains: Proteoglycan 4 C-terminal part] [MSF] [SZP] | ||
|- | |- | ||
Строка 7438: | Строка 8286: | ||
|- | |- | ||
|[[LPO]] | |[[LPO]] | ||
| | |24 | ||
|Lactoperoxidase precursor (EC 1.11.1.7) (LPO) (Salivary peroxidase) (SPO) [SAPX] | |Lactoperoxidase precursor (EC 1.11.1.7) (LPO) (Salivary peroxidase) (SPO) [SAPX] | ||
|- | |- | ||
|[[CX3CL1]] | |[[CX3CL1]] | ||
| | |10 | ||
|Fractalkine precursor (C-X3-C motif chemokine 1) (CX3C membrane-anchored chemokine) (Neurotactin) (Small-inducible cytokine D1) [Contains: Processed fractalkine] [FKN] [NTT] [SCYD1] [A-152E5.2] | |Fractalkine precursor (C-X3-C motif chemokine 1) (CX3C membrane-anchored chemokine) (Neurotactin) (Small-inducible cytokine D1) [Contains: Processed fractalkine] [FKN] [NTT] [SCYD1] [A-152E5.2] | ||
|- | |- | ||
Строка 7458: | Строка 8306: | ||
|- | |- | ||
|[[TBK1]] | |[[TBK1]] | ||
| | |3 | ||
|Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1) [NAK] | |Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1) [NAK] | ||
|- | |- | ||
Строка 7466: | Строка 8314: | ||
|- | |- | ||
|[[TPP1]] | |[[TPP1]] | ||
| | |7 | ||
|Tripeptidyl-peptidase 1 precursor (EC 3.4.14.9) (TPP-1) (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) [CLN2] [GIG1] [UNQ267/PRO304] | |Tripeptidyl-peptidase 1 precursor (EC 3.4.14.9) (TPP-1) (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) [CLN2] [GIG1] [UNQ267/PRO304] | ||
|- | |- | ||
Строка 7474: | Строка 8322: | ||
|- | |- | ||
|[[AMT]] | |[[AMT]] | ||
| | |6 | ||
|Aminomethyltransferase, mitochondrial precursor (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT) [GCST] | |Aminomethyltransferase, mitochondrial precursor (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT) [GCST] | ||
|- | |- | ||
|[[TAZ]] | |[[TAZ]] | ||
| | |10 | ||
|Tafazzin (Protein G4.5) [EFE2] [G4.5] | |Tafazzin (Protein G4.5) [EFE2] [G4.5] | ||
|- | |- | ||
Строка 7484: | Строка 8332: | ||
|1 | |1 | ||
|Structural maintenance of chromosomes protein 1B (SMC protein 1B) (SMC-1-beta) (SMC-1B) [SMC1L2] | |Structural maintenance of chromosomes protein 1B (SMC protein 1B) (SMC-1-beta) (SMC-1B) [SMC1L2] | ||
|- | |||
|[[ZC3H11A]] | |||
|1 | |||
|Zinc finger CCCH domain-containing protein 11A [KIAA0663] [ZC3HDC11A] | |||
|- | |- | ||
|[[CDK1]] | |[[CDK1]] | ||
| | |13 | ||
|Cyclin-dependent kinase 1 (EC 2.7.11.22) (EC 2.7.11.23) (CDK1) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) [CDC2] [CDC28A] [CDKN1] [P34CDC2] | |Cyclin-dependent kinase 1 (EC 2.7.11.22) (EC 2.7.11.23) (CDK1) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) [CDC2] [CDC28A] [CDKN1] [P34CDC2] | ||
|- | |- | ||
|[[FN1]] | |[[FN1]] | ||
| | |3 | ||
|Fibronectin precursor (FN) (Cold-insoluble globulin) (CIG) [Contains: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3] [FN] | |Fibronectin precursor (FN) (Cold-insoluble globulin) (CIG) [Contains: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3] [FN] | ||
|- | |- | ||
|[[KLF4]] | |[[KLF4]] | ||
| | |19 | ||
|Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor) [EZF] [GKLF] | |Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor) [EZF] [GKLF] | ||
|- | |- | ||
Строка 7500: | Строка 8352: | ||
|1 | |1 | ||
|C-C chemokine receptor type 1 (C-C CKR-1) (CC-CKR-1) (CCR-1) (CCR1) (HM145) (LD78 receptor) (Macrophage inflammatory protein 1-alpha receptor) (MIP-1alpha-R) (RANTES-R) (CD191 antigen) [CMKBR1] [CMKR1] [SCYAR1] | |C-C chemokine receptor type 1 (C-C CKR-1) (CC-CKR-1) (CCR-1) (CCR1) (HM145) (LD78 receptor) (Macrophage inflammatory protein 1-alpha receptor) (MIP-1alpha-R) (RANTES-R) (CD191 antigen) [CMKBR1] [CMKR1] [SCYAR1] | ||
|- | |||
|[[NDUFA8]] | |||
|1 | |||
|NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (Complex I-19kD) (CI-19kD) (Complex I-PGIV) (CI-PGIV) (NADH-ubiquinone oxidoreductase 19 kDa subunit) | |||
|- | |- | ||
|[[IGSF1]] | |[[IGSF1]] | ||
| | |2 | ||
|Immunoglobulin superfamily member 1 precursor (IgSF1) (Immunoglobulin-like domain-containing protein 1) (Inhibin-binding protein) (InhBP) (Pituitary gland-specific factor 2) (p120) [IGDC1] [KIAA0364] [PGSF2] | |Immunoglobulin superfamily member 1 precursor (IgSF1) (Immunoglobulin-like domain-containing protein 1) (Inhibin-binding protein) (InhBP) (Pituitary gland-specific factor 2) (p120) [IGDC1] [KIAA0364] [PGSF2] | ||
|- | |- | ||
|[[KDM3A]] | |[[KDM3A]] | ||
| | |3 | ||
|Lysine-specific demethylase 3A (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A) [JHDM2A] [JMJD1] [JMJD1A] [KIAA0742] [TSGA] | |Lysine-specific demethylase 3A (EC 1.14.11.65) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A) ([histone H3]-dimethyl-L-lysine(9) demethylase 3A) [JHDM2A] [JMJD1] [JMJD1A] [KIAA0742] [TSGA] | ||
|- | |||
|[[PRRC2A]] | |||
|1 | |||
|Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2) [BAT2] [G2] | |||
|- | |- | ||
|[[HNF4A]] | |[[HNF4A]] | ||
| | |2 | ||
|Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) (Transcription factor 14) (TCF-14) (Transcription factor HNF-4) [HNF4] [NR2A1] [TCF14] | |Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) (Transcription factor 14) (TCF-14) (Transcription factor HNF-4) [HNF4] [NR2A1] [TCF14] | ||
|- | |- | ||
Строка 7538: | Строка 8398: | ||
|- | |- | ||
|[[PDE4B]] | |[[PDE4B]] | ||
| | |3 | ||
|cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32) [DPDE4] | |cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32) [DPDE4] | ||
|- | |- | ||
Строка 7546: | Строка 8406: | ||
|- | |- | ||
|[[TYROBP]] | |[[TYROBP]] | ||
| | |4 | ||
|TYRO protein tyrosine kinase-binding protein precursor (DNAX-activation protein 12) (Killer-activating receptor-associated protein) (KAR-associated protein) [DAP12] [KARAP] | |TYRO protein tyrosine kinase-binding protein precursor (DNAX-activation protein 12) (Killer-activating receptor-associated protein) (KAR-associated protein) [DAP12] [KARAP] | ||
|- | |- | ||
Строка 7562: | Строка 8422: | ||
|- | |- | ||
|[[INS]] | |[[INS]] | ||
| | |15 | ||
|Insulin precursor [Contains: Insulin B chain; Insulin A chain] | |Insulin precursor [Contains: Insulin B chain; Insulin A chain] | ||
|- | |||
|[[BLVRA]] | |||
|1 | |||
|Biliverdin reductase A precursor (EC 1.3.1.24) (BVR A) (Biliverdin-IX alpha-reductase) [BLVR] [BVR] | |||
|- | |- | ||
|[[SOX10]] | |[[SOX10]] | ||
Строка 7572: | Строка 8436: | ||
|1 | |1 | ||
|finger protein 704 | |finger protein 704 | ||
|- | |||
|[[NUSAP1]] | |||
|1 | |||
|Nucleolar and spindle-associated protein 1 (NuSAP) [ANKT] [BM-037] [PRO0310] | |||
|- | |- | ||
|[[RPL37]] | |[[RPL37]] | ||
Строка 7578: | Строка 8446: | ||
|- | |- | ||
|[[SAG]] | |[[SAG]] | ||
| | |14 | ||
|S-arrestin (48 kDa protein) (Retinal S-antigen) (S-AG) (Rod photoreceptor arrestin) | |S-arrestin (48 kDa protein) (Retinal S-antigen) (S-AG) (Rod photoreceptor arrestin) | ||
|- | |- | ||
Строка 7586: | Строка 8454: | ||
|- | |- | ||
|[[PF4]] | |[[PF4]] | ||
| | |4 | ||
|Platelet factor 4 precursor (PF-4) (C-X-C motif chemokine 4) (Iroplact) (Oncostatin-A) [Contains: Platelet factor 4, short form (Endothelial cell growth inhibitor)] [CXCL4] [SCYB4] | |Platelet factor 4 precursor (PF-4) (C-X-C motif chemokine 4) (Iroplact) (Oncostatin-A) [Contains: Platelet factor 4, short form (Endothelial cell growth inhibitor)] [CXCL4] [SCYB4] | ||
|- | |- | ||
Строка 7610: | Строка 8478: | ||
|- | |- | ||
|[[MSH6]] | |[[MSH6]] | ||
| | |2 | ||
|DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160) [GTBP] | |DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160) [GTBP] | ||
|- | |- | ||
Строка 7622: | Строка 8490: | ||
|- | |- | ||
|[[SET]] | |[[SET]] | ||
| | |7 | ||
|Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) | |Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I) | ||
|- | |- | ||
Строка 7630: | Строка 8498: | ||
|- | |- | ||
|[[GATA3]] | |[[GATA3]] | ||
| | |4 | ||
|Trans-acting T-cell-specific transcription factor GATA-3 (GATA-binding factor 3) | |Trans-acting T-cell-specific transcription factor GATA-3 (GATA-binding factor 3) | ||
|- | |- | ||
Строка 7636: | Строка 8504: | ||
|1 | |1 | ||
|EKC/KEOPS complex subunit LAGE3 (L antigen family member 3) (Protein ESO-3) (Protein ITBA2) [DXS9879E] [ESO3] [ITBA2] | |EKC/KEOPS complex subunit LAGE3 (L antigen family member 3) (Protein ESO-3) (Protein ITBA2) [DXS9879E] [ESO3] [ITBA2] | ||
|- | |||
|[[ANXA2]] | |||
|1 | |||
|Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36) [ANX2] [ANX2L4] [CAL1H] [LPC2D] | |||
|- | |- | ||
|[[HLA-DPB1]] | |[[HLA-DPB1]] | ||
Строка 7642: | Строка 8514: | ||
|- | |- | ||
|[[CD40]] | |[[CD40]] | ||
| | |25 | ||
|Tumor necrosis factor receptor superfamily member 5 precursor (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD40 antigen) [TNFRSF5] | |Tumor necrosis factor receptor superfamily member 5 precursor (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD40 antigen) [TNFRSF5] | ||
|- | |- | ||
|[[MFN1]] | |[[MFN1]] | ||
| | |4 | ||
|Mitofusin-1 (EC 3.6.5.-) (Fzo homolog) (Transmembrane GTPase MFN1) | |Mitofusin-1 (EC 3.6.5.-) (Fzo homolog) (Transmembrane GTPase MFN1) | ||
|- | |- | ||
Строка 7654: | Строка 8526: | ||
|- | |- | ||
|[[BCL2L1]] | |[[BCL2L1]] | ||
| | |2 | ||
|Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X) [BCL2L] [BCLX] | |Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X) [BCL2L] [BCLX] | ||
|- | |- | ||
Строка 7670: | Строка 8542: | ||
|- | |- | ||
|[[JAK1]] | |[[JAK1]] | ||
| | |6 | ||
|Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1) [JAK1A] [JAK1B] | |Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1) [JAK1A] [JAK1B] | ||
|- | |- | ||
Строка 7682: | Строка 8554: | ||
|- | |- | ||
|[[OPTN]] | |[[OPTN]] | ||
| | |2 | ||
|Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP) [FIP2] [GLC1E] [HIP7] [HYPL] [NRP] | |Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP) [FIP2] [GLC1E] [HIP7] [HYPL] [NRP] | ||
|- | |- | ||
|[[CA4]] | |[[CA4]] | ||
| | |17 | ||
|Carbonic anhydrase 4 precursor (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV) | |Carbonic anhydrase 4 precursor (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV) | ||
|- | |||
|[[SGPP2]] | |||
|1 | |||
|Sphingosine-1-phosphate phosphatase 2 (EC 3.1.3.-) (SPPase2) (Spp2) (hSPP2) (Sphingosine-1-phosphatase 2) | |||
|- | |- | ||
|[[BECN1]] | |[[BECN1]] | ||
|3 | |3 | ||
|Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) (Protein GT197) [Contains: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa] [GT197] | |Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) (Protein GT197) [Contains: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa] [GT197] | ||
|- | |||
|[[ARL4C]] | |||
|1 | |||
|ADP-ribosylation factor-like protein 4C (ADP-ribosylation factor-like protein 7) (ADP-ribosylation factor-like protein LAK) [ARL7] | |||
|- | |- | ||
|[[RAD21]] | |[[RAD21]] | ||
Строка 7710: | Строка 8590: | ||
|- | |- | ||
|[[MMP7]] | |[[MMP7]] | ||
| | |4 | ||
|Matrilysin precursor (EC 3.4.24.23) (Matrin) (Matrix metalloproteinase-7) (MMP-7) (Pump-1 protease) (Uterine metalloproteinase) [MPSL1] [PUMP1] | |Matrilysin precursor (EC 3.4.24.23) (Matrin) (Matrix metalloproteinase-7) (MMP-7) (Pump-1 protease) (Uterine metalloproteinase) [MPSL1] [PUMP1] | ||
|- | |- | ||
Строка 7718: | Строка 8598: | ||
|- | |- | ||
|[[TIMP1]] | |[[TIMP1]] | ||
| | |8 | ||
|Metalloproteinase inhibitor 1 precursor (Erythroid-potentiating activity) (EPA) (Fibroblast collagenase inhibitor) (Collagenase inhibitor) (Tissue inhibitor of metalloproteinases 1) (TIMP-1) [CLGI] [TIMP] | |Metalloproteinase inhibitor 1 precursor (Erythroid-potentiating activity) (EPA) (Fibroblast collagenase inhibitor) (Collagenase inhibitor) (Tissue inhibitor of metalloproteinases 1) (TIMP-1) [CLGI] [TIMP] | ||
|- | |- | ||
|[[MRE11]] | |[[MRE11]] | ||
| | |9 | ||
|Double-strand break repair protein MRE11 (EC 3.1.-.-) (Double-strand break repair protein MRE11A) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A) [HNGS1] [MRE11A] | |Double-strand break repair protein MRE11 (EC 3.1.-.-) (Double-strand break repair protein MRE11A) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A) [HNGS1] [MRE11A] | ||
|- | |- | ||
Строка 7729: | Строка 8609: | ||
|Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Aspartate 1-decarboxylase) (EC 4.1.1.11) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase) [CSD] | |Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Aspartate 1-decarboxylase) (EC 4.1.1.11) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase) [CSD] | ||
|- | |- | ||
|[[ | |[[ERCC6]] | ||
|2 | |2 | ||
| | |Chimeric ERCC6-PGBD3 protein (Chimeric CSB-PGBD3 protein) | ||
|- | |- | ||
|[[ | |[[PIK3C2B]] | ||
|1 | |1 | ||
| | |Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (EC 2.7.1.137) (EC 2.7.1.154) (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) | ||
|- | |- | ||
|[[APOA5]] | |[[APOA5]] | ||
Строка 7742: | Строка 8622: | ||
|- | |- | ||
|[[DUSP2]] | |[[DUSP2]] | ||
|2 | |||
|Dual specificity protein phosphatase 2 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PAC-1) [PAC1] | |||
|- | |||
|[[KCNJ4]] | |||
|1 | |1 | ||
| | |Inward rectifier potassium channel 4 (HIRK2) (HRK1) (Hippocampal inward rectifier) (HIR) (Inward rectifier K( ) channel Kir2.3) (IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4) [IRK3] | ||
|- | |- | ||
|[[F5]] | |[[F5]] | ||
| | |10 | ||
|Coagulation factor V precursor (Activated protein C cofactor) (Proaccelerin, labile factor) [Contains: Coagulation factor V heavy chain; Coagulation factor V light chain] | |Coagulation factor V precursor (Activated protein C cofactor) (Proaccelerin, labile factor) [Contains: Coagulation factor V heavy chain; Coagulation factor V light chain] | ||
|- | |- | ||
Строка 7754: | Строка 8638: | ||
|- | |- | ||
|[[TXNIP]] | |[[TXNIP]] | ||
| | |11 | ||
|Thioredoxin-interacting protein (Thioredoxin-binding protein 2) (Vitamin D3 up-regulated protein 1) [VDUP1] | |Thioredoxin-interacting protein (Thioredoxin-binding protein 2) (Vitamin D3 up-regulated protein 1) [VDUP1] | ||
|- | |||
|[[ZNF211]] | |||
|1 | |||
|Zinc finger protein 211 (Zinc finger protein C2H2-25) | |||
|- | |||
|[[PCGF2]] | |||
|1 | |||
|Polycomb group RING finger protein 2 (DNA-binding protein Mel-18) (RING finger protein 110) (Zinc finger protein 144) [MEL18] [RNF110] [ZNF144] | |||
|- | |- | ||
|[[PTH1R]] | |[[PTH1R]] | ||
Строка 7766: | Строка 8658: | ||
|- | |- | ||
|[[AFM]] | |[[AFM]] | ||
| | |28 | ||
|Afamin precursor (Alpha-albumin) (Alpha-Alb) [ALB2] [ALBA] | |Afamin precursor (Alpha-albumin) (Alpha-Alb) [ALB2] [ALBA] | ||
|- | |- | ||
Строка 7778: | Строка 8670: | ||
|- | |- | ||
|[[ACR]] | |[[ACR]] | ||
| | |14 | ||
|Acrosin precursor (EC 3.4.21.10) [Contains: Acrosin light chain; Acrosin heavy chain] [ACRS] | |Acrosin precursor (EC 3.4.21.10) [Contains: Acrosin light chain; Acrosin heavy chain] [ACRS] | ||
|- | |- | ||
Строка 7786: | Строка 8678: | ||
|- | |- | ||
|[[ACTN3]] | |[[ACTN3]] | ||
| | |8 | ||
|(Alpha-actinin skeletal muscle isoform 3) (F-actin cross-linking protein) | |(Alpha-actinin skeletal muscle isoform 3) (F-actin cross-linking protein) | ||
|- | |||
|[[CDK9]] | |||
|1 | |||
|Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) [CDC2L4] [TAK] | |||
|- | |- | ||
|[[HSPA1L]] | |[[HSPA1L]] | ||
Строка 7794: | Строка 8690: | ||
|- | |- | ||
|[[SMARCA4]] | |[[SMARCA4]] | ||
| | |2 | ||
|Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4) [BAF190A] [BRG1] [SNF2B] [SNF2L4] | |Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4) [BAF190A] [BRG1] [SNF2B] [SNF2L4] | ||
|- | |- | ||
Строка 7800: | Строка 8696: | ||
|1 | |1 | ||
|Ribosomal protein S6 kinase beta-1 (EC 2.7.11.1) (S6K-beta-1) (S6K1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) [STK14A] | |Ribosomal protein S6 kinase beta-1 (EC 2.7.11.1) (S6K-beta-1) (S6K1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) [STK14A] | ||
|- | |||
|[[ITGA8]] | |||
|1 | |||
|Integrin alpha-8 precursor [Contains: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain] | |||
|- | |||
|[[MANBA]] | |||
|1 | |||
|Beta-mannosidase precursor (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase) [MANB1] | |||
|- | |- | ||
|[[ABCC6]] | |[[ABCC6]] | ||
| | |3 | ||
|Multidrug resistance-associated protein 6 (ATP-binding cassette sub-family C member 6) (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E) (MOAT-E) [ARA] [MRP6] | |Multidrug resistance-associated protein 6 (ATP-binding cassette sub-family C member 6) (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E) (MOAT-E) [ARA] [MRP6] | ||
|- | |- | ||
Строка 7816: | Строка 8720: | ||
|4 | |4 | ||
|GTP-binding protein Rheb precursor (Ras homolog enriched in brain) [RHEB2] | |GTP-binding protein Rheb precursor (Ras homolog enriched in brain) [RHEB2] | ||
|- | |||
|[[ALCAM]] | |||
|1 | |||
|CD166 antigen precursor (Activated leukocyte cell adhesion molecule) [MEMD] | |||
|- | |- | ||
|[[DROSHA]] | |[[DROSHA]] | ||
|2 | |2 | ||
|Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241) [RN3] [RNASE3L] [RNASEN] | |Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241) [RN3] [RNASE3L] [RNASEN] | ||
|- | |||
|[[MOB1B]] | |||
|1 | |||
|MOB kinase activator 1B (Mob1 homolog 1A) (Mob1A) (Mob1B) (Mps one binder kinase activator-like 1A) [MOB4A] [MOBKL1A] | |||
|- | |- | ||
|[[FCGR2A]] | |[[FCGR2A]] | ||
Строка 7830: | Строка 8742: | ||
|- | |- | ||
|[[GK]] | |[[GK]] | ||
| | |9 | ||
|Glycerol kinase (EC 2.7.1.30) (GK) (Glycerokinase) (ATP:glycerol 3-phosphotransferase) | |Glycerol kinase (EC 2.7.1.30) (GK) (Glycerokinase) (ATP:glycerol 3-phosphotransferase) | ||
|- | |- | ||
Строка 7837: | Строка 8749: | ||
|Alpha-1-antitrypsin precursor (Alpha-1 protease inhibitor) (Alpha-1-antiproteinase) (Serpin A1) [Contains: Short peptide from AAT (SPAAT)] [AAT] [PI] [PRO0684] [PRO2209] | |Alpha-1-antitrypsin precursor (Alpha-1 protease inhibitor) (Alpha-1-antiproteinase) (Serpin A1) [Contains: Short peptide from AAT (SPAAT)] [AAT] [PI] [PRO0684] [PRO2209] | ||
|- | |- | ||
|[[ | |[[GBA2]] | ||
|1 | |||
|Non-lysosomal glucosylceramidase (EC 3.2.1.45) (NLGase) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2) [KIAA1605] [SPG46] [AD035] | |||
|- | |||
|[[CD8A]] | |||
|1 | |1 | ||
| | |T-cell surface glycoprotein CD8 alpha chain precursor (T-lymphocyte differentiation antigen T8/Leu-2) (CD8a antigen) [MAL] | ||
|- | |- | ||
|[[IL2RA]] | |[[IL2RA]] | ||
Строка 7850: | Строка 8766: | ||
|- | |- | ||
|[[U2AF1]] | |[[U2AF1]] | ||
| | |3 | ||
|Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 small nuclear RNA auxiliary factor 1) (U2 snRNP auxiliary factor small subunit) [U2AF35] [U2AFBP] [FP793] | |Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 small nuclear RNA auxiliary factor 1) (U2 snRNP auxiliary factor small subunit) [U2AF35] [U2AFBP] [FP793] | ||
|- | |- | ||
Строка 7858: | Строка 8774: | ||
|- | |- | ||
|[[TMPRSS2]] | |[[TMPRSS2]] | ||
| | |5 | ||
|Transmembrane protease serine 2 precursor (EC 3.4.21.-) (Serine protease 10) [Contains: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain] [PRSS10] | |Transmembrane protease serine 2 precursor (EC 3.4.21.-) (Serine protease 10) [Contains: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain] [PRSS10] | ||
|- | |- | ||
Строка 7864: | Строка 8780: | ||
|2 | |2 | ||
|Proenkephalin-A precursor [Contains: Synenkephalin; Met-enkephalin (Opioid growth factor) (OGF); PENK(114-133); PENK(143-183); Met-enkephalin-Arg-Gly-Leu; Leu-enkephalin; PENK(237-258); Met-enkephalin-Arg-Phe] | |Proenkephalin-A precursor [Contains: Synenkephalin; Met-enkephalin (Opioid growth factor) (OGF); PENK(114-133); PENK(143-183); Met-enkephalin-Arg-Gly-Leu; Leu-enkephalin; PENK(237-258); Met-enkephalin-Arg-Phe] | ||
|- | |- | ||
|[[SAA2]] | |[[SAA2]] | ||
Строка 7890: | Строка 8802: | ||
|- | |- | ||
|[[COL2A1]] | |[[COL2A1]] | ||
|3 | |||
|Collagen alpha-1(II) chain precursor (Alpha-1 type II collagen) [Contains: Collagen alpha-1(II) chain; Chondrocalcin] | |||
|- | |||
|[[MBNL1]] | |||
|2 | |2 | ||
| | |Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) [EXP] [KIAA0428] [MBNL] | ||
|- | |- | ||
|[[FGFBP1]] | |[[FGFBP1]] | ||
|1 | |1 | ||
|Fibroblast growth factor-binding protein 1 precursor (FGF-BP) (FGF-BP1) (FGF-binding protein 1) (FGFBP-1) (17 kDa heparin-binding growth factor-binding protein) (17 kDa HBGF-binding protein) (HBp17) [FGFBP] [HBP17] | |Fibroblast growth factor-binding protein 1 precursor (FGF-BP) (FGF-BP1) (FGF-binding protein 1) (FGFBP-1) (17 kDa heparin-binding growth factor-binding protein) (17 kDa HBGF-binding protein) (HBp17) [FGFBP] [HBP17] | ||
|- | |||
|[[SREBF2]] | |||
|2 | |||
|Sterol regulatory element-binding protein 2 (SREBP-2) (Class D basic helix-loop-helix protein 2) (bHLHd2) (Sterol regulatory element-binding transcription factor 2) [Contains: Processed sterol regulatory element-binding protein 2 (Transcription factor SREBF2)] [BHLHD2] [SREBP2] | |||
|- | |- | ||
|[[STC1]] | |[[STC1]] | ||
Строка 7902: | Строка 8822: | ||
|- | |- | ||
|[[SF3B1]] | |[[SF3B1]] | ||
| | |3 | ||
|Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155) [SAP155] | |Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155) [SAP155] | ||
|- | |- | ||
Строка 7910: | Строка 8830: | ||
|- | |- | ||
|[[ZMPSTE24]] | |[[ZMPSTE24]] | ||
| | |15 | ||
|CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog) [FACE1] [STE24] | |CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog) [FACE1] [STE24] | ||
|- | |- | ||
Строка 7918: | Строка 8838: | ||
|- | |- | ||
|[[NDUFS3]] | |[[NDUFS3]] | ||
|4 | |||
|NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial precursor (EC 7.1.1.2) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit) | |||
|- | |||
|[[OGDH]] | |||
|1 | |1 | ||
| | |2-oxoglutarate dehydrogenase, mitochondrial precursor (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) | ||
|- | |- | ||
|[[SOST]] | |[[SOST]] | ||
| | |6 | ||
|Sclerostin precursor [UNQ2976/PRO7455/PRO7476] | |Sclerostin precursor [UNQ2976/PRO7455/PRO7476] | ||
|- | |- | ||
Строка 7934: | Строка 8858: | ||
|- | |- | ||
|[[LPP]] | |[[LPP]] | ||
| | |12 | ||
|Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma) | |Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma) | ||
|- | |- | ||
Строка 7942: | Строка 8866: | ||
|- | |- | ||
|[[KISS1]] | |[[KISS1]] | ||
| | |5 | ||
|Metastasis-suppressor KiSS-1 precursor (Kisspeptin-1) [Contains: Metastin (Kisspeptin-54); Kisspeptin-14; Kisspeptin-13; Kisspeptin-10] [PP5098] | |Metastasis-suppressor KiSS-1 precursor (Kisspeptin-1) [Contains: Metastin (Kisspeptin-54); Kisspeptin-14; Kisspeptin-13; Kisspeptin-10] [PP5098] | ||
|- | |- | ||
Строка 7954: | Строка 8878: | ||
|- | |- | ||
|[[SERPINB2]] | |[[SERPINB2]] | ||
| | |2 | ||
|Plasminogen activator inhibitor 2 precursor (PAI-2) (Monocyte Arg-serpin) (Placental plasminogen activator inhibitor) (Serpin B2) (Urokinase inhibitor) [PAI2] [PLANH2] | |Plasminogen activator inhibitor 2 precursor (PAI-2) (Monocyte Arg-serpin) (Placental plasminogen activator inhibitor) (Serpin B2) (Urokinase inhibitor) [PAI2] [PLANH2] | ||
|- | |- | ||
Строка 7978: | Строка 8902: | ||
|- | |- | ||
|[[CD160]] | |[[CD160]] | ||
| | |3 | ||
|CD160 antigen precursor (Natural killer cell receptor BY55) (CD160 antigen) [Contains: CD160 antigen, soluble form] [BY55] | |CD160 antigen precursor (Natural killer cell receptor BY55) (CD160 antigen) [Contains: CD160 antigen, soluble form] [BY55] | ||
|- | |- | ||
Строка 7984: | Строка 8908: | ||
|1 | |1 | ||
|Vascular endothelial growth factor C precursor (VEGF-C) (Flt4 ligand) (Flt4-L) (Vascular endothelial growth factor-related protein) (VRP) | |Vascular endothelial growth factor C precursor (VEGF-C) (Flt4 ligand) (Flt4-L) (Vascular endothelial growth factor-related protein) (VRP) | ||
|- | |||
|[[CAMK2A]] | |||
|1 | |||
|Calcium/calmodulin-dependent protein kinase type II subunit alpha (EC 2.7.11.17) (CaM kinase II subunit alpha) (CaMK-II subunit alpha) [CAMKA] [KIAA0968] | |||
|- | |- | ||
|[[KCNE4]] | |[[KCNE4]] | ||
Строка 7990: | Строка 8918: | ||
|- | |- | ||
|[[LBR]] | |[[LBR]] | ||
| | |8 | ||
|Delta(14)-sterol reductase LBR (EC 1.3.1.70) (Delta-14-SR) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase) | |Delta(14)-sterol reductase LBR (EC 1.3.1.70) (Delta-14-SR) (3-beta-hydroxysterol Delta (14)-reductase) (C-14 sterol reductase) (C14SR) (Integral nuclear envelope inner membrane protein) (LMN2R) (Lamin-B receptor) (Sterol C14-reductase) | ||
|- | |- | ||
Строка 7996: | Строка 8924: | ||
|2 | |2 | ||
|Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20) [KIAA0016] | |Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20) [KIAA0016] | ||
|- | |||
|[[PRKACA]] | |||
|1 | |||
|cAMP-dependent protein kinase catalytic subunit alpha (EC 2.7.11.11) (PKA C-alpha) [PKACA] | |||
|- | |- | ||
|[[APOC2]] | |[[APOC2]] | ||
|1 | |1 | ||
|Apolipoprotein C-II precursor (Apo-CII) (ApoC-II) (Apolipoprotein C2) [Contains: Proapolipoprotein C-II (ProapoC-II)] [APC2] | |Apolipoprotein C-II precursor (Apo-CII) (ApoC-II) (Apolipoprotein C2) [Contains: Proapolipoprotein C-II (ProapoC-II)] [APC2] | ||
|- | |||
|[[CLPTM1]] | |||
|1 | |||
|Cleft lip and palate transmembrane protein 1 | |||
|- | |||
|[[NCSTN]] | |||
|1 | |||
|Nicastrin precursor [KIAA0253] [UNQ1874/PRO4317] | |||
|- | |- | ||
|[[S1PR1]] | |[[S1PR1]] | ||
Строка 8006: | Строка 8946: | ||
|- | |- | ||
|[[PRC1]] | |[[PRC1]] | ||
| | |6 | ||
|Protein regulator of cytokinesis 1 | |Protein regulator of cytokinesis 1 | ||
|- | |- | ||
Строка 8016: | Строка 8956: | ||
|1 | |1 | ||
|Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-conjugating enzyme E2(17)KB 2) (Ubiquitin-conjugating enzyme E2-17 kDa 2) (Ubiquitin-protein ligase D2) (p53-regulated ubiquitin-conjugating enzyme 1) [PUBC1] [UBC4] [UBC5B] [UBCH4] [UBCH5B] | |Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-conjugating enzyme E2(17)KB 2) (Ubiquitin-conjugating enzyme E2-17 kDa 2) (Ubiquitin-protein ligase D2) (p53-regulated ubiquitin-conjugating enzyme 1) [PUBC1] [UBC4] [UBC5B] [UBCH4] [UBCH5B] | ||
|- | |||
|[[P2RX3]] | |||
|1 | |||
|P2X purinoceptor 3 (P2X3) (ATP receptor) (Purinergic receptor) | |||
|- | |||
|[[PLEKHA6]] | |||
|1 | |||
|Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3) [KIAA0969] [PEPP3] | |||
|- | |||
|[[SMG1]] | |||
|1 | |||
|Serine/threonine-protein kinase SMG1 (EC 2.7.11.1) (SMG-1) (hSMG-1) (61E3.4) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) [ATX] [KIAA0421] [LIP] | |||
|- | |- | ||
|[[ENC1]] | |[[ENC1]] | ||
Строка 8030: | Строка 8982: | ||
|- | |- | ||
|[[TPX2]] | |[[TPX2]] | ||
|2 | |||
|Targeting protein for Xklp2 (Differentially expressed in cancerous and non-cancerous lung cells 2) (DIL-2) (Hepatocellular carcinoma-associated antigen 519) (Hepatocellular carcinoma-associated antigen 90) (Protein fls353) (Restricted expression proliferation-associated protein 100) (p100) [C20orf1] [C20orf2] [DIL2] [HCA519] | |||
|- | |||
|[[DNA2]] | |||
|2 | |||
|DNA replication ATP-dependent helicase/nuclease DNA2 (hDNA2) (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] [DNA2L] [KIAA0083] | |||
|- | |||
|[[PDE4A]] | |||
|1 | |||
|cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) (DPDE2) (PDE46) [DPDE2] | |||
|- | |||
|[[LIPG]] | |||
|1 | |||
|Endothelial lipase precursor (EC 3.1.1.3) (Endothelial cell-derived lipase) (EDL) (EL) (Phospholipase A1) (EC 3.1.1.32) [UNQ387/PRO719] | |||
|- | |||
|[[BAAT]] | |||
|1 | |1 | ||
| | |Bile acid-CoA:amino acid N-acyltransferase (EC 2.3.1.65) (BACAT) (BAT) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2) | ||
|- | |||
|[[ADAMTS4]] | |||
|2 | |||
|A disintegrin and metalloproteinase with thrombospondin motifs 4 precursor (EC 3.4.24.82) (ADAM-TS 4) (ADAM-TS4) (ADAMTS-4) (ADMP-1) (Aggrecanase-1) [KIAA0688] [UNQ769/PRO1563] | |||
|- | |- | ||
|[[MTMR14]] | |[[MTMR14]] | ||
Строка 8050: | Строка 9022: | ||
|- | |- | ||
|[[BMP7]] | |[[BMP7]] | ||
| | |4 | ||
|Bone morphogenetic protein 7 precursor (BMP-7) (Osteogenic protein 1) (OP-1) (Eptotermin alfa) [OP1] | |Bone morphogenetic protein 7 precursor (BMP-7) (Osteogenic protein 1) (OP-1) (Eptotermin alfa) [OP1] | ||
|- | |- | ||
|[[ABR]] | |[[ABR]] | ||
| | |46 | ||
|Active breakpoint cluster region-related protein | |Active breakpoint cluster region-related protein | ||
|- | |- | ||
|[[CXCL1]] | |[[CXCL1]] | ||
| | |26 | ||
|Growth-regulated alpha protein precursor (C-X-C motif chemokine 1) (GRO-alpha(1-73)) (Melanoma growth stimulatory activity) (MGSA) (Neutrophil-activating protein 3) (NAP-3) [Contains: GRO-alpha(4-73); GRO-alpha(5-73); GRO-alpha(6-73)] [GRO] [GRO1] [GROA] [MGSA] [SCYB1] | |Growth-regulated alpha protein precursor (C-X-C motif chemokine 1) (GRO-alpha(1-73)) (Melanoma growth stimulatory activity) (MGSA) (Neutrophil-activating protein 3) (NAP-3) [Contains: GRO-alpha(4-73); GRO-alpha(5-73); GRO-alpha(6-73)] [GRO] [GRO1] [GROA] [MGSA] [SCYB1] | ||
|- | |- | ||
|[[EMD]] | |[[EMD]] | ||
| | |3 | ||
|Emerin [EDMD] [STA] | |Emerin [EDMD] [STA] | ||
|- | |- | ||
|[[F3]] | |[[F3]] | ||
| | |25 | ||
|Tissue factor precursor (TF) (Coagulation factor III) (Thromboplastin) (CD142 antigen) | |Tissue factor precursor (TF) (Coagulation factor III) (Thromboplastin) (CD142 antigen) | ||
|- | |- | ||
|[[CTSL]] | |[[CTSL]] | ||
| | |3 | ||
|Procathepsin L precursor (EC 3.4.22.15) (Cathepsin L1) (Major excreted protein) (MEP) [Contains: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain] [CTSL1] | |Procathepsin L precursor (EC 3.4.22.15) (Cathepsin L1) (Major excreted protein) (MEP) [Contains: Cathepsin L; Cathepsin L heavy chain; Cathepsin L light chain] [CTSL1] | ||
|- | |- | ||
Строка 8078: | Строка 9050: | ||
|- | |- | ||
|[[NR4A2]] | |[[NR4A2]] | ||
| | |3 | ||
|Nuclear receptor subfamily 4 group A member 2 (Immediate-early response protein NOT) (Orphan nuclear receptor NURR1) (Transcriptionally-inducible nuclear receptor) [NOT] [NURR1] [TINUR] | |Nuclear receptor subfamily 4 group A member 2 (Immediate-early response protein NOT) (Orphan nuclear receptor NURR1) (Transcriptionally-inducible nuclear receptor) [NOT] [NURR1] [TINUR] | ||
|- | |- | ||
Строка 8098: | Строка 9070: | ||
|- | |- | ||
|[[PLA2R1]] | |[[PLA2R1]] | ||
| | |4 | ||
|Secretory phospholipase A2 receptor precursor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) [Contains: Soluble secretory phospholipase A2 receptor (Soluble PLA2-R) (Soluble PLA2R)] [CLEC13C] | |Secretory phospholipase A2 receptor precursor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) [Contains: Soluble secretory phospholipase A2 receptor (Soluble PLA2-R) (Soluble PLA2R)] [CLEC13C] | ||
|- | |- | ||
Строка 8114: | Строка 9086: | ||
|- | |- | ||
|[[CASP1]] | |[[CASP1]] | ||
| | |2 | ||
|Caspase-1 precursor (EC 3.4.22.36) (CASP-1) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Contains: Caspase-1 subunit p20; Caspase-1 subunit p10] [IL1BC] [IL1BCE] | |Caspase-1 precursor (EC 3.4.22.36) (CASP-1) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Contains: Caspase-1 subunit p20; Caspase-1 subunit p10] [IL1BC] [IL1BCE] | ||
|- | |- | ||
|[[HP]] | |[[HP]] | ||
| | |49 | ||
|Haptoglobin precursor (Zonulin) [Contains: Haptoglobin alpha chain; Haptoglobin beta chain] | |Haptoglobin precursor (Zonulin) [Contains: Haptoglobin alpha chain; Haptoglobin beta chain] | ||
|- | |- | ||
|[[ATG7]] | |[[ATG7]] | ||
| | |16 | ||
|Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) (hAGP7) (Ubiquitin-activating enzyme E1-like protein) [APG7L] | |Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) (hAGP7) (Ubiquitin-activating enzyme E1-like protein) [APG7L] | ||
|- | |- | ||
Строка 8132: | Строка 9104: | ||
|3 | |3 | ||
|C-X-C motif chemokine 11 precursor (Beta-R1) (H174) (Interferon gamma-inducible protein 9) (IP-9) (Interferon-inducible T-cell alpha chemoattractant) (I-TAC) (Small-inducible cytokine B11) [ITAC] [SCYB11] [SCYB9B] | |C-X-C motif chemokine 11 precursor (Beta-R1) (H174) (Interferon gamma-inducible protein 9) (IP-9) (Interferon-inducible T-cell alpha chemoattractant) (I-TAC) (Small-inducible cytokine B11) [ITAC] [SCYB11] [SCYB9B] | ||
|- | |- | ||
|[[ADAM17]] | |[[ADAM17]] | ||
| | |6 | ||
|Disintegrin and metalloproteinase domain-containing protein 17 precursor (EC 3.4.24.86) (ADAM 17) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD156b antigen) [CSVP] [TACE] | |Disintegrin and metalloproteinase domain-containing protein 17 precursor (EC 3.4.24.86) (ADAM 17) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD156b antigen) [CSVP] [TACE] | ||
|- | |- | ||
Строка 8160: | Строка 9128: | ||
|1 | |1 | ||
|Beta-casein precursor [CASB] | |Beta-casein precursor [CASB] | ||
|- | |||
|[[ATP13A2]] | |||
|1 | |||
|Polyamine-transporting ATPase 13A2 (EC 7.6.2.-) [PARK9] | |||
|- | |- | ||
|[[SF1]] | |[[SF1]] | ||
Строка 8170: | Строка 9142: | ||
|- | |- | ||
|[[PSEN1]] | |[[PSEN1]] | ||
| | |8 | ||
|Presenilin-1 (EC 3.4.23.-) (PS-1) (Protein S182) [Contains: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)] [AD3] [PS1] [PSNL1] | |Presenilin-1 (EC 3.4.23.-) (PS-1) (Protein S182) [Contains: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)] [AD3] [PS1] [PSNL1] | ||
|- | |- | ||
|[[HMOX1]] | |[[HMOX1]] | ||
| | |8 | ||
|Heme oxygenase 1 (EC 1.14.14.18) (HO-1) [HO] [HO1] | |Heme oxygenase 1 (EC 1.14.14.18) (HO-1) [HO] [HO1] | ||
|- | |||
|[[LRRC23]] | |||
|1 | |||
|repeat-containing protein 23 (Leucine-rich protein B7) [LRPB7] | |||
|- | |- | ||
|[[STOML2]] | |[[STOML2]] | ||
|1 | |1 | ||
|Stomatin-like protein 2, mitochondrial precursor (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7) [SLP2] [HSPC108] | |Stomatin-like protein 2, mitochondrial precursor (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7) [SLP2] [HSPC108] | ||
|- | |||
|[[KDM1A]] | |||
|1 | |||
|Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A) [AOF2] [KDM1] [KIAA0601] [LSD1] | |||
|- | |- | ||
|[[ALDH1A1]] | |[[ALDH1A1]] | ||
| | |3 | ||
|Retinal dehydrogenase 1 (EC 1.2.1.-) (EC 1.2.1.36) (RALDH 1) (RalDH1) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) [ALDC] [ALDH1] [PUMB1] | |Retinal dehydrogenase 1 (EC 1.2.1.-) (EC 1.2.1.36) (RALDH 1) (RalDH1) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) [ALDC] [ALDH1] [PUMB1] | ||
|- | |- | ||
Строка 8210: | Строка 9190: | ||
|- | |- | ||
|[[HDAC4]] | |[[HDAC4]] | ||
| | |12 | ||
|Histone deacetylase 4 (EC 3.5.1.98) (HD4) [KIAA0288] | |Histone deacetylase 4 (EC 3.5.1.98) (HD4) [KIAA0288] | ||
|- | |- | ||
|[[HSPA8]] | |[[HSPA8]] | ||
| | |5 | ||
|Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1) [HSC70] [HSP73] [HSPA10] | |Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1) [HSC70] [HSP73] [HSPA10] | ||
|- | |- | ||
Строка 8234: | Строка 9214: | ||
|- | |- | ||
|[[PPP3CB]] | |[[PPP3CB]] | ||
| | |2 | ||
|Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta) [CALNA2] [CALNB] [CNA2] | |Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform) (CNA beta) [CALNA2] [CALNB] [CNA2] | ||
|- | |- | ||
|[[GATA4]] | |[[GATA4]] | ||
| | |15 | ||
|Transcription factor GATA-4 (GATA-binding factor 4) | |Transcription factor GATA-4 (GATA-binding factor 4) | ||
|- | |- | ||
Строка 8260: | Строка 9240: | ||
|1 | |1 | ||
|protein 12 | |protein 12 | ||
|- | |||
|[[CCNI2]] | |||
|1 | |||
|#f | |||
|- | |- | ||
|[[DLX5]] | |[[DLX5]] | ||
Строка 8270: | Строка 9254: | ||
|- | |- | ||
|[[MARCO]] | |[[MARCO]] | ||
| | |3 | ||
|Macrophage receptor MARCO (Macrophage receptor with collagenous structure) (Scavenger receptor class A member 2) [SCARA2] | |Macrophage receptor MARCO (Macrophage receptor with collagenous structure) (Scavenger receptor class A member 2) [SCARA2] | ||
|- | |- | ||
Строка 8285: | Строка 9269: | ||
|DDB1- and CUL4-associated factor 17 [C2orf37] | |DDB1- and CUL4-associated factor 17 [C2orf37] | ||
|- | |- | ||
|[[ | |[[ZPBP2]] | ||
|1 | |1 | ||
| | |Zona pellucida-binding protein 2 precursor (ZPBP-like protein) [ZPBPL] | ||
|- | |- | ||
|[[EFNB2]] | |[[EFNB2]] | ||
Строка 8300: | Строка 9284: | ||
|1 | |1 | ||
|Desmocollin-1 precursor (Cadherin family member 1) (Desmosomal glycoprotein 2/3) (DG2/DG3) [CDHF1] | |Desmocollin-1 precursor (Cadherin family member 1) (Desmosomal glycoprotein 2/3) (DG2/DG3) [CDHF1] | ||
|- | |||
|[[CHMP4C]] | |||
|1 | |||
|Charged multivesicular body protein 4c (Chromatin-modifying protein 4c) (CHMP4c) (SNF7 homolog associated with Alix 3) (SNF7-3) (hSnf7-3) (Vacuolar protein sorting-associated protein 32-3) (Vps32-3) (hVps32-3) [SHAX3] | |||
|- | |- | ||
|[[ASB7]] | |[[ASB7]] | ||
Строка 8306: | Строка 9294: | ||
|- | |- | ||
|[[HTRA1]] | |[[HTRA1]] | ||
| | |3 | ||
|Serine protease HTRA1 precursor (EC 3.4.21.-) (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11) [HTRA] [PRSS11] | |Serine protease HTRA1 precursor (EC 3.4.21.-) (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11) [HTRA] [PRSS11] | ||
|- | |- | ||
Строка 8314: | Строка 9302: | ||
|- | |- | ||
|[[CDKN2B]] | |[[CDKN2B]] | ||
| | |3 | ||
|Cyclin-dependent kinase 4 inhibitor B (Multiple tumor suppressor 2) (MTS-2) (p14-INK4b) (p15-INK4b) (p15INK4B) [MTS2] | |Cyclin-dependent kinase 4 inhibitor B (Multiple tumor suppressor 2) (MTS-2) (p14-INK4b) (p15-INK4b) (p15INK4B) [MTS2] | ||
|- | |- | ||
|[[PRDM16]] | |[[PRDM16]] | ||
| | |3 | ||
|Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.367) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1) [KIAA1675] [MEL1] [PFM13] | |Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.367) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1) [KIAA1675] [MEL1] [PFM13] | ||
|- | |- | ||
|[[SIRT3]] | |[[SIRT3]] | ||
| | |95 | ||
|NAD-dependent protein deacetylase sirtuin-3, mitochondrial precursor (EC 2.3.1.286) (hSIRT3) (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3) [SIR2L3] | |NAD-dependent protein deacetylase sirtuin-3, mitochondrial precursor (EC 2.3.1.286) (hSIRT3) (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3) [SIR2L3] | ||
|- | |- | ||
|[[EHF]] | |[[EHF]] | ||
| | |4 | ||
|ETS homologous factor (hEHF) (ETS domain-containing transcription factor) (Epithelium-specific Ets transcription factor 3) (ESE-3) [ESE3] [ESE3B] [ESEJ] | |ETS homologous factor (hEHF) (ETS domain-containing transcription factor) (Epithelium-specific Ets transcription factor 3) (ESE-3) [ESE3] [ESE3B] [ESEJ] | ||
|- | |- | ||
|[[SLC26A2]] | |[[SLC26A2]] | ||
| | |2 | ||
|Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2) [DTD] [DTDST] | |Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2) [DTD] [DTDST] | ||
|- | |- | ||
Строка 8338: | Строка 9326: | ||
|- | |- | ||
|[[SLC2A4]] | |[[SLC2A4]] | ||
| | |2 | ||
|Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4) [GLUT4] | |Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4) [GLUT4] | ||
|- | |- | ||
Строка 8344: | Строка 9332: | ||
|1 | |1 | ||
|Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase) [GC] | |Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase) [GC] | ||
|- | |||
|[[NMU]] | |||
|1 | |||
|Neuromedin-U precursor [Contains: Neuromedin precursor-related peptide 36 (NURP36); Neuromedin precursor-related peptide 33 (NURP33); Neuromedin-U-25 (NmU-25)] | |||
|- | |- | ||
|[[ADM]] | |[[ADM]] | ||
|10 | |10 | ||
|Pro-adrenomedullin precursor [Contains: Adrenomedullin (AM); Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide) (PAMP) (ProAM-N20)] [AM] | |Pro-adrenomedullin precursor [Contains: Adrenomedullin (AM); Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide) (PAMP) (ProAM-N20)] [AM] | ||
|- | |||
|[[GUSB]] | |||
|1 | |||
|Beta-glucuronidase precursor (EC 3.2.1.31) (Beta-G1) | |||
|- | |||
|[[TFE3]] | |||
|1 | |||
|Transcription factor E3 (Class E basic helix-loop-helix protein 33) (bHLHe33) [BHLHE33] | |||
|- | |- | ||
|[[OTX2]] | |[[OTX2]] | ||
Строка 8362: | Строка 9362: | ||
|- | |- | ||
|[[C3]] | |[[C3]] | ||
| | |70 | ||
|Complement C3 precursor (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Contains: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2] [CPAMD1] | |Complement C3 precursor (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Contains: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2] [CPAMD1] | ||
|- | |- | ||
Строка 8370: | Строка 9370: | ||
|- | |- | ||
|[[GSTP1]] | |[[GSTP1]] | ||
| | |6 | ||
|Glutathione S-transferase P (EC 2.5.1.18) (GST class-pi) (GSTP1-1) [FAEES3] [GST3] | |Glutathione S-transferase P (EC 2.5.1.18) (GST class-pi) (GSTP1-1) [FAEES3] [GST3] | ||
|- | |- | ||
Строка 8378: | Строка 9378: | ||
|- | |- | ||
|[[MMP13]] | |[[MMP13]] | ||
| | |11 | ||
|Collagenase 3 precursor (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13) | |Collagenase 3 precursor (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13) | ||
|- | |||
|[[DLK1]] | |||
|1 | |||
|Protein delta homolog 1 precursor (DLK-1) (pG2) [Contains: Fetal antigen 1 (FA1)] [DLK] | |||
|- | |- | ||
|[[POU2F1]] | |[[POU2F1]] | ||
Строка 8386: | Строка 9390: | ||
|- | |- | ||
|[[LIF]] | |[[LIF]] | ||
| | |5 | ||
|Leukemia inhibitory factor precursor (LIF) (Differentiation-stimulating factor) (D factor) (Melanoma-derived LPL inhibitor) (MLPLI) (Emfilermin) [HILDA] | |Leukemia inhibitory factor precursor (LIF) (Differentiation-stimulating factor) (D factor) (Melanoma-derived LPL inhibitor) (MLPLI) (Emfilermin) [HILDA] | ||
|- | |- | ||
Строка 8400: | Строка 9404: | ||
|1 | |1 | ||
|Macrophage colony-stimulating factor 1 precursor (CSF-1) (M-CSF) (MCSF) (Lanimostim) [Contains: Processed macrophage colony-stimulating factor 1] | |Macrophage colony-stimulating factor 1 precursor (CSF-1) (M-CSF) (MCSF) (Lanimostim) [Contains: Processed macrophage colony-stimulating factor 1] | ||
|- | |||
|[[REEP4]] | |||
|1 | |||
|Receptor expression-enhancing protein 4 [C8orf20] [PP432] | |||
|- | |||
|[[IRF9]] | |||
|1 | |||
|Interferon regulatory factor 9 (IRF-9) (IFN-alpha-responsive transcription factor subunit) (ISGF3 p48 subunit) (Interferon-stimulated gene factor 3 gamma) (ISGF-3 gamma) (Transcriptional regulator ISGF3 subunit gamma) [ISGF3G] | |||
|- | |- | ||
|[[HIP1]] | |[[HIP1]] | ||
Строка 8406: | Строка 9418: | ||
|- | |- | ||
|[[ENO1]] | |[[ENO1]] | ||
| | |3 | ||
|Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein) [ENO1L1] [MBPB1] [MPB1] | |Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein) [ENO1L1] [MBPB1] [MPB1] | ||
|- | |- | ||
|[[CCN3]] | |[[CCN3]] | ||
| | |4 | ||
|CCN family member 3 precursor (Cellular communication network factor 3) (Insulin-like growth factor-binding protein 9) (IBP-9) (IGF-binding protein 9) (IGFBP-9) (Nephro blastoma-overexpressed gene protein homolog) (Protein NOV homolog) (NovH) [IGFBP9] [NOV] [NOVH] | |CCN family member 3 precursor (Cellular communication network factor 3) (Insulin-like growth factor-binding protein 9) (IBP-9) (IGF-binding protein 9) (IGFBP-9) (Nephro blastoma-overexpressed gene protein homolog) (Protein NOV homolog) (NovH) [IGFBP9] [NOV] [NOVH] | ||
|- | |- | ||
Строка 8422: | Строка 9434: | ||
|- | |- | ||
|[[TNNT1]] | |[[TNNT1]] | ||
| | |2 | ||
|Troponin T, slow skeletal muscle (TnTs) (Slow skeletal muscle troponin T) (sTnT) [TNT] | |Troponin T, slow skeletal muscle (TnTs) (Slow skeletal muscle troponin T) (sTnT) [TNT] | ||
|- | |- | ||
Строка 8434: | Строка 9446: | ||
|- | |- | ||
|[[NPY1R]] | |[[NPY1R]] | ||
| | |2 | ||
|Neuropeptide Y receptor type 1 (NPY1-R) [NPYR] [NPYY1] | |Neuropeptide Y receptor type 1 (NPY1-R) [NPYR] [NPYY1] | ||
|- | |- | ||
Строка 8452: | Строка 9464: | ||
|1 | |1 | ||
|Cerebral cavernous malformations 2 protein (Malcavernin) [C7orf22] [PP10187] | |Cerebral cavernous malformations 2 protein (Malcavernin) [C7orf22] [PP10187] | ||
|- | |||
|[[NR2F2]] | |||
|1 | |||
|COUP transcription factor 2 (COUP-TF2) (Apolipoprotein A-I regulatory protein 1) (ARP-1) (COUP transcription factor II) (COUP-TF II) (Nuclear receptor subfamily 2 group F member 2) [ARP1] [TFCOUP2] | |||
|- | |- | ||
|[[LINC00862]] | |[[LINC00862]] | ||
Строка 8458: | Строка 9474: | ||
|- | |- | ||
|[[FOXP3]] | |[[FOXP3]] | ||
| | |7 | ||
|Forkhead box protein P3 (Scurfin) [Contains: Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form] [IPEX] [JM2] | |Forkhead box protein P3 (Scurfin) [Contains: Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form] [IPEX] [JM2] | ||
|- | |- | ||
|[[F2]] | |[[F2]] | ||
| | |73 | ||
|Prothrombin precursor (EC 3.4.21.5) (Coagulation factor II) [Contains: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain] | |Prothrombin precursor (EC 3.4.21.5) (Coagulation factor II) [Contains: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain] | ||
|- | |- | ||
|[[NPC1]] | |[[NPC1]] | ||
| | |11 | ||
|NPC intracellular cholesterol transporter 1 precursor (Niemann-Pick C1 protein) | |NPC intracellular cholesterol transporter 1 precursor (Niemann-Pick C1 protein) | ||
|- | |- | ||
Строка 8478: | Строка 9494: | ||
|- | |- | ||
|[[RAC1]] | |[[RAC1]] | ||
| | |3 | ||
|Ras-related C3 botulinum toxin substrate 1 precursor (EC 3.6.5.2) (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1) [TC25] [MIG5] | |Ras-related C3 botulinum toxin substrate 1 precursor (EC 3.6.5.2) (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1) [TC25] [MIG5] | ||
|- | |||
|[[CST5]] | |||
|1 | |||
|Cystatin-D precursor (Cystatin-5) | |||
|- | |- | ||
|[[PSEN2]] | |[[PSEN2]] | ||
Строка 8496: | Строка 9516: | ||
|1 | |1 | ||
|Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1) [ACF1] [WCRF180] [HSPC317] | |Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1) [ACF1] [WCRF180] [HSPC317] | ||
|- | |||
|[[ZW10]] | |||
|1 | |||
|Centromere/kinetochore protein zw10 homolog | |||
|- | |- | ||
|[[NUPR1]] | |[[NUPR1]] | ||
|1 | |1 | ||
|Nuclear protein 1 (Candidate of metastasis 1) (Protein p8) [COM1] | |Nuclear protein 1 (Candidate of metastasis 1) (Protein p8) [COM1] | ||
|- | |||
|[[EPHA7]] | |||
|1 | |||
|Ephrin type-A receptor 7 precursor (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) [EHK3] [HEK11] | |||
|- | |- | ||
|[[VAV3]] | |[[VAV3]] | ||
Строка 8508: | Строка 9536: | ||
|1 | |1 | ||
|DNA (cytosine-5)-methyltransferase 3-like | |DNA (cytosine-5)-methyltransferase 3-like | ||
|- | |||
|[[ZNF619]] | |||
|1 | |||
|finger protein 619 | |||
|- | |- | ||
|[[IK]] | |[[IK]] | ||
| | |3 | ||
|Protein Red (Cytokine IK) (IK factor) (Protein RER) [RED] [RER] | |Protein Red (Cytokine IK) (IK factor) (Protein RER) [RED] [RER] | ||
|- | |- | ||
Строка 8520: | Строка 9552: | ||
|1 | |1 | ||
|Mesoderm-specific transcript homolog protein (EC 3.-.-.-) (Paternally-expressed gene 1 protein) [PEG1] | |Mesoderm-specific transcript homolog protein (EC 3.-.-.-) (Paternally-expressed gene 1 protein) [PEG1] | ||
|- | |||
|[[OASL]] | |||
|1 | |||
|2'-5'-oligoadenylate synthase-like protein (2'-5'-OAS-related protein) (2'-5'-OAS-RP) (59 kDa 2'-5'-oligoadenylate synthase-like protein) (Thyroid receptor-interacting protein 14) (TR-interacting protein 14) (TRIP-14) (p59 OASL) (p59OASL) [TRIP14] | |||
|- | |- | ||
|[[CHL1]] | |[[CHL1]] | ||
Строка 8526: | Строка 9562: | ||
|- | |- | ||
|[[IL6R]] | |[[IL6R]] | ||
| | |3 | ||
|Interleukin-6 receptor subunit alpha precursor (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD126 antigen) [Contains: Soluble interleukin-6 receptor subunit alpha (sIL6R)] | |Interleukin-6 receptor subunit alpha precursor (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD126 antigen) [Contains: Soluble interleukin-6 receptor subunit alpha (sIL6R)] | ||
|- | |- | ||
|[[SFRP1]] | |[[SFRP1]] | ||
| | |5 | ||
|Secreted frizzled-related protein 1 precursor (FRP-1) (sFRP-1) (Secreted apoptosis-related protein 2) (SARP-2) [FRP] [FRP1] [SARP2] | |Secreted frizzled-related protein 1 precursor (FRP-1) (sFRP-1) (Secreted apoptosis-related protein 2) (SARP-2) [FRP] [FRP1] [SARP2] | ||
|- | |- | ||
|[[PIR]] | |[[PIR]] | ||
| | |3 | ||
|Pirin (EC 1.13.11.24) (Probable quercetin 2,3-dioxygenase PIR) (Probable quercetinase) | |Pirin (EC 1.13.11.24) (Probable quercetin 2,3-dioxygenase PIR) (Probable quercetinase) | ||
|- | |- | ||
|[[C9orf72]] | |[[C9orf72]] | ||
| | |11 | ||
|Guanine nucleotide exchange C9orf72 | |Guanine nucleotide exchange C9orf72 | ||
|- | |- | ||
|[[MIB1]] | |[[MIB1]] | ||
| | |2 | ||
|E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2) [DIP1] [KIAA1323] [ZZANK2] | |E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2) [DIP1] [KIAA1323] [ZZANK2] | ||
|- | |- | ||
|[[DSP]] | |[[DSP]] | ||
| | |7 | ||
|Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen) | |Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen) | ||
|- | |- | ||
Строка 8554: | Строка 9590: | ||
|- | |- | ||
|[[PINK1]] | |[[PINK1]] | ||
| | |45 | ||
|Serine/threonine-protein kinase PINK1, mitochondrial precursor (EC 2.7.11.1) (BRPK) (PTEN-induced putative kinase protein 1) | |Serine/threonine-protein kinase PINK1, mitochondrial precursor (EC 2.7.11.1) (BRPK) (PTEN-induced putative kinase protein 1) | ||
|- | |- | ||
|[[SHE]] | |[[SHE]] | ||
Строка 8570: | Строка 9602: | ||
|- | |- | ||
|[[NRF1]] | |[[NRF1]] | ||
| | |11 | ||
|Nuclear respiratory factor 1 (NRF-1) (Alpha palindromic-binding protein) (Alpha-pal) | |Nuclear respiratory factor 1 (NRF-1) (Alpha palindromic-binding protein) (Alpha-pal) | ||
|- | |- | ||
Строка 8578: | Строка 9610: | ||
|- | |- | ||
|[[WNT16]] | |[[WNT16]] | ||
| | |3 | ||
|Protein Wnt-16 precursor | |Protein Wnt-16 precursor | ||
|- | |- | ||
|[[GPX1]] | |[[GPX1]] | ||
| | |12 | ||
|Glutathione peroxidase 1 (EC 1.11.1.9) (GPx-1) (GSHPx-1) (Cellular glutathione peroxidase) | |Glutathione peroxidase 1 (EC 1.11.1.9) (GPx-1) (GSHPx-1) (Cellular glutathione peroxidase) | ||
|- | |- | ||
Строка 8594: | Строка 9626: | ||
|- | |- | ||
|[[CYP17A1]] | |[[CYP17A1]] | ||
| | |6 | ||
|Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (17-alpha-hydroxyprogesterone aldolase) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17) (Steroid 17-alpha-monooxygenase) [CYP17] [S17AH] | |Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (17-alpha-hydroxyprogesterone aldolase) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17) (Steroid 17-alpha-monooxygenase) [CYP17] [S17AH] | ||
|- | |- | ||
Строка 8604: | Строка 9636: | ||
|1 | |1 | ||
|Lysosomal protective protein precursor (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Contains: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain] [PPGB] | |Lysosomal protective protein precursor (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Contains: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain] [PPGB] | ||
|- | |||
|[[ZNF518B]] | |||
|1 | |||
|Zinc finger protein 518B [KIAA1729] | |||
|- | |- | ||
|[[CPT1C]] | |[[CPT1C]] | ||
Строка 8630: | Строка 9666: | ||
|- | |- | ||
|[[CLSTN2]] | |[[CLSTN2]] | ||
| | |2 | ||
|Calsyntenin-2 precursor (Alcadein-gamma) (Alc-gamma) [CS2] | |Calsyntenin-2 precursor (Alcadein-gamma) (Alc-gamma) [CS2] | ||
|- | |- | ||
Строка 8646: | Строка 9682: | ||
|- | |- | ||
|[[TBC1D4]] | |[[TBC1D4]] | ||
| | |2 | ||
|TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160) [AS160] [KIAA0603] | |TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160) [AS160] [KIAA0603] | ||
|- | |- | ||
|[[CBX7]] | |[[CBX7]] | ||
| | |3 | ||
|Chromobox protein homolog 7 | |Chromobox protein homolog 7 | ||
|- | |- | ||
|[[CIDEA]] | |[[CIDEA]] | ||
| | |2 | ||
|Cell death activator CIDE-A (Cell death-inducing DFFA-like effector A) | |Cell death activator CIDE-A (Cell death-inducing DFFA-like effector A) | ||
|- | |- | ||
Строка 8666: | Строка 9702: | ||
|- | |- | ||
|[[XRCC6]] | |[[XRCC6]] | ||
| | |3 | ||
|X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6) [G22P1] | |X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6) [G22P1] | ||
|- | |- | ||
Строка 8686: | Строка 9722: | ||
|- | |- | ||
|[[HFE]] | |[[HFE]] | ||
| | |8 | ||
|Hereditary hemochromatosis protein precursor (HLA-H) [HLAH] | |Hereditary hemochromatosis protein precursor (HLA-H) [HLAH] | ||
|- | |- | ||
Строка 8694: | Строка 9730: | ||
|- | |- | ||
|[[EXO1]] | |[[EXO1]] | ||
| | |3 | ||
|Exonuclease 1 (EC 3.1.-.-) (hExo1) (Exonuclease I) (hExoI) [EXOI] [HEX1] | |Exonuclease 1 (EC 3.1.-.-) (hExo1) (Exonuclease I) (hExoI) [EXOI] [HEX1] | ||
|- | |||
|[[PGLYRP2]] | |||
|1 | |||
|N-acetylmuramoyl-L-alanine amidase precursor (EC 3.5.1.28) (Peptidoglycan recognition protein 2) (Peptidoglycan recognition protein long) (PGRP-L) [PGLYRPL] [PGRPL] [UNQ3103/PRO10102] | |||
|- | |- | ||
|[[CYB5A]] | |[[CYB5A]] | ||
Строка 8702: | Строка 9742: | ||
|- | |- | ||
|[[RPE65]] | |[[RPE65]] | ||
| | |5 | ||
|Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase) | |Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase) | ||
|- | |- | ||
Строка 8726: | Строка 9766: | ||
|- | |- | ||
|[[MMP10]] | |[[MMP10]] | ||
| | |2 | ||
|Stromelysin-2 precursor (EC 3.4.24.22) (SL-2) (Matrix metalloproteinase-10) (MMP-10) (Transin-2) [STMY2] | |Stromelysin-2 precursor (EC 3.4.24.22) (SL-2) (Matrix metalloproteinase-10) (MMP-10) (Transin-2) [STMY2] | ||
|- | |- | ||
Строка 8740: | Строка 9780: | ||
|1 | |1 | ||
|Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog) [CRM1] | |Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog) [CRM1] | ||
|- | |||
|[[ODC1]] | |||
|1 | |||
|Ornithine decarboxylase (EC 4.1.1.17) (ODC) | |||
|- | |- | ||
|[[GAST]] | |[[GAST]] | ||
|1 | |1 | ||
|Gastrin precursor [Contains: Gastrin-71 (Gastrin component I); Gastrin-52 (G52); Big gastrin (Gastrin component II) (Gastrin-34) (G34); Gastrin (Gastrin component III) (Gastrin-17) (G17); Gastrin-14 (G14); Gastrin-6 (G6)] [GAS] | |Gastrin precursor [Contains: Gastrin-71 (Gastrin component I); Gastrin-52 (G52); Big gastrin (Gastrin component II) (Gastrin-34) (G34); Gastrin (Gastrin component III) (Gastrin-17) (G17); Gastrin-14 (G14); Gastrin-6 (G6)] [GAS] | ||
|- | |||
|[[PLTP]] | |||
|1 | |||
|Phospholipid transfer protein precursor (Lipid transfer protein II) | |||
|- | |- | ||
|[[ITGA5]] | |[[ITGA5]] | ||
Строка 8754: | Строка 9802: | ||
|- | |- | ||
|[[CFTR]] | |[[CFTR]] | ||
| | |17 | ||
|Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel) [ABCC7] | |Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel) [ABCC7] | ||
|- | |- | ||
|[[CXCL10]] | |[[CXCL10]] | ||
| | |21 | ||
|C-X-C motif chemokine 10 precursor (10 kDa interferon gamma-induced protein) (Gamma-IP10) (IP-10) (Small-inducible cytokine B10) [Contains: CXCL10(1-73)] [INP10] [SCYB10] | |C-X-C motif chemokine 10 precursor (10 kDa interferon gamma-induced protein) (Gamma-IP10) (IP-10) (Small-inducible cytokine B10) [Contains: CXCL10(1-73)] [INP10] [SCYB10] | ||
|- | |- | ||
|[[COL15A1]] | |[[COL15A1]] | ||
Строка 8770: | Строка 9814: | ||
|- | |- | ||
|[[ATF4]] | |[[ATF4]] | ||
| | |30 | ||
|Cyclic AMP-dependent transcription factor ATF-4 (cAMP-dependent transcription factor ATF-4) (Activating transcription factor 4) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (Tax-responsive enhancer element-binding protein 67) (TaxREB67) [CREB2] [TXREB] | |Cyclic AMP-dependent transcription factor ATF-4 (cAMP-dependent transcription factor ATF-4) (Activating transcription factor 4) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (Tax-responsive enhancer element-binding protein 67) (TaxREB67) [CREB2] [TXREB] | ||
|- | |- | ||
Строка 8778: | Строка 9822: | ||
|- | |- | ||
|[[CYP2E1]] | |[[CYP2E1]] | ||
| | |7 | ||
|Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J) [CYP2E] | |Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J) [CYP2E] | ||
|- | |- | ||
Строка 8790: | Строка 9834: | ||
|- | |- | ||
|[[MYC]] | |[[MYC]] | ||
| | |38 | ||
|Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39) (bHLHe39) (Proto-oncogene c-Myc) (Transcription factor p64) [BHLHE39] | |Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39) (bHLHe39) (Proto-oncogene c-Myc) (Transcription factor p64) [BHLHE39] | ||
|- | |- | ||
Строка 8822: | Строка 9866: | ||
|- | |- | ||
|[[ATR]] | |[[ATR]] | ||
| | |38 | ||
|Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1) [FRP1] | |Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1) [FRP1] | ||
|- | |||
|[[KIAA0930]] | |||
|1 | |||
|protein KIAA0930 [C22orf9] | |||
|- | |||
|[[MACROD2]] | |||
|1 | |||
|ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2) (EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2) (EC 3.2.2.-) [C20orf133] | |||
|- | |- | ||
|[[GEM]] | |[[GEM]] | ||
| | |6 | ||
|GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR) [KIR] | |GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR) [KIR] | ||
|- | |- | ||
|[[UCP1]] | |[[UCP1]] | ||
| | |24 | ||
|Mitochondrial brown fat uncoupling protein 1 (UCP 1) (Solute carrier family 25 member 7) (Thermogenin) [SLC25A7] [UCP] | |Mitochondrial brown fat uncoupling protein 1 (UCP 1) (Solute carrier family 25 member 7) (Thermogenin) [SLC25A7] [UCP] | ||
|- | |- | ||
Строка 8842: | Строка 9894: | ||
|- | |- | ||
|[[HDAC3]] | |[[HDAC3]] | ||
| | |16 | ||
|Histone deacetylase 3 (EC 3.5.1.98) (HD3) (RPD3-2) (SMAP45) | |Histone deacetylase 3 (EC 3.5.1.98) (HD3) (RPD3-2) (SMAP45) | ||
|- | |- | ||
Строка 8858: | Строка 9910: | ||
|- | |- | ||
|[[GSR]] | |[[GSR]] | ||
| | |4 | ||
|Glutathione reductase, mitochondrial precursor (EC 1.8.1.7) (GR) (GRase) [GLUR] [GRD1] | |Glutathione reductase, mitochondrial precursor (EC 1.8.1.7) (GR) (GRase) [GLUR] [GRD1] | ||
|- | |- | ||
Строка 8864: | Строка 9916: | ||
|2 | |2 | ||
|Progesterone receptor (PR) (Nuclear receptor subfamily 3 group C member 3) [NR3C3] | |Progesterone receptor (PR) (Nuclear receptor subfamily 3 group C member 3) [NR3C3] | ||
|- | |||
|[[CDC5L]] | |||
|1 | |||
|Cell division cycle 5-like protein (Cdc5-like protein) (Pombe cdc5-related protein) [KIAA0432] [PCDC5RP] | |||
|- | |||
|[[PDE11A]] | |||
|1 | |||
|Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A) | |||
|- | |- | ||
|[[CBSL]] | |[[CBSL]] | ||
Строка 8870: | Строка 9930: | ||
|- | |- | ||
|[[ULK1]] | |[[ULK1]] | ||
| | |14 | ||
|Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1) [KIAA0722] | |Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1) [KIAA0722] | ||
|- | |- | ||
Строка 8880: | Строка 9940: | ||
|2 | |2 | ||
|Transient receptor potential cation channel subfamily M member 6 (EC 2.7.11.1) (Channel kinase 2) (Melastatin-related TRP cation channel 6) [CHAK2] | |Transient receptor potential cation channel subfamily M member 6 (EC 2.7.11.1) (Channel kinase 2) (Melastatin-related TRP cation channel 6) [CHAK2] | ||
|- | |||
|[[PBX4]] | |||
|1 | |||
|Pre-B-cell leukemia transcription factor 4 (Homeobox protein PBX4) | |||
|- | |- | ||
|[[ACLY]] | |[[ACLY]] | ||
Строка 8894: | Строка 9958: | ||
|- | |- | ||
|[[NQO1]] | |[[NQO1]] | ||
| | |23 | ||
|NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) (QR1) [DIA4] [NMOR1] | |NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) (QR1) [DIA4] [NMOR1] | ||
|- | |- | ||
Строка 8918: | Строка 9982: | ||
|- | |- | ||
|[[BAD]] | |[[BAD]] | ||
| | |5 | ||
|Bcl2-associated agonist of cell death (BAD) (Bcl-2-binding component 6) (Bcl-2-like protein 8) (Bcl2-L-8) (Bcl-xL/Bcl-2-associated death promoter) (Bcl2 antagonist of cell death) [BBC6] [BCL2L8] | |Bcl2-associated agonist of cell death (BAD) (Bcl-2-binding component 6) (Bcl-2-like protein 8) (Bcl2-L-8) (Bcl-xL/Bcl-2-associated death promoter) (Bcl2 antagonist of cell death) [BBC6] [BCL2L8] | ||
|- | |- | ||
Строка 8924: | Строка 9988: | ||
|2 | |2 | ||
|Dickkopf-related protein 2 precursor (Dickkopf-2) (Dkk-2) (hDkk-2) [UNQ682/PRO1316] | |Dickkopf-related protein 2 precursor (Dickkopf-2) (Dkk-2) (hDkk-2) [UNQ682/PRO1316] | ||
|- | |||
|[[CNTNAP4]] | |||
|1 | |||
|Contactin-associated protein-like 4 precursor (Cell recognition molecule Caspr4) [CASPR4] [KIAA1763] | |||
|- | |- | ||
|[[CEBPD]] | |[[CEBPD]] | ||
Строка 8934: | Строка 10 002: | ||
|- | |- | ||
|[[AKT1]] | |[[AKT1]] | ||
| | |16 | ||
|RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) [PKB] [RAC] | |RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) [PKB] [RAC] | ||
|- | |- | ||
|[[VIPR2]] | |[[VIPR2]] | ||
| | |2 | ||
|Vasoactive intestinal polypeptide receptor 2 precursor (VIP-R-2) (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor) (PACAP type III receptor) (PACAP-R-3) (PACAP-R3) (VPAC2) [VIP2R] | |Vasoactive intestinal polypeptide receptor 2 precursor (VIP-R-2) (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor) (PACAP type III receptor) (PACAP-R-3) (PACAP-R3) (VPAC2) [VIP2R] | ||
|- | |- | ||
Строка 8968: | Строка 10 036: | ||
|3 | |3 | ||
|Cryptochrome-2 [KIAA0658] | |Cryptochrome-2 [KIAA0658] | ||
|- | |- | ||
|[[TRPC7]] | |[[TRPC7]] | ||
Строка 8978: | Строка 10 042: | ||
|- | |- | ||
|[[VIM]] | |[[VIM]] | ||
| | |6 | ||
|Vimentin | |Vimentin | ||
|- | |- | ||
|[[PARK7]] | |[[PARK7]] | ||
| | |3 | ||
|Parkinson disease protein 7 precursor (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) | |Parkinson disease protein 7 precursor (Maillard deglycase) (Oncogene DJ1) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1) (Protein/nucleic acid deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) | ||
|- | |- | ||
Строка 8994: | Строка 10 058: | ||
|- | |- | ||
|[[DLD]] | |[[DLD]] | ||
| | |4 | ||
|Dihydrolipoyl dehydrogenase, mitochondrial precursor (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein) [GCSL] [LAD] [PHE3] | |Dihydrolipoyl dehydrogenase, mitochondrial precursor (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein) [GCSL] [LAD] [PHE3] | ||
|- | |- | ||
Строка 9000: | Строка 10 064: | ||
|1 | |1 | ||
|receptor 2AG1 (HT3) (Olfactory receptor 2AG3) (Olfactory receptor OR11-79) [OR2AG3] | |receptor 2AG1 (HT3) (Olfactory receptor 2AG3) (Olfactory receptor OR11-79) [OR2AG3] | ||
|- | |||
|[[CDC7]] | |||
|1 | |||
|Cell division cycle 7-related protein kinase (EC 2.7.11.1) (CDC7-related kinase) (HsCdc7) (huCdc7) [CDC7L1] | |||
|- | |- | ||
|[[XK]] | |[[XK]] | ||
Строка 9026: | Строка 10 094: | ||
|- | |- | ||
|[[CREM]] | |[[CREM]] | ||
| | |3 | ||
|cAMP-responsive element modulator (Inducible cAMP early repressor) (ICER) | |cAMP-responsive element modulator (Inducible cAMP early repressor) (ICER) | ||
|- | |- | ||
Строка 9036: | Строка 10 104: | ||
|1 | |1 | ||
|Zinc finger protein ZFPM2 (Friend of GATA protein 2) (FOG-2) (Friend of GATA 2) (hFOG-2) (Zinc finger protein 89B) (Zinc finger protein multitype 2) [FOG2] [ZNF89B] | |Zinc finger protein ZFPM2 (Friend of GATA protein 2) (FOG-2) (Friend of GATA 2) (hFOG-2) (Zinc finger protein 89B) (Zinc finger protein multitype 2) [FOG2] [ZNF89B] | ||
|- | |||
|[[FKBP1B]] | |||
|1 | |||
|Peptidyl-prolyl cis-trans isomerase FKBP1B (EC 5.2.1.8) (PPIase FKBP1B) (12.6 kDa FK506-binding protein) (12.6 kDa FKBP) (FKBP-12.6) (FK506-binding protein 1B) (FKBP-1B) (Immunophilin FKBP12.6) (Rotamase) (h-FKBP-12) [FKBP12.6] [FKBP1L] [FKBP9] [OTK4] | |||
|- | |- | ||
|[[ID3]] | |[[ID3]] | ||
Строка 9042: | Строка 10 114: | ||
|- | |- | ||
|[[ABCG1]] | |[[ABCG1]] | ||
| | |2 | ||
|ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog) [ABC8] [WHT1] | |ATP-binding cassette sub-family G member 1 (EC 7.6.2.-) (ATP-binding cassette transporter 8) (White protein homolog) [ABC8] [WHT1] | ||
|- | |- | ||
Строка 9098: | Строка 10 170: | ||
|- | |- | ||
|[[MBL2]] | |[[MBL2]] | ||
| | |3 | ||
|Mannose-binding protein C precursor (MBP-C) (Collectin-1) (MBP1) (Mannan-binding protein) (Mannose-binding lectin) [COLEC1] [MBL] | |Mannose-binding protein C precursor (MBP-C) (Collectin-1) (MBP1) (Mannan-binding protein) (Mannose-binding lectin) [COLEC1] [MBL] | ||
|- | |- | ||
Строка 9112: | Строка 10 184: | ||
|2 | |2 | ||
|G-protein coupled receptor 39 | |G-protein coupled receptor 39 | ||
|- | |||
|[[MIPEP]] | |||
|1 | |||
|Mitochondrial intermediate peptidase precursor (EC 3.4.24.59) (MIP) [MIP] | |||
|- | |- | ||
|[[WDR48]] | |[[WDR48]] | ||
Строка 9118: | Строка 10 194: | ||
|- | |- | ||
|[[B2M]] | |[[B2M]] | ||
| | |8 | ||
|Beta-2-microglobulin precursor [Contains: Beta-2-microglobulin form pI 5.3] [CDABP0092] [HDCMA22P] | |Beta-2-microglobulin precursor [Contains: Beta-2-microglobulin form pI 5.3] [CDABP0092] [HDCMA22P] | ||
|- | |- | ||
|[[CFP]] | |[[CFP]] | ||
| | |3 | ||
|Properdin precursor (Complement factor P) [PFC] | |Properdin precursor (Complement factor P) [PFC] | ||
|- | |- | ||
Строка 9128: | Строка 10 204: | ||
|6 | |6 | ||
|box-containing protein 1 (HMG box transcription factor 1) (High mobility group box transcription factor 1) | |box-containing protein 1 (HMG box transcription factor 1) (High mobility group box transcription factor 1) | ||
|- | |||
|[[CAP1]] | |||
|1 | |||
|Adenylyl cyclase-associated protein 1 (CAP 1) [CAP] | |||
|- | |- | ||
|[[DEGS1]] | |[[DEGS1]] | ||
Строка 9144: | Строка 10 224: | ||
|3 | |3 | ||
|Protein Wnt-3a precursor | |Protein Wnt-3a precursor | ||
|- | |||
|[[PLP1]] | |||
|1 | |||
|Myelin proteolipid protein (PLP) (Lipophilin) [PLP] | |||
|- | |- | ||
|[[CARM1]] | |[[CARM1]] | ||
Строка 9160: | Строка 10 244: | ||
|1 | |1 | ||
|Interleukin-33 precursor (IL-33) (Interleukin-1 family member 11) (IL-1F11) (Nuclear factor from high endothelial venules) (NF-HEV) [Contains: Interleukin-33 (95-270); Interleukin-33 (99-270); Interleukin-33 (109-270)] [C9orf26] [IL1F11] [NFHEV] | |Interleukin-33 precursor (IL-33) (Interleukin-1 family member 11) (IL-1F11) (Nuclear factor from high endothelial venules) (NF-HEV) [Contains: Interleukin-33 (95-270); Interleukin-33 (99-270); Interleukin-33 (109-270)] [C9orf26] [IL1F11] [NFHEV] | ||
|- | |||
|[[SLC16A10]] | |||
|1 | |||
|Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1) [MCT10] [TAT1] | |||
|- | |- | ||
|[[RELB]] | |[[RELB]] | ||
Строка 9178: | Строка 10 266: | ||
|- | |- | ||
|[[FNDC5]] | |[[FNDC5]] | ||
| | |10 | ||
|Fibronectin type III domain-containing protein 5 precursor (Fibronectin type III repeat-containing protein 2) [Contains: Irisin] [FRCP2] | |Fibronectin type III domain-containing protein 5 precursor (Fibronectin type III repeat-containing protein 2) [Contains: Irisin] [FRCP2] | ||
|- | |- | ||
|[[NRG1]] | |[[NRG1]] | ||
| | |5 | ||
|Pro-neuregulin-1, membrane-bound isoform precursor (Pro-NRG1) [Contains: Neuregulin-1 (Acetylcholine receptor-inducing activity) (ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin) (HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor)] [GGF] [HGL] [HRGA] [NDF] [SMDF] | |Pro-neuregulin-1, membrane-bound isoform precursor (Pro-NRG1) [Contains: Neuregulin-1 (Acetylcholine receptor-inducing activity) (ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin) (HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor)] [GGF] [HGL] [HRGA] [NDF] [SMDF] | ||
|- | |- | ||
Строка 9190: | Строка 10 278: | ||
|- | |- | ||
|[[HAMP]] | |[[HAMP]] | ||
| | |1 | ||
|Hepcidin precursor (Liver-expressed antimicrobial peptide 1) (LEAP-1) (Putative liver tumor regressor) (PLTR) [Contains: Hepcidin-25 (Hepc25); Hepcidin-20 (Hepc20)] [HEPC] [LEAP1] [UNQ487/PRO1003] | |Hepcidin precursor (Liver-expressed antimicrobial peptide 1) (LEAP-1) (Putative liver tumor regressor) (PLTR) [Contains: Hepcidin-25 (Hepc25); Hepcidin-20 (Hepc20)] [HEPC] [LEAP1] [UNQ487/PRO1003] | ||
|- | |- | ||
|[[APOE]] | |[[APOE]] | ||
| | |449 | ||
|Apolipoprotein E precursor (Apo-E) | |Apolipoprotein E precursor (Apo-E) | ||
|- | |- | ||
Строка 9202: | Строка 10 290: | ||
|- | |- | ||
|[[TAP1]] | |[[TAP1]] | ||
| | |1 | ||
|Antigen peptide transporter 1 (EC 7.4.2.-) (APT1) (ATP-binding cassette sub-family B member 2) (Peptide supply factor 1) (Peptide transporter PSF1) (PSF-1) (Peptide transporter TAP1) (Peptide transporter involved in antigen processing 1) (Really interesting new gene 4 protein) (RING4) [ABCB2] [PSF1] [RING4] [Y3] | |Antigen peptide transporter 1 (EC 7.4.2.-) (APT1) (ATP-binding cassette sub-family B member 2) (Peptide supply factor 1) (Peptide transporter PSF1) (PSF-1) (Peptide transporter TAP1) (Peptide transporter involved in antigen processing 1) (Really interesting new gene 4 protein) (RING4) [ABCB2] [PSF1] [RING4] [Y3] | ||
|- | |- | ||
|[[ADH1B]] | |[[ADH1B]] | ||
| | |3 | ||
|All-trans-retinol dehydrogenase [NAD( )] ADH1B (EC 1.1.1.105) (Alcohol dehydrogenase 1B) (Alcohol dehydrogenase subunit beta) [ADH2] | |All-trans-retinol dehydrogenase [NAD( )] ADH1B (EC 1.1.1.105) (Alcohol dehydrogenase 1B) (Alcohol dehydrogenase subunit beta) [ADH2] | ||
|- | |- | ||
|[[ACOX1]] | |[[ACOX1]] | ||
| | |5 | ||
|Peroxisomal acyl-coenzyme A oxidase 1 (EC 1.3.3.6) (AOX) (Palmitoyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX) [Contains: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain] [ACOX] | |Peroxisomal acyl-coenzyme A oxidase 1 (EC 1.3.3.6) (AOX) (Palmitoyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX) [Contains: Peroxisomal acyl-CoA oxidase 1, A chain; Peroxisomal acyl-CoA oxidase 1, B chain; Peroxisomal acyl-CoA oxidase 1, C chain] [ACOX] | ||
|- | |- | ||
Строка 9222: | Строка 10 310: | ||
|- | |- | ||
|[[EBP]] | |[[EBP]] | ||
| | |3 | ||
|3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein) | |3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein) | ||
|- | |- | ||
Строка 9230: | Строка 10 318: | ||
|- | |- | ||
|[[ABO]] | |[[ABO]] | ||
| | |13 | ||
|Histo-blood group ABO system transferase (Fucosylglycoprotein 3-alpha-galactosyltransferase) (Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase) (Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase) (EC 2.4.1.40) (Glycoprotein-fucosylgalactoside alpha-galactosyltransferase) (EC 2.4.1.37) (Histo-blood group A transferase) (A transferase) (Histo-blood group B transferase) (B transferase) (NAGAT) [Contains: Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form] | |Histo-blood group ABO system transferase (Fucosylglycoprotein 3-alpha-galactosyltransferase) (Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase) (Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase) (EC 2.4.1.40) (Glycoprotein-fucosylgalactoside alpha-galactosyltransferase) (EC 2.4.1.37) (Histo-blood group A transferase) (A transferase) (Histo-blood group B transferase) (B transferase) (NAGAT) [Contains: Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form] | ||
|- | |- | ||
Строка 9238: | Строка 10 326: | ||
|- | |- | ||
|[[DMP1]] | |[[DMP1]] | ||
| | |5 | ||
|Dentin matrix acidic phosphoprotein 1 precursor (DMP-1) (Dentin matrix protein 1) | |Dentin matrix acidic phosphoprotein 1 precursor (DMP-1) (Dentin matrix protein 1) | ||
|- | |||
|[[FGFR3]] | |||
|1 | |||
|Fibroblast growth factor receptor 3 precursor (EC 2.7.10.1) (FGFR-3) (CD333 antigen) [JTK4] | |||
|- | |- | ||
|[[AMPH]] | |[[AMPH]] | ||
| | |7 | ||
|Amphiphysin [AMPH1] | |Amphiphysin [AMPH1] | ||
|- | |- | ||
Строка 9252: | Строка 10 344: | ||
|1 | |1 | ||
|Calmodulin regulator protein PCP4 (Brain-specific polypeptide PEP-19) (Purkinje cell protein 4) [PEP19] | |Calmodulin regulator protein PCP4 (Brain-specific polypeptide PEP-19) (Purkinje cell protein 4) [PEP19] | ||
|- | |||
|[[TOP2A]] | |||
|2 | |||
|DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme) [TOP2] | |||
|- | |||
|[[ETV1]] | |||
|1 | |||
|ETS translocation variant 1 (Ets-related protein 81) [ER81] | |||
|- | |- | ||
|[[ORAI1]] | |[[ORAI1]] | ||
| | |2 | ||
|Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A) [CRACM1] [TMEM142A] | |Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A) [CRACM1] [TMEM142A] | ||
|- | |- | ||
|[[CD34]] | |[[CD34]] | ||
| | |46 | ||
|Hematopoietic progenitor cell antigen CD34 precursor (CD34 antigen) | |Hematopoietic progenitor cell antigen CD34 precursor (CD34 antigen) | ||
|- | |||
|[[TLR10]] | |||
|1 | |||
|Toll-like receptor 10 precursor (EC 3.2.2.6) (CD290 antigen) [UNQ315/PRO358] | |||
|- | |- | ||
|[[HLF]] | |[[HLF]] | ||
Строка 9290: | Строка 10 394: | ||
|- | |- | ||
|[[GLA]] | |[[GLA]] | ||
| | |8 | ||
|Alpha-galactosidase A precursor (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Galactosylgalactosylglucosylceramidase GLA) (EC 3.2.1.47) (Melibiase) (Agalsidase) | |Alpha-galactosidase A precursor (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Galactosylgalactosylglucosylceramidase GLA) (EC 3.2.1.47) (Melibiase) (Agalsidase) | ||
|- | |- | ||
Строка 9312: | Строка 10 416: | ||
|2 | |2 | ||
|Serum amyloid A-1 protein precursor (SAA) [Contains: Amyloid protein A (Amyloid fibril protein AA); Serum amyloid protein A(2-104); Serum amyloid protein A(3-104); Serum amyloid protein A(2-103); Serum amyloid protein A(2-102); Serum amyloid protein A(4-101)] | |Serum amyloid A-1 protein precursor (SAA) [Contains: Amyloid protein A (Amyloid fibril protein AA); Serum amyloid protein A(2-104); Serum amyloid protein A(3-104); Serum amyloid protein A(2-103); Serum amyloid protein A(2-102); Serum amyloid protein A(4-101)] | ||
|- | |||
|[[CDK8]] | |||
|1 | |||
|Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35) | |||
|- | |- | ||
|[[DPT]] | |[[DPT]] | ||
| | |4 | ||
|Dermatopontin precursor (Tyrosine-rich acidic matrix protein) (TRAMP) | |Dermatopontin precursor (Tyrosine-rich acidic matrix protein) (TRAMP) | ||
|- | |- | ||
|[[STIM1]] | |[[STIM1]] | ||
| | |4 | ||
|Stromal interaction molecule 1 precursor [GOK] | |Stromal interaction molecule 1 precursor [GOK] | ||
|- | |||
|[[UBXN2B]] | |||
|1 | |||
|UBX domain-containing protein 2B (NSFL1 cofactor p37) (p97 cofactor p37) | |||
|- | |- | ||
|[[LAMP2]] | |[[LAMP2]] | ||
| | |6 | ||
|Lysosome-associated membrane glycoprotein 2 precursor (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD107b antigen) | |Lysosome-associated membrane glycoprotein 2 precursor (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD107b antigen) | ||
|- | |- | ||
Строка 9330: | Строка 10 442: | ||
|- | |- | ||
|[[MEFV]] | |[[MEFV]] | ||
| | |2 | ||
|Pyrin (Marenostrin) [MEF] [TRIM20] | |Pyrin (Marenostrin) [MEF] [TRIM20] | ||
|- | |- | ||
Строка 9342: | Строка 10 454: | ||
|- | |- | ||
|[[AGTR1]] | |[[AGTR1]] | ||
| | |5 | ||
|Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1) [AGTR1A] [AGTR1B] [AT2R1] [AT2R1B] | |Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1) [AGTR1A] [AGTR1B] [AT2R1] [AT2R1B] | ||
|- | |- | ||
Строка 9350: | Строка 10 462: | ||
|- | |- | ||
|[[DSE]] | |[[DSE]] | ||
| | |4 | ||
|Dermatan-sulfate epimerase precursor (EC 5.1.3.19) (DS epimerase) (Chondroitin-glucuronate 5-epimerase) (Squamous cell carcinoma antigen recognized by T-cells 2) (SART-2) [SART2] | |Dermatan-sulfate epimerase precursor (EC 5.1.3.19) (DS epimerase) (Chondroitin-glucuronate 5-epimerase) (Squamous cell carcinoma antigen recognized by T-cells 2) (SART-2) [SART2] | ||
|- | |- | ||
Строка 9360: | Строка 10 472: | ||
|1 | |1 | ||
|Small ubiquitin-related modifier 1 precursor (SUMO-1) (GAP-modifying protein 1) (GMP1) (SMT3 homolog 3) (Sentrin) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C) (Ubiquitin-like protein UBL1) [SMT3C] [SMT3H3] [UBL1] [OK/SW-cl.43] | |Small ubiquitin-related modifier 1 precursor (SUMO-1) (GAP-modifying protein 1) (GMP1) (SMT3 homolog 3) (Sentrin) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C) (Ubiquitin-like protein UBL1) [SMT3C] [SMT3H3] [UBL1] [OK/SW-cl.43] | ||
|- | |||
|[[CCL25]] | |||
|1 | |||
|C-C motif chemokine 25 precursor (Chemokine TECK) (Small-inducible cytokine A25) (Thymus-expressed chemokine) [SCYA25] [TECK] | |||
|- | |- | ||
|[[CPE]] | |[[CPE]] | ||
Строка 9370: | Строка 10 486: | ||
|- | |- | ||
|[[LRRK2]] | |[[LRRK2]] | ||
| | |28 | ||
|Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin) [PARK8] | |Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin) [PARK8] | ||
|- | |- | ||
Строка 9378: | Строка 10 494: | ||
|- | |- | ||
|[[ALOX5]] | |[[ALOX5]] | ||
| | |2 | ||
|Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (EC 1.13.11.34) (5-LO) (5-lipoxygenase) [LOG5] | |Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (EC 1.13.11.34) (5-LO) (5-lipoxygenase) [LOG5] | ||
|- | |- | ||
Строка 9386: | Строка 10 502: | ||
|- | |- | ||
|[[CGA]] | |[[CGA]] | ||
| | |81 | ||
|Glycoprotein hormones alpha chain precursor (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) | |Glycoprotein hormones alpha chain precursor (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) | ||
|- | |- | ||
|[[PMP22]] | |[[PMP22]] | ||
|2 | |||
|Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3) [GAS3] | |||
|- | |||
|[[CYBA]] | |||
|1 | |1 | ||
| | |Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox) (p22phox) | ||
|- | |- | ||
|[[SRL]] | |[[SRL]] | ||
|1 | |1 | ||
|Sarcalumenin precursor | |Sarcalumenin precursor | ||
|- | |||
|[[CASP8]] | |||
|2 | |||
|Caspase-8 precursor (EC 3.4.22.61) (CASP-8) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Contains: Caspase-8 subunit p18; Caspase-8 subunit p10] [MCH5] | |||
|- | |- | ||
|[[IL17D]] | |[[IL17D]] | ||
Строка 9414: | Строка 10 538: | ||
|- | |- | ||
|[[GALC]] | |[[GALC]] | ||
| | |4 | ||
|Galactocerebrosidase precursor (EC 3.2.1.46) (GALCERase) (Galactocerebroside beta-galactosidase) (Galactosylceramidase) (Galactosylceramide beta-galactosidase) | |Galactocerebrosidase precursor (EC 3.2.1.46) (GALCERase) (Galactocerebroside beta-galactosidase) (Galactosylceramidase) (Galactosylceramide beta-galactosidase) | ||
|- | |- | ||
Строка 9422: | Строка 10 546: | ||
|- | |- | ||
|[[FGFR1]] | |[[FGFR1]] | ||
| | |12 | ||
|Fibroblast growth factor receptor 1 precursor (EC 2.7.10.1) (FGFR-1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD331 antigen) [BFGFR] [CEK] [FGFBR] [FLG] [FLT2] [HBGFR] | |Fibroblast growth factor receptor 1 precursor (EC 2.7.10.1) (FGFR-1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD331 antigen) [BFGFR] [CEK] [FGFBR] [FLG] [FLT2] [HBGFR] | ||
|- | |- | ||
Строка 9432: | Строка 10 556: | ||
|7 | |7 | ||
|Neurotensin/neuromedin N precursor [Contains: Large neuromedin N (NmN-125); Neuromedin N (NN) (NmN); Neurotensin (NT); Tail peptide] | |Neurotensin/neuromedin N precursor [Contains: Large neuromedin N (NmN-125); Neuromedin N (NN) (NmN); Neurotensin (NT); Tail peptide] | ||
|- | |||
|[[AURKC]] | |||
|1 | |||
|Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) [AIE2] [AIK3] [AIRK3] [ARK3] [STK13] | |||
|- | |||
|[[CD244]] | |||
|1 | |||
|Natural killer cell receptor 2B4 precursor (NK cell activation-inducing ligand) (NAIL) (NK cell type I receptor protein 2B4) (NKR2B4) (h2B4) (SLAM family member 4) (SLAMF4) (Signaling lymphocytic activation molecule 4) (CD244 antigen) [2B4] | |||
|- | |- | ||
|[[ISL1]] | |[[ISL1]] | ||
| | |2 | ||
|Insulin gene enhancer protein ISL-1 (Islet-1) | |Insulin gene enhancer protein ISL-1 (Islet-1) | ||
|- | |- | ||
Строка 9440: | Строка 10 572: | ||
|2 | |2 | ||
|Apolipoprotein L1 precursor (Apolipoprotein L) (Apo-L) (ApoL) (Apolipoprotein L-I) (ApoL-I) [APOL] | |Apolipoprotein L1 precursor (Apolipoprotein L) (Apo-L) (ApoL) (Apolipoprotein L-I) (ApoL-I) [APOL] | ||
|- | |||
|[[SUSD1]] | |||
|1 | |||
|domain-containing protein 1 precursor [UNQ2438/PRO4999] | |||
|- | |- | ||
|[[SIX2]] | |[[SIX2]] | ||
Строка 9448: | Строка 10 584: | ||
|1 | |1 | ||
|Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3) [CTNNG] [DP3] | |Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3) [CTNNG] [DP3] | ||
|- | |||
|[[HJURP]] | |||
|1 | |||
|Holliday junction recognition protein (14-3-3-associated AKT substrate) (Fetal liver-expressing gene 1 protein) (Up-regulated in lung cancer 9) [FAKTS] [FLEG1] [URLC9] | |||
|- | |- | ||
|[[FZD4]] | |[[FZD4]] | ||
Строка 9458: | Строка 10 598: | ||
|- | |- | ||
|[[GNE]] | |[[GNE]] | ||
| | |4 | ||
|Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)] [GLCNE] | |Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)] [GLCNE] | ||
|- | |||
|[[EIF5A]] | |||
|2 | |||
|Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (Rev-binding factor) (eIF-4D) | |||
|- | |- | ||
|[[TREM1]] | |[[TREM1]] | ||
Строка 9478: | Строка 10 622: | ||
|- | |- | ||
|[[HGF]] | |[[HGF]] | ||
| | |29 | ||
|Hepatocyte growth factor precursor (Hepatopoietin-A) (Scatter factor) (SF) [Contains: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain] [HPTA] | |Hepatocyte growth factor precursor (Hepatopoietin-A) (Scatter factor) (SF) [Contains: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain] [HPTA] | ||
|- | |- | ||
Строка 9494: | Строка 10 638: | ||
|- | |- | ||
|[[DRD4]] | |[[DRD4]] | ||
| | |5 | ||
|D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor) | |D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor) | ||
|- | |- | ||
|[[ACE]] | |[[ACE]] | ||
| | |80 | ||
|Angiotensin-converting enzyme precursor (EC 3.2.1.-) (EC 3.4.15.1) (ACE) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD143 antigen) [Contains: Angiotensin-converting enzyme, soluble form] [DCP] [DCP1] | |Angiotensin-converting enzyme precursor (EC 3.2.1.-) (EC 3.4.15.1) (ACE) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD143 antigen) [Contains: Angiotensin-converting enzyme, soluble form] [DCP] [DCP1] | ||
|- | |- | ||
Строка 9506: | Строка 10 650: | ||
|- | |- | ||
|[[CALR]] | |[[CALR]] | ||
| | |2 | ||
|Calreticulin precursor (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60) [CRTC] | |Calreticulin precursor (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60) [CRTC] | ||
|- | |- | ||
|[[NAMPT]] | |[[NAMPT]] | ||
| | |23 | ||
|Nicotinamide phosphoribosyltransferase (EC 2.4.2.12) (NAmPRTase) (Nampt) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin) [PBEF] [PBEF1] | |Nicotinamide phosphoribosyltransferase (EC 2.4.2.12) (NAmPRTase) (Nampt) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin) [PBEF] [PBEF1] | ||
|- | |- | ||
|[[NOTCH1]] | |[[NOTCH1]] | ||
| | |7 | ||
|Neurogenic locus notch homolog protein 1 precursor (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Contains: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] [TAN1] | |Neurogenic locus notch homolog protein 1 precursor (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Contains: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)] [TAN1] | ||
|- | |- | ||
Строка 9532: | Строка 10 676: | ||
|6 | |6 | ||
|Glycerol-3-phosphate phosphatase (EC 3.1.3.21) (G3PP) (Aspartate-based ubiquitous Mg(2 )-dependent phosphatase) (EC 3.1.3.48) (AUM) (Phosphoglycolate phosphatase) (PGP) | |Glycerol-3-phosphate phosphatase (EC 3.1.3.21) (G3PP) (Aspartate-based ubiquitous Mg(2 )-dependent phosphatase) (EC 3.1.3.48) (AUM) (Phosphoglycolate phosphatase) (PGP) | ||
|- | |||
|[[PPT1]] | |||
|1 | |||
|Palmitoyl-protein thioesterase 1 precursor (EC 3.1.2.22) (PPT-1) (Palmitoyl-protein hydrolase 1) [CLN1] [PPT] | |||
|- | |- | ||
|[[ITGB2]] | |[[ITGB2]] | ||
| | |2 | ||
|Integrin beta-2 precursor (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD18 antigen) [CD18] [MFI7] | |Integrin beta-2 precursor (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD18 antigen) [CD18] [MFI7] | ||
|- | |- | ||
Строка 9550: | Строка 10 698: | ||
|- | |- | ||
|[[NOX4]] | |[[NOX4]] | ||
| | |22 | ||
|NADPH oxidase 4 (EC 1.6.3.-) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase) [RENOX] | |NADPH oxidase 4 (EC 1.6.3.-) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase) [RENOX] | ||
|- | |- | ||
Строка 9560: | Строка 10 708: | ||
|2 | |2 | ||
|[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial precursor (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII) [PDHK2] | |[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial precursor (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII) [PDHK2] | ||
|- | |||
|[[NEGR1]] | |||
|1 | |||
|Neuronal growth regulator 1 precursor (IgLON family member 4) [IGLON4] [UNQ2433/PRO4993] | |||
|- | |- | ||
|[[FRAS1]] | |[[FRAS1]] | ||
|1 | |1 | ||
|Extracellular matrix organizing protein FRAS1 precursor (Fraser syndrome 1 protein) [KIAA1500] | |Extracellular matrix organizing protein FRAS1 precursor (Fraser syndrome 1 protein) [KIAA1500] | ||
|- | |||
|[[CCNI]] | |||
|1 | |||
|Cyclin-I | |||
|- | |- | ||
|[[NKX6-1]] | |[[NKX6-1]] | ||
Строка 9570: | Строка 10 726: | ||
|- | |- | ||
|[[MAP2]] | |[[MAP2]] | ||
| | |11 | ||
|Microtubule-associated protein 2 (MAP-2) | |Microtubule-associated protein 2 (MAP-2) | ||
|- | |- | ||
Строка 9578: | Строка 10 734: | ||
|- | |- | ||
|[[SMN2]] | |[[SMN2]] | ||
| | |5 | ||
|Survival motor neuron protein (Component of gems 1) (Gemin-1) [SMNC] | |Survival motor neuron protein (Component of gems 1) (Gemin-1) [SMNC] | ||
|- | |- | ||
|[[FOXL2]] | |[[FOXL2]] | ||
| | |3 | ||
|Forkhead box protein L2 | |Forkhead box protein L2 | ||
|- | |- | ||
Строка 9590: | Строка 10 746: | ||
|- | |- | ||
|[[LOX]] | |[[LOX]] | ||
| | |20 | ||
|Protein-lysine 6-oxidase precursor (EC 1.4.3.13) (Lysyl oxidase) [Contains: Protein-lysine 6-oxidase, long form; Protein-lysine 6-oxidase, short form] | |Protein-lysine 6-oxidase precursor (EC 1.4.3.13) (Lysyl oxidase) [Contains: Protein-lysine 6-oxidase, long form; Protein-lysine 6-oxidase, short form] | ||
|- | |- | ||
Строка 9624: | Строка 10 780: | ||
|1 | |1 | ||
|ER degradation-enhancing alpha-mannosidase-like protein 1 [EDEM] [KIAA0212] | |ER degradation-enhancing alpha-mannosidase-like protein 1 [EDEM] [KIAA0212] | ||
|- | |||
|[[MVP]] | |||
|1 | |||
|Major vault protein (MVP) (Lung resistance-related protein) [LRP] | |||
|- | |- | ||
|[[ADA2]] | |[[ADA2]] | ||
Строка 9636: | Строка 10 796: | ||
|2 | |2 | ||
|Uracil nucleotide/cysteinyl leukotriene receptor (UDP/CysLT receptor) (G-protein coupled receptor 17) (P2Y-like receptor) (R12) | |Uracil nucleotide/cysteinyl leukotriene receptor (UDP/CysLT receptor) (G-protein coupled receptor 17) (P2Y-like receptor) (R12) | ||
|- | |||
|[[FTL]] | |||
|1 | |||
|Ferritin light chain (Ferritin L subunit) | |||
|- | |||
|[[FOXA3]] | |||
|1 | |||
|Hepatocyte nuclear factor 3-gamma (HNF-3-gamma) (HNF-3G) (Fork head-related protein FKH H3) (Forkhead box protein A3) (Transcription factor 3G) (TCF-3G) [HNF3G] [TCF3G] | |||
|- | |- | ||
|[[GPT]] | |[[GPT]] | ||
Строка 9646: | Строка 10 814: | ||
|- | |- | ||
|[[IL2]] | |[[IL2]] | ||
| | |7 | ||
|Interleukin-2 precursor (IL-2) (T-cell growth factor) (TCGF) (Aldesleukin) | |Interleukin-2 precursor (IL-2) (T-cell growth factor) (TCGF) (Aldesleukin) | ||
|- | |- | ||
Строка 9658: | Строка 10 826: | ||
|- | |- | ||
|[[ESR1]] | |[[ESR1]] | ||
| | |8 | ||
|Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) [ESR] [NR3A1] | |Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) [ESR] [NR3A1] | ||
|- | |- | ||
Строка 9666: | Строка 10 834: | ||
|- | |- | ||
|[[SOD2]] | |[[SOD2]] | ||
| | |95 | ||
|Superoxide dismutase [Mn], mitochondrial precursor (EC 1.15.1.1) | |Superoxide dismutase [Mn], mitochondrial precursor (EC 1.15.1.1) | ||
|- | |- | ||
Строка 9674: | Строка 10 842: | ||
|- | |- | ||
|[[PKP2]] | |[[PKP2]] | ||
|2 | |||
|Plakophilin-2 | |||
|- | |||
|[[SLC16A3]] | |||
|1 | |1 | ||
| | |Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3) [MCT4] | ||
|- | |- | ||
|[[UQCRFS1]] | |[[UQCRFS1]] | ||
Строка 9682: | Строка 10 854: | ||
|- | |- | ||
|[[ANGPTL2]] | |[[ANGPTL2]] | ||
| | |3 | ||
|Angiopoietin-related protein 2 precursor (Angiopoietin-like protein 2) [ARP2] [UNQ170/PRO196] | |Angiopoietin-related protein 2 precursor (Angiopoietin-like protein 2) [ARP2] [UNQ170/PRO196] | ||
|- | |- | ||
|[[GCKR]] | |[[GCKR]] | ||
| | |4 | ||
|Glucokinase regulatory protein (GKRP) (Glucokinase regulator) | |Glucokinase regulatory protein (GKRP) (Glucokinase regulator) | ||
|- | |||
|[[DEK]] | |||
|1 | |||
|Protein DEK | |||
|- | |||
|[[JMJD1C]] | |||
|1 | |||
|Probable JmjC domain-containing histone demethylation protein 2C (EC 1.14.11.-) (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8) (TR-interacting protein 8) (TRIP-8) [JHDM2C] [KIAA1380] [TRIP8] | |||
|- | |- | ||
|[[VAPB]] | |[[VAPB]] | ||
Строка 9696: | Строка 10 876: | ||
|1 | |1 | ||
|Delta-like protein 4 precursor (Drosophila Delta homolog 4) (Delta4) [UNQ1895/PRO4341] | |Delta-like protein 4 precursor (Drosophila Delta homolog 4) (Delta4) [UNQ1895/PRO4341] | ||
|- | |||
|[[COX5A]] | |||
|1 | |||
|Cytochrome c oxidase subunit 5A, mitochondrial precursor (Cytochrome c oxidase polypeptide Va) | |||
|- | |- | ||
|[[STAT6]] | |[[STAT6]] | ||
| | |4 | ||
|Signal transducer and activator of transcription 6 (IL-4 Stat) | |Signal transducer and activator of transcription 6 (IL-4 Stat) | ||
|- | |- | ||
|[[TLR6]] | |[[TLR6]] | ||
| | |3 | ||
|Toll-like receptor 6 precursor (EC 3.2.2.6) (CD286 antigen) | |Toll-like receptor 6 precursor (EC 3.2.2.6) (CD286 antigen) | ||
|- | |- | ||
|[[GAP43]] | |[[GAP43]] | ||
| | |7 | ||
|Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46) | |Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46) | ||
|- | |- | ||
Строка 9734: | Строка 10 918: | ||
|- | |- | ||
|[[HDAC6]] | |[[HDAC6]] | ||
| | |6 | ||
|Histone deacetylase 6 (EC 3.5.1.98) (HD6) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) [KIAA0901] [JM21] | |Histone deacetylase 6 (EC 3.5.1.98) (HD6) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-) [KIAA0901] [JM21] | ||
|- | |- | ||
|[[LGI1]] | |[[LGI1]] | ||
|2 | |||
|Leucine-rich glioma-inactivated protein 1 precursor (Epitempin-1) [EPT] [UNQ775/PRO1569] | |||
|- | |||
|[[PCGF3]] | |||
|1 | |1 | ||
| | |group RING finger protein 3 (RING finger protein 3A) [RNF3] [RNF3A] | ||
|- | |- | ||
|[[AKT3]] | |[[AKT3]] | ||
Строка 9766: | Строка 10 954: | ||
|- | |- | ||
|[[CD9]] | |[[CD9]] | ||
| | |10 | ||
|CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD9 antigen) [MIC3] [TSPAN29] [GIG2] | |CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD9 antigen) [MIC3] [TSPAN29] [GIG2] | ||
|- | |- | ||
Строка 9776: | Строка 10 964: | ||
|1 | |1 | ||
|Nascent polypeptide-associated complex subunit alpha (NAC-alpha) (Alpha-NAC) (Allergen Hom s 2) [HSD48] | |Nascent polypeptide-associated complex subunit alpha (NAC-alpha) (Alpha-NAC) (Allergen Hom s 2) [HSD48] | ||
|- | |||
|[[CD70]] | |||
|2 | |||
|CD70 antigen (CD27 ligand) (CD27-L) (Tumor necrosis factor ligand superfamily member 7) [CD27L] [CD27LG] [TNFSF7] | |||
|- | |- | ||
|[[OR51E1]] | |[[OR51E1]] | ||
|1 | |1 | ||
|Olfactory receptor 51E1 (D-GPCR) (G-protein coupled receptor 164) (Olfactory receptor 52A3) (Prostate-overexpressed G protein-coupled receptor) (Prostate-specific G protein-coupled receptor 2) [GPR164] [OR51E1P] [OR52A3P] [POGR] [PSGR2] | |Olfactory receptor 51E1 (D-GPCR) (G-protein coupled receptor 164) (Olfactory receptor 52A3) (Prostate-overexpressed G protein-coupled receptor) (Prostate-specific G protein-coupled receptor 2) [GPR164] [OR51E1P] [OR52A3P] [POGR] [PSGR2] | ||
|- | |||
|[[CDK18]] | |||
|1 | |||
|Cyclin-dependent kinase 18 (EC 2.7.11.22) (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3) [PCTAIRE3] [PCTK3] | |||
|- | |- | ||
|[[NBPF6]] | |[[NBPF6]] | ||
Строка 9786: | Строка 10 982: | ||
|- | |- | ||
|[[AFP]] | |[[AFP]] | ||
| | |6 | ||
|Alpha-fetoprotein precursor (Alpha-1-fetoprotein) (Alpha-fetoglobulin) [HPAFP] | |Alpha-fetoprotein precursor (Alpha-1-fetoprotein) (Alpha-fetoglobulin) [HPAFP] | ||
|- | |- | ||
Строка 9798: | Строка 10 994: | ||
|- | |- | ||
|[[MGA]] | |[[MGA]] | ||
| | |4 | ||
|MAX gene-associated protein (MAX dimerization protein 5) [KIAA0518] [MAD5] | |MAX gene-associated protein (MAX dimerization protein 5) [KIAA0518] [MAD5] | ||
|- | |- | ||
Строка 9806: | Строка 11 002: | ||
|- | |- | ||
|[[SRF]] | |[[SRF]] | ||
| | |11 | ||
|Serum response factor (SRF) | |Serum response factor (SRF) | ||
|- | |- | ||
|[[TBP]] | |[[TBP]] | ||
| | |6 | ||
|TATA-box-binding protein (TATA sequence-binding protein) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit) [GTF2D1] [TF2D] [TFIID] | |TATA-box-binding protein (TATA sequence-binding protein) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit) [GTF2D1] [TF2D] [TFIID] | ||
|- | |- | ||
Строка 9830: | Строка 11 026: | ||
|- | |- | ||
|[[TNFSF10]] | |[[TNFSF10]] | ||
| | |2 | ||
|Tumor necrosis factor ligand superfamily member 10 (Apo-2 ligand) (Apo-2L) (TNF-related apoptosis-inducing ligand) (Protein TRAIL) (CD253 antigen) [APO2L] [TRAIL] | |Tumor necrosis factor ligand superfamily member 10 (Apo-2 ligand) (Apo-2L) (TNF-related apoptosis-inducing ligand) (Protein TRAIL) (CD253 antigen) [APO2L] [TRAIL] | ||
|- | |- | ||
Строка 9842: | Строка 11 038: | ||
|- | |- | ||
|[[STS]] | |[[STS]] | ||
| | |38 | ||
|Steryl-sulfatase precursor (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase) [ARSC1] | |Steryl-sulfatase precursor (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Estrone sulfatase) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase) [ARSC1] | ||
|- | |- | ||
|[[BPIFB4]] | |[[BPIFB4]] | ||
| | |9 | ||
|BPI fold-containing family B member 4 precursor (Ligand-binding protein RY2G5) (Long palate, lung and nasal epithelium carcinoma-associated protein 4) [C20orf186] [LPLUNC4] | |BPI fold-containing family B member 4 precursor (Ligand-binding protein RY2G5) (Long palate, lung and nasal epithelium carcinoma-associated protein 4) [C20orf186] [LPLUNC4] | ||
|- | |- | ||
Строка 9862: | Строка 11 058: | ||
|- | |- | ||
|[[NEDD4]] | |[[NEDD4]] | ||
| | |2 | ||
|E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (Cell proliferation-inducing gene 53 protein) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4) [KIAA0093] [NEDD4-1] [PIG53] | |E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (Cell proliferation-inducing gene 53 protein) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4) [KIAA0093] [NEDD4-1] [PIG53] | ||
|- | |- | ||
|[[XIAP]] | |[[XIAP]] | ||
| | |9 | ||
|E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP) [API3] [BIRC4] [IAP3] | |E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP) [API3] [BIRC4] [IAP3] | ||
|- | |- | ||
Строка 9888: | Строка 11 084: | ||
|1 | |1 | ||
|Collagen alpha-1(XIII) chain (COLXIIIA1) | |Collagen alpha-1(XIII) chain (COLXIIIA1) | ||
|- | |||
|[[CMKLR1]] | |||
|1 | |||
|Chemokine-like receptor 1 (G-protein coupled receptor ChemR23) (G-protein coupled receptor DEZ) [CHEMR23] [DEZ] | |||
|- | |- | ||
|[[CABLES1]] | |[[CABLES1]] | ||
Строка 9896: | Строка 11 096: | ||
|1 | |1 | ||
|Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor) [GPR74] [NPFF2] [NPGPR] | |Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor) [GPR74] [NPFF2] [NPGPR] | ||
|- | |||
|[[MTHFD2]] | |||
|1 | |||
|Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial precursor [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)] [NMDMC] | |||
|- | |- | ||
|[[MALT1]] | |[[MALT1]] | ||
Строка 9905: | Строка 11 109: | ||
|G1/S-specific cyclin-D2 | |G1/S-specific cyclin-D2 | ||
|- | |- | ||
|[[ | |[[CD226]] | ||
|1 | |1 | ||
| | |CD226 antigen precursor (DNAX accessory molecule 1) (DNAM-1) [DNAM1] | ||
|- | |- | ||
|[[ | |[[CCL23]] | ||
|1 | |||
|C-C motif chemokine 23 precursor (CK-beta-8) (CKB-8) (Macrophage inflammatory protein 3) (MIP-3) (Myeloid progenitor inhibitory factor 1) (MPIF-1) (Small-inducible cytokine A23) [Contains: CCL23(19-99); CCL23(22-99); CCL23(27-99); CCL23(30-99)] [MIP3] [MPIF1] [SCYA23] | |||
|- | |||
|[[ZNF644]] | |||
|1 | |||
|Zinc finger protein 644 (Zinc finger motif enhancer-binding protein 2) (Zep-2) [KIAA1221] [ZEP2] | |||
|- | |||
|[[PSTK]] | |||
|1 | |1 | ||
| | |L-seryl-tRNA(Sec) kinase (EC 2.7.1.164) (O-phosphoseryl-tRNA(Sec) kinase) [C10orf89] | ||
|- | |- | ||
|[[GCLC]] | |[[GCLC]] | ||
| | |10 | ||
|Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase) [GLCL] [GLCLC] | |Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase) [GLCL] [GLCLC] | ||
|- | |- | ||
Строка 9926: | Строка 11 138: | ||
|- | |- | ||
|[[DSPP]] | |[[DSPP]] | ||
|2 | |||
|Dentin sialophosphoprotein precursor [Contains: Dentin phosphoprotein (Dentin phosphophoryn) (DPP); Dentin sialoprotein (DSP)] | |||
|- | |||
|[[HOXA9]] | |||
|1 | |1 | ||
| | |Homeobox protein Hox-A9 (Homeobox protein Hox-1G) [HOX1G] | ||
|- | |||
|[[ONECUT1]] | |||
|1 | |||
|Hepatocyte nuclear factor 6 (HNF-6) (One cut domain family member 1) (One cut homeobox 1) [HNF6] [HNF6A] | |||
|- | |- | ||
|[[IL17RC]] | |[[IL17RC]] | ||
Строка 9942: | Строка 11 162: | ||
|- | |- | ||
|[[RCAN1]] | |[[RCAN1]] | ||
| | |4 | ||
|Calcipressin-1 (Adapt78) (Down syndrome critical region protein 1) (Myocyte-enriched calcineurin-interacting protein 1) (MCIP1) (Regulator of calcineurin 1) [ADAPT78] [CSP1] [DSC1] [DSCR1] | |Calcipressin-1 (Adapt78) (Down syndrome critical region protein 1) (Myocyte-enriched calcineurin-interacting protein 1) (MCIP1) (Regulator of calcineurin 1) [ADAPT78] [CSP1] [DSC1] [DSCR1] | ||
|- | |- | ||
Строка 9948: | Строка 11 168: | ||
|1 | |1 | ||
|Propionyl-CoA carboxylase alpha chain, mitochondrial precursor (EC 6.4.1.3) (PCCase subunit alpha) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) | |Propionyl-CoA carboxylase alpha chain, mitochondrial precursor (EC 6.4.1.3) (PCCase subunit alpha) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) | ||
|- | |||
|[[FKBP1A]] | |||
|1 | |||
|Peptidyl-prolyl cis-trans isomerase FKBP1A (EC 5.2.1.8) (PPIase FKBP1A) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) [FKBP1] [FKBP12] | |||
|- | |- | ||
|[[GABARAP]] | |[[GABARAP]] | ||
| | |2 | ||
|Gamma-aminobutyric acid receptor-associated protein precursor (GABA(A) receptor-associated protein) (MM46) [FLC3B] [HT004] | |Gamma-aminobutyric acid receptor-associated protein precursor (GABA(A) receptor-associated protein) (MM46) [FLC3B] [HT004] | ||
|- | |- | ||
|[[FSTL3]] | |[[FSTL3]] | ||
| | |3 | ||
|Follistatin-related protein 3 precursor (Follistatin-like protein 3) (Follistatin-related gene protein) [FLRG] [UNQ674/PRO1308] | |Follistatin-related protein 3 precursor (Follistatin-like protein 3) (Follistatin-related gene protein) [FLRG] [UNQ674/PRO1308] | ||
|- | |- | ||
|[[TIMP2]] | |[[TIMP2]] | ||
| | |4 | ||
|Metalloproteinase inhibitor 2 precursor (CSC-21K) (Tissue inhibitor of metalloproteinases 2) (TIMP-2) | |Metalloproteinase inhibitor 2 precursor (CSC-21K) (Tissue inhibitor of metalloproteinases 2) (TIMP-2) | ||
|- | |- | ||
Строка 9982: | Строка 11 206: | ||
|- | |- | ||
|[[CD74]] | |[[CD74]] | ||
| | |6 | ||
|HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain) (Ii) (CD74 antigen) [Contains: Class-II-associated invariant chain peptide (CLIP)] [DHLAG] | |HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain) (Ii) (CD74 antigen) [Contains: Class-II-associated invariant chain peptide (CLIP)] [DHLAG] | ||
|- | |- | ||
Строка 9988: | Строка 11 212: | ||
|1 | |1 | ||
|[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial precursor (EC 3.1.3.43) (PDP 2) (Pyruvate dehydrogenase phosphatase catalytic subunit 2) (PDPC 2) [KIAA1348] | |[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial precursor (EC 3.1.3.43) (PDP 2) (Pyruvate dehydrogenase phosphatase catalytic subunit 2) (PDPC 2) [KIAA1348] | ||
|- | |||
|[[TPCN1]] | |||
|1 | |||
|Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1) [KIAA1169] [TPC1] | |||
|- | |- | ||
|[[NR3C1]] | |[[NR3C1]] | ||
Строка 9994: | Строка 11 222: | ||
|- | |- | ||
|[[CXCR4]] | |[[CXCR4]] | ||
| | |25 | ||
|C-X-C chemokine receptor type 4 (CXC-R4) (CXCR-4) (FB22) (Fusin) (HM89) (LCR1) (Leukocyte-derived seven transmembrane domain receptor) (LESTR) (Lipopolysaccharide-associated protein 3) (LAP-3) (LPS-associated protein 3) (NPYRL) (Stromal cell-derived factor 1 receptor) (SDF-1 receptor) (CD184 antigen) | |C-X-C chemokine receptor type 4 (CXC-R4) (CXCR-4) (FB22) (Fusin) (HM89) (LCR1) (Leukocyte-derived seven transmembrane domain receptor) (LESTR) (Lipopolysaccharide-associated protein 3) (LAP-3) (LPS-associated protein 3) (NPYRL) (Stromal cell-derived factor 1 receptor) (SDF-1 receptor) (CD184 antigen) | ||
|- | |||
|[[ENTPD1]] | |||
|1 | |||
|Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (NTPDase 1) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (CD39 antigen) [CD39] | |||
|- | |- | ||
|[[RNASEL]] | |[[RNASEL]] | ||
Строка 10 002: | Строка 11 234: | ||
|- | |- | ||
|[[STAR]] | |[[STAR]] | ||
| | |2 | ||
|Steroidogenic acute regulatory protein, mitochondrial precursor (StAR) (START domain-containing protein 1) (StARD1) [STARD1] | |Steroidogenic acute regulatory protein, mitochondrial precursor (StAR) (START domain-containing protein 1) (StARD1) [STARD1] | ||
|- | |- | ||
Строка 10 008: | Строка 11 240: | ||
|1 | |1 | ||
|Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) [CHSY] [CSS1] [KIAA0990] [UNQ756/PRO1487] | |Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) [CHSY] [CSS1] [KIAA0990] [UNQ756/PRO1487] | ||
|- | |||
|[[DCXR]] | |||
|1 | |||
|L-xylulose reductase (EC 1.1.1.10) (XR) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H) [SDR20C1] | |||
|- | |- | ||
|[[RAD50]] | |[[RAD50]] | ||
| | |8 | ||
|DNA repair protein RAD50 (EC 3.6.-.-) (hRAD50) | |DNA repair protein RAD50 (EC 3.6.-.-) (hRAD50) | ||
|- | |- | ||
Строка 10 018: | Строка 11 254: | ||
|- | |- | ||
|[[CDK5]] | |[[CDK5]] | ||
| | |8 | ||
|Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) [CDKN5] | |Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) [CDKN5] | ||
|- | |- | ||
Строка 10 024: | Строка 11 260: | ||
|1 | |1 | ||
|Gremlin-1 precursor (Cell proliferation-inducing gene 2 protein) (Cysteine knot superfamily 1, BMP antagonist 1) (DAN domain family member 2) (Down-regulated in Mos-transformed cells protein) (Increased in high glucose protein 2) (IHG-2) [CKTSF1B1] [DAND2] [DRM] [PIG2] | |Gremlin-1 precursor (Cell proliferation-inducing gene 2 protein) (Cysteine knot superfamily 1, BMP antagonist 1) (DAN domain family member 2) (Down-regulated in Mos-transformed cells protein) (Increased in high glucose protein 2) (IHG-2) [CKTSF1B1] [DAND2] [DRM] [PIG2] | ||
|- | |||
|[[TDRD1]] | |||
|1 | |||
|Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1) | |||
|- | |- | ||
|[[ATG16L2]] | |[[ATG16L2]] | ||
Строка 10 042: | Строка 11 282: | ||
|- | |- | ||
|[[MTOR]] | |[[MTOR]] | ||
| | |24 | ||
|Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1) [FRAP] [FRAP1] [FRAP2] [RAFT1] [RAPT1] | |Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1) [FRAP] [FRAP1] [FRAP2] [RAFT1] [RAPT1] | ||
|- | |- | ||
|[[AGA]] | |[[AGA]] | ||
| | |7 | ||
|N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase precursor (EC 3.5.1.26) (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Contains: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] | |N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase precursor (EC 3.5.1.26) (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Contains: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] | ||
|- | |||
|[[MATN2]] | |||
|1 | |||
|Matrilin-2 precursor [UNQ193/PRO219] | |||
|- | |- | ||
|[[TLR8]] | |[[TLR8]] | ||
| | |5 | ||
|Toll-like receptor 8 precursor (CD288 antigen) [UNQ249/PRO286] | |Toll-like receptor 8 precursor (CD288 antigen) [UNQ249/PRO286] | ||
|- | |- | ||
Строка 10 062: | Строка 11 306: | ||
|- | |- | ||
|[[BMP15]] | |[[BMP15]] | ||
| | |6 | ||
|Bone morphogenetic protein 15 precursor (BMP-15) (Growth/differentiation factor 9B) (GDF-9B) [GDF9B] | |Bone morphogenetic protein 15 precursor (BMP-15) (Growth/differentiation factor 9B) (GDF-9B) [GDF9B] | ||
|- | |- | ||
|[[APOA1]] | |[[APOA1]] | ||
| | |4 | ||
|Apolipoprotein A-I precursor (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Contains: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))] | |Apolipoprotein A-I precursor (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Contains: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))] | ||
|- | |- | ||
Строка 10 084: | Строка 11 328: | ||
|1 | |1 | ||
|Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2) [SYB2] | |Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2) [SYB2] | ||
|- | |||
|[[RAMP2]] | |||
|1 | |||
|Receptor activity-modifying protein 2 precursor (Calcitonin-receptor-like receptor activity-modifying protein 2) (CRLR activity-modifying protein 2) | |||
|- | |- | ||
|[[RTN4]] | |[[RTN4]] | ||
Строка 10 090: | Строка 11 338: | ||
|- | |- | ||
|[[GIT2]] | |[[GIT2]] | ||
| | |5 | ||
|ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2) [KIAA0148] | |ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2) [KIAA0148] | ||
|- | |- | ||
|[[PTS]] | |[[PTS]] | ||
| | |4 | ||
|6-pyruvoyl tetrahydrobiopterin synthase (EC 4.2.3.12) (PTP synthase) (PTPS) | |6-pyruvoyl tetrahydrobiopterin synthase (EC 4.2.3.12) (PTP synthase) (PTPS) | ||
|- | |- | ||
|[[SGK1]] | |[[SGK1]] | ||
|2 | |||
|Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) [SGK] | |||
|- | |||
|[[BSG]] | |||
|1 | |1 | ||
| | |Basigin precursor (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD147 antigen) [UNQ6505/PRO21383] | ||
|- | |- | ||
|[[FUNDC1]] | |[[FUNDC1]] | ||
|3 | |3 | ||
|FUN14 domain-containing protein 1 | |FUN14 domain-containing protein 1 | ||
|- | |- | ||
|[[AVPR1A]] | |[[AVPR1A]] | ||
Строка 10 118: | Строка 11 366: | ||
|- | |- | ||
|[[S100A8]] | |[[S100A8]] | ||
| | |6 | ||
|Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calcium-binding protein A8) (Urinary stone protein band A) [CAGA] [CFAG] [MRP8] | |Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calcium-binding protein A8) (Urinary stone protein band A) [CAGA] [CFAG] [MRP8] | ||
|- | |- | ||
|[[SNAP25]] | |[[SNAP25]] | ||
| | |6 | ||
|Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein) [SNAP] | |Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein) [SNAP] | ||
|- | |||
|[[NHP2]] | |||
|1 | |||
|H/ACA ribonucleoprotein complex subunit 2 (Nucleolar protein family A member 2) (snoRNP protein NHP2) [NOLA2] [HSPC286] | |||
|- | |||
|[[TERF2]] | |||
|2 | |||
|Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein) [TRBF2] [TRF2] | |||
|- | |- | ||
|[[GZMH]] | |[[GZMH]] | ||
Строка 10 137: | Строка 11 393: | ||
|Uromodulin precursor (Tamm-Horsfall urinary glycoprotein) (THP) [Contains: Uromodulin, secreted form] | |Uromodulin precursor (Tamm-Horsfall urinary glycoprotein) (THP) [Contains: Uromodulin, secreted form] | ||
|- | |- | ||
|[[DRAM1]] | |[[TIMP3]] | ||
|1 | |||
|Metalloproteinase inhibitor 3 precursor (Protein MIG-5) (Tissue inhibitor of metalloproteinases 3) (TIMP-3) | |||
|- | |||
|[[CD207]] | |||
|1 | |||
|C-type lectin domain family 4 member K (Langerin) (CD207 antigen) [CLEC4K] | |||
|- | |||
|[[DRAM1]] | |||
|2 | |2 | ||
|DNA damage-regulated autophagy modulator protein 1 (Damage-regulated autophagy modulator) [DRAM] | |DNA damage-regulated autophagy modulator protein 1 (Damage-regulated autophagy modulator) [DRAM] | ||
|- | |- | ||
|[[NGF]] | |[[NGF]] | ||
| | |45 | ||
|Beta-nerve growth factor precursor (Beta-NGF) [NGFB] | |Beta-nerve growth factor precursor (Beta-NGF) [NGFB] | ||
|- | |- | ||
Строка 10 152: | Строка 11 416: | ||
|2 | |2 | ||
|Laforin (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase) (LAFPTPase) | |Laforin (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (Glucan phosphatase) (Glycogen phosphatase) (Lafora PTPase) (LAFPTPase) | ||
|- | |||
|[[MTCH2]] | |||
|1 | |||
|Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein) [MIMP] [HSPC032] | |||
|- | |- | ||
|[[CDK2]] | |[[CDK2]] | ||
| | |18 | ||
|Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) [CDKN2] | |Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) [CDKN2] | ||
|- | |- | ||
|[[TFAM]] | |[[TFAM]] | ||
| | |31 | ||
|Transcription factor A, mitochondrial precursor (mtTFA) (Mitochondrial transcription factor 1) (MtTF1) (Transcription factor 6) (TCF-6) (Transcription factor 6-like 2) [TCF6] [TCF6L2] | |Transcription factor A, mitochondrial precursor (mtTFA) (Mitochondrial transcription factor 1) (MtTF1) (Transcription factor 6) (TCF-6) (Transcription factor 6-like 2) [TCF6] [TCF6L2] | ||
|- | |- | ||
Строка 10 186: | Строка 11 454: | ||
|- | |- | ||
|[[GSTK1]] | |[[GSTK1]] | ||
| | |2 | ||
|Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13) [HDCMD47P] | |Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13) [HDCMD47P] | ||
|- | |- | ||
Строка 10 208: | Строка 11 476: | ||
|1 | |1 | ||
|Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) [ABL] [JTK7] | |Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) [ABL] [JTK7] | ||
|- | |||
|[[MPP3]] | |||
|1 | |||
|MAGUK p55 subfamily member 3 (Discs large homolog 3) (Protein MPP3) [DLG3] | |||
|- | |- | ||
|[[TSHR]] | |[[TSHR]] | ||
Строка 10 214: | Строка 11 486: | ||
|- | |- | ||
|[[MFN2]] | |[[MFN2]] | ||
| | |14 | ||
|Mitofusin-2 (EC 3.6.5.-) (Transmembrane GTPase MFN2) [CPRP1] [KIAA0214] | |Mitofusin-2 (EC 3.6.5.-) (Transmembrane GTPase MFN2) [CPRP1] [KIAA0214] | ||
|- | |- | ||
Строка 10 222: | Строка 11 494: | ||
|- | |- | ||
|[[CXCL12]] | |[[CXCL12]] | ||
| | |18 | ||
|Stromal cell-derived factor 1 precursor (SDF-1) (hSDF-1) (C-X-C motif chemokine 12) (Intercrine reduced in hepatomas) (IRH) (hIRH) (Pre-B cell growth-stimulating factor) (PBSF) [Contains: SDF-1-beta(3-72); SDF-1-alpha(3-67)] [SDF1] [SDF1A] [SDF1B] | |Stromal cell-derived factor 1 precursor (SDF-1) (hSDF-1) (C-X-C motif chemokine 12) (Intercrine reduced in hepatomas) (IRH) (hIRH) (Pre-B cell growth-stimulating factor) (PBSF) [Contains: SDF-1-beta(3-72); SDF-1-alpha(3-67)] [SDF1] [SDF1A] [SDF1B] | ||
|- | |- | ||
|[[BIN1]] | |[[BIN1]] | ||
| | |8 | ||
|Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1) [AMPHL] | |Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1) [AMPHL] | ||
|- | |||
|[[SDHD]] | |||
|1 | |||
|Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial precursor (CybS) (CII-4) (QPs3) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone oxidoreductase cytochrome b small subunit) (Succinate-ubiquinone reductase membrane anchor subunit) [SDH4] | |||
|- | |- | ||
|[[POU3F2]] | |[[POU3F2]] | ||
Строка 10 236: | Строка 11 512: | ||
|1 | |1 | ||
|Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (hCAP-C) (XCAP-C homolog) [CAPC] [SMC4L1] | |Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (hCAP-C) (XCAP-C homolog) [CAPC] [SMC4L1] | ||
|- | |||
|[[ADAMTS7]] | |||
|1 | |||
|A disintegrin and metalloproteinase with thrombospondin motifs 7 precursor (EC 3.4.24.-) (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (COMPase) | |||
|- | |- | ||
|[[SLC25A15]] | |[[SLC25A15]] | ||
Строка 10 250: | Строка 11 530: | ||
|- | |- | ||
|[[COMP]] | |[[COMP]] | ||
| | |8 | ||
|Cartilage oligomeric matrix protein precursor (COMP) (Thrombospondin-5) (TSP5) | |Cartilage oligomeric matrix protein precursor (COMP) (Thrombospondin-5) (TSP5) | ||
|- | |- | ||
|[[KDM4B]] | |[[KDM4B]] | ||
| | |2 | ||
|Lysine-specific demethylase 4B (EC 1.14.11.66) (JmjC domain-containing histone demethylation protein 3B) (Jumonji domain-containing protein 2B) ([histone H3]-trimethyl-L-lysine(9) demethylase 4B) [JHDM3B] [JMJD2B] [KIAA0876] | |Lysine-specific demethylase 4B (EC 1.14.11.66) (JmjC domain-containing histone demethylation protein 3B) (Jumonji domain-containing protein 2B) ([histone H3]-trimethyl-L-lysine(9) demethylase 4B) [JHDM3B] [JMJD2B] [KIAA0876] | ||
|- | |- | ||
|[[BLM]] | |[[BLM]] | ||
| | |10 | ||
|Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) [RECQ2] [RECQL3] | |Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) [RECQ2] [RECQL3] | ||
|- | |- | ||
Строка 10 266: | Строка 11 546: | ||
|- | |- | ||
|[[TMEM18]] | |[[TMEM18]] | ||
| | |2 | ||
|Transmembrane protein 18 | |Transmembrane protein 18 | ||
|- | |- | ||
Строка 10 272: | Строка 11 552: | ||
|2 | |2 | ||
|ABI gene family member 3 (New molecule including SH3) (Nesh) [NESH] | |ABI gene family member 3 (New molecule including SH3) (Nesh) [NESH] | ||
|- | |||
|[[CDCA4]] | |||
|1 | |||
|Cell division cycle-associated protein 4 (Hematopoietic progenitor protein) [HEPP] | |||
|- | |- | ||
|[[MPL]] | |[[MPL]] | ||
Строка 10 282: | Строка 11 566: | ||
|- | |- | ||
|[[IL7]] | |[[IL7]] | ||
| | |3 | ||
|Interleukin-7 precursor (IL-7) | |Interleukin-7 precursor (IL-7) | ||
|- | |- | ||
Строка 10 304: | Строка 11 588: | ||
|1 | |1 | ||
|Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1) (TTF-1) (Thyroid-specific enhancer-binding protein) (T/EBP) [NKX2A] [TITF1] [TTF1] | |Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1) (TTF-1) (Thyroid-specific enhancer-binding protein) (T/EBP) [NKX2A] [TITF1] [TTF1] | ||
|- | |||
|[[NAF1]] | |||
|1 | |||
|H/ACA ribonucleoprotein complex non-core subunit NAF1 (hNAF1) | |||
|- | |- | ||
|[[SYT4]] | |[[SYT4]] | ||
Строка 10 332: | Строка 11 620: | ||
|1 | |1 | ||
|Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor) [INSP3R1] | |Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor) [INSP3R1] | ||
|- | |||
|[[ALX4]] | |||
|1 | |||
|Homeobox protein aristaless-like 4 [KIAA1788] | |||
|- | |- | ||
|[[SLC39A6]] | |[[SLC39A6]] | ||
Строка 10 340: | Строка 11 632: | ||
|1 | |1 | ||
|Solute carrier family 22 member 14 (Organic cation transporter-like 4) (ORCTL-4) [OCTL2] [ORCTL4] | |Solute carrier family 22 member 14 (Organic cation transporter-like 4) (ORCTL-4) [OCTL2] [ORCTL4] | ||
|- | |||
|[[CKAP2]] | |||
|1 | |||
|Cytoskeleton-associated protein 2 (CTCL tumor antigen se20-10) (Tumor- and microtubule-associated protein) [LB1] [TMAP] | |||
|- | |- | ||
|[[DLL1]] | |[[DLL1]] | ||
Строка 10 358: | Строка 11 654: | ||
|- | |- | ||
|[[MMP1]] | |[[MMP1]] | ||
| | |17 | ||
|Interstitial collagenase precursor (EC 3.4.24.7) (Fibroblast collagenase) (Matrix metalloproteinase-1) (MMP-1) [Contains: 22 kDa interstitial collagenase; 27 kDa interstitial collagenase] [CLG] | |Interstitial collagenase precursor (EC 3.4.24.7) (Fibroblast collagenase) (Matrix metalloproteinase-1) (MMP-1) [Contains: 22 kDa interstitial collagenase; 27 kDa interstitial collagenase] [CLG] | ||
|- | |- | ||
|[[UCP2]] | |[[UCP2]] | ||
| | |19 | ||
|Mitochondrial uncoupling protein 2 (UCP 2) (Solute carrier family 25 member 8) (UCPH) [SLC25A8] | |Mitochondrial uncoupling protein 2 (UCP 2) (Solute carrier family 25 member 8) (UCPH) [SLC25A8] | ||
|- | |- | ||
Строка 10 382: | Строка 11 678: | ||
|- | |- | ||
|[[BRCA2]] | |[[BRCA2]] | ||
| | |17 | ||
|Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein) [FACD] [FANCD1] | |Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein) [FACD] [FANCD1] | ||
|- | |- | ||
Строка 10 388: | Строка 11 684: | ||
|1 | |1 | ||
|Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) [KIAA0797] [SSP1] [SUSP1] [FKSG6] | |Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) [KIAA0797] [SSP1] [SUSP1] [FKSG6] | ||
|- | |||
|[[KCNJ11]] | |||
|1 | |||
|ATP-sensitive inward rectifier potassium channel 11 (IKATP) (Inward rectifier K( ) channel Kir6.2) (Potassium channel, inwardly rectifying subfamily J member 11) | |||
|- | |- | ||
|[[GHSR]] | |[[GHSR]] | ||
| | |4 | ||
|Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) | |Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) | ||
|- | |- | ||
Строка 10 412: | Строка 11 712: | ||
|2 | |2 | ||
|WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2) (WIPI49-like protein 2) [CGI-50] | |WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2) (WIPI49-like protein 2) [CGI-50] | ||
|- | |||
|[[PDE7B]] | |||
|1 | |||
|cAMP-specific 3',5'-cyclic phosphodiesterase 7B (EC 3.1.4.53) | |||
|- | |- | ||
|[[MGAT1]] | |[[MGAT1]] | ||
Строка 10 422: | Строка 11 726: | ||
|- | |- | ||
|[[CCL2]] | |[[CCL2]] | ||
| | |39 | ||
|C-C motif chemokine 2 precursor (HC11) (Monocyte chemoattractant protein 1) (Monocyte chemotactic and activating factor) (MCAF) (Monocyte chemotactic protein 1) (MCP-1) (Monocyte secretory protein JE) (Small-inducible cytokine A2) [MCP1] [SCYA2] | |C-C motif chemokine 2 precursor (HC11) (Monocyte chemoattractant protein 1) (Monocyte chemotactic and activating factor) (MCAF) (Monocyte chemotactic protein 1) (MCP-1) (Monocyte secretory protein JE) (Small-inducible cytokine A2) [MCP1] [SCYA2] | ||
|- | |- | ||
Строка 10 430: | Строка 11 734: | ||
|- | |- | ||
|[[SOX4]] | |[[SOX4]] | ||
| | |4 | ||
|Transcription factor SOX-4 | |Transcription factor SOX-4 | ||
|- | |- | ||
Строка 10 438: | Строка 11 742: | ||
|- | |- | ||
|[[SIRT7]] | |[[SIRT7]] | ||
| | |25 | ||
|NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7) [SIR2L7] | |NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7) [SIR2L7] | ||
|- | |- | ||
Строка 10 458: | Строка 11 762: | ||
|- | |- | ||
|[[ADAM10]] | |[[ADAM10]] | ||
| | |21 | ||
|Disintegrin and metalloproteinase domain-containing protein 10 precursor (EC 3.4.24.81) (ADAM 10) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD156c antigen) [KUZ] [MADM] | |Disintegrin and metalloproteinase domain-containing protein 10 precursor (EC 3.4.24.81) (ADAM 10) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD156c antigen) [KUZ] [MADM] | ||
|- | |- | ||
|[[DAZL]] | |[[DAZL]] | ||
| | |2 | ||
|Deleted in azoospermia-like (DAZ homolog) (DAZ-like autosomal) (Deleted in azoospermia-like 1) (SPGY-like-autosomal) [DAZH] [DAZL1] [DAZLA] [SPGYLA] | |Deleted in azoospermia-like (DAZ homolog) (DAZ-like autosomal) (Deleted in azoospermia-like 1) (SPGY-like-autosomal) [DAZH] [DAZL1] [DAZLA] [SPGYLA] | ||
|- | |- | ||
Строка 10 470: | Строка 11 774: | ||
|- | |- | ||
|[[ASL]] | |[[ASL]] | ||
| | |27 | ||
|Argininosuccinate lyase (EC 4.3.2.1) (ASAL) (Arginosuccinase) | |Argininosuccinate lyase (EC 4.3.2.1) (ASAL) (Arginosuccinase) | ||
|- | |- | ||
|[[CXCR3]] | |[[CXCR3]] | ||
| | |12 | ||
|C-X-C chemokine receptor type 3 (CXC-R3) (CXCR-3) (CKR-L2) (G protein-coupled receptor 9) (Interferon-inducible protein 10 receptor) (IP-10 receptor) (CD183 antigen) [GPR9] | |C-X-C chemokine receptor type 3 (CXC-R3) (CXCR-3) (CKR-L2) (G protein-coupled receptor 9) (Interferon-inducible protein 10 receptor) (IP-10 receptor) (CD183 antigen) [GPR9] | ||
|- | |- | ||
Строка 10 482: | Строка 11 786: | ||
|- | |- | ||
|[[VEGFA]] | |[[VEGFA]] | ||
| | |3 | ||
|Vascular endothelial growth factor A precursor (VEGF-A) (Vascular permeability factor) (VPF) [VEGF] | |Vascular endothelial growth factor A precursor (VEGF-A) (Vascular permeability factor) (VPF) [VEGF] | ||
|- | |- | ||
Строка 10 498: | Строка 11 802: | ||
|- | |- | ||
|[[CXCL13]] | |[[CXCL13]] | ||
| | |4 | ||
|C-X-C motif chemokine 13 precursor (Angie) (B cell-attracting chemokine 1) (BCA-1) (B lymphocyte chemoattractant) (CXC chemokine BLC) (Small-inducible cytokine B13) [BCA1] [BLC] [SCYB13] | |C-X-C motif chemokine 13 precursor (Angie) (B cell-attracting chemokine 1) (BCA-1) (B lymphocyte chemoattractant) (CXC chemokine BLC) (Small-inducible cytokine B13) [BCA1] [BLC] [SCYB13] | ||
|- | |- | ||
Строка 10 522: | Строка 11 826: | ||
|- | |- | ||
|[[DPP4]] | |[[DPP4]] | ||
| | |10 | ||
|Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD26 antigen) [Contains: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)] [ADCP2] [CD26] | |Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD26 antigen) [Contains: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)] [ADCP2] [CD26] | ||
|- | |- | ||
Строка 10 530: | Строка 11 834: | ||
|- | |- | ||
|[[CD163]] | |[[CD163]] | ||
| | |14 | ||
|Scavenger receptor cysteine-rich type 1 protein M130 precursor (Hemoglobin scavenger receptor) (CD163 antigen) [Contains: Soluble CD163 (sCD163)] [M130] | |Scavenger receptor cysteine-rich type 1 protein M130 precursor (Hemoglobin scavenger receptor) (CD163 antigen) [Contains: Soluble CD163 (sCD163)] [M130] | ||
|- | |- | ||
Строка 10 538: | Строка 11 842: | ||
|- | |- | ||
|[[DCT]] | |[[DCT]] | ||
| | |11 | ||
|L-dopachrome tautomerase precursor (EC 5.3.3.12) (DCT) (DT) (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2) (TRP-2) (TRP2) [TYRP2] | |L-dopachrome tautomerase precursor (EC 5.3.3.12) (DCT) (DT) (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2) (TRP-2) (TRP2) [TYRP2] | ||
|- | |- | ||
Строка 10 546: | Строка 11 850: | ||
|- | |- | ||
|[[XRCC1]] | |[[XRCC1]] | ||
| | |8 | ||
|DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1) | |DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1) | ||
|- | |- | ||
|[[FST]] | |[[FST]] | ||
| | |20 | ||
|Follistatin precursor (FS) (Activin-binding protein) | |Follistatin precursor (FS) (Activin-binding protein) | ||
|- | |- | ||
Строка 10 562: | Строка 11 866: | ||
|- | |- | ||
|[[BMP6]] | |[[BMP6]] | ||
| | |4 | ||
|Bone morphogenetic protein 6 precursor (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1) [VGR] | |Bone morphogenetic protein 6 precursor (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1) [VGR] | ||
|- | |- | ||
Строка 10 572: | Строка 11 876: | ||
|1 | |1 | ||
|Synaptonemal complex protein 3 (SCP-3) [SCP3] | |Synaptonemal complex protein 3 (SCP-3) [SCP3] | ||
|- | |||
|[[STAT5B]] | |||
|1 | |||
|Signal transducer and activator of transcription 5B | |||
|- | |- | ||
|[[AIF1]] | |[[AIF1]] | ||
Строка 10 578: | Строка 11 886: | ||
|- | |- | ||
|[[FAS]] | |[[FAS]] | ||
| | |22 | ||
|Tumor necrosis factor receptor superfamily member 6 precursor (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD95 antigen) [APT1] [FAS1] [TNFRSF6] | |Tumor necrosis factor receptor superfamily member 6 precursor (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD95 antigen) [APT1] [FAS1] [TNFRSF6] | ||
|- | |- | ||
Строка 10 589: | Строка 11 897: | ||
|Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) | |Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor) | ||
|- | |- | ||
|[[ | |[[OPRD1]] | ||
|1 | |1 | ||
| | |Delta-type opioid receptor (D-OR-1) (DOR-1) [OPRD] | ||
|- | |- | ||
|[[CAPN1]] | |[[CAPN1]] | ||
Строка 10 610: | Строка 11 918: | ||
|- | |- | ||
|[[CD5]] | |[[CD5]] | ||
| | |16 | ||
|T-cell surface glycoprotein CD5 precursor (Lymphocyte antigen T1/Leu-1) (CD5 antigen) [LEU1] | |T-cell surface glycoprotein CD5 precursor (Lymphocyte antigen T1/Leu-1) (CD5 antigen) [LEU1] | ||
|- | |- | ||
Строка 10 642: | Строка 11 950: | ||
|- | |- | ||
|[[ADA]] | |[[ADA]] | ||
| | |12 | ||
|Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase) [ADA1] | |Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase) [ADA1] | ||
|- | |- | ||
|[[SPR]] | |[[SPR]] | ||
| | |6 | ||
|Sepiapterin reductase (EC 1.1.1.153) (SPR) | |Sepiapterin reductase (EC 1.1.1.153) (SPR) | ||
|- | |- | ||
Строка 10 658: | Строка 11 966: | ||
|- | |- | ||
|[[RTEL1]] | |[[RTEL1]] | ||
| | |3 | ||
|Regulator of telomere elongation helicase 1 (EC 3.6.4.12) (Novel helicase-like) [C20orf41] [KIAA1088] [NHL] | |Regulator of telomere elongation helicase 1 (EC 3.6.4.12) (Novel helicase-like) [C20orf41] [KIAA1088] [NHL] | ||
|- | |- | ||
Строка 10 666: | Строка 11 974: | ||
|- | |- | ||
|[[CD33]] | |[[CD33]] | ||
| | |12 | ||
|Myeloid cell surface antigen CD33 precursor (Sialic acid-binding Ig-like lectin 3) (Siglec-3) (gp67) (CD33 antigen) [SIGLEC3] | |Myeloid cell surface antigen CD33 precursor (Sialic acid-binding Ig-like lectin 3) (Siglec-3) (gp67) (CD33 antigen) [SIGLEC3] | ||
|- | |- | ||
|[[CBL]] | |[[CBL]] | ||
| | |7 | ||
|E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING finger protein 55) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL) [CBL2] [RNF55] | |E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING finger protein 55) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL) [CBL2] [RNF55] | ||
|- | |- | ||
Строка 10 678: | Строка 11 986: | ||
|- | |- | ||
|[[HMGA1]] | |[[HMGA1]] | ||
| | |3 | ||
|High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R) [HMGIY] | |High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R) [HMGIY] | ||
|- | |- | ||
|[[CCR6]] | |[[CCR6]] | ||
| | |6 | ||
|C-C chemokine receptor type 6 (C-C CKR-6) (CC-CKR-6) (CCR-6) (Chemokine receptor-like 3) (CKR-L3) (DRY6) (G-protein coupled receptor 29) (GPR-CY4) (GPRCY4) (LARC receptor) (CD196 antigen) [CKRL3] [CMKBR6] [GPR29] [STRL22] | |C-C chemokine receptor type 6 (C-C CKR-6) (CC-CKR-6) (CCR-6) (Chemokine receptor-like 3) (CKR-L3) (DRY6) (G-protein coupled receptor 29) (GPR-CY4) (GPRCY4) (LARC receptor) (CD196 antigen) [CKRL3] [CMKBR6] [GPR29] [STRL22] | ||
|- | |- | ||
Строка 10 690: | Строка 11 998: | ||
|- | |- | ||
|[[MMP14]] | |[[MMP14]] | ||
| | |2 | ||
|Matrix metalloproteinase-14 precursor (EC 3.4.24.80) (MMP-14) (MMP-X1) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP) | |Matrix metalloproteinase-14 precursor (EC 3.4.24.80) (MMP-14) (MMP-X1) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP) | ||
|- | |- | ||
Строка 10 702: | Строка 12 010: | ||
|- | |- | ||
|[[CAV1]] | |[[CAV1]] | ||
|2 | |||
|Caveolin-1 [CAV] | |||
|- | |||
|[[TOP3A]] | |||
|1 | |1 | ||
| | |DNA topoisomerase 3-alpha (EC 5.6.2.1) (DNA topoisomerase III alpha) [TOP3] | ||
|- | |||
|[[GOT2]] | |||
|1 | |||
|Aspartate aminotransferase, mitochondrial precursor (EC 2.6.1.1) (EC 2.6.1.7) (mAspAT) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A) [KYAT4] | |||
|- | |- | ||
|[[PIK3CA]] | |[[PIK3CA]] | ||
| | |7 | ||
|Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.137) (EC 2.7.1.153) (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1) | |Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.137) (EC 2.7.1.153) (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide 3-kinase alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1) | ||
|- | |- | ||
Строка 10 714: | Строка 12 030: | ||
|- | |- | ||
|[[RIPK2]] | |[[RIPK2]] | ||
| | |3 | ||
|Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) [CARDIAK] [RICK] [RIP2] [UNQ277/PRO314/PRO34092] | |Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) [CARDIAK] [RICK] [RIP2] [UNQ277/PRO314/PRO34092] | ||
|- | |||
|[[FLT4]] | |||
|1 | |||
|Vascular endothelial growth factor receptor 3 precursor (EC 2.7.10.1) (VEGFR-3) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4) [VEGFR3] | |||
|- | |- | ||
|[[MAPK8]] | |[[MAPK8]] | ||
Строка 10 726: | Строка 12 046: | ||
|- | |- | ||
|[[SOX9]] | |[[SOX9]] | ||
| | |17 | ||
|Transcription factor SOX-9 | |Transcription factor SOX-9 | ||
|- | |- | ||
|[[LONP1]] | |[[LONP1]] | ||
| | |5 | ||
|Lon protease homolog, mitochondrial precursor (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) [PRSS15] | |Lon protease homolog, mitochondrial precursor (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) [PRSS15] | ||
|- | |- | ||
|[[GAL]] | |[[GAL]] | ||
| | |17 | ||
|Galanin peptides precursor [Contains: Galanin; Galanin message-associated peptide (GMAP)] [GAL1] [GALN] [GLNN] | |Galanin peptides precursor [Contains: Galanin; Galanin message-associated peptide (GMAP)] [GAL1] [GALN] [GLNN] | ||
|- | |- | ||
Строка 10 752: | Строка 12 072: | ||
|1 | |1 | ||
|Bone marrow proteoglycan precursor (BMPG) (Proteoglycan 2) [Contains: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)] [MBP] | |Bone marrow proteoglycan precursor (BMPG) (Proteoglycan 2) [Contains: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)] [MBP] | ||
|- | |- | ||
|[[KIFC3]] | |[[KIFC3]] | ||
Строка 10 762: | Строка 12 078: | ||
|- | |- | ||
|[[BMPR2]] | |[[BMPR2]] | ||
| | |5 | ||
|Bone morphogenetic protein receptor type-2 precursor (EC 2.7.11.30) (BMP type-2 receptor) (BMPR-2) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II) [PPH1] | |Bone morphogenetic protein receptor type-2 precursor (EC 2.7.11.30) (BMP type-2 receptor) (BMPR-2) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II) [PPH1] | ||
|- | |- | ||
Строка 10 772: | Строка 12 088: | ||
|1 | |1 | ||
|Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18) [CYK18] [PIG46] | |Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18) [CYK18] [PIG46] | ||
|- | |||
|[[SLAMF1]] | |||
|1 | |||
|Signaling lymphocytic activation molecule precursor (CDw150) (IPO-3) (SLAM family member 1) (CD150 antigen) [SLAM] | |||
|- | |- | ||
|[[IL15]] | |[[IL15]] | ||
| | |4 | ||
|Interleukin-15 precursor (IL-15) | |Interleukin-15 precursor (IL-15) | ||
|- | |- | ||
|[[DUSP16]] | |[[DUSP16]] | ||
| | |3 | ||
|Dual specificity protein phosphatase 16 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 7) (MAP kinase phosphatase 7) (MKP-7) [KIAA1700] [MKP7] | |Dual specificity protein phosphatase 16 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 7) (MAP kinase phosphatase 7) (MKP-7) [KIAA1700] [MKP7] | ||
|- | |- | ||
Строка 10 790: | Строка 12 110: | ||
|- | |- | ||
|[[CD38]] | |[[CD38]] | ||
| | |37 | ||
|ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1) (ADPRC 1) (Cyclic ADP-ribose hydrolase 1) (cADPr hydrolase 1) (T10) (CD38 antigen) | |ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1) (ADPRC 1) (Cyclic ADP-ribose hydrolase 1) (cADPr hydrolase 1) (T10) (CD38 antigen) | ||
|- | |- | ||
Строка 10 814: | Строка 12 134: | ||
|- | |- | ||
|[[MKI67]] | |[[MKI67]] | ||
| | |3 | ||
|Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67) | |Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67) | ||
|- | |- | ||
Строка 10 826: | Строка 12 146: | ||
|- | |- | ||
|[[TDRD7]] | |[[TDRD7]] | ||
| | |2 | ||
|Tudor domain-containing protein 7 (PCTAIRE2-binding protein) (Tudor repeat associator with PCTAIRE-2) (Trap) [PCTAIRE2BP] | |Tudor domain-containing protein 7 (PCTAIRE2-binding protein) (Tudor repeat associator with PCTAIRE-2) (Trap) [PCTAIRE2BP] | ||
|- | |- | ||
|[[TF]] | |[[TF]] | ||
| | |47 | ||
|Serotransferrin precursor (Transferrin) (Beta-1 metal-binding globulin) (Siderophilin) [PRO1400] | |Serotransferrin precursor (Transferrin) (Beta-1 metal-binding globulin) (Siderophilin) [PRO1400] | ||
|- | |- | ||
|[[SMAD3]] | |[[SMAD3]] | ||
| | |11 | ||
|Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) [MADH3] | |Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) [MADH3] | ||
|- | |- | ||
Строка 10 846: | Строка 12 166: | ||
|- | |- | ||
|[[TLR7]] | |[[TLR7]] | ||
| | |11 | ||
|Toll-like receptor 7 precursor [UNQ248/PRO285] | |Toll-like receptor 7 precursor [UNQ248/PRO285] | ||
|- | |- | ||
Строка 10 852: | Строка 12 172: | ||
|1 | |1 | ||
|Kinesin-like protein KIF6 [C6orf102] | |Kinesin-like protein KIF6 [C6orf102] | ||
|- | |- | ||
|[[TRPV2]] | |[[TRPV2]] | ||
Строка 10 874: | Строка 12 190: | ||
|- | |- | ||
|[[PGD]] | |[[PGD]] | ||
| | |3 | ||
|6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44) [PGDH] | |6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44) [PGDH] | ||
|- | |- | ||
Строка 10 886: | Строка 12 202: | ||
|- | |- | ||
|[[MNT]] | |[[MNT]] | ||
| | |3 | ||
|Max-binding protein MNT (Class D basic helix-loop-helix protein 3) (bHLHd3) (Myc antagonist MNT) (Protein ROX) [BHLHD3] [ROX] | |Max-binding protein MNT (Class D basic helix-loop-helix protein 3) (bHLHd3) (Myc antagonist MNT) (Protein ROX) [BHLHD3] [ROX] | ||
|- | |- | ||
Строка 10 902: | Строка 12 218: | ||
|- | |- | ||
|[[USP14]] | |[[USP14]] | ||
| | |2 | ||
|Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14) [TGT] | |Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14) [TGT] | ||
|- | |- | ||
|[[ECD]] | |[[ECD]] | ||
| | |19 | ||
|Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1) | |Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1) | ||
|- | |- | ||
Строка 10 930: | Строка 12 246: | ||
|- | |- | ||
|[[CA2]] | |[[CA2]] | ||
| | |28 | ||
|Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) | |Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) | ||
|- | |- | ||
|[[GCA]] | |[[GCA]] | ||
| | |10 | ||
|Grancalcin [GCL] | |Grancalcin [GCL] | ||
|- | |- | ||
Строка 10 940: | Строка 12 256: | ||
|1 | |1 | ||
|Keratinocyte differentiation factor 1 [C1orf172] | |Keratinocyte differentiation factor 1 [C1orf172] | ||
|- | |||
|[[TIE1]] | |||
|1 | |||
|Tyrosine-protein kinase receptor Tie-1 precursor (EC 2.7.10.1) [TIE] | |||
|- | |- | ||
|[[NR2C2]] | |[[NR2C2]] | ||
Строка 10 946: | Строка 12 266: | ||
|- | |- | ||
|[[PTX3]] | |[[PTX3]] | ||
| | |6 | ||
|Pentraxin-related protein PTX3 precursor (Pentaxin-related protein PTX3) (Tumor necrosis factor alpha-induced protein 5) (TNF alpha-induced protein 5) (Tumor necrosis factor-inducible gene 14 protein) (TSG-14) [TNFAIP5] [TSG14] | |Pentraxin-related protein PTX3 precursor (Pentaxin-related protein PTX3) (Tumor necrosis factor alpha-induced protein 5) (TNF alpha-induced protein 5) (Tumor necrosis factor-inducible gene 14 protein) (TSG-14) [TNFAIP5] [TSG14] | ||
|- | |||
|[[ERVK-7]] | |||
|1 | |||
|Endogenous retrovirus group K member 7 Np9 protein (HERV-K(III) Np9 protein) (HERV-K102 Np9 protein) (HERV-K_1q22 provirus Np9 protein) | |||
|- | |- | ||
|[[C8orf48]] | |[[C8orf48]] | ||
Строка 10 954: | Строка 12 278: | ||
|- | |- | ||
|[[F9]] | |[[F9]] | ||
| | |2 | ||
|Coagulation factor IX precursor (EC 3.4.21.22) (Christmas factor) (Plasma thromboplastin component) (PTC) [Contains: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain] | |Coagulation factor IX precursor (EC 3.4.21.22) (Christmas factor) (Plasma thromboplastin component) (PTC) [Contains: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain] | ||
|- | |- | ||
|[[SST]] | |[[SST]] | ||
| | |21 | ||
|Somatostatin precursor (Growth hormone release-inhibiting factor) [Contains: Somatostatin-28; Somatostatin-14 (SST-14); Neuronostatin (NST)] | |Somatostatin precursor (Growth hormone release-inhibiting factor) [Contains: Somatostatin-28; Somatostatin-14 (SST-14); Neuronostatin (NST)] | ||
|- | |- | ||
|[[CHAT]] | |[[CHAT]] | ||
| | |4 | ||
|Choline O-acetyltransferase (EC 2.3.1.6) (CHOACTase) (ChAT) (Choline acetylase) | |Choline O-acetyltransferase (EC 2.3.1.6) (CHOACTase) (ChAT) (Choline acetylase) | ||
|- | |||
|[[WNT5B]] | |||
|1 | |||
|Protein Wnt-5b precursor | |||
|- | |- | ||
|[[EIF2B5]] | |[[EIF2B5]] | ||
Строка 10 990: | Строка 12 318: | ||
|- | |- | ||
|[[KEAP1]] | |[[KEAP1]] | ||
| | |7 | ||
|Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19) [INRF2] [KIAA0132] [KLHL19] | |Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19) [INRF2] [KIAA0132] [KLHL19] | ||
|- | |- | ||
Строка 11 004: | Строка 12 332: | ||
|1 | |1 | ||
|protein 5 precursor (Follistatin-like protein 5) [KIAA1263] | |protein 5 precursor (Follistatin-like protein 5) [KIAA1263] | ||
|- | |||
|[[S100A10]] | |||
|1 | |||
|Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (Cellular ligand of annexin II) (S100 calcium-binding protein A10) (p10 protein) (p11) [ANX2LG] [CAL1L] [CLP11] | |||
|- | |- | ||
|[[PCDH9]] | |[[PCDH9]] | ||
Строка 11 020: | Строка 12 352: | ||
|3 | |3 | ||
|Death-associated protein 1 (DAP-1) [DAP1] | |Death-associated protein 1 (DAP-1) [DAP1] | ||
|- | |||
|[[CASP6]] | |||
|1 | |||
|Caspase-6 precursor (EC 3.4.22.59) (CASP-6) (Apoptotic protease Mch-2) [Contains: Caspase-6 subunit p18; Caspase-6 subunit p11] [MCH2] | |||
|- | |- | ||
|[[PPARA]] | |[[PPARA]] | ||
Строка 11 030: | Строка 12 366: | ||
|- | |- | ||
|[[MYBL2]] | |[[MYBL2]] | ||
| | |2 | ||
|Myb-related protein B (B-Myb) (Myb-like protein 2) [BMYB] | |Myb-related protein B (B-Myb) (Myb-like protein 2) [BMYB] | ||
|- | |- | ||
|[[MELK]] | |[[MELK]] | ||
| | |2 | ||
|Maternal embryonic leucine zipper kinase (EC 2.7.11.1) (hMELK) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) [KIAA0175] | |Maternal embryonic leucine zipper kinase (EC 2.7.11.1) (hMELK) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) [KIAA0175] | ||
|- | |- | ||
|[[GATA6]] | |[[GATA6]] | ||
| | |4 | ||
|Transcription factor GATA-6 (GATA-binding factor 6) | |Transcription factor GATA-6 (GATA-binding factor 6) | ||
|- | |- | ||
Строка 11 044: | Строка 12 380: | ||
|1 | |1 | ||
|Doublesex- and mab-3-related transcription factor 1 (DM domain expressed in testis protein 1) [DMT1] | |Doublesex- and mab-3-related transcription factor 1 (DM domain expressed in testis protein 1) [DMT1] | ||
|- | |- | ||
|[[TAS2R38]] | |[[TAS2R38]] | ||
| | |4 | ||
|Taste receptor type 2 member 38 (T2R38) (PTC bitter taste receptor) (Taste receptor type 2 member 61) (T2R61) [PTC] | |Taste receptor type 2 member 38 (T2R38) (PTC bitter taste receptor) (Taste receptor type 2 member 61) (T2R61) [PTC] | ||
|- | |- | ||
Строка 11 070: | Строка 12 402: | ||
|- | |- | ||
|[[MB]] | |[[MB]] | ||
| | |65 | ||
|Myoglobin | |Myoglobin | ||
|- | |- | ||
Строка 11 118: | Строка 12 450: | ||
|- | |- | ||
|[[DKC1]] | |[[DKC1]] | ||
| | |5 | ||
|H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1) [NOLA4] | |H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1) [NOLA4] | ||
|- | |- | ||
|[[MARCKS]] | |[[MARCKS]] | ||
| | |5 | ||
|Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL) [MACS] [PRKCSL] | |Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL) [MACS] [PRKCSL] | ||
|- | |- | ||
Строка 11 128: | Строка 12 460: | ||
|1 | |1 | ||
|Neuroblast differentiation-associated protein AHNAK (Desmoyokin) [PM227] | |Neuroblast differentiation-associated protein AHNAK (Desmoyokin) [PM227] | ||
|- | |||
|[[ABCC8]] | |||
|1 | |||
|ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1) [HRINS] [SUR] [SUR1] | |||
|- | |- | ||
|[[PIK3R1]] | |[[PIK3R1]] | ||
|1 | |1 | ||
|Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha) [GRB1] | |Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha) [GRB1] | ||
|- | |||
|[[KIR2DS5]] | |||
|2 | |||
|Killer cell immunoglobulin-like receptor 2DS5 precursor (CD158 antigen-like family member G) (MHC class I NK cell receptor) (Natural killer-associated transcript 9) (NKAT-9) (CD158g antigen) [CD158G] [NKAT9] | |||
|- | |- | ||
|[[GJA8]] | |[[GJA8]] | ||
Строка 11 138: | Строка 12 478: | ||
|- | |- | ||
|[[GRK2]] | |[[GRK2]] | ||
| | |5 | ||
|Beta-adrenergic receptor kinase 1 (EC 2.7.11.15) (Beta-ARK-1) (G-protein coupled receptor kinase 2) [ADRBK1] [BARK] [BARK1] | |Beta-adrenergic receptor kinase 1 (EC 2.7.11.15) (Beta-ARK-1) (G-protein coupled receptor kinase 2) [ADRBK1] [BARK] [BARK1] | ||
|- | |||
|[[KCNE1]] | |||
|1 | |||
|Potassium voltage-gated channel subfamily E member 1 (Delayed rectifier potassium channel subunit IsK) (IKs producing slow voltage-gated potassium channel subunit beta Mink) (Minimal potassium channel) | |||
|- | |- | ||
|[[GGCT]] | |[[GGCT]] | ||
|5 | |5 | ||
|Gamma-glutamylcyclotransferase (EC 4.3.2.9) (Cytochrome c-releasing factor 21) [C7orf24] [CRF21] | |Gamma-glutamylcyclotransferase (EC 4.3.2.9) (Cytochrome c-releasing factor 21) [C7orf24] [CRF21] | ||
|- | |||
|[[KCNJ2]] | |||
|1 | |||
|Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K( ) channel Kir2.1) (IRK-1) (hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2) [IRK1] | |||
|- | |- | ||
|[[CHRNA7]] | |[[CHRNA7]] | ||
Строка 11 158: | Строка 12 506: | ||
|- | |- | ||
|[[HMGB1]] | |[[HMGB1]] | ||
| | |34 | ||
|High mobility group protein B1 (High mobility group protein 1) (HMG-1) [HMG1] | |High mobility group protein B1 (High mobility group protein 1) (HMG-1) [HMG1] | ||
|- | |- | ||
|[[LMNA]] | |[[LMNA]] | ||
| | |60 | ||
|Prelamin-A/C precursor [Contains: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] [LMN1] | |Prelamin-A/C precursor [Contains: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] [LMN1] | ||
|- | |- | ||
Строка 11 170: | Строка 12 518: | ||
|- | |- | ||
|[[GDF11]] | |[[GDF11]] | ||
| | |62 | ||
|Growth/differentiation factor 11 precursor (GDF-11) (Bone morphogenetic protein 11) (BMP-11) [BMP11] | |Growth/differentiation factor 11 precursor (GDF-11) (Bone morphogenetic protein 11) (BMP-11) [BMP11] | ||
|- | |- | ||
Строка 11 182: | Строка 12 530: | ||
|- | |- | ||
|[[AIP]] | |[[AIP]] | ||
| | |12 | ||
|AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9) [XAP2] | |AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9) [XAP2] | ||
|- | |- | ||
Строка 11 202: | Строка 12 550: | ||
|- | |- | ||
|[[DST]] | |[[DST]] | ||
| | |5 | ||
|Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) [BP230] [BP240] [BPAG1] [DMH] [DT] [KIAA0728] | |Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) [BP230] [BP240] [BPAG1] [DMH] [DT] [KIAA0728] | ||
|- | |- | ||
Строка 11 214: | Строка 12 562: | ||
|- | |- | ||
|[[SDS]] | |[[SDS]] | ||
| | |51 | ||
|L-serine dehydratase/L-threonine deaminase (EC 4.3.1.17) (SDH) (L-serine deaminase) (L-threonine dehydratase) (EC 4.3.1.19) (TDH) [SDH] | |L-serine dehydratase/L-threonine deaminase (EC 4.3.1.17) (SDH) (L-serine deaminase) (L-threonine dehydratase) (EC 4.3.1.19) (TDH) [SDH] | ||
|- | |- | ||
|[[MGMT]] | |[[MGMT]] | ||
| | |11 | ||
|Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase) | |Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase) | ||
|- | |- | ||
Строка 11 226: | Строка 12 574: | ||
|- | |- | ||
|[[PSD]] | |[[PSD]] | ||
| | |41 | ||
|PH and SEC7 domain-containing protein 1 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6) (Exchange factor for ARF6) (Exchange factor for ARF6 A) (Pleckstrin homology and SEC7 domain-containing protein 1) [EFA6] [EFA6A] [KIAA2011] [PSD1] [TYL] | |PH and SEC7 domain-containing protein 1 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6) (Exchange factor for ARF6) (Exchange factor for ARF6 A) (Pleckstrin homology and SEC7 domain-containing protein 1) [EFA6] [EFA6A] [KIAA2011] [PSD1] [TYL] | ||
|- | |||
|[[CRIP2]] | |||
|1 | |||
|Cysteine-rich protein 2 (CRP-2) (Protein ESP1) [CRP2] | |||
|- | |- | ||
|[[CDK6]] | |[[CDK6]] | ||
| | |18 | ||
|Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) [CDKN6] | |Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) [CDKN6] | ||
|- | |- | ||
Строка 11 238: | Строка 12 590: | ||
|- | |- | ||
|[[CCL3]] | |[[CCL3]] | ||
| | |5 | ||
|C-C motif chemokine 3 precursor (G0/G1 switch regulatory protein 19-1) (Macrophage inflammatory protein 1-alpha) (MIP-1-alpha) (PAT 464.1) (SIS-beta) (Small-inducible cytokine A3) (Tonsillar lymphocyte LD78 alpha protein) [Contains: MIP-1-alpha(4-69) (LD78-alpha(4-69))] [G0S19-1] [MIP1A] [SCYA3] | |C-C motif chemokine 3 precursor (G0/G1 switch regulatory protein 19-1) (Macrophage inflammatory protein 1-alpha) (MIP-1-alpha) (PAT 464.1) (SIS-beta) (Small-inducible cytokine A3) (Tonsillar lymphocyte LD78 alpha protein) [Contains: MIP-1-alpha(4-69) (LD78-alpha(4-69))] [G0S19-1] [MIP1A] [SCYA3] | ||
|- | |- | ||
|[[S100A4]] | |[[S100A4]] | ||
| | |3 | ||
|Protein S100-A4 (Calvasculin) (Metastasin) (Placental calcium-binding protein) (Protein Mts1) (S100 calcium-binding protein A4) [CAPL] [MTS1] | |Protein S100-A4 (Calvasculin) (Metastasin) (Placental calcium-binding protein) (Protein Mts1) (S100 calcium-binding protein A4) [CAPL] [MTS1] | ||
|- | |- | ||
Строка 11 278: | Строка 12 630: | ||
|- | |- | ||
|[[DSG2]] | |[[DSG2]] | ||
| | |2 | ||
|Desmoglein-2 precursor (Cadherin family member 5) (HDGC) [CDHF5] | |Desmoglein-2 precursor (Cadherin family member 5) (HDGC) [CDHF5] | ||
|- | |- | ||
Строка 11 290: | Строка 12 642: | ||
|- | |- | ||
|[[ISG15]] | |[[ISG15]] | ||
| | |2 | ||
|Ubiquitin-like protein ISG15 precursor (Interferon-induced 15 kDa protein) (Interferon-induced 17 kDa protein) (IP17) (Ubiquitin cross-reactive protein) (hUCRP) [G1P2] [UCRP] | |Ubiquitin-like protein ISG15 precursor (Interferon-induced 15 kDa protein) (Interferon-induced 17 kDa protein) (IP17) (Ubiquitin cross-reactive protein) (hUCRP) [G1P2] [UCRP] | ||
|- | |- | ||
Строка 11 302: | Строка 12 654: | ||
|- | |- | ||
|[[SCT]] | |[[SCT]] | ||
| | |8 | ||
|Secretin precursor | |Secretin precursor | ||
|- | |- | ||
Строка 11 312: | Строка 12 664: | ||
|1 | |1 | ||
|Sorting nexin-15 | |Sorting nexin-15 | ||
|- | |- | ||
|[[NOS1]] | |[[NOS1]] | ||
| | |7 | ||
|Nitric oxide synthase, brain (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Peptidyl-cysteine S-nitrosylase NOS1) (bNOS) | |Nitric oxide synthase, brain (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Peptidyl-cysteine S-nitrosylase NOS1) (bNOS) | ||
|- | |- | ||
Строка 11 330: | Строка 12 678: | ||
|- | |- | ||
|[[MVD]] | |[[MVD]] | ||
| | |6 | ||
|Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase) [MPD] | |Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase) [MPD] | ||
|- | |- | ||
|[[IVD]] | |[[IVD]] | ||
| | |54 | ||
|Isovaleryl-CoA dehydrogenase, mitochondrial precursor (EC 1.3.8.4) (IVD) (Butyryl-CoA dehydrogenase) (EC 1.3.8.1) | |Isovaleryl-CoA dehydrogenase, mitochondrial precursor (EC 1.3.8.4) (IVD) (Butyryl-CoA dehydrogenase) (EC 1.3.8.1) | ||
|- | |- | ||
Строка 11 376: | Строка 12 724: | ||
|3 | |3 | ||
|class II histocompatibility antigen, DRB1 beta chain precursor (Human leukocyte antigen DRB1) (HLA-DRB1) | |class II histocompatibility antigen, DRB1 beta chain precursor (Human leukocyte antigen DRB1) (HLA-DRB1) | ||
|- | |||
|[[PDE1B]] | |||
|1 | |||
|Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B (EC 3.1.4.17) (Cam-PDE 1B) (63 kDa Cam-PDE) [PDE1B1] [PDES1B] | |||
|- | |- | ||
|[[LOXL1]] | |[[LOXL1]] | ||
Строка 11 384: | Строка 12 736: | ||
|1 | |1 | ||
|ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57) | |ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57) | ||
|- | |||
|[[NXF1]] | |||
|1 | |||
|Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) [TAP] | |||
|- | |||
|[[CASP2]] | |||
|1 | |||
|Caspase-2 precursor (EC 3.4.22.55) (CASP-2) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Contains: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12] [ICH1] [NEDD2] | |||
|- | |- | ||
|[[CRHR1]] | |[[CRHR1]] | ||
| | |3 | ||
|Corticotropin-releasing factor receptor 1 precursor (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1) [CRFR] [CRFR1] [CRHR] | |Corticotropin-releasing factor receptor 1 precursor (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1) [CRFR] [CRFR1] [CRHR] | ||
|- | |- | ||
Строка 11 398: | Строка 12 758: | ||
|- | |- | ||
|[[CYP3A4]] | |[[CYP3A4]] | ||
| | |12 | ||
|Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55) [CYP3A3] | |Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55) [CYP3A3] | ||
|- | |- | ||
Строка 11 414: | Строка 12 774: | ||
|- | |- | ||
|[[IGF1]] | |[[IGF1]] | ||
| | |62 | ||
|Insulin-like growth factor I precursor (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C) [IBP1] | |Insulin-like growth factor I precursor (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C) [IBP1] | ||
|- | |- | ||
Строка 11 426: | Строка 12 786: | ||
|- | |- | ||
|[[GAA]] | |[[GAA]] | ||
| | |9 | ||
|Lysosomal alpha-glucosidase precursor (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Contains: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] | |Lysosomal alpha-glucosidase precursor (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Contains: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] | ||
|- | |- | ||
Строка 11 442: | Строка 12 802: | ||
|- | |- | ||
|[[AGT]] | |[[AGT]] | ||
| | |4 | ||
|Angiotensinogen precursor (Serpin A8) [Contains: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4] [SERPINA8] | |Angiotensinogen precursor (Serpin A8) [Contains: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4] [SERPINA8] | ||
|- | |- | ||
Строка 11 452: | Строка 12 812: | ||
|1 | |1 | ||
|PMS1 protein homolog 1 (DNA mismatch repair protein PMS1) [PMSL1] | |PMS1 protein homolog 1 (DNA mismatch repair protein PMS1) [PMSL1] | ||
|- | |||
|[[WWC1]] | |||
|1 | |||
|Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1) [KIAA0869] | |||
|- | |||
|[[DSC2]] | |||
|1 | |||
|Desmocollin-2 precursor (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III) [CDHF2] [DSC3] | |||
|- | |- | ||
|[[ADIPOQ]] | |[[ADIPOQ]] | ||
| | |4 | ||
|Adiponectin precursor (30 kDa adipocyte complement-related protein) (Adipocyte complement-related 30 kDa protein) (ACRP30) (Adipocyte, C1q and collagen domain-containing protein) (Adipose most abundant gene transcript 1 protein) (apM-1) (Gelatin-binding protein) [ACDC] [ACRP30] [APM1] [GBP28] | |Adiponectin precursor (30 kDa adipocyte complement-related protein) (Adipocyte complement-related 30 kDa protein) (ACRP30) (Adipocyte, C1q and collagen domain-containing protein) (Adipose most abundant gene transcript 1 protein) (apM-1) (Gelatin-binding protein) [ACDC] [ACRP30] [APM1] [GBP28] | ||
|- | |- | ||
Строка 11 466: | Строка 12 834: | ||
|- | |- | ||
|[[ITGB3]] | |[[ITGB3]] | ||
| | |3 | ||
|Integrin beta-3 precursor (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD61 antigen) [GP3A] | |Integrin beta-3 precursor (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD61 antigen) [GP3A] | ||
|- | |- | ||
Строка 11 494: | Строка 12 862: | ||
|- | |- | ||
|[[MAL]] | |[[MAL]] | ||
| | |4 | ||
|Myelin and lymphocyte protein (T-lymphocyte maturation-associated protein) | |Myelin and lymphocyte protein (T-lymphocyte maturation-associated protein) | ||
|- | |||
|[[NTNG2]] | |||
|1 | |||
|Netrin-G2 precursor (Laminet-2) [KIAA1857] [LMNT2] [UNQ9381/PRO34206] | |||
|- | |- | ||
|[[CEBPB]] | |[[CEBPB]] | ||
Строка 11 506: | Строка 12 878: | ||
|- | |- | ||
|[[PDE4D]] | |[[PDE4D]] | ||
| | |5 | ||
|cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43) [DPDE3] | |cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43) [DPDE3] | ||
|- | |- | ||
Строка 11 512: | Строка 12 884: | ||
|2 | |2 | ||
|Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity) [BAP] [REA] | |Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity) [BAP] [REA] | ||
|- | |- | ||
|[[CXCL9]] | |[[CXCL9]] | ||
| | |11 | ||
|C-X-C motif chemokine 9 precursor (Gamma-interferon-induced monokine) (Monokine induced by interferon-gamma) (HuMIG) (MIG) (Small-inducible cytokine B9) [CMK] [MIG] [SCYB9] | |C-X-C motif chemokine 9 precursor (Gamma-interferon-induced monokine) (Monokine induced by interferon-gamma) (HuMIG) (MIG) (Small-inducible cytokine B9) [CMK] [MIG] [SCYB9] | ||
|- | |- | ||
Строка 11 526: | Строка 12 894: | ||
|- | |- | ||
|[[RAD52]] | |[[RAD52]] | ||
| | |4 | ||
|DNA repair protein RAD52 homolog | |DNA repair protein RAD52 homolog | ||
|- | |- | ||
Строка 11 538: | Строка 12 906: | ||
|- | |- | ||
|[[FSHB]] | |[[FSHB]] | ||
| | |1 | ||
|Follitropin subunit beta precursor (Follicle-stimulating hormone beta subunit) (FSH-B) (FSH-beta) (Follitropin beta chain) | |Follitropin subunit beta precursor (Follicle-stimulating hormone beta subunit) (FSH-B) (FSH-beta) (Follitropin beta chain) | ||
|- | |- | ||
Строка 11 544: | Строка 12 912: | ||
|1 | |1 | ||
|Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta) [NR1F2] [RZRB] | |Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta) [NR1F2] [RZRB] | ||
|- | |||
|[[GPR78]] | |||
|1 | |||
|G-protein coupled receptor 78 [UNQ5925/PRO19818] | |||
|- | |- | ||
|[[MLN]] | |[[MLN]] | ||
Строка 11 554: | Строка 12 926: | ||
|- | |- | ||
|[[PRKAA2]] | |[[PRKAA2]] | ||
| | |2 | ||
|5'-AMP-activated protein kinase catalytic subunit alpha-2 (EC 2.7.11.1) (AMPK subunit alpha-2) (Acetyl-CoA carboxylase kinase) (EC 2.7.11.27) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (EC 2.7.11.31) (HMGCR kinase) [AMPK] [AMPK2] | |5'-AMP-activated protein kinase catalytic subunit alpha-2 (EC 2.7.11.1) (AMPK subunit alpha-2) (Acetyl-CoA carboxylase kinase) (EC 2.7.11.27) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (EC 2.7.11.31) (HMGCR kinase) [AMPK] [AMPK2] | ||
|- | |- | ||
Строка 11 594: | Строка 12 966: | ||
|- | |- | ||
|[[DAXX]] | |[[DAXX]] | ||
| | |4 | ||
|Death domain-associated protein 6 (Daxx) (hDaxx) (ETS1-associated protein 1) (EAP1) (Fas death domain-associated protein) [BING2] [DAP6] | |Death domain-associated protein 6 (Daxx) (hDaxx) (ETS1-associated protein 1) (EAP1) (Fas death domain-associated protein) [BING2] [DAP6] | ||
|- | |||
|[[EEA1]] | |||
|1 | |||
|Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2) [ZFYVE2] | |||
|- | |- | ||
|[[RHO]] | |[[RHO]] | ||
Строка 11 602: | Строка 12 978: | ||
|- | |- | ||
|[[ERCC1]] | |[[ERCC1]] | ||
| | |15 | ||
|DNA excision repair protein ERCC-1 | |DNA excision repair protein ERCC-1 | ||
|- | |- | ||
|[[MIA]] | |[[MIA]] | ||
| | |9 | ||
|Melanoma-derived growth regulatory protein precursor (Melanoma inhibitory activity protein) | |Melanoma-derived growth regulatory protein precursor (Melanoma inhibitory activity protein) | ||
|- | |- | ||
|[[GLO1]] | |[[GLO1]] | ||
| | |4 | ||
|Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase) | |Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase) | ||
|- | |- | ||
|[[GSS]] | |[[GSS]] | ||
| | |8 | ||
|Glutathione synthetase (EC 6.3.2.3) (GSH synthetase) (GSH-S) (Glutathione synthase) | |Glutathione synthetase (EC 6.3.2.3) (GSH synthetase) (GSH-S) (Glutathione synthase) | ||
|- | |- | ||
|[[NTRK2]] | |[[NTRK2]] | ||
| | |2 | ||
|BDNF/NT-3 growth factors receptor precursor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B) [TRKB] | |BDNF/NT-3 growth factors receptor precursor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B) [TRKB] | ||
|- | |- | ||
|[[S100A6]] | |[[S100A6]] | ||
| | |2 | ||
|Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6) [CACY] | |Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6) [CACY] | ||
|- | |- | ||
Строка 11 630: | Строка 13 006: | ||
|- | |- | ||
|[[TARDBP]] | |[[TARDBP]] | ||
| | |3 | ||
|TAR DNA-binding protein 43 (TDP-43) [TDP43] | |TAR DNA-binding protein 43 (TDP-43) [TDP43] | ||
|- | |- | ||
|[[ALDH2]] | |[[ALDH2]] | ||
| | |18 | ||
|Aldehyde dehydrogenase, mitochondrial precursor (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI) [ALDM] | |Aldehyde dehydrogenase, mitochondrial precursor (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI) [ALDM] | ||
|- | |- | ||
Строка 11 644: | Строка 13 020: | ||
|1 | |1 | ||
|Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1) [KIAA0313] [NRAPGEP] [PDZGEF1] | |Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1) [KIAA0313] [NRAPGEP] [PDZGEF1] | ||
|- | |||
|[[GSTA2]] | |||
|2 | |||
|Glutathione S-transferase A2 (EC 2.5.1.18) (GST HA subunit 2) (GST class-alpha member 2) (GST-gamma) (GSTA2-2) (GTH2) [GST2] | |||
|- | |- | ||
|[[GHRH]] | |[[GHRH]] | ||
| | |12 | ||
|Somatoliberin precursor (Growth hormone-releasing factor) (GRF) (Growth hormone-releasing hormone) (GHRH) (Somatocrinin) (Somatorelin) (Sermorelin) [GHRF] | |Somatoliberin precursor (Growth hormone-releasing factor) (GRF) (Growth hormone-releasing hormone) (GHRH) (Somatocrinin) (Somatorelin) (Sermorelin) [GHRF] | ||
|- | |- | ||
Строка 11 656: | Строка 13 036: | ||
|1 | |1 | ||
|Junctional adhesion molecule A precursor (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD321 antigen) [JAM1] [JCAM] [UNQ264/PRO301] | |Junctional adhesion molecule A precursor (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD321 antigen) [JAM1] [JCAM] [UNQ264/PRO301] | ||
|- | |||
|[[LRRN3]] | |||
|2 | |||
|repeat neuronal protein 3 precursor (Neuronal leucine-rich repeat protein 3) (NLRR-3) [Nbla10363] [UNQ194/PRO220] | |||
|- | |- | ||
|[[ANKS1B]] | |[[ANKS1B]] | ||
Строка 11 694: | Строка 13 078: | ||
|- | |- | ||
|[[ABCA1]] | |[[ABCA1]] | ||
| | |8 | ||
|Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) [ABC1] [CERP] | |Phospholipid-transporting ATPase ABCA1 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 1) (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein) [ABC1] [CERP] | ||
|- | |- | ||
Строка 11 716: | Строка 13 100: | ||
|1 | |1 | ||
|Solute carrier family 52, riboflavin transporter, member 2 (Porcine endogenous retrovirus A receptor 1) (PERV-A receptor 1) (Protein GPR172A) (Riboflavin transporter 3) (hRFT3) [GPR172A] [PAR1] [RFT3] | |Solute carrier family 52, riboflavin transporter, member 2 (Porcine endogenous retrovirus A receptor 1) (PERV-A receptor 1) (Protein GPR172A) (Riboflavin transporter 3) (hRFT3) [GPR172A] [PAR1] [RFT3] | ||
|- | |||
|[[ZBTB7A]] | |||
|1 | |||
|Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1) (FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor) (POK erythroid myeloid ontogenic factor) (Pokemon) (Pokemon 1) (TTF-I-interacting peptide 21) (TIP21) (Zinc finger protein 857A) [FBI1] [LRF] [ZBTB7] [ZNF857A] | |||
|- | |- | ||
|[[PRDM8]] | |[[PRDM8]] | ||
Строка 11 722: | Строка 13 110: | ||
|- | |- | ||
|[[CD22]] | |[[CD22]] | ||
| | |5 | ||
|B-cell receptor CD22 precursor (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD22 antigen) [SIGLEC2] | |B-cell receptor CD22 precursor (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD22 antigen) [SIGLEC2] | ||
|- | |- | ||
Строка 11 742: | Строка 13 130: | ||
|- | |- | ||
|[[TRIM21]] | |[[TRIM21]] | ||
| | |2 | ||
|E3 ubiquitin-protein ligase TRIM21 (EC 2.3.2.27) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (RING-type E3 ubiquitin transferase TRIM21) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21) [RNF81] [RO52] [SSA1] | |E3 ubiquitin-protein ligase TRIM21 (EC 2.3.2.27) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (RING-type E3 ubiquitin transferase TRIM21) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21) [RNF81] [RO52] [SSA1] | ||
|- | |- | ||
|[[IGF2]] | |[[IGF2]] | ||
| | |6 | ||
|Insulin-like growth factor II precursor (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Contains: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin] [PP1446] | |Insulin-like growth factor II precursor (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Contains: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin] [PP1446] | ||
|- | |- | ||
Строка 11 754: | Строка 13 142: | ||
|- | |- | ||
|[[PC]] | |[[PC]] | ||
| | |145 | ||
|Pyruvate carboxylase, mitochondrial precursor (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) | |Pyruvate carboxylase, mitochondrial precursor (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) | ||
|- | |- | ||
Строка 11 782: | Строка 13 170: | ||
|- | |- | ||
|[[EED]] | |[[EED]] | ||
| | |2 | ||
|Polycomb protein EED (hEED) (Embryonic ectoderm development protein) (WD protein associating with integrin cytoplasmic tails 1) (WAIT-1) | |Polycomb protein EED (hEED) (Embryonic ectoderm development protein) (WD protein associating with integrin cytoplasmic tails 1) (WAIT-1) | ||
|- | |- | ||
|[[IRS1]] | |[[IRS1]] | ||
| | |17 | ||
|Insulin receptor substrate 1 (IRS-1) | |Insulin receptor substrate 1 (IRS-1) | ||
|- | |- | ||
|[[IDO1]] | |[[IDO1]] | ||
|2 | |||
|Indoleamine 2,3-dioxygenase 1 (EC 1.13.11.52) (IDO-1) (Indoleamine-pyrrole 2,3-dioxygenase) [IDO] [INDO] | |||
|- | |||
|[[SUCLA2]] | |||
|1 | |1 | ||
| | |Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial precursor (EC 6.2.1.5) (ATP-specific succinyl-CoA synthetase subunit beta) (A-SCS) (Succinyl-CoA synthetase beta-A chain) (SCS-betaA) | ||
|- | |- | ||
|[[PAX1]] | |[[PAX1]] | ||
Строка 11 806: | Строка 13 198: | ||
|- | |- | ||
|[[IRF8]] | |[[IRF8]] | ||
| | |6 | ||
|Interferon regulatory factor 8 (IRF-8) (Interferon consensus sequence-binding protein) (H-ICSBP) (ICSBP) [ICSBP1] | |Interferon regulatory factor 8 (IRF-8) (Interferon consensus sequence-binding protein) (H-ICSBP) (ICSBP) [ICSBP1] | ||
|- | |- | ||
Строка 11 822: | Строка 13 214: | ||
|- | |- | ||
|[[PIP]] | |[[PIP]] | ||
| | |15 | ||
|Prolactin-inducible protein precursor (Gross cystic disease fluid protein 15) (GCDFP-15) (Prolactin-induced protein) (Secretory actin-binding protein) (SABP) (gp17) [GCDFP15] [GPIP4] | |Prolactin-inducible protein precursor (Gross cystic disease fluid protein 15) (GCDFP-15) (Prolactin-induced protein) (Secretory actin-binding protein) (SABP) (gp17) [GCDFP15] [GPIP4] | ||
|- | |- | ||
Строка 11 834: | Строка 13 226: | ||
|- | |- | ||
|[[IDH1]] | |[[IDH1]] | ||
| | |5 | ||
|Isocitrate dehydrogenase [NADP] cytoplasmic (EC 1.1.1.42) (IDH) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP( )-specific ICDH) (Oxalosuccinate decarboxylase) [PICD] | |Isocitrate dehydrogenase [NADP] cytoplasmic (EC 1.1.1.42) (IDH) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP( )-specific ICDH) (Oxalosuccinate decarboxylase) [PICD] | ||
|- | |- | ||
|[[H2AX]] | |[[H2AX]] | ||
| | |74 | ||
|Histone H2AX (H2a/x) (Histone H2A.X) [H2AFX] | |Histone H2AX (H2a/x) (Histone H2A.X) [H2AFX] | ||
|- | |- | ||
|[[PDX1]] | |[[PDX1]] | ||
| | |4 | ||
|Pancreas/duodenum homeobox protein 1 (PDX-1) (Glucose-sensitive factor) (GSF) (Insulin promoter factor 1) (IPF-1) (Insulin upstream factor 1) (IUF-1) (Islet/duodenum homeobox-1) (IDX-1) (Somatostatin-transactivating factor 1) (STF-1) [IPF1] [STF1] | |Pancreas/duodenum homeobox protein 1 (PDX-1) (Glucose-sensitive factor) (GSF) (Insulin promoter factor 1) (IPF-1) (Insulin upstream factor 1) (IUF-1) (Islet/duodenum homeobox-1) (IDX-1) (Somatostatin-transactivating factor 1) (STF-1) [IPF1] [STF1] | ||
|- | |- | ||
Строка 11 848: | Строка 13 240: | ||
|3 | |3 | ||
|Heat shock protein 75 kDa, mitochondrial precursor (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1) [HSP75] | |Heat shock protein 75 kDa, mitochondrial precursor (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1) [HSP75] | ||
|- | |||
|[[CEBPE]] | |||
|1 | |||
|CCAAT/enhancer-binding protein epsilon (C/EBP epsilon) | |||
|- | |- | ||
|[[CD28]] | |[[CD28]] | ||
| | |107 | ||
|T-cell-specific surface glycoprotein CD28 precursor (TP44) (CD28 antigen) | |T-cell-specific surface glycoprotein CD28 precursor (TP44) (CD28 antigen) | ||
|- | |- | ||
Строка 11 858: | Строка 13 254: | ||
|- | |- | ||
|[[TACR3]] | |[[TACR3]] | ||
| | |2 | ||
|Neuromedin-K receptor (NKR) (NK-3 receptor) (NK-3R) (Neurokinin B receptor) (Tachykinin receptor 3) [NK3R] [TAC3R] | |Neuromedin-K receptor (NKR) (NK-3 receptor) (NK-3R) (Neurokinin B receptor) (Tachykinin receptor 3) [NK3R] [TAC3R] | ||
|- | |- | ||
Строка 11 870: | Строка 13 266: | ||
|- | |- | ||
|[[CD68]] | |[[CD68]] | ||
| | |51 | ||
|Macrosialin precursor (Gp110) (CD68 antigen) | |Macrosialin precursor (Gp110) (CD68 antigen) | ||
|- | |- | ||
|[[NCAM1]] | |[[NCAM1]] | ||
| | |2 | ||
|Neural cell adhesion molecule 1 precursor (N-CAM-1) (NCAM-1) (CD56 antigen) [NCAM] | |Neural cell adhesion molecule 1 precursor (N-CAM-1) (NCAM-1) (CD56 antigen) [NCAM] | ||
|- | |- | ||
|[[MSH2]] | |[[MSH2]] | ||
| | |3 | ||
|DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2) | |DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2) | ||
|- | |- | ||
Строка 11 894: | Строка 13 290: | ||
|- | |- | ||
|[[RNF168]] | |[[RNF168]] | ||
| | |2 | ||
|E3 ubiquitin-protein ligase RNF168 (EC 2.3.2.27) (hRNF168) (RING finger protein 168) (RING-type E3 ubiquitin transferase RNF168) | |E3 ubiquitin-protein ligase RNF168 (EC 2.3.2.27) (hRNF168) (RING finger protein 168) (RING-type E3 ubiquitin transferase RNF168) | ||
|} | |} |